Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,-0.6277866361144314,-1.9498822010431944,0.0,0.6173609408027654,0.32,8/15,16.08%,SIKE1;TRIM4;TBK1;IKBKE;TANK;TRAF6;RIGI;IRF7
prerank,KEGG_2021_Human__Protein export,0.5104121762021442,1.9166710803713718,0.0,0.5217501211265826,0.37,12/23,19.03%,SRP14;SRPRA;SEC61B;SEC61A2;SRPRB;HSPA5;SEC63;SPCS3;SPCS1;SEC11C;SRP72;SEC11A
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.5752326094121822,-1.8731773174978301,0.0,0.6614581508601058,0.54,8/17,16.08%,PTPN11;UBB;TBK1;IKBKE;LY96;TANK;SARM1;IRF7
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.5949991596209581,-1.86299311952646,0.0,0.4666954731068524,0.55,7/17,8.10%,EXOSC2;EXOSC6;EXOSC9;AKT1;MAPK14;DCP2;KHSRP
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,-0.5613534885283625,-1.84321223735614,0.0,0.4244356468019012,0.64,10/20,19.30%,BCO2;APOE;LRP12;PLB1;LPL;AKR1C1;LRP8;RDH11;SDC4;APOM
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.5067054547890486,1.8047177622571422,0.0,0.766320490404668,0.72,11/25,21.14%,NCOA1;NAMPT;BHLHE40;NOCT;PPARA;NLRP3;MBD4;HSD17B4;HELZ2;BMAL1;BHLHE41
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.47896680613332565,-1.7506636129016864,0.0,0.8312324095808663,0.88,10/33,9.39%,PHC3;RING1;RNF2;PHC1;PCGF5;ARID1B;CBFB;ARID1A;CBX4;PHC2
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.4145841177297215,1.7288434780306983,0.0,0.8831707779486424,0.93,14/34,19.03%,ROCK1;VAMP3;NIPSNAP2;LAMTOR1;VCP;OSBPL11;PKN1;VANGL1;RALGAPA1;ZAP70;LCK;JUP;NSFL1C;TMEM59
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.4382469869680212,1.7079481329763329,0.0,0.760206231172716,0.95,11/34,12.61%,TXNL1;PARD6B;ZNF512B;SPTBN1;CDC42;PEAK1;MAP3K11;PKN1;VANGL1;DLG5;NCK1
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.4924994520848383,1.6897018326020328,0.0,0.6847970339786397,0.96,10/17,29.18%,HTD2;ACSL6;ACSL1;ACACB;ACSL4;HSD17B8;OLAH;FASN;OXSM;ACSF3
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.4165729050656932,-1.6710588496446905,0.0,1.0,0.99,16/51,13.13%,OIP5;H2AZ2;CENPU;MIS18A;MIS18BP1;H2AZ1;H2BC3;H2AC7;CENPO;RBBP7;CENPA;CENPS-CORT;H2AC4;SMARCA5;H2BC13;NPM1
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.34805469806780015,1.6710192851578942,0.0,0.6616987213245983,0.97,11/43,13.55%,PTPN4;HDAC3;SGK1;MECP2;CREB1;AGO1;HIPK2;RNMT;GPS2;GAMT;TNRC6A
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,0.46063180213349814,1.6696222403949248,0.024390243902439025,0.5741580574004581,0.97,4/20,7.27%,ATP6V0B;ATP6V1A;ATP6V0A1;ATP6V0C
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.3387751622659984,-1.6525074404794617,0.0,1.0,0.99,34/119,18.44%,RAB8B;DENND2A;TBC1D3I;RAB31;CHML;SBF2;TSC2;TBC1D25;AKT1;RIC1;RAB18;TBC1D24;TBC1D10C;DENND4C;GABARAPL2;RAB33B;RAB27B;RAB6A;TBC1D2;CCZ1B;RAB10;TRAPPC5;DENND6A;ULK1;GGA3;DENND1B;TSC1;TRAPPC11;DENND2B;AKT2;RAB14;RABEP1;DENND4B;TRAPPC4
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,0.4117165312598817,1.6248639672538594,0.02564102564102564,0.6919303364159171,0.98,4/28,1.42%,ATP6V0B;CYBB;ATP6V1A;ATP6V0A1
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.39044401091067105,-1.619865654739114,0.0,1.0,1.0,16/44,21.84%,GATC;GATB;MTFMT;PARS2;HARS2;MARS1;FARS2;NARS2;GARS1;AARS2;SARS1;KARS1;YARS2;AARS1;TARS1;EARS2
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.366610296594476,1.5962617714525134,0.0,0.7500157991194624,0.99,7/41,7.27%,ATP6V0B;ATP6V1A;ATP6V0A1;SEC61B;SEC61A2;ARF1;ATP6V0C
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,-0.4906131818755203,-1.5957354237300565,0.0,1.0,1.0,10/23,19.46%,LPIN1;CHPT1;PCTP;SLC44A2;STARD10;PEMT;STARD7;SLC44A4;SH2D3C;CEPT1
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.38174528509479083,-1.5918217343263277,0.014925373134328358,1.0,1.0,22/67,19.96%,SIKE1;UBA7;ATG5;TRIM4;UBB;NFKB2;TBK1;S100A12;IKBKE;CYLD;RNF216;TANK;RELA;TRAF6;PDZD2;RIGI;IRF7;NKIRAS2;TKFC;NKIRAS1;OTUD5;NFKB1
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.4128490363245306,-1.591499086399536,0.034482758620689655,1.0,1.0,15/40,18.99%,CRKL;PTPN11;IL3RA;CLSTN1;SHC1;INPPL1;CRK;IL5RA;SYK;PIK3R1;PIK3R2;TEC;IL2RG;PIK3CB;JAK3
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.3811690133058696,1.5841920340967548,0.0,0.7328958732699965,0.99,13/32,16.30%,HTD2;ACSL6;ELOVL6;ACSL1;SLC25A1;ELOVL1;ELOVL5;PPT1;HACD4;ACSL4;SCD;HSD17B8;MORC2
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.40784277469096875,-1.5838695267886895,0.06666666666666667,1.0,1.0,14/43,18.06%,RAB8B;TBC1D3I;TSC2;TBC1D25;TBC1D24;TBC1D10C;GABARAPL2;RAB33B;RAB6A;TBC1D2;ULK1;GGA3;TSC1;RABEP1
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.4079142887381904,-1.5837677700546802,0.028985507246376812,1.0,1.0,10/35,15.92%,UBA7;ATG5;TRIM4;UBB;TBK1;IKBKE;CYLD;RNF216;PDZD2;RIGI
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.47921396254869986,-1.580727248874175,0.037037037037037035,1.0,1.0,12/21,30.26%,PARS2;FARS2;NARS2;GARS1;AARS2;KARS1;YARS2;EARS2;TARS2;LARS2;DARS2;QARS1
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,0.43009892212682954,1.579862591037179,0.02127659574468085,0.6840559116474939,0.99,5/20,8.73%,NF2;MYH9;CDC42;MYL9;PKN1
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,-0.4167908774674098,-1.568503335129269,0.043478260869565216,1.0,1.0,17/28,29.56%,PCCA;AFMID;MMUT;GCSH;ACSS1;ACSS2;MDH1;GRHPR;MCEE;CS;AMT;GLDC;PCCB;HOGA1;SHMT2;DLD;CAT
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.4868772817572878,-1.5645624475357334,0.058823529411764705,1.0,1.0,9/17,22.97%,KLKB1;MMP28;KLK2;ELANE;MMP9;TPSAB1;MMP8;MMP14;MMP11
prerank,KEGG_2021_Human__Histidine metabolism,0.49291009142123066,1.5590963247922753,0.02127659574468085,0.7228413136441196,1.0,11/16,27.14%,ALDH1B1;ALDH2;HAL;CARNS1;AMDHD1;HNMT;ALDH7A1;AOC1;HDC;MAOA;CNDP1
prerank,KEGG_2021_Human__Tight junction,0.2896882204496648,1.5533489634647906,0.0,0.6973391041980285,1.0,40/129,18.98%,MAP3K5;PARD6B;RAP1A;EZR;ROCK1;JAM3;NF2;RAPGEF6;ACTR3;PPP2CB;ARPC5;MYH9;CDC42;SYMPK;DLG2;CLDN7;MYL9;PATJ;MPP4;ACTR3B;ERBB2;ARPC5L;TJAP1;PRKCI;PARD3;NEDD4L;PRKAB1;SYNPO;PPP2R1B;RAB8A;CDK4;PPP2R1A;F11R;WHAMM;ACTR2;YBX3;AFDN;DLG1;ACTB;MYL12A
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,-0.45763788025112373,-1.5486693491677008,0.07017543859649122,1.0,1.0,7/22,14.93%,ITGB3;FN1;AKT1;RASGRP2;SHC1;CRK;SYK
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.4461092429017113,-1.5479224002984715,0.046875,1.0,1.0,10/25,19.96%,TRIM4;NFKB2;S100A12;TANK;RELA;TRAF6;RIGI;NKIRAS2;NKIRAS1;NFKB1
prerank,KEGG_2021_Human__Propanoate metabolism,-0.4105468394499873,-1.544181652600805,0.04,1.0,1.0,12/31,18.53%,BCKDHA;PCCA;MMUT;ACSS1;ACSS2;LDHA;ECHDC1;LDHB;ABAT;MCEE;SUCLG2;ALDH6A1
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.3139364180504212,-1.5417838188094346,0.0,1.0,1.0,28/87,23.45%,RAB8B;DENND2A;RAB31;CHML;SBF2;AKT1;RIC1;RAB18;DENND4C;RAB27B;RAB6A;CCZ1B;RAB10;TRAPPC5;DENND6A;ULK1;DENND1B;TRAPPC11;DENND2B;AKT2;RAB14;DENND4B;TRAPPC4;TRAPPC12;DENND2D;TRAPPC8;MON1B;HPS1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.49183496229945467,-1.5260236750248595,0.031746031746031744,1.0,1.0,3/19,4.44%,JMY;TTC5;UBB
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.45138990188418104,-1.5259359831613055,0.03571428571428571,1.0,1.0,9/25,12.55%,PDP2;PDK4;GSTZ1;SLC16A3;DLAT;LDHA;BSG;MPC2;LDHB
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.42510074197606196,-1.5237337246936853,0.017543859649122806,1.0,1.0,9/28,12.90%,VPS4B;VPS37A;UBB;STAM;VPS37C;VPS37B;CHMP4B;UBAP1;SNF8
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.4289292345479401,-1.5235278716489293,0.04918032786885246,1.0,1.0,9/22,24.97%,ATG5;TOMM20;UBB;TOMM7;MTERF3;TOMM5;TOMM22;SQSTM1;MFN1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,0.33383809419890836,1.5220926470423255,0.05714285714285714,0.7919421481385629,1.0,9/41,8.54%,NXF1;NDC1;WDR33;POM121C;CPSF1;SYMPK;NUP85;NUP153;NCBP1
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.385131603368685,1.5198542683353935,0.0,0.7505592888289693,1.0,5/20,8.54%,WDR33;CPSF1;SYMPK;CSTF2T;NCBP1
prerank,KEGG_2021_Human__Antigen processing and presentation,0.33344569788824524,1.5168976979070807,0.0,0.7148588085357376,1.0,15/63,14.35%,HSPA6;PDIA3;HLA-G;KLRC1;CD8A;B2M;CREB1;IFI30;HSPA5;KLRC2;KLRC4;KLRD1;CTSS;HLA-DRB3;CTSB
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,0.33051189910165857,1.5143872406544736,0.0,0.6843174842349571,1.0,9/42,8.54%,NXF1;NDC1;WDR33;POM121C;CPSF1;SYMPK;NUP85;NUP153;NCBP1
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.4865411575210986,-1.512570252673297,0.047619047619047616,1.0,1.0,5/17,6.27%,EXOSC2;EXOSC6;EXOSC9;AKT1;DCP2
prerank,KEGG_2021_Human__Calcium signaling pathway,-0.30545957141857083,-1.5100259693832847,0.012987012987012988,1.0,1.0,23/127,9.94%,PHKG1;TPCN2;HRH2;FGFR1;ORAI3;PDGFD;PDGFRB;MCU;ASPH;P2RX1;RYR3;STIM2;PLCB2;GNA15;VEGFA;PPIF;PDGFRA;CACNA1E;NOS3;ITPKC;TBXA2R;PLCD3;SLC25A5
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.4812993834633834,-1.507455936862827,0.06666666666666667,1.0,1.0,8/19,18.29%,B4GALT2;FUT8;B4GALT4;MOGAT3;MGAT5;ST8SIA6;B4GALT3;ST6GAL1
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,-0.4415972944008724,-1.5037399305677341,0.06557377049180328,1.0,1.0,7/23,11.65%,GNAI1;KCNJ15;KCNJ2;GNG3;GNG5;GNB2;ADCY4
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.4219862654559531,-1.5036239140391194,0.03333333333333333,1.0,1.0,6/33,7.53%,PHC3;RING1;RNF2;PHC1;RBBP7;EED
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,-0.44225173483401947,-1.503383267914674,0.017241379310344827,1.0,1.0,9/26,18.40%,CRKL;PTPN11;PDGFRB;PDGFRA;CRK;PIK3R1;PIK3R2;STAT1;PIK3CB
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,0.4001662952518429,1.497646392188972,0.0,0.7083482547239367,1.0,7/29,9.44%,NADK;NAMPT;SIRT3;NUDT12;SIRT2;CD38;ENPP1
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.42546866441224396,1.4958018139999258,0.024390243902439025,0.6779319008059214,1.0,7/16,17.71%,BPNT2;BPNT1;SLC35B3;SULT1B1;PODXL2;TPST1;SLC35B2
prerank,KEGG_2021_Human__Melanoma,-0.35241966360137394,-1.4949291780422727,0.07462686567164178,1.0,1.0,21/51,23.53%,FGFR1;PDGFD;PDGFRB;IGF1R;AKT1;PDGFRA;BAK1;RB1;GADD45G;PIK3R1;PIK3R2;AKT2;PIK3CB;E2F2;E2F3;RAF1;CDKN1A;GADD45A;MAPK3;HGF;NRAS
prerank,Reactome_2022__Mitophagy R-HSA-5205647,-0.3794011819990429,-1.4949035235428225,0.04918032786885246,1.0,1.0,10/28,24.97%,ATG5;TOMM20;UBB;TOMM7;MTERF3;ULK1;TOMM5;TOMM22;SQSTM1;MFN1
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,-0.4681956085510449,-1.4888235933015153,0.08064516129032258,1.0,1.0,7/17,22.93%,CYP4F2;LTA4H;GGT5;CYP4B1;CYP4F3;DPEP2;ABCC1
prerank,KEGG_2021_Human__mTOR signaling pathway,-0.2992236903333223,-1.4873121352702185,0.0,1.0,1.0,34/124,19.40%,LPIN1;GRB10;CAB39;TTI1;STK11;TSC2;ULK2;RRAGD;FZD2;STRADA;IGF1R;LRP5;AKT1;SLC38A9;RPTOR;WNT10A;NPRL2;RPS6KA2;TELO2;WNT10B;ATP6V1G1;CASTOR1;ULK1;NPRL3;MLST8;RPS6;PIK3R1;PIK3R2;MIOS;TSC1;AKT2;PIK3CB;DDIT4;RAF1
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.49371748850260483,-1.4872017136098201,0.06451612903225806,1.0,1.0,10/17,27.31%,ZBP1;NFKB2;DHX9;RELA;NKIRAS2;NKIRAS1;NFKB1;TICAM1;IKBKB;TLR3
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.30503502902486385,1.4816912303703205,0.0,0.7039550462387564,1.0,11/73,10.85%,FOS;ATP6V0B;CXCL8;ATP6V1A;ATP6V0A1;ANGPT1;IL6;CSF1;ATP6V0C;IL15;CTLA4
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.3560306183676168,1.4811525161604462,0.07894736842105263,0.6727626189824163,1.0,8/34,10.75%,ACTA2;CALD1;ITGB5;ALDH2;MYL9;PKN1;MYL11;MYL5
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.44547139640149214,-1.4775635564968352,0.017241379310344827,1.0,1.0,10/23,19.30%,BCO2;APOE;LRP12;PLB1;LPL;AKR1C1;LRP8;RDH11;SDC4;APOM
prerank,KEGG_2021_Human__Collecting duct acid secretion,0.4321708407074675,1.4744743790198036,0.08571428571428572,0.668121781527861,1.0,7/19,20.97%,ATP6V1A;ATP6V0A1;CA2;ATP6V0C;SLC12A7;ATP6V1E1;ATP6V1G2
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.4279033772363083,-1.4700848075171655,0.06153846153846154,1.0,1.0,8/26,13.04%,ANAPC11;UBB;UBE2C;NEK2;ANAPC4;ANAPC5;CDC26;CDC20
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,-0.36697307148193714,-1.4685092880072828,0.028985507246376812,1.0,1.0,13/44,18.40%,CRKL;PTPN11;PDGFD;PDGFRB;THBS1;PDGFRA;COL6A2;CRK;PIK3R1;PIK3R2;STAT1;PLAT;PIK3CB
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,-0.38598546245731474,-1.4651116374923965,0.03508771929824561,1.0,1.0,6/29,8.26%,ITGB3;LAMC1;DCN;ITGAX;LMNB2;NCAM1
prerank,KEGG_2021_Human__Phagosome,0.26595716987492307,1.465082492316251,0.0,0.6833792347364478,1.0,27/127,14.60%,ATP6V0B;TUBB3;CYBB;PIKFYVE;ATP6V1A;ATP6V0A1;ITGB5;VAMP3;STX7;SEC61B;HLA-G;SEC61A2;SFTPD;TUBB1;RAB5A;SCARB1;ATP6V0C;STX12;FCGR3B;CD14;MRC2;THBS3;RAB5C;CTSS;TLR6;HLA-DRB3;FCGR3A
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.343850008988223,-1.4635486561648272,0.06153846153846154,1.0,1.0,16/51,19.96%,SIKE1;MAPK8;ATG5;MAPK14;TBK1;IL12A;IKBKE;CYLD;CXCL10;TANK;RELA;TRAF6;IRF7;TKFC;OTUD5;NFKB1
prerank,KEGG_2021_Human__Cocaine addiction,-0.41846148275411377,-1.4625076304517677,0.1,1.0,1.0,10/25,16.17%,GNAI1;CREB3L4;RGS9;FOSB;CREB3L2;RELA;PRKACA;GPSM1;ATF2;ATF4
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.4229721917601695,-1.4599847758416418,0.1,0.9995367612997154,1.0,5/19,10.04%,PCCA;LMBRD1;MMUT;MCCC1;PROC
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.4773011959529785,-1.4507157530307082,0.07142857142857142,1.0,1.0,6/15,15.91%,GSTZ1;HPD;ALDH3B1;ADH5;GOT1;AOC3
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.32521948270744877,-1.4476246960535286,0.014705882352941176,1.0,1.0,25/79,18.51%,HOXB3;H2AZ2;CTCF;H2AZ1;H2BC3;H2AC7;RBBP7;RARA;EED;NCOA3;MEIS1;POLR2K;HOXB4;H2AC4;POLR2B;H2BC13;POLR2D;KMT2D;NCOA6;ZNF335;RARG;ASH2L;H2AC14;HOXB2;CNOT9
prerank,KEGG_2021_Human__Fatty acid degradation,0.34634562121753365,1.4457443139555541,0.03333333333333333,0.7343904699711403,1.0,11/36,17.44%,CPT2;ACAT1;ACSL6;ALDH1B1;ACADL;ACSL1;ALDH2;ACSL4;ACAA2;ACOX1;ECHS1
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.4051006660893229,-1.4454293951733508,0.09836065573770492,1.0,1.0,6/24,9.89%,PTPN18;UBB;RNF41;AKT1;USP8;ERBIN
prerank,KEGG_2021_Human__Galactose metabolism,-0.41838019829817086,-1.445003626129379,0.0967741935483871,1.0,1.0,2/24,0.03%,B4GALT2;GALK1
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.44291749267794367,-1.4415639178459603,0.09375,1.0,1.0,9/16,32.40%,UBB;LY96;SARM1;TRAF6;TICAM1;IRAK2;TAB3;MAP3K7;TAB2
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,-0.35924816691354083,-1.440128596443131,0.07352941176470588,1.0,1.0,10/34,16.61%,B4GALT2;ST8SIA1;B4GALT4;GBGT1;ST6GALNAC4;HEXA;GLA;ST3GAL3;B4GALT3;ABO
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,-0.39473990283432897,-1.4362619460292358,0.1206896551724138,1.0,1.0,7/29,11.65%,RGS19;GNAI1;PRKCD;GNG3;GNG5;GNB2;ADCY4
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.3320004018060168,-1.4345573338832078,0.028985507246376812,0.9924077123404456,1.0,12/54,13.55%,RAB8B;RAB31;CHML;RAB22A;RAB19;RAB18;RABGGTB;PTP4A2;RAB33B;RAB27B;RAB6A;RAB10
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.41700376252716737,-1.4326431225993452,0.11764705882352941,0.9857023424581969,1.0,9/24,18.40%,FCGR2A;PRKCD;PLD2;PLD4;SYK;PLA2G6;PIK3R1;PIK3R2;PIK3CB
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.3605316440421418,-1.4313579800522818,0.04411764705882353,0.9743787376131559,1.0,8/39,9.60%,DEGS1;PLPP1;PPM1L;SAMD8;CERS2;SPTLC1;ACER2;ALDH3B1
prerank,Reactome_2022__RET Signaling R-HSA-8853659,-0.4108684878689621,-1.4294897682771903,0.07272727272727272,0.9649384785660474,1.0,11/27,19.88%,PTPN11;GRB10;CLSTN1;SHC1;DOK4;DOK2;MAPK7;PIK3R1;PIK3R2;PIK3CB;DOK1
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.4000675293131463,-1.4238098444221348,0.07142857142857142,0.9834086150287438,1.0,4/24,2.16%,DHCR7;SREBF1;MVD;SQLE
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,-0.42635365174577233,-1.4232128593622657,0.08196721311475409,0.9699381793975915,1.0,9/15,32.13%,XRCC4;FEN1;XRCC6;LRIG1;CCR5;CXCR4;HMGA1;SGIP1;BANF1
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.3574771339611785,1.4225665662706541,0.025,0.8136040951317648,1.0,6/24,12.97%,PGM1;FBP1;G6PD;TALDO1;TKT;GLYCTK
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.4492704539153072,-1.4170592791569643,0.08333333333333333,0.9858876248533958,1.0,13/20,33.08%,ZBP1;NFKB2;DHX9;TBK1;RELA;NKIRAS2;NKIRAS1;NFKB1;TICAM1;IKBKB;TLR3;RIPK3;IRF3
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,-0.30424047045535885,-1.416202390111318,0.07142857142857142,0.9736199799502259,1.0,21/107,12.71%,MCM5;KPNA6;ANAPC11;H2AZ2;CDC6;H2AZ1;H2BC3;UBB;PSMD3;H2AC7;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;MCM4;CDC26;H2AC4;H2BC13;MCM7
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,-0.42274623271072764,-1.4158893519750764,0.08333333333333333,0.9596845412909982,1.0,6/18,17.78%,BNIP3L;STEAP3;BBC3;TP53BP2;PMAIP1;PPP1R13B
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.3567200993421948,-1.4134818143868475,0.1076923076923077,0.9568720877272886,1.0,12/40,14.91%,PHC3;RING1;RNF2;PHC1;DDX5;NRIP1;PIAS3;CBX4;PHC2;PIAS1;NPM1;DDX17
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.30028912235681027,-1.4131668657411998,0.014084507042253521,0.942026649849934,1.0,48/114,27.39%,OIP5;H2AZ2;CENPU;WRAP53;MIS18A;MIS18BP1;H2AZ1;H2BC3;FEN1;H2AC7;CENPO;RBBP7;CENPA;CHTF8;CTC1;ANKRD28;POLR2K;CENPS-CORT;H2AC4;POLR2B;SMARCA5;RFC5;SLC19A1;H2BC13;POT1;POLR2D;RPA3;NPM1;POLD1;CHTF18;POLD2;LRIG1;H2AC14;PIF1;KNL1;ATRX;POLA2;CENPK;WRN;POLR2J;CENPH;CDK2;DKC1;H4C15;H2BC21;POLA1;CCNA1;H2AC20
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.2997582762091855,-1.4127042462165647,0.07692307692307693,0.9289330315357771,1.0,30/88,25.10%,FGFR1;TCF3;SMARCAD1;FZD2;PCGF5;IGF1R;AKT1;MAPK14;ID3;MEIS1;WNT10A;IL6ST;WNT10B;ID1;PIK3R1;PIK3R2;POU5F1B;AKT2;PIK3CB;JAK3;PCGF3;RAF1;SMAD4;SETDB1;RIF1;MAPK3;NRAS;MAPK13;WNT7A;BMPR2
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.445037180063986,1.410758236134698,0.047619047619047616,0.841572911721002,1.0,6/17,16.67%,PARD6B;CLDN7;PATJ;PRKCI;PARD3;F11R
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,-0.42589251239507575,-1.4102968998089884,0.047619047619047616,0.927463901851159,1.0,5/19,9.88%,APRT;UCKL1;TK2;SCO2;TK1
prerank,KEGG_2021_Human__Legionellosis,0.3005839694974527,1.4101618751457152,0.04878048780487805,0.8140268093502699,1.0,13/56,12.32%,CXCL8;IL6;HSPA6;CASP8;CLK4;ARF1;APAF1;VCP;CD14;BNIP3;CASP3;EEF1A1;CR1
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.34672323900534574,-1.4095616010402805,0.06153846153846154,0.9174669536929986,1.0,11/55,9.85%,PHC3;RING1;RNF2;PHC1;RRAGD;RBBP7;SLC38A9;EED;CBX4;PHC2;RPTOR
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,-0.39136969646991165,-1.4085511406974698,0.07272727272727272,0.9095049574326455,1.0,12/33,22.57%,GNAI1;AKT1;PNPLA2;ADCY4;MGLL;PRKACA;PIK3R1;PIK3R2;AKT2;PIK3CB;PTGS2;ADCY3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.4300535550957034,-1.4048931964911195,0.09375,0.9180699924630136,1.0,6/20,12.61%,ANAPC11;UBE2C;ANAPC4;ANAPC5;CDC26;RB1
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,-0.45356285409536445,-1.4043291587620892,0.03389830508474576,0.9068323992473523,1.0,4/17,6.85%,IL24;PTPN11;IL10RB;IFNLR1
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.304713367476355,-1.4021323302050592,0.029850746268656716,0.9074481845754934,1.0,20/89,13.21%,PHC3;RING1;MAPK8;RNF2;H2AZ2;PHC1;H2AZ1;H2BC3;UBB;H2AC7;MAPK14;RBBP7;EED;CBX4;PHC2;AGO3;H2AC4;H2BC13;TXN2;AGO4
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,-0.44907760917892914,-1.3999903480237699,0.05454545454545454,0.9064246376124636,1.0,7/18,18.40%,CRKL;CLSTN1;CRK;SYK;PIK3R1;PIK3R2;PIK3CB
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.3505554813808567,1.39581180924784,0.14285714285714285,0.8469704812261322,1.0,6/30,8.73%,ROCK1;ACTR3;ARPC5;CDC42;SDC2;PKN1
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.4131779014939817,-1.3957266188404567,0.1206896551724138,0.9202896011966689,1.0,5/22,15.67%,B4GALT2;B4GALT4;HEXA;ST3GAL3;B4GALT3
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.4094835883881975,-1.3944843253094379,0.1111111111111111,0.9164345190130847,1.0,13/27,27.93%,TLR10;NFKB2;TLR5;IRAK4;LY96;TIRAP;RELA;S100A8;NFKB1;TICAM1;IKBKB;TLR3;HMGB1
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.3248784814549927,1.3918410777217187,0.04878048780487805,0.8436272163259021,1.0,19/34,33.39%,ACTR3;ARPC5;CDC42;ABI1;NCKAP1;NCK1;ABL1;WASF3;ACTR2;BAIAP2;ARPC2;PTK2;GRB2;ARPC4-TTLL3;WIPF1;NCKIPSD;CYFIP1;ARPC1B;WASL
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.3843742240019784,1.3843874779518779,0.1,0.8565397821828064,1.0,9/23,15.00%,ROCK1;ARHGAP35;MYH9;RNMT;MYL9;ERBB2;RRAS;RND1;SEMA4D
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.4026061599186105,1.383653711832479,0.1702127659574468,0.8331171288956721,1.0,4/18,6.04%,FXYD2;CA2;GLUD1;PCK2
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,-0.26666876066262335,-1.3832023181433324,0.012658227848101266,0.9647041059375205,1.0,32/157,13.17%,PLS1;OR2B11;BCO2;APOE;KCNJ2;WHRN;OR6C74;SCNN1D;RDH10;PPEF1;SNAP25;MYO1E;LRP12;PLCB2;EPS8L2;OR7C1;TMC1;LHFPL5;OR4F17;KCNMB1;OR51M1;PLB1;OR2A7;LPL;TAS2R50;TAS2R13;CDH23;OR1A1;OR10H1;AKR1C1;RDX;LRP8
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.42793977563406627,-1.3831804882374594,0.12962962962962962,0.9513054377994993,1.0,4/19,4.44%,PTPN11;FGFR1;SPRY2;UBB
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,-0.44485820077709093,-1.3817356707701804,0.05084745762711865,0.9479389983901562,1.0,2/17,4.45%,B4GALT2;B4GALT4
prerank,KEGG_2021_Human__PPAR signaling pathway,0.31663849841015274,1.3816770227602875,0.05405405405405406,0.8152345642602852,1.0,15/50,17.80%,CPT2;ACSL6;PPARA;ACADL;PCK2;ACSL1;PDPK1;ME3;ACSL4;SCD;OLR1;ACOX1;GK;SLC27A1;ILK
prerank,KEGG_2021_Human__Lysosome,0.26222319331499966,1.3811036593701735,0.0,0.7937420166570595,1.0,28/120,14.35%,LAMP3;ATP6V0B;ATP6V0A1;CTNS;GALC;AGA;AP4S1;AP3S1;AP3M1;AP3S2;CTSG;PLA2G15;CTSE;TPP1;ATP6V0C;CD68;GALNS;PPT1;NAGA;CD63;AP1G1;FUCA2;CTSS;CTSC;ENTPD4;SLC11A1;MCOLN1;CTSB
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.3455106046816322,-1.3803278460226898,0.07462686567164178,0.9416840026096236,1.0,14/44,19.58%,PHC3;RING1;RNF2;NUP210;PHC1;NOP58;CBX4;PHC2;NUP88;NUP54;POM121;NUP37;NUP58;NUP205
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.32050881778690277,1.3789590739324045,0.08333333333333333,0.7811865324588264,1.0,8/44,7.64%,BPGM;HK1;PDHA1;PGM1;FBP1;ALDH1B1;PCK2;ALDH2
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.4117632113224412,-1.3759348848073498,0.125,0.9529407093391259,1.0,7/24,13.04%,ANAPC11;UBB;UBE2C;ANAPC4;ANAPC5;CDC26;CDC20
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.3612327438324601,1.3731107607384307,0.10256410256410256,0.7812276367225703,1.0,10/23,26.69%,CDC25C;CDK5R1;GOLGA2;CDKN2A;CAPN1;PRDX1;C1QBP;TP53;JUN;CDC25A
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.36024339180996484,1.3696571540277833,0.1282051282051282,0.7751521981841545,1.0,2/16,1.32%,YWHAB;NPHP4
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.33799981755306363,-1.3690412624796693,0.1016949152542373,0.9789870745953627,1.0,11/46,12.55%,PDP2;PDK4;IDH3G;GSTZ1;SLC16A3;DLAT;IDH3B;LDHA;BSG;MPC2;LDHB
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,-0.2846010366849713,-1.364401630924189,0.016129032258064516,0.99333260836957,1.0,38/93,27.90%,PTPN11;MAPK8;CLEC7A;PAK1;CBLB;PRKCD;NFKB2;AKT1;MAPK14;IL12A;IKBKE;CYLD;CLEC1B;IRF1;RELA;SYK;RRAS2;PIK3R1;PIK3R2;CALM2;CLEC4M;AKT2;STAT1;PIK3CB;PYCARD;RAF1;CALM3;NFKB1;MAPK3;PTGS2;NRAS;MAPK13;BCL10;PPP3CB;EGR3;IKBKB;CALM1;ARHGEF12
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.3808194736209448,-1.3638330581936078,0.1016949152542373,0.9719527469916956,1.0,10/30,18.40%,PTPN11;FGFR1;IGF1R;SHC1;FLT3LG;THEM4;PIK3R1;PIK3R2;AKT2;PIK3CB
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,-0.3808194736209448,-1.3638330581936078,0.1016949152542373,0.9719527469916956,1.0,10/30,18.40%,PTPN11;FGFR1;IGF1R;SHC1;FLT3LG;THEM4;PIK3R1;PIK3R2;AKT2;PIK3CB
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,-0.41199610352046284,-1.3596373258701446,0.12727272727272726,0.9830921767158324,1.0,11/23,21.42%,IL3RA;CLSTN1;SHC1;INPPL1;IL5RA;PIK3R1;PIK3R2;IL2RG;PIK3CB;JAK3;PTPN6
prerank,KEGG_2021_Human__Autophagy,-0.2743816374109883,-1.3591004627337215,0.03125,0.974221696266798,1.0,38/129,19.40%,MAPK8;ATG5;STX17;ATG14;SH3GLB1;STK11;TSC2;ULK2;RRAGD;PRKCD;IGF1R;AKT1;TBK1;WIPI2;RUBCN;RPTOR;TANK;GABARAPL2;RAB33B;MTMR4;SUPT20H;PRKACA;TRAF6;ULK1;ATG10;ATG4A;RRAS2;DAPK1;MLST8;PIK3R1;PIK3R2;TSC1;AKT2;ERN1;PPP2CA;PIK3CB;DDIT4;RAF1
prerank,KEGG_2021_Human__Ether lipid metabolism,-0.38011479437554635,-1.3556431718673254,0.08928571428571429,0.9795496112127502,1.0,17/35,31.52%,LPCAT2;PLPP1;CHPT1;PLA2G2C;PLB1;PLD2;PLD4;PLA2G6;TMEM86B;PEDS1-UBE2V1;CEPT1;GDPD1;PLPP3;PAFAH1B1;PLD1;SELENOI;PLA2G4A
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.3380938450602837,1.3546118250044399,0.1282051282051282,0.8288952515532954,1.0,8/32,13.55%,NCOA1;HDAC3;ABCG1;AGO1;ABCA1;GPS2;KDM3A;TNRC6A
prerank,Reactome_2022__Signal Amplification R-HSA-392518,-0.37233508008702926,-1.35307625036798,0.15873015873015872,0.981561392541402,1.0,7/28,10.22%,GNAI1;GNA15;MAPK14;GNG3;TBXA2R;GNG5;GNB2
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,-0.3519751290445122,-1.3510770140702084,0.1016949152542373,0.9818191322588197,1.0,12/41,19.73%,B4GALT2;FUT8;B4GALT4;EXTL3;HS2ST1;DSE;ST3GAL3;B4GALT3;CHPF;CHST11;CSGALNACT1;HS3ST3B1
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,-0.41487846035924225,-1.348768035339382,0.1076923076923077,0.9819411098356591,1.0,8/15,32.40%,UBB;LY96;TRAF6;TICAM1;IRAK2;TAB3;MAP3K7;TAB2
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.2853385027173242,1.3482101783239475,0.09523809523809523,0.8409788136579784,1.0,9/48,10.97%,NCOA1;HDAC3;SIRT3;GLUD1;PPARA;CREB1;GABPA;CRTC3;MBD4
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.4231699998442291,-1.348114507646878,0.11290322580645161,0.9739843081850938,1.0,6/20,13.04%,ANAPC11;UBE2C;ANAPC4;ANAPC5;CDC26;CDC20
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,-0.42639772749372173,-1.3443492043397174,0.08196721311475409,0.9850911235223108,1.0,4/15,8.33%,PDP2;PDK4;GSTZ1;DLAT
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.375157216087287,1.3411113700975068,0.1875,0.8541149819403911,1.0,2/15,2.19%,NCOA1;ARNT2
prerank,KEGG_2021_Human__Gastric acid secretion,-0.33542403026392364,-1.3399077802630823,0.08928571428571429,1.0,1.0,18/49,24.40%,GNAI1;HRH2;SLC9A4;KCNJ15;KCNJ2;PLCB2;KCNQ1;ADCY4;PRKACA;ATP1B2;CALM2;MYLK;CAMK2D;CALM3;ADCY3;ATP1B3;CAMK2G;PLCB3
prerank,KEGG_2021_Human__Drug metabolism,-0.31687509755451027,-1.3393624591179083,0.12307692307692308,0.9944168605065411,1.0,19/59,19.59%,MGST1;UCKL1;TK2;DPYD;NAT1;GSTM2;ALDH3B1;DUT;TK1;ADH5;GSTO2;NME3;UPB1;FMO5;NME6;RRM2;GSTM1;CMPK1;RRM2B
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,0.3817487222004196,1.3367955541393155,0.15555555555555556,0.8488629900360221,1.0,4/16,11.33%,KCND3;KCNQ5;KCNG1;KCNC3
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.4262977729995591,-1.3365909672371283,0.1320754716981132,1.0,1.0,9/18,21.73%,FN1;ZC3HC1;SKP1;NPM1;RPS6;CLTC;RNASEH2A;RBX1;MAPK3
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.25131823436384954,1.332007090020038,0.07142857142857142,0.8528148892956983,1.0,22/121,12.00%,KCND3;RANGRF;KCNE1;ACTA2;FXYD2;CALD1;ITGB5;ATP2A1;CACNG8;STIM1;CACNA2D2;HIPK2;KCNK7;ALDH2;MYL9;PKN1;MYL11;KCNE3;MYL5;SCN7A;HIPK1;ORAI2
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,-0.3705732413486084,-1.3317854430278555,0.15517241379310345,1.0,1.0,7/27,11.65%,GNAI1;KCNJ15;KCNJ2;GNG3;GNG5;GNB2;ADCY4
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.26431004511114414,-1.3284434155677516,0.05555555555555555,1.0,1.0,65/165,32.20%,WAPL;INCENP;ANAPC11;KNTC1;PPP2R5B;CENPU;SKA1;UBB;PSMD3;CLASP2;RANGAP1;CENPO;CENPA;UBE2C;PSMA5;ANAPC4;MAPRE1;DYNC1LI2;ANAPC5;PSMD6;PSMD12;CLASP1;CENPS-CORT;CDC26;DYNC1LI1;CDC20;RCC2;PPP2CA;PLK1;ESPL1;NUP37;KNL1;PSMC4;SGO1;ZW10;HDAC8;CENPK;SEM1;PPP1CC;XPO1;PSMD11;PMEPA1;PSMD7;PDS5A;DYNLL2;CENPH;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;NUP133;PSME1;PAFAH1B1;PSMA7;ITGB3BP;ANAPC10;CENPL;AURKB;CENPF;PMF1-BGLAP;NUP107;NDEL1;PSMC5;PSMA3
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,0.34439187618774697,1.327217855504619,0.13513513513513514,0.8528906369904032,1.0,8/26,14.85%,POLR1B;HSPA6;SERPINH1;VCP;HSBP1;EEF1A1;RLN1;HDAC6
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.3710149661380273,-1.3264827139620001,0.13333333333333333,1.0,1.0,7/26,11.98%,VPS4B;VPS37A;UBB;VPS37C;VPS37B;CHMP4B;UBAP1
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.33739562394738537,1.3246599141429782,0.11764705882352941,0.8436729792926208,1.0,4/30,2.77%,B3GLCT;POMGNT1;GALNT12;POMT2
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.2684407367469346,1.3244207633778637,0.125,0.8256102768963252,1.0,14/71,12.00%,KCND3;RANGRF;KCNE1;FXYD2;ATP2A1;CACNG8;STIM1;CACNA2D2;HIPK2;KCNK7;KCNE3;SCN7A;HIPK1;ORAI2
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,-0.37999965444252803,-1.321666750663131,0.1896551724137931,1.0,1.0,8/27,14.93%,ITGB3;FN1;AKT1;RASGRP2;SHC1;CRK;MPL;SYK
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.2953989737968478,1.3190945854760179,0.08108108108108109,0.8342567040930253,1.0,12/55,9.46%,CDK5R1;ROCK1;PLXNC1;ARHGAP35;PLXNA3;MYH9;PLXND1;RNMT;MYL9;PKN1;ERBB2;RRAS
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.2947340033525482,1.317585433082018,0.13333333333333333,0.8230324600923402,1.0,21/54,24.34%,B3GLCT;POMGNT1;GALNT12;B3GNT9;POMT2;POFUT2;LARGE2;B3GNT8;SPON2;B4GALT6;B3GNT5;ST6GALNAC3;GALNT10;GALNT2;DAG1;B3GALNT2;ST3GAL1;ADAMTS17;ADAMTS10;LARGE1;GALNT11
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,-0.33047338474664384,-1.3168465076534788,0.09836065573770492,1.0,1.0,9/57,4.96%,TPCN2;TRPV2;CLCN6;BEST1;TRPM7;SCNN1D;ASPH;UBB;RYR3
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,-0.4184124806965317,-1.3159296304948334,0.14705882352941177,1.0,1.0,3/16,4.68%,EXOSC2;EXOSC6;EXOSC9
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.38098395507140487,1.3156448279076511,0.14583333333333334,0.8133265684715909,1.0,5/18,10.07%,KIF14;MYH9;PRC1;MYL9;CDKN1B
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,-0.2981565972933488,-1.3117107977435907,0.11290322580645161,1.0,1.0,32/77,27.38%,GNAI1;ANAPC11;MAPK8;SPDYE18;IGF1R;AKT1;MAPK14;CDC25B;ANAPC4;ANAPC5;CDC26;ADCY4;RPS6KA2;PRKACA;PIK3R1;PIK3R2;AKT2;PLK1;PIK3CB;RAF1;SPDYA;MAPK3;ADCY3;MAPK13;CPEB2;KIF22;HSP90AB1;CDK2;CPEB4;ARAF;CCNA1;SPDYE16
prerank,KEGG_2021_Human__Choline metabolism in cancer,-0.2797192722566015,-1.3113464444095495,0.05714285714285714,1.0,1.0,22/85,19.49%,MAPK8;PDGFD;PDGFRB;PLPP1;CHPT1;DGKQ;TSC2;DGKD;AKT1;PDGFRA;SLC44A2;DGKH;PLD2;PIK3R1;PIK3R2;TSC1;AKT2;SLC22A1;SLC44A4;PIK3CB;RAF1;WAS
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.2919538604843126,-1.3108051049725182,0.043478260869565216,1.0,1.0,23/75,21.41%,LPCAT2;LPIN1;PLPP1;CHPT1;DGKQ;DGKD;PLA2G2C;PLB1;PEMT;DGKH;LCLAT1;PLD2;PLD4;MBOAT1;LPGAT1;PNPLA7;PLA2G6;GPAT2;GNPAT;GPD2;CEPT1;PISD;MBOAT2
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,-0.36737119912410804,-1.3096909563240038,0.12727272727272726,1.0,1.0,15/33,28.87%,PTPN11;FGFR1;GRB10;SHC1;FLT3LG;THEM4;PIK3R1;PIK3R2;AKT2;PIK3CB;MAPK3;NRAS;FGF13;IRS2;PIK3R4
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.39058817956866004,-1.3091804553059478,0.14545454545454545,1.0,1.0,9/27,16.29%,CAB39;STK11;TSC2;RRAGD;STRADA;SLC38A9;RPTOR;MLST8;TSC1
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.39384023652713496,-1.3077719114227813,0.12903225806451613,1.0,1.0,14/26,31.49%,EXOSC2;EXOSC6;ATF3;EXOSC9;DCP2;KHSRP;ATF4;PARN;ASNS;EXOSC1;EXOSC3;EXOSC5;DIS3;CEBPB
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.2847515892111228,1.3076286276976077,0.075,0.8373138337090013,1.0,12/46,9.88%,EZR;OTOF;MYO15A;SPTBN1;MYO7A;MYH9;RAB3A;CACNA2D2;SYP;CAPZB;TPRN;PJVK
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,0.3430759554372379,1.306352535792345,0.1794871794871795,0.8263816491185382,1.0,5/25,8.92%,NADK;NAMPT;NAXD;NUDT12;CD38
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.34362179538878346,1.304629440196531,0.16216216216216217,0.8180063617787703,1.0,4/25,7.27%,ATP6V0B;ATP6V1A;ATP6V0A1;ATP6V0C
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.24666825185500924,1.3015937209122073,0.05405405405405406,0.8177921628932586,1.0,14/100,9.55%,CPT2;NCOA1;MED16;HDAC3;ARNT2;ABCB4;DAND5;PPARA;ACSL1;MED15;AGXT;ABCA1;GPS2;FDFT1
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.33689608023916134,-1.3008609082227103,0.08108108108108109,1.0,1.0,28/43,40.08%,ADM;FZD2;SCT;GNG3;RAMP1;GNG5;GNB2;WNT10A;ADGRE3;WNT10B;VIPR1;GNG11;WNT7A;GNG7;GNG8;WNT7B;SMOX;PTH2R;ADGRE1;PTCH1;GNG2;IAPP;GNB4;GNB1;CD55;ADGRE5;GNB3;ADGRE2
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,0.36291308161373803,1.3003904086791618,0.16666666666666666,0.8077093221286518,1.0,3/15,6.08%,NAMPT;NAXD;NUDT12
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.26143604202793314,1.295235206069661,0.09375,0.8130811144678995,1.0,21/83,16.81%,NCOA1;HDAC3;MTX1;SIRT3;ATP5PD;GLUD1;PPARA;CREB1;ATP5MF;GABPA;CHCHD3;CRTC3;MBD4;PRKAB1;MICOS13;DNAJC11;SAMM50;HELZ2;CYCS;CHCHD6;MAPK11
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,-0.27082597558689864,-1.294360088021263,0.08974358974358974,1.0,1.0,30/123,15.67%,RGS19;DGKQ;UTS2R;PRKCD;DGKD;PLCB2;GNA15;RASGRP2;GPR68;GNG3;NPFF;TBXA2R;RGS18;GNG5;GNB2;DGKH;LPAR6;FFAR3;PTAFR;RPS6KA2;MGLL;MAPK7;CASR;UTS2B;P2RY1;PPAN-P2RY11;GHRL;PIK3R1;UTS2;PIK3R2
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.27026337075117873,-1.2938086954177692,0.08333333333333333,1.0,1.0,32/107,24.15%,INCENP;ANAPC11;KNTC1;PPP2R5B;CENPU;SKA1;CLASP2;RANGAP1;CENPO;CENPA;UBE2C;ANAPC4;MAPRE1;DYNC1LI2;ANAPC5;CLASP1;CENPS-CORT;CDC26;DYNC1LI1;CDC20;RCC2;PPP2CA;PLK1;NUP37;KNL1;SGO1;ZW10;CENPK;PPP1CC;XPO1;DYNLL2;CENPH
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.2767023955330643,1.2924143309653249,0.047619047619047616,0.8105545139839762,1.0,12/49,9.88%,EZR;OTOF;MYO15A;SPTBN1;MYO7A;MYH9;RAB3A;CACNA2D2;SYP;CAPZB;TPRN;PJVK
prerank,KEGG_2021_Human__Fructose and mannose metabolism,0.34858515672300255,1.2913669771390297,0.10869565217391304,0.8005603421036002,1.0,6/29,12.16%,HK1;GMDS;FBP1;MPI;SORD;PMM2
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.23740093067173537,1.2906338732120959,0.06451612903225806,0.789321751324869,1.0,29/96,19.68%,CEP76;CEP290;NPHP4;HAUS8;B9D1;CEP152;ODF2;HAUS2;NINL;CETN2;CEP164;TMEM216;CEP70;CEP72;MARK4;CDK1;NPHP1;CEP63;B9D2;AHI1;ACTR1A;CEP41;RAB8A;PPP2R1A;C2CD3;FBF1;RAB11A;SFI1;HAUS4
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,-0.30806357758742375,-1.289058117513503,0.12280701754385964,1.0,1.0,14/54,15.72%,CRKL;PTPN11;LAMC1;SPINT1;UBB;SHC1;LMNB2;STAM;USP8;CRK;RANBP10;GGA3;PIK3R1;LRIG1
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,0.38605102644143136,1.2889529682124012,0.14285714285714285,0.782053087258814,1.0,4/17,4.00%,POLR1B;DNA2;POLD4;TERF1
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,-0.33868478232104543,-1.2854347615065818,0.125,1.0,1.0,12/39,16.75%,CAB39;STK11;TSC2;RRAGD;STRADA;AKT1;SLC38A9;RPTOR;MLST8;RPS6;TSC1;AKT2
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.24184397050262973,1.2843944437674695,0.034482758620689655,0.7872635852451478,1.0,16/106,10.26%,UQCR10;ATP6V0B;ATP6V1A;ATP6V0A1;NDUFB10;ATP5PD;NDUFS6;COX7B;PPA1;ATP5MF;NDUFB7;COX8A;ATP6V0C;COX4I1;SDHD;NDUFB2
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,-0.33181903536432933,-1.28402877619691,0.14285714285714285,1.0,1.0,25/47,34.89%,H2AZ2;H2AZ1;ARID1B;H2AC7;RBBP7;ARID1A;H2AC4;PRMT3;H2AC12;H2AC14;SMARCD1;PRMT7;PRMT6;ARID2;SMARCB1;H2AC11;H4C15;CARM1;H2AC20;JAK2;H3C13;PBRM1;CCND1;H2AC6;SMARCA2
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.3242129684899375,1.2827420285448643,0.175,0.7823488309901245,1.0,3/28,3.30%,TUBB3;TTLL4;TTLL7
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.3572088012871687,-1.2822877729630235,0.15789473684210525,1.0,1.0,13/29,28.87%,PTPN11;FGFR1;IGF1R;FLT3LG;THEM4;PIK3R1;PIK3R2;AKT2;PIK3CB;NRAS;FGF13;IRS2;PIK3R4
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.36281849717352227,1.2820099368219715,0.07142857142857142,0.7724347496366202,1.0,3/20,6.99%,CDC25C;CDK5R1;GOLGA2
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,-0.2545609926407149,-1.2817943714413722,0.056338028169014086,1.0,1.0,50/174,21.41%,LPCAT2;GDE1;LPIN1;PITPNM2;SBF2;CHPT1;INPP5K;PCTP;PTPMT1;CLSTN1;MTMR2;OSBPL10;SLC44A2;PLB1;PI4KA;STARD10;PEMT;PNPLA2;INPPL1;LCLAT1;TNFAIP8L1;PLD2;MTMR4;PLD4;MBOAT1;MGLL;STARD7;LPGAT1;PNPLA7;SYNJ1;PLA2G6;PLEKHA1;PIK3R1;PIK3R2;PLEKHA2;SLC44A4;RAB14;SH2D3C;MTM1;CPNE3;GPAT2;PIK3CB;GNPAT;TMEM86B;GPD2;CEPT1;PIP4K2C;PISD;GDPD1;MBOAT2
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.37965498219939603,-1.2816863407774755,0.16129032258064516,1.0,1.0,10/16,35.37%,NFKB2;TXN2;RELA;PYCARD;NFKB1;HSP90AB1;MEFV;SUGT1;P2RX7;TXNIP
prerank,KEGG_2021_Human__Fat digestion and absorption,0.3607571403872285,1.2789486687282345,0.16666666666666666,0.7717999358365815,1.0,4/19,7.95%,DGAT2;ACAT1;SCARB1;ABCA1
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,-0.40057927560612644,-1.2784493131991654,0.16393442622950818,1.0,1.0,6/22,13.30%,DGKQ;PRKCD;DGKD;RASGRP2;DGKH;MGLL
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,-0.35393274292891275,-1.2784061173525378,0.29508196721311475,1.0,1.0,5/28,6.15%,PTPN11;GALNT3;SPRY2;UBB;SHC1
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,-0.34451149912781676,-1.2774462354651084,0.14084507042253522,1.0,1.0,12/31,15.72%,MCM5;FEN1;MCM4;RFC5;SLC19A1;MCM7;RPA3;GINS3;POLD1;GINS1;POLD2;LRIG1
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,-0.4181770848839795,-1.2759672371056145,0.1320754716981132,1.0,1.0,10/19,31.23%,ITGB3;FGFR1;NCAM1;NRP1;L1CAM;MAPK3;ITGB1;ITGA2B;MAPK1;CSNK2A2
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,-0.4167899592296689,-1.2732627169882083,0.12698412698412698,1.0,1.0,5/16,11.98%,VPS37A;UBB;VPS37C;VPS37B;UBAP1
prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.24261660546498112,1.2711817155684741,0.125,0.7926183795743548,1.0,19/84,14.35%,IL9R;GP9;ITGA3;IL6;CD8A;CSF1;ITGA4;CD9;IL1R1;CD22;CD38;CD3G;CD14;CD44;CR2;GP1BA;CR1;KIT;HLA-DRB3
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.23284670580669378,1.2702918421942353,0.07142857142857142,0.7830133886252358,1.0,21/138,10.26%,MAP3K5;EIF2S1;UQCR10;FOS;CXCL8;CEBPA;NDUFB10;IL6;CASP8;NDUFS6;PPARA;CDC42;COX7B;NDUFB7;COX8A;MAP3K11;COX4I1;PIK3R3;SDHD;CASP3;NDUFB2
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,-0.2911839641312129,-1.269244602363205,0.16666666666666666,1.0,1.0,26/64,29.46%,GFER;IDH3G;CMC4;TIMM8B;TOMM20;TIMM13;TOMM7;TIMM10B;TIMM8A;GRPEL2;ATP5MC1;COA6;TIMM17A;TIMM9;TIMM21;TIMM44;TOMM5;CS;PAM16;TOMM22;BCS1L;COQ2;CHCHD2;CHCHD5;ATP5F1B;SLC25A6
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,-0.2712322664390673,-1.2681490210010005,0.1076923076923077,1.0,1.0,30/100,21.41%,LPCAT2;LPIN1;PITPNM2;CHPT1;PCTP;PTPMT1;OSBPL10;SLC44A2;PLB1;STARD10;PEMT;PNPLA2;LCLAT1;PLD2;PLD4;MBOAT1;MGLL;STARD7;LPGAT1;PLA2G6;SLC44A4;SH2D3C;CPNE3;GPAT2;GNPAT;TMEM86B;GPD2;CEPT1;PISD;MBOAT2
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.3680012520318,1.2681349461887135,0.1590909090909091,0.7808418560805545,1.0,3/18,4.57%,COL13A1;COL28A1;COL6A1
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.31482516997632815,1.2644434638239603,0.11904761904761904,0.7823743402854861,1.0,6/29,9.31%,HDAC3;MECP2;CREB1;AGO1;HIPK2;GPS2
prerank,KEGG_2021_Human__Mitophagy,-0.2899412735954302,-1.2616879734941553,0.11290322580645161,1.0,1.0,13/65,16.17%,BNIP3L;MAPK8;ATG5;UBB;CALCOCO2;TOMM7;TBK1;USP8;GABARAPL2;RELA;ULK1;RRAS2;ATF4
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,-0.30403911117695176,-1.2615453150066391,0.11267605633802817,1.0,1.0,13/49,19.30%,BCO2;APOE;RDH10;PPEF1;LRP12;PLB1;LPL;AKR1C1;LRP8;RDH11;SDC4;FNTA;APOM
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.28637035735405125,-1.2599338840231635,0.12857142857142856,1.0,1.0,16/54,20.80%,PHC3;RING1;RNF2;NUP210;PHC1;CBX4;PHC2;NUP88;PIAS1;NUP54;POM121;HDAC4;NUP37;NUP58;NUP205;PIAS2
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.27879503006313106,1.2589063776955136,0.14285714285714285,0.7942360982111566,1.0,14/50,17.76%,VAMP3;ARHGAP35;ARL13B;CDC42;NIPSNAP2;LAMTOR1;FMNL3;PKN1;VANGL1;ARHGAP1;CPNE8;ARHGAP5;JUP;ARHGAP26
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,-0.35241672124584417,-1.258815927396415,0.21818181818181817,1.0,1.0,8/25,18.40%,PTPN11;FGFR1;FLT3LG;THEM4;PIK3R1;PIK3R2;AKT2;PIK3CB
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.2394797257347851,1.256254888380764,0.02702702702702703,0.7961313065604547,1.0,14/102,9.55%,CPT2;NCOA1;MED16;HDAC3;ARNT2;ABCB4;DAND5;PPARA;ACSL1;MED15;AGXT;ABCA1;GPS2;FDFT1
prerank,KEGG_2021_Human__Proteoglycans in cancer,-0.24816475113123737,-1.2560473669499364,0.07692307692307693,1.0,1.0,46/151,24.88%,ITGB3;FN1;CAV2;PTPN11;FGFR1;PAK1;FZD2;DCN;IGF1R;THBS1;DDX5;AKT1;MAPK14;VEGFA;FAS;FASLG;WNT10A;RDX;MMP9;WNT10B;PRKACA;RRAS2;MSN;RPS6;PIK3R1;PIK3R2;SDC4;AKT2;CAMK2D;PIK3CB;IQGAP1;RAF1;PLAU;CDKN1A;PLAUR;PTPN6;MAPK3;PPP1CC;DROSHA;HGF;CAMK2G;NRAS;MAPK13;WNT7A;ITGB1;ARHGEF1
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.2870524389533123,-1.255577219134894,0.16923076923076924,1.0,1.0,13/48,20.34%,SLC22A16;SLC30A7;SLC11A2;SLC16A3;SLC39A14;SLC44A2;BSG;SLC6A15;SLC30A5;SLC22A1;SLC44A4;SLC30A6;SLC22A15
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.2712068994277523,-1.2550563953158358,0.140625,1.0,1.0,31/103,24.15%,WAPL;INCENP;KNTC1;PPP2R5B;CENPU;SKA1;CLASP2;RANGAP1;CENPO;CENPA;MAPRE1;DYNC1LI2;CLASP1;CENPS-CORT;DYNC1LI1;CDC20;RCC2;PPP2CA;PLK1;NUP37;KNL1;SGO1;ZW10;HDAC8;CENPK;PPP1CC;XPO1;PMEPA1;PDS5A;DYNLL2;CENPH
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.42107121834703987,-1.2530310590741112,0.22033898305084745,1.0,1.0,5/16,10.22%,KCNJ15;KCNJ2;GNG3;GNG5;GNB2
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.34054339074876117,-1.252263450472148,0.09836065573770492,1.0,1.0,13/32,17.60%,YKT6;STX17;USE1;BET1L;STX2;STX3;STX18;VAMP4;GOSR1;SNAP23;BET1;STX4;VTI1B
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,-0.37277861513516114,-1.2521330566912063,0.1016949152542373,1.0,1.0,5/23,10.78%,KCNJ2;SCNN1D;PLCB2;TAS2R50;TAS2R13
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",-0.279423790390888,-1.2505816739490176,0.171875,1.0,1.0,27/90,24.40%,GNAI1;CRKL;MAPK8;JUNB;CREB3L4;PLCB2;AKT1;MAPK14;SHC1;CRK;ADCY4;CREB3L2;PRKACA;GHRL;ATF2;PIK3R1;PIK3R2;ATF4;AKT2;STAT1;PIK3CB;RAF1;MAPK3;ADCY3;NRAS;MAPK13;PLCB3
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,-0.37450313861487344,-1.2490735987426775,0.15517241379310345,1.0,1.0,10/26,21.43%,ST8SIA1;NPL;SLC35A1;ST6GALNAC4;NEU3;ST6GALNAC1;ST8SIA6;ST3GAL3;ST6GAL1;ST3GAL5
prerank,KEGG_2021_Human__Prostate cancer,-0.2730188070392383,-1.248764486038037,0.14285714285714285,1.0,1.0,32/86,26.85%,FGFR1;PDGFD;PDGFRB;SPINT1;CREB3L4;IGF1R;AKT1;PDGFRA;HSP90B1;RB1;CREB3L2;RELA;MMP9;PIK3R1;PIK3R2;ATF4;AKT2;PLAT;PIK3CB;E2F2;E2F3;RAF1;NFKB1;PLAU;CDKN1A;MAPK3;NRAS;HSP90AB1;CDK2;FOXO1;ARAF;IKBKB
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.2480595163110577,-1.2487619765063496,0.0759493670886076,1.0,1.0,34/157,13.65%,PHC3;RING1;ANAPC11;MAPK8;RNF2;H2AZ2;PHC1;H2AZ1;H2BC3;UBB;H2AC7;MAPK14;H1-4;RBBP7;UBE2C;EED;ANAPC4;EP400;ANAPC5;CBX4;PHC2;AGO3;CDC26;H2AC4;HIRA;H2BC13;HMGA2;POT1;RB1;RPS6KA2;TXN2;AGO4;RELA;MAPK7
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,0.3080114285969096,1.2475320963324468,0.1388888888888889,0.8188311873379043,1.0,11/29,21.80%,MTX1;ATP5PD;ATP5MF;CHCHD3;MICOS13;DNAJC11;SAMM50;CHCHD6;MICOS10;ATP5F1C;HSPA9
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.2926265367127966,1.2467609177431311,0.16216216216216217,0.8106267167231618,1.0,9/38,12.61%,TXNL1;SPTBN1;CDC42;PEAK1;PKN1;VANGL1;DLG5;MYO6;NCK1
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.29309177359904864,-1.2463091863616456,0.15,1.0,1.0,14/55,15.89%,MVD;ST8SIA1;NPL;SLC35A1;ST6GALNAC4;PGM3;NUDT14;NAGK;NEU3;NUS1;ST6GALNAC1;ST8SIA6;ST3GAL3;GFPT1
prerank,KEGG_2021_Human__Relaxin signaling pathway,-0.26762376844479635,-1.2434167643858605,0.12121212121212122,1.0,1.0,33/95,23.54%,GNAI1;MAPK8;GNAO1;CREB3L4;PLCB2;GNA15;AKT1;MAPK14;VEGFA;SHC1;GNG3;NOS3;GNG5;GNB2;ADCY4;CREB3L2;RELA;MMP9;PRKACA;ATF2;PIK3R1;PIK3R2;ATF4;AKT2;PIK3CB;RAF1;NFKB1;MAP2K7;GNG11;MAPK3;ADCY3;NRAS;MAPK13
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,0.275252647736673,1.2428954541811779,0.23076923076923078,0.8158168746633283,1.0,16/55,18.30%,NCOA1;HDAC3;PPARA;COX19;COX7B;COX16;COX8A;NLRP3;COX4I1;MBD4;SIN3B;HM13;HELZ2;CYCS;SIN3A;BLVRB
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.3568521526206564,-1.2426568710866632,0.18181818181818182,1.0,1.0,9/25,15.72%,PARP2;APEX1;FEN1;RFC5;SLC19A1;RPA3;POLD1;POLD2;LRIG1
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.2356142242464021,1.2395292924012802,0.1724137931034483,0.8162679601868124,1.0,18/79,16.31%,CYBB;MTX1;CDC42EP4;VAMP3;VRK2;ARHGAP35;CDC42;LAMTOR1;ABI1;PKN1;PIK3R3;VANGL1;NCKAP1;VAV2;ARHGAP1;SAMM50;SWAP70;DOCK2
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.339313472122166,-1.2378776310901807,0.19117647058823528,1.0,1.0,8/30,12.05%,MGST1;AKR7A2;GSTM2;ALDH3B1;AKR7L;ADH5;GSTO2;AKR1C1
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.3376195682862944,-1.2369284483818952,0.17857142857142858,1.0,1.0,7/30,11.91%,UBE2Q2;USP9X;UBB;UBE2G1;UBE2C;USP5;UBE2L3
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,-0.28420991371889553,-1.2358286214296241,0.16176470588235295,1.0,1.0,9/66,6.92%,FN1;CAV2;CRKL;SEPTIN6;CLTB;ARPC4;CLTCL1;SHC1;ELMO3
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,-0.24876625258307622,-1.2344867317330823,0.1038961038961039,1.0,1.0,38/151,18.38%,ECSIT;PTPN11;MAPK8;DUSP6;TLR10;UBB;NFKB2;TLR5;MAPK14;IRAK4;TBK1;SKP1;S100A12;EEA1;IKBKE;HSP90B1;DUSP7;LY96;TLR8;TANK;TIRAP;DNM1;SARM1;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;BIRC3;IRF7;S100A8;LY86;NKIRAS2;PPP2CA;ITGB2;N4BP1
prerank,KEGG_2021_Human__Graft-versus-host disease,0.2981708602970812,1.2323125152859744,0.17142857142857143,0.8362947905036758,1.0,6/32,14.35%,IL6;HLA-G;KLRC1;PRF1;KLRD1;HLA-DRB3
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.2906515190043153,-1.2322037670217718,0.12903225806451613,1.0,1.0,18/62,19.96%,ZBP1;UBB;NFKB2;DHX9;TBK1;CRCP;IFI16;POLR3C;POLR2K;POLR1D;POLR3K;RELA;XRCC6;IRF7;NKIRAS2;POLR3A;NKIRAS1;NFKB1
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,0.36132800271323023,1.2321439682819875,0.21951219512195122,0.8250620494184914,1.0,5/15,15.24%,FUT1;FUT2;B4GALNT2;ST3GAL6;RHCE
prerank,KEGG_2021_Human__Glioma,-0.2889620341937658,-1.2312833976924862,0.14925373134328357,1.0,1.0,23/65,23.53%,PDGFRB;IGF1R;AKT1;SHC1;PDGFRA;BAK1;RB1;GADD45G;PIK3R1;PIK3R2;CALM2;AKT2;CAMK2D;PIK3CB;E2F2;E2F3;RAF1;CALM3;CDKN1A;GADD45A;MAPK3;CAMK2G;NRAS
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,-0.23637094063247333,-1.231158372970854,0.11538461538461539,1.0,1.0,64/219,24.66%,WAPL;INCENP;ANAPC11;KNTC1;PPP2R5B;CENPU;SKA1;UBB;PSMD3;CLASP2;RANGAP1;FBXO5;CENPO;CENPA;UBE2C;IST1;PSMA5;ANAPC4;MAPRE1;DYNC1LI2;LEMD2;ANAPC5;PSMD6;PSMD12;CHMP4B;CLASP1;CENPS-CORT;CDC26;TUBA4A;DYNC1LI1;EMD;CDC20;RAN;SPAST;NUP54;POM121;TUBB2A;TUBB6;RCC2;PPP2CA;PLK1;ESPL1;NUP37;KNL1;NUP58;PSMC4;SGO1;NUP205;ZW10;HDAC8;LBR;CENPK;SEM1;UBE2I;PPP1CC;XPO1;PSMD11;PMEPA1;PSMD7;PDS5A;DYNLL2;CENPH;PSME2;PSME4
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,-0.34311758853539887,-1.2304306254033832,0.1694915254237288,1.0,1.0,9/29,17.78%,MAPK8;AKT1;BBC3;TP53BP2;YWHAQ;REXO2;PMAIP1;AKT2;PPP1R13B
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,-0.289441952980491,-1.2279537451649984,0.11940298507462686,1.0,1.0,10/56,10.22%,GNAI1;CACNB3;AKAP5;SNAP25;PLCB2;GNA15;GNG3;CACNA1E;GNG5;GNB2
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.3660479781869557,-1.2278560478973837,0.19047619047619047,1.0,1.0,8/21,15.72%,APEX1;FEN1;RFC5;SLC19A1;RPA3;POLD1;POLD2;LRIG1
prerank,KEGG_2021_Human__DNA replication,-0.30901262856023504,-1.2241732333540023,0.140625,1.0,1.0,11/36,15.39%,MCM5;LIG1;FEN1;MCM4;RNASEH2C;RFC1;RFC5;MCM7;RPA3;POLD1;POLD2
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.3793310750981949,-1.2237231599870928,0.27419354838709675,1.0,1.0,6/21,13.04%,ANAPC11;UBE2C;ANAPC4;ANAPC5;CDC26;CDC20
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,-0.30442883662930176,-1.2229469916143032,0.23529411764705882,1.0,1.0,9/37,16.75%,PTPN11;GRB10;UBB;AKT1;ABL2;FLT3LG;SYK;PIK3R1;AKT2
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.2642064135399412,1.2215224899438082,0.21875,0.8606232994596417,1.0,12/64,10.97%,NCOA1;NAMPT;BHLHE40;HDAC3;NOCT;PPARA;CRY2;CREB1;CUL1;NLRP3;CRTC3;MBD4
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.38158612222022104,-1.2205906384099636,0.24615384615384617,1.0,1.0,9/20,24.49%,SLC30A7;EXOC7;EXOC3;EXOC4;SLC30A5;KIF5C;SLC30A6;STX1A;ERO1A
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.25206294576981925,1.2188849932558143,0.1724137931034483,0.8611050957426639,1.0,8/60,7.27%,ATP6V0B;CXCL8;ATP6V1A;ATP6V0A1;JAM3;CXCR1;CDC42;ATP6V0C
prerank,KEGG_2021_Human__Rap1 signaling pathway,-0.24637163713002316,-1.2185849817261325,0.08450704225352113,1.0,1.0,21/152,7.84%,ITGB3;GNAI1;CRKL;FGFR1;GNAO1;SIPA1L2;PDGFD;CTNND1;PDGFRB;PGF;IGF1R;THBS1;PLCB2;AKT1;MAPK14;RASGRP2;VEGFA;TLN2;PDGFRA;FARP2;DOCK4
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,-0.25608073530899234,-1.2180920748954864,0.1917808219178082,1.0,1.0,22/124,13.09%,MCM5;KPNA6;ANAPC11;H2AZ2;CDC6;H2AZ1;H2BC3;UBB;PSMD3;H2AC7;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;MCM4;CDC26;H2AC4;H2BC13;MCM7;RPA3
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,-0.2725190690887056,-1.2180333924218365,0.11594202898550725,1.0,1.0,12/71,10.47%,DEGS1;PLPP1;PPM1L;SAMD8;STS;CERS2;SPTLC1;GLTP;ACER2;ALDH3B1;NEU3;HEXA
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.36551189741836243,-1.2179282282002086,0.2647058823529412,1.0,1.0,5/20,10.39%,ANAPC11;UBE2C;ANAPC4;ANAPC5;CDC26
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.3347942233464608,1.2161428615748804,0.17647058823529413,0.8627541579401939,1.0,7/21,16.60%,ORC3;PPP2CB;PRIM2;CDK1;PPP2R1B;CCNB1;PPP2R1A
prerank,KEGG_2021_Human__N-Glycan biosynthesis,-0.29325396220448835,-1.2160240314144115,0.16071428571428573,1.0,1.0,3/45,2.65%,B4GALT2;GANAB;FUT8
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.34834491769519405,1.2141123713297075,0.22727272727272727,0.8600195279852333,1.0,5/18,13.69%,RANGRF;CACNG8;CACNA2D2;SCN7A;FGF11
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.19973178039253994,1.2125069195790383,0.14285714285714285,0.8567279132360972,1.0,68/256,20.21%,NCOA1;CEP76;HDAC3;CEP290;NPHP4;HAUS8;B9D1;MTX1;CEP152;SIRT3;ATP5PD;ODF2;HAUS2;GLUD1;EXOC5;BBS2;PPARA;ARL13B;NINL;CREB1;ATP5MF;ASAP1;CETN2;CEP164;CCT3;TMEM216;CEP70;GABPA;CEP72;IFT57;CHCHD3;CRTC3;MBD4;DYNLT2;MARK4;CDK1;NPHP1;CEP63;B9D2;AHI1;IFT88;PRKAB1;DYNLT2B;ACTR1A;MICOS13;HDAC6;TCP1;CEP41;RAB8A;DNAJC11;BBS7;SAMM50;HELZ2;PPP2R1A;CYCS;CHCHD6;MAPK11;BBS10;IFT43;C2CD3;FBF1;RAB11A;SFI1;MICOS10;HAUS4;TTC21B;ATP5F1C;RAB11FIP3
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,0.353125972211051,1.2102426524901615,0.15,0.8553771269814563,1.0,4/19,4.00%,POLR1B;DNA2;POLD4;TERF1
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.3954012723664514,-1.2092306339815122,0.21875,1.0,1.0,4/17,6.27%,EXOSC2;EXOSC6;EXOSC9;DCP2
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,-0.3301941135433645,-1.2074038538646095,0.1896551724137931,1.0,1.0,12/28,28.87%,PTPN11;FGFR1;FLT3LG;THEM4;PIK3R1;PIK3R2;AKT2;PIK3CB;NRAS;FGF13;IRS2;PIK3R4
prerank,KEGG_2021_Human__Selenocompound metabolism,0.3920885332925665,1.2071447493253002,0.30303030303030304,0.8597667523330034,1.0,4/16,9.85%,KYAT3;INMT;PSTK;TXNRD2
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.34824522539272273,-1.2068482978040727,0.24561403508771928,1.0,1.0,14/26,33.42%,LIAS;BCKDHA;GCSH;DLAT;GRHPR;ALDH4A1;AMT;GLDC;HOGA1;BCKDHB;DLST;PDHB;PXMP2;LIPT2
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.26275656157026905,1.205717534528993,0.21951219512195122,0.8556943537457956,1.0,10/37,16.77%,TXNL1;KIF14;ARHGAP35;PLXND1;VANGL1;DLG5;NISCH;ARHGAP1;ARHGAP5;FRS2
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,-0.2313104497664394,-1.2056772631440396,0.1282051282051282,1.0,1.0,63/218,24.66%,WAPL;INCENP;ANAPC11;KNTC1;PPP2R5B;CENPU;SKA1;UBB;PSMD3;CLASP2;RANGAP1;CENPO;CENPA;UBE2C;IST1;PSMA5;ANAPC4;MAPRE1;DYNC1LI2;LEMD2;ANAPC5;PSMD6;PSMD12;CHMP4B;CLASP1;CENPS-CORT;CDC26;TUBA4A;DYNC1LI1;EMD;CDC20;RAN;SPAST;NUP54;POM121;TUBB2A;TUBB6;RCC2;PPP2CA;PLK1;ESPL1;NUP37;KNL1;NUP58;PSMC4;SGO1;NUP205;ZW10;HDAC8;LBR;CENPK;SEM1;UBE2I;PPP1CC;XPO1;PSMD11;PMEPA1;PSMD7;PDS5A;DYNLL2;CENPH;PSME2;PSME4
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,0.35963347794002243,1.2048425278128472,0.29411764705882354,0.8491363918715971,1.0,4/15,6.87%,POLR1B;DNA2;POLD4;PRIM2
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.35001711999983776,1.2047418879767458,0.19148936170212766,0.8395933801562552,1.0,7/19,13.44%,ACSL6;ELOVL6;ACSL1;ELOVL1;ELOVL5;HACD4;ACSL4
prerank,KEGG_2021_Human__Pyrimidine metabolism,-0.29101987765516296,-1.2034582560762936,0.15254237288135594,1.0,1.0,17/50,21.56%,UCKL1;TK2;DPYD;CMPK2;DUT;TK1;NME3;ENTPD5;UPB1;NME6;RRM2;ENTPD1;NUDT2;CMPK1;RRM2B;NT5E;UCK1
prerank,Reactome_2022__DNA Replication R-HSA-69306,-0.24293383645403566,-1.2024207272487475,0.18421052631578946,1.0,1.0,52/150,27.42%,MCM5;KPNA6;ANAPC11;H2AZ2;CDC6;H2AZ1;H2BC3;UBB;PSMD3;FEN1;H2AC7;SKP1;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;MCM4;CDC26;H2AC4;RFC5;SLC19A1;H2BC13;MCM7;RPA3;GINS3;POLD1;GINS1;POLD2;LRIG1;H2AC14;MCM10;PSMC4;POLA2;RBX1;SEM1;PSMD11;PSMD7;DBF4;CDK2;PSME2;PSME4;H4C15;PSMB10;UBE2E1;H2BC21;POLA1;PSMB2;CCNA1;H2AC20;PSME1
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.2617701367368427,-1.200776359353307,0.1791044776119403,1.0,1.0,27/90,24.15%,INCENP;KNTC1;PPP2R5B;CENPU;SKA1;CLASP2;RANGAP1;CENPO;CENPA;MAPRE1;DYNC1LI2;CLASP1;CENPS-CORT;DYNC1LI1;CDC20;RCC2;PPP2CA;PLK1;NUP37;KNL1;SGO1;ZW10;CENPK;PPP1CC;XPO1;DYNLL2;CENPH
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.3011563484677016,1.1987301733823283,0.2702702702702703,0.856287447674821,1.0,12/36,18.58%,PPP2CB;SGK1;CCNA2;PDPK1;RICTOR;USP7;CDK1;CDKN2A;PRDM1;PPP2R1B;PPP2R1A;MDM4
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.3284390095827166,-1.1983130601313274,0.2727272727272727,1.0,1.0,14/35,24.89%,SOX13;BCL9;CBY1;UBB;AKT1;PROC;KMT2D;ASH2L;AKT2;CTNNBIP1;SOX6;TLE2;XPO1;PYGO2
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.27128829090482376,-1.1974098677138993,0.1206896551724138,1.0,1.0,16/69,15.89%,MVD;ST8SIA1;NPL;SLC35A1;ST6GALNAC4;PGM3;NUDT14;NAGK;NEU3;NUS1;ST6GALNAC1;ALG13;ST8SIA6;ALG3;ST3GAL3;GFPT1
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.23424194278325508,-1.1964873152455788,0.11538461538461539,1.0,1.0,47/210,18.59%,ITGB3;CLEC3B;FN1;GNAI1;TEX264;PTPN11;CYB5R1;RHOB;GNA12;DGKQ;PRKCD;QSOX1;THBS1;DGKD;GNA15;AKT1;MAPK14;RASGRP2;VEGFA;SHC1;GNG3;CD109;TBXA2R;ACTN1;GNG5;CLEC1B;GNB2;DGKH;RAB27B;CRK;TUBA4A;MPL;CYRIB;MGLL;P2RY1;TGFB3;SYK;PIK3R1;PIK3R2;STX4;PPBP;SGPP2;F8;VTI1B;SELENOP;PIK3CB;F5
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,-0.4015576930447143,-1.1962972119717468,0.27419354838709675,1.0,1.0,5/15,21.41%,LPCAT2;PLB1;PLA2G6;TMEM86B;MBOAT2
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.2559419922438132,-1.1948772411013118,0.12162162162162163,1.0,1.0,27/92,21.73%,ECSIT;MAPK8;DUSP6;TLR10;UBB;NFKB2;TLR5;MAPK14;IRAK4;SKP1;S100A12;DUSP7;TANK;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3
prerank,KEGG_2021_Human__GABAergic synapse,-0.2864723234327857,-1.1934842802636974,0.21666666666666667,1.0,1.0,12/53,14.02%,GNAI1;GNAO1;GNG3;PLCL1;GNG5;HAP1;GABRD;GNB2;GABARAPL2;ADCY4;ABAT;PRKACA
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.31855756286660486,-1.1922972505717082,0.24561403508771928,1.0,1.0,14/24,35.37%,NFKB2;ENTPD5;TXN2;RELA;PYCARD;ENTPD1;NFKB1;NT5E;HSP90AB1;MEFV;C3AR1;SUGT1;P2RX7;TXNIP
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,-0.3655373703330509,-1.1903678924256913,0.22580645161290322,1.0,1.0,3/20,7.72%,B4GALT2;POMGNT2;CRPPA
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,-0.36981228986598014,-1.1892003659012107,0.19298245614035087,1.0,1.0,6/24,14.53%,ITGB3;LOXL1;LTBP4;FBN2;FBLN5;TGFB3
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.2701511578820506,-1.1874661442793915,0.22727272727272727,1.0,1.0,24/73,24.06%,PHC3;RING1;RNF2;NUP210;PHC1;XRCC4;NSMCE2;CBX4;PHC2;NSMCE1;NUP88;PIAS1;NUP54;POM121;RNF168;PML;NUP37;NUP58;NUP205;PIAS2;UBE2I;WRN;PMEPA1;PIAS4
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,-0.3547086087222412,-1.187207683172976,0.22413793103448276,1.0,1.0,8/20,21.73%,DUSP6;MAPK14;DUSP7;RPS6KA2;MEF2C;MAPK7;PPP2CA;MAPK3
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,-0.38057525044745216,-1.1864438157538189,0.3018867924528302,1.0,1.0,3/16,4.44%,PTPN11;SPRY2;UBB
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.30471879262999385,1.186296858724901,0.28205128205128205,0.9019371579180849,1.0,7/29,9.23%,GNG10;PIK3R5;CDC42;PDPK1;PKN1;PIK3CG;GNB5
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,-0.3019171771084972,-1.1856384672030793,0.21052631578947367,1.0,1.0,8/43,9.89%,PTPN18;UBB;PRKCD;RNF41;AKT1;SHC1;USP8;ERBIN
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,-0.3483738927640345,-1.1848319468148187,0.23529411764705882,1.0,1.0,6/28,13.59%,BEGAIN;NRXN3;NRXN2;LIN7C;DBNL;NLGN3
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",-0.27863612354628875,-1.182929721532677,0.2033898305084746,1.0,1.0,24/76,22.57%,GNAI1;FGFR1;GNA12;NR4A2;CREB3L4;LRP5;GCM1;PLCB2;ADCY4;PLD2;MEF2C;CREB3L2;CASR;PRKACA;MEF2D;ATF2;ATF4;PDE4C;RAF1;CDKN1A;MMP14;MAPK3;EGR1;ADCY3
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.2881274973069281,-1.1820049711900922,0.203125,1.0,1.0,16/42,27.77%,PARS2;MARS1;FARS2;NARS2;GARS1;AARS2;AIMP2;SARS1;KARS1;YARS2;AARS1;TARS1;EARS2;TARS2;LARS2;DARS2
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,0.24238872716051543,1.180801311020925,0.125,0.9142950432895873,1.0,13/55,15.91%,CDC42EP4;VAMP3;ARHGAP35;ARL13B;CDC42;LAMTOR1;PKN1;VANGL1;ARHGAP1;CPNE8;ARHGAP5;DLC1;JUP
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.30283270339953805,-1.1803605957295242,0.2459016393442623,1.0,1.0,18/43,28.75%,OXCT1;BCKDHA;PCCA;MMUT;ACADSB;HADH;MCCC1;ABAT;MCEE;ALDH6A1;HIBADH;ACAD8;PCCB;EHHADH;HADHB;BCKDHB;DLD;ALDH9A1
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,-0.37377778015594837,-1.179524337129017,0.31666666666666665,1.0,1.0,5/18,10.22%,KCNJ15;KCNJ2;GNG3;GNG5;GNB2
prerank,KEGG_2021_Human__Hippo signaling pathway,0.21985250043813886,1.1781945134542111,0.1111111111111111,0.9146556990511086,1.0,22/111,14.63%,PARD6B;TGFBR2;YWHAB;NF2;PPP2CB;RASSF4;CCND2;DLG2;BIRC5;AREG;PATJ;CDH1;TCF7L1;AMH;DLG5;TCF7L2;LEF1;PRKCI;BMP7;PARD3;TGFB1;PPP2R1B
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.2624129855706237,-1.1776975612929528,0.12857142857142856,1.0,1.0,32/103,23.54%,CRKL;PTPN11;MAPK8;ARHGDIB;PRKCD;AKT1;MAPK14;IRAK4;SHC1;MAP3K3;FASLG;CRK;RPS6KA2;RELA;MAPK7;TRAF6;PIK3R1;PIK3R2;CALM2;ATF4;AKT2;CAMK2D;PIK3CB;RAF1;SORT1;CALM3;NFKB1;MAP2K7;MAPK3;CAMK2G;NRAS;MAPK13
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.3236518292689265,1.1769108737662346,0.28,0.910283503229723,1.0,8/22,15.25%,HDAC3;RBM14-RBM4;SATB2;AREG;MAF;BGLAP;HDAC6;ABL1
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.33404201828171914,1.1742069430767224,0.2708333333333333,0.9121467180790921,1.0,7/18,15.25%,HDAC3;SATB2;AREG;MAF;BGLAP;HDAC6;ABL1
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.25563091687039713,-1.174025258782238,0.208955223880597,1.0,1.0,28/94,24.15%,INCENP;KNTC1;PPP2R5B;CENPU;SKA1;CLASP2;RANGAP1;CENPO;CENPA;MAPRE1;DYNC1LI2;CLASP1;CENPS-CORT;DYNC1LI1;CDC20;NEK9;RCC2;PPP2CA;PLK1;NUP37;KNL1;SGO1;ZW10;CENPK;PPP1CC;XPO1;DYNLL2;CENPH
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,0.2820135112470872,1.1727908476916473,0.25,0.9095300288597249,1.0,4/37,2.04%,CCRL2;CXCL8;CXCR1;CXCR3
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,-0.33573702676719913,-1.1709050879565774,0.27450980392156865,1.0,1.0,9/22,29.57%,HMOX2;HCCS;CPOX;FECH;ALAS2;EARS2;UROD;BLVRA;PPOX
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,-0.31102927734197683,-1.1671866362985341,0.2807017543859649,1.0,1.0,10/34,15.07%,PLS1;WHRN;MYO1E;EPS8L2;TMC1;LHFPL5;KCNMB1;CDH23;RDX;MSN
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.28625496964116187,-1.166610886249733,0.18181818181818182,1.0,1.0,10/41,15.39%,ERCC5;PARP2;UBB;DDB1;RFC5;SLC19A1;RPA3;POLD1;ERCC1;POLD2
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.23044074341059856,-1.1663422601819733,0.14705882352941177,1.0,1.0,52/141,27.22%,BCO2;SLC46A1;APOE;PCCA;CYB5A;CYB5R3;RFK;LMBRD1;ST20-MTHFS;LRP12;MMUT;AKT1;PLB1;SLC2A3;PTS;MCCC1;BST1;LPL;GCHFR;PROC;SLC19A2;GSTO2;SLC19A1;AKR1C1;LRP8;PANK1;RDH11;SDC4;TPK1;PARP9;PDSS2;APOM;PARP16;SLC2A1;PARP6;QPRT;NT5E;FPGS;MTRR;PTGS2;DHFR;ABCC1;PCCB;NAPRT;MTHFD2L;PPCDC;SLC19A3;NAXE;SHMT2;COQ2;SLC52A1;MMADHC
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.2754495673182972,1.16628277644444,0.21052631578947367,0.9292778170408724,1.0,6/29,8.71%,WDR33;CPSF1;SYMPK;CSTF2T;NCBP1;SNRPF
prerank,KEGG_2021_Human__MAPK signaling pathway,-0.21777806874059585,-1.1657147401138364,0.15789473684210525,1.0,1.0,45/225,15.61%,CRKL;ECSIT;MAPK8;FGFR1;DUSP6;PDGFD;RASGRP4;CACNB3;PDGFRB;PAK1;GNA12;PGF;NFKB2;IGF1R;AKT1;MAPK14;IRAK4;MAPK8IP3;RASGRP2;VEGFA;PDGFRA;DUSP10;CACNA1E;CDC25B;MAP3K3;FAS;DUSP7;FASLG;FLT3LG;CRK;RPS6KA2;MAPT;MEF2C;GADD45G;RELA;MAPK7;MAP4K1;PRKACA;MAP3K6;TRAF6;TGFB3;MAPKAPK3;RRAS2;ATF2;HSPA2
prerank,KEGG_2021_Human__Insulin signaling pathway,-0.2559490966875232,-1.1637398297074921,0.2,1.0,1.0,38/115,28.41%,PHKG1;CRKL;FLOT2;MAPK8;SREBF1;EXOC7;TSC2;CBLB;AKT1;SHC1;RPTOR;INPPL1;CRK;PRKACA;RPS6;PIK3R1;PIK3R2;CALM2;TSC1;AKT2;PHKG2;PIK3CB;RAF1;CALM3;MAPK3;PRKAR2A;PPP1CC;NRAS;PRKAG1;FOXO1;PRKAR1B;ARAF;IKBKB;PHKA2;CALM1;TRIP10;IRS2;SLC2A4
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,-0.2265303717304912,-1.1618784845188677,0.11538461538461539,1.0,1.0,82/240,28.70%,SOX13;SMURF1;VPS26A;PPP2R5B;GNAO1;BCL9;H2AZ2;FRAT1;CBY1;CLTB;ZRANB1;FZD2;H2AZ1;H2BC3;UBB;PSMD3;LRP5;H2AC7;PRICKLE1;PLCB2;AKT1;SKP1;GNG3;PSMA5;DAAM1;NCOA3;USP8;GNG5;PSMD6;PSMD12;AGO3;PROC;GNB2;H2AC4;CDC73;WNT10A;H2BC13;PORCN;KMT2D;AGO4;CSNK1G2;WNT10B;TLE5;LGR6;ASH2L;AKT2;H2AC14;PPP2CA;CTNNBIP1;PSMC4;CLTC;AP2S1;SOX6;RBX1;TLE2;GNG11;SNX3;SEM1;XPO1;RUNX3;PSMD11;NRAS;PSMD7;PLCB3;WNT7A;PSME2;PSME4;PYGO2;H4C15;PSMB10;PPP3CB;H2BC21;PSMB2;H2AC20;PSME1;GNG7;PIP5K1B;CALM1;PSMA7;GNG8;WNT7B;TCF7
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.31535944401303073,1.1606653144122323,0.1794871794871795,0.9463809941630268,1.0,12/25,22.86%,PPP2R5E;TNKS2;PPP2CB;TCF7L2;LRP6;CSNK1A1;PPP2R1B;CTBP1;PPP2R1A;PPP2R5A;PPP2R5D;KREMEN1
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.28336180002769973,-1.160574901150685,0.18867924528301888,1.0,1.0,15/46,20.07%,ZBP1;TBK1;CCL5;IKBKE;POLR3C;CXCL10;POLR2K;POLR1D;POLR3K;RELA;IRF7;POLR3A;PYCARD;NFKB1;POLR1C
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.2573305572622883,-1.1605477524669967,0.24285714285714285,1.0,1.0,30/85,28.48%,EXOSC2;EXOSC6;UBB;PRKCD;PSMD3;EXOSC9;AKT1;MAPK14;DCP2;PSMA5;KHSRP;PSMD6;PSMD12;ELAVL1;TNFSF13;PSMC4;PARN;SEM1;XPO1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;EXOSC1;EXOSC3;PSMB2;PSME1;PSMA7;EXOSC5
prerank,KEGG_2021_Human__Endocytosis,-0.22461042835936126,-1.159527592632037,0.2112676056338028,1.0,1.0,35/234,9.79%,CAV2;ARFGEF2;SMURF1;VPS26A;VPS4B;PSD3;RAB31;RAB22A;SNX5;VPS37A;AGAP5;CLTB;SH3GLB1;CBLB;SH3GLB2;RNF41;IGF1R;BIN1;ARPC4;ARFGAP1;ACAP2;AGAP9;CLTCL1;STAM;PDGFRA;IST1;EEA1;SNX4;VPS37C;USP8;STAMBP;VPS37B;EHD3;CHMP1A;CHMP4B
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,0.32266015343474913,1.1591359961804384,0.23255813953488372,0.9430423056249622,1.0,6/15,14.08%,MTHFD1L;MTHFD1;MTHFR;MTHFD2;SLC25A32;FOLR2
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,-0.2591200238394769,-1.159040504154174,0.234375,1.0,1.0,34/80,29.45%,MRPL24;MRPL53;MRPL15;MRPL58;MRPS11;MRPS7;MRPS30;MRPL34;MRPS24;PTCD3;MRPL39;MRPL41;MRPS34;CHCHD1;MRPL4;MRPL1;MRPS18C;MRPS22;MRPS6;MRPL3;MRPL47;MRPS15;AURKAIP1;MRPL37;MTRF1L;MRPS5;MRPS26;MRPL17;MRPL13;MRPS2;MRPS27;MRPL11;MRPS18A;MRPL35
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,-0.24467602645666464,-1.158868155310963,0.22972972972972974,1.0,1.0,40/113,27.87%,ITGB3;MGST1;CAV2;MAPK8;AKT1;MAPK14;SUMO4;VEGFA;NOS3;HSP90B1;GSTM2;GSTO2;MEF2C;TXN2;KEAP1;RELA;MAPK7;MMP9;PIK3R1;PIK3R2;NQO1;CALM2;SDC4;AKT2;PLAT;GSTM1;PIK3CB;CALM3;NFKB1;MAP2K7;SQSTM1;MAPK13;PIAS4;HSP90AB1;BMPR2;SUMO3;GSTM3;IKBKB;CYBA;CALM1
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.2913987012238249,1.1583256523465693,0.29545454545454547,0.9370861134928066,1.0,15/37,26.20%,COL13A1;COL28A1;COL6A1;SERPINH1;P4HA2;PLOD1;COL7A1;P3H1;COL9A3;PCOLCE;COL6A3;PLOD2;COLGALT2;COL8A2;PLOD3
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,-0.32421465451811715,-1.1562310141864733,0.2909090909090909,1.0,1.0,5/31,6.15%,PTPN11;FGFR1;SPRY2;UBB;SHC1
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,-0.3250004521302664,-1.1544775788622763,0.3492063492063492,1.0,1.0,7/30,11.27%,UBB;H2AC7;STAM;MYSM1;STAMBP;H2AC4;H2AC12
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.23788298877752667,-1.1541374559462572,0.23880597014925373,1.0,1.0,36/107,24.58%,ITGB3;FN1;PTPN11;SLC7A8;SLC16A3;CD99L2;ITGAX;SHC1;CEACAM8;VPREB3;PROC;BSG;DOK2;PROCR;PIK3R1;PIK3R2;ATP1B2;SDC4;ITGB2;SELENOP;PIK3CB;SELL;GRB14;GAS6;DEAF1;L1CAM;TNFRSF10B;PTPN6;CD177;ATP1B3;CD2;PICK1;NRAS;CD58;CEACAM1;ITGB1
prerank,KEGG_2021_Human__Sphingolipid metabolism,-0.30186756160311157,-1.1521094266269507,0.24193548387096775,1.0,1.0,8/40,11.91%,DEGS1;PLPP1;PSAP;CERS2;SPTLC1;ACER2;NEU3;GLA
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,0.30673334087441695,1.151137734415996,0.34285714285714286,0.9591449183933903,1.0,3/16,5.95%,H1-3;H1-2;CABIN1
prerank,Reactome_2022__S Phase R-HSA-69242,-0.22933368535627777,-1.1497734373898327,0.22972972972972974,1.0,1.0,55/158,28.17%,WAPL;MCM5;ANAPC11;CDC6;UBB;PSMD3;FEN1;AKT1;ESCO2;SKP1;UBE2C;PSMA5;CDC25B;ANAPC4;ANAPC5;PSMD6;PSMD12;MCM4;CDC26;RFC5;SLC19A1;RB1;MCM7;RPA3;GINS3;POLD1;GINS1;POLD2;LRIG1;AKT2;PTK6;PSMC4;E2F4;POLA2;RBX1;CDKN1A;SEM1;PSMD11;PMEPA1;PSMD7;TFDP2;PDS5A;CDK2;CABLES1;PSME2;PSME4;LIN52;PSMB10;UBE2E1;POLA1;PSMB2;CCNA1;PSME1;WEE1;PSMA7
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,-0.32673789390133157,-1.1495424769413325,0.3125,1.0,1.0,7/31,11.83%,UHRF1;H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13
prerank,KEGG_2021_Human__Estrogen signaling pathway,-0.26453267780394885,-1.14742956643195,0.22413793103448276,1.0,1.0,31/88,24.41%,GNAI1;GNAO1;PRKCD;CREB3L4;PLCB2;AKT1;SHC1;RARA;NOS3;HSP90B1;NCOA3;ADCY4;CREB3L2;MMP9;PRKACA;ATF2;PIK3R1;HSPA2;PIK3R2;CALM2;ATF4;AKT2;PIK3CB;RAF1;CALM3;NCOA2;MAPK3;ADCY3;NRAS;PLCB3;HSP90AB1
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,-0.36295026582807294,-1.1466509229642654,0.3050847457627119,1.0,1.0,6/19,16.82%,SNAP25;IL10RB;IFNLR1;STX3;CSF3R;STX4
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.2946431477581845,1.1461119283772285,0.32432432432432434,0.9742053042910408,1.0,7/25,16.60%,CDC25C;PPP2CB;CCNA2;CDK1;PPP2R1B;CCNB1;PPP2R1A
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.366012399062036,-1.1459268809122052,0.2857142857142857,1.0,1.0,5/20,10.22%,GNAI1;CACNB3;GNG3;GNG5;GNB2
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,0.34969763900092277,1.1454944897814174,0.3888888888888889,0.9663471154499752,1.0,2/16,0.44%,NCOA1;ACOT8
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,-0.2424387035810205,-1.1448371142393152,0.2112676056338028,1.0,1.0,30/103,21.73%,PTPN11;MAPK8;DUSP6;UBB;NFKB2;MAPK14;TBK1;SKP1;S100A12;IKBKE;DUSP7;LY96;TANK;SARM1;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;BIRC3;IRF7;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3
prerank,KEGG_2021_Human__GnRH signaling pathway,-0.2532932776695483,-1.144718390444396,0.265625,1.0,1.0,24/71,25.48%,MAPK8;PRKCD;PLCB2;MAPK14;MAP3K3;ADCY4;PLD2;MAPK7;PRKACA;CALM2;ATF4;CAMK2D;RAF1;CALM3;MMP14;MAP2K7;MAPK3;EGR1;ADCY3;CAMK2G;NRAS;MAPK13;PLCB3;MAP3K4
prerank,Reactome_2022__Glycolysis R-HSA-70171,0.25485054966655557,1.1440363110004228,0.24,0.963058219432788,1.0,20/62,22.03%,BPGM;NDC1;LOC112694756;PPP2CB;POM121C;NUP85;NUP153;ENO1;PPP2R1B;PGM2L1;PGP;PPP2R1A;NUP214;MAP4K2;ENO2;NUP155;HOOK3;PFKFB2;NUP98;PPP2R5D
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.3240801379754873,-1.1428645200787972,0.2631578947368421,1.0,1.0,5/30,9.08%,ITGB3;LAMC1;THBS1;LMNB2;ACTN1
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.28791678748457816,-1.142716469775679,0.2631578947368421,1.0,1.0,29/48,37.72%,SBF2;INPP5K;CLSTN1;MTMR2;INPPL1;SYNJ1;PLEKHA1;PIK3R1;PIK3R2;PLEKHA2;RAB14;MTM1;PIK3CB;PIP4K2C;INPP5D;INPP4B;RAB4A;PIP5K1B;OCRL;SYNJ2;PI4K2B;PLEKHA5;PIP5K1A;BMX;PIK3C2B;PTPN13;MTMR9;PIP5K1C;PIK3R6
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,-0.23399720431224352,-1.142455022180905,0.19402985074626866,1.0,1.0,41/130,28.17%,PHC3;RING1;RNF2;PHC1;RRAGD;UBB;PSMD3;AKT1;RBBP7;PSMA5;SLC38A9;EED;CBX4;PHC2;PSMD6;PSMD12;AGO3;RPTOR;FRK;ATN1;AGO4;MKRN1;MLST8;AKT2;PML;PSMC4;MTA3;MAPK3;EGR1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;EZH2;HDAC2;PSMB2;PSME1;GATAD2A;PSMA7
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.25701647812249906,-1.1423314642401872,0.2153846153846154,1.0,1.0,14/87,10.39%,MCM5;ANAPC11;CDC6;UBB;PSMD3;SKP1;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;MCM4;CDC26
prerank,KEGG_2021_Human__Chemical carcinogenesis,-0.2263442693804667,-1.1418422150411411,0.2676056338028169,1.0,1.0,58/136,35.11%,MGST1;KPNA6;GNAI1;SULT1A3;CDC6;CREB3L4;AKT1;VEGFA;IKBKE;SULT1A1;HSP90B1;NAT1;GSTM2;GSTO2;ADCY4;RB1;RPS6KA2;CREB3L2;RELA;PRKACA;ATF2;PIK3R1;PIK3R2;ATF4;AKT2;GSTM1;KPNA4;PIK3CB;SULT1A2;RAF1;NFKB1;MAPK3;PTGS2;ADCY3;NRAS;HSP90AB1;CYP3A5;CACNA1A;KPNA3;GSTM3;KPNA5;PAQR7;JAK2;GSTO1;PTGES3;MAPK1;CREB5;ARRB2;CACNA1F;GSTT1;CHRNB4;CHRNA7;XIAP;KPNA2;HSP90AA1;CCND1;RPS6KA1;ARNT
prerank,KEGG_2021_Human__Insulin resistance,-0.248411133083556,-1.1411221625513954,0.30985915492957744,1.0,1.0,22/91,20.65%,PTPN11;MAPK8;SREBF1;PRKCD;CREB3L4;OGT;PTPA;CPT1A;AKT1;PPARGC1B;NOS3;RPS6KA2;CREB3L2;RELA;PIK3R1;PIK3R2;GFPT1;AKT2;PIK3CB;NFKB1;SLC2A1;CRTC2
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,-0.3089297286836339,-1.1408300950966666,0.26666666666666666,1.0,1.0,16/33,31.98%,ITGB3;FN1;CNKSR2;CAMK2D;IQGAP1;MARK3;MAPK3;CAMK2G;NRAS;ARAF;CALM1;JAK2;ITGA2B;MAPK1;VWF;ARRB2
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,-0.3121911561459251,-1.1406904219307952,0.29310344827586204,1.0,1.0,12/28,31.35%,GANAB;UBB;ST6GALNAC4;ST3GAL3;PARP9;ST6GAL1;PARP16;PARP6;UBE2I;CANX;ST6GALNAC2;MOGS
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.23091762997477697,1.1404590270199801,0.16666666666666666,0.9696350499156423,1.0,20/78,18.65%,BPGM;NDC1;LOC112694756;FBP1;PPP2CB;POM121C;NUP85;PCK2;NUP153;SLC25A1;ENO1;PPP2R1B;PGM2L1;PGP;PPP2R1A;NUP214;MAP4K2;ENO2;NUP155;HOOK3
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,-0.24078458282281587,-1.1402435069057528,0.24615384615384617,1.0,1.0,23/83,21.56%,APRT;ENTPD7;UCKL1;TK2;DPYD;SCO2;DUT;TK1;PFAS;GDA;NME3;ENTPD5;UPB1;TXN2;AK1;RRM2;NUDT13;ENTPD1;CMPK1;RRM2B;PAICS;NT5E;UCK1
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,-0.36129890142054744,-1.137097552882661,0.27419354838709675,1.0,1.0,9/18,29.69%,PDGFRA;STRN;PIK3R1;PIK3R2;STAT1;PIK3CB;NRAS;ETV6;GOLGA4
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.23816111115479113,-1.1353777160105207,0.2318840579710145,1.0,1.0,33/131,18.38%,ECSIT;PTPN11;MAPK8;DUSP6;UBB;NFKB2;MAPK14;IRAK4;TBK1;SKP1;S100A12;IKBKE;DUSP7;LY96;TANK;TIRAP;DNM1;SARM1;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;BIRC3;IRF7;S100A8;LY86;NKIRAS2;PPP2CA;ITGB2;N4BP1
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.23355118646810621,-1.1344117436153793,0.2535211267605634,1.0,1.0,34/114,24.58%,INCENP;KNTC1;PPP2R5B;RHOB;CENPU;SKA1;CLASP2;RANGAP1;CENPO;CENPA;MAPRE1;DAAM1;DYNC1LI2;FMNL1;CLASP1;CENPS-CORT;DYNC1LI1;CDC20;RHOC;RCC2;PPP2CA;PLK1;NUP37;KNL1;SRF;SGO1;ZW10;CENPK;PPP1CC;XPO1;FMNL2;DYNLL2;CENPH;ITGB1
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.23612307642643462,-1.1327486456414197,0.23684210526315788,1.0,1.0,29/102,21.99%,ECSIT;MAPK8;DUSP6;UBB;NFKB2;MAPK14;IRAK4;SKP1;S100A12;EEA1;DUSP7;LY96;TANK;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;IRF7;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3;RBSN
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,0.28866055164536014,1.1301724204178358,0.20930232558139536,1.0,1.0,4/29,5.36%,CDK5R1;FOS;SGK1;CREB1
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.25055602145087635,-1.1298313015103132,0.28169014084507044,1.0,1.0,21/79,21.52%,PTPN11;TRIM14;TRIM45;OAS3;PRKCD;NCAM1;TRIM22;GBP1;PTAFR;IRF1;TRIM3;PIAS1;IRF7;CAMK2D;PML;STAT1;TRIM10;OAS2;MID1;PTPN6;TRIM68
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.20243255068994706,-1.1266893422219626,0.18181818181818182,1.0,1.0,95/448,18.86%,ITGB3;ZNF91;ZNF610;ZNF676;EIF2B3;ZNF74;PTPN11;ZNF486;ZNF700;ZNF268;ZNF33A;ZNF2;ZNF749;ZNF557;ZNF222;TSC2;HCFC2;ZNF135;OAS3;ZNF205;ZNF587;ZNF418;ZNF674;ZNF616;AKT1;IRAK4;ZNF836;ZNF568;ZNF543;ZNF81;ZNF570;TBK1;ZNF415;CCL5;SRSF5;IL12A;ZNF623;IKBKE;ZNF41;ZNF84;BAK1;ZNF709;ZNF540;ZNF689;ZNF721;FAS;ZNF529;ZNF790;ZNF519;ZNF791;ZNF180;ZNF275;ZNF805;ZNF584;FASLG;ZNF546;ZNF304;ZNF273;ZNF480;ZFP92;ZNF530;ZNF561;ZNF563;ZNF841;ZNF30;ZNF254;RELA;ZNF777;TRAF6;ZNF433;ZNF778;ZNF792;SYK;ZNF528;ZNF565;BIRC3;ZNF460;PIK3R1;PIK3R2;ZNF267;IRF7;TSC1;AKT2;ZNF846;ZNF34;PML;ZFP30;STAT1;SRSF7;ZNF551;ZNF256;PIK3CB;SRSF4;ZNF461;ZNF226
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,-0.24760295974561214,-1.1266334922183592,0.22727272727272727,1.0,1.0,34/80,29.45%,MRPL24;MRPL53;MRPL15;MTFMT;MRPL58;MRPS11;MRPS7;MRPS30;MRPL34;MRPS24;PTCD3;MRPL39;MRPL41;MRPS34;CHCHD1;MRPL4;MRPL1;MRPS18C;MRPS22;MRPS6;MRPL3;MRPL47;MRPS15;AURKAIP1;MRPL37;MRPS5;MRPS26;MRPL17;MRPL13;MRPS2;MRPS27;MRPL11;MRPS18A;MRPL35
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.20586980042076952,-1.1262970002403336,0.1951219512195122,1.0,1.0,123/304,33.49%,LIAS;RPS15A;BCKDHA;PAOX;RPL37A;KYNU;RPLP0;GSTZ1;GPT2;BCKDK;RIDA;AFMID;HPD;PSMD3;GCSH;RPS21;ACADSB;RPS23;RPS4X;PSMA5;MARS1;SLC5A5;TPH2;DLAT;RSL24D1;PEMT;MCCC1;AGMAT;DUOX2;PSMD6;PSMD12;IYD;GCAT;GRHPR;OAZ3;RPS20;NPRL2;NAGS;SARDH;TXN2;RPS14;RPL9;RPS3A;DUOX1;ALDH4A1;RPS16;CHDH;RPS6;AIMP2;NQO1;AHCY;SARS1;KARS1;RPL32;SQOR;ALDH6A1;RPL11;ETHE1;PSMC4;AZIN2;HYKK;RPS7;RPL7;HECA;ADO;HIBADH;ATAT1;RPL10A;AMT;MTRR;GLDC;ACAD8;SEM1;KYAT1;PSMD11;PSMD7;RPS12;GSR;PSME2;PSME4;ASNS;RPS8;PSMB10;HOGA1;RPL27;PSMB2;RPL14;MRPL13;RPL22L1;RPL23;PSME1;PHYKPL;CRYM;PSMA7;RPS10;ENOPH1;PYCR1;RIMKLB;PHGDH;BCKDHB;ALDH9A1;FAU;DLST;RPL37;SMOX;QARS1;VSIG2;CARNMT1;PDHB;BCAT2;PXMP2;DIDO1;MPST;SLC3A2;PSMC5;MTAP;PSMA3;RPL41;EEF1E1;GLS2;LIPT2;PSMC1;CKB
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.23069281045168052,-1.1257037185879084,0.23943661971830985,1.0,1.0,35/133,21.22%,UBA7;ANAPC11;SMURF1;UBE2Q2;CBLB;UBB;UBE2M;SKP1;UBE2G1;DDB1;UBE2C;ANAPC4;ERCC8;PIAS3;ANAPC5;UBE2J1;CDC26;SYVN1;UBE2L3;PIAS1;CDC20;KEAP1;TRAF6;BIRC3;DET1;UBR5;UBE2B;PML;COP1;MID1;RHOBTB1;FBXO4;RBX1;PIAS2;UBE2O
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,-0.3470271381134684,-1.1248679512818371,0.3064516129032258,1.0,1.0,4/17,14.53%,ITGB3;LTBP4;FBLN5;TGFB3
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,-0.31158107633455445,-1.124087182786758,0.2727272727272727,1.0,1.0,8/21,24.19%,RNF185;UBB;UGGT1;SYVN1;OS9;MARCHF6;RNF103;EDEM3
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,-0.2200419253985451,-1.1231460799196455,0.19696969696969696,1.0,1.0,63/249,19.71%,SIKE1;RPS15A;PTPN11;ZDHHC9;GANAB;ATG14;TRIM4;NUP210;FUT8;UBB;DDX5;AKT1;RPS21;SNRPB;TBK1;ST6GALNAC4;RPS23;RPS4X;IKBKE;TLR8;CHMP4B;RPS20;VPS33B;YWHAQ;NUP88;CNBP;RB1;VPS18;ZDHHC20;MGAT5;G3BP2;RPS14;G3BP1;RPS3A;GEMIN6;NUP54;TRAF6;SNRPE;ST3GAL3;POM121;RPS16;REXO2;RPS6;RIGI;IRF7;SDC4;AKT2;VPS45;STAT1;PARP9;ZCRB1;NUP37;ZDHHC5;ST6GAL1;NRP1;ZDHHC2;NUP58;HAVCR1;SEC23A;PARP16;NUP205;TKFC;RPS7
prerank,Reactome_2022__tRNA Processing R-HSA-72306,-0.23714660948806313,-1.1230690567873307,0.25675675675675674,1.0,1.0,32/101,24.92%,ADAT3;RPP25;NUP210;RPP40;ZBTB8OS;URM1;LCMT2;RTCB;METTL1;ELAC2;RPP38;NUP88;TRMT112;RAN;PUS7;NUP54;POM121;FAM98B;PUS3;TP53RK;QTRT1;NUP37;PRORP;NUP58;TSEN2;NUP205;RPP14;XPOT;COLEC12;TRMT13;TRMT9B;CSTF2
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.33276043954475437,-1.1228578372324916,0.2641509433962264,1.0,1.0,10/24,24.06%,NR4A2;NR3C2;RARA;PIAS3;THRA;PIAS1;HDAC4;PIAS2;UBE2I;PIAS4
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.38146312476976707,-1.1228238855152912,0.3387096774193548,1.0,1.0,3/15,9.08%,SYN3;SNAP25;LIN7C
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,-0.2544693951077727,-1.1221787982314162,0.2698412698412698,1.0,1.0,33/80,29.45%,MRPL24;MRPL53;MRPL15;MRPL58;MRPS11;MRPS7;MRPS30;MRPL34;MRPS24;PTCD3;MRPL39;MRPL41;MRPS34;CHCHD1;MRPL4;MRPL1;MRPS18C;MRPS22;MRPS6;MRPL3;MRPL47;MRPS15;AURKAIP1;MRPL37;MRPS5;MRPS26;MRPL17;MRPL13;MRPS2;MRPS27;MRPL11;MRPS18A;MRPL35
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,-0.2747252491544514,-1.122092967598078,0.26865671641791045,1.0,1.0,18/54,21.50%,RPP25;NUP210;RPP40;ZBTB8OS;RTCB;ELAC2;RPP38;NUP88;RAN;NUP54;POM121;FAM98B;NUP37;NUP58;TSEN2;NUP205;RPP14;XPOT
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.23572237562455525,1.12154038819199,0.37037037037037035,1.0,1.0,23/83,18.98%,CYBB;RAP1A;EZR;ROCK1;JAM3;ARHGAP35;CDC42;ITGA4;CLDN7;PXN;MYL9;PIK3R3;MYL5;PECAM1;RASSF5;VAV2;ARHGAP5;F11R;MAPK11;GNAI3;AFDN;ACTB;MYL12A
prerank,KEGG_2021_Human__Steroid biosynthesis,-0.3513469610112335,-1.1213347409321983,0.25,1.0,1.0,7/16,31.01%,DHCR7;SQLE;TM7SF2;LBR;DHCR24;MSMO1;LIPA
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,-0.2722796150081225,-1.1212379044853398,0.3125,1.0,1.0,11/59,12.45%,PTPN11;FGFR1;GALNT3;HNRNPA1;SPRY2;UBB;SHC1;GTF2F2;POLR2K;POLR2B;POLR2D
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,-0.34763927749756374,-1.1208318048653285,0.27419354838709675,1.0,1.0,6/21,15.48%,TMOD1;TPM2;MYBPC3;TNNI2;TMOD4;DES
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,-0.3492565087596462,-1.1201527698404838,0.26865671641791045,1.0,1.0,2/19,1.29%,PTPN11;CD274
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,-0.24957308173144907,-1.1178165338464576,0.2676056338028169,1.0,1.0,27/97,19.58%,ANG;H2AZ2;NUP210;PIWIL2;IPO8;H2AZ1;H2BC3;H2AC7;ELAC2;POLR2K;AGO3;H2AC4;POLR2B;H2BC13;NUP88;POLR2D;TDRKH;AGO4;RAN;NUP54;POM121;XPO5;H2AC14;NUP37;DGCR8;NUP58;NUP205
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,0.30487237985826826,1.117102737197071,0.3023255813953488,1.0,1.0,6/20,17.35%,B2M;AP1G1;LCK;AP1S3;AP1B1;AP1S2
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.2637068370590412,-1.1170931420203156,0.3,1.0,1.0,9/42,13.73%,ERCC5;PARP2;UBB;DDB1;RAD23B;PIAS3;PIAS1;RPA3;ERCC1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.30659482132223415,-1.1170172225505053,0.3076923076923077,1.0,1.0,7/35,11.83%,KPNA6;H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,-0.20782811818668687,-1.1163482471855568,0.30666666666666664,1.0,1.0,41/255,14.35%,B4GALT2;DCTN3;YKT6;RNF185;STX17;SEC31A;MVD;GANAB;FUT8;COG2;ST8SIA1;NPL;UBB;B4GALT4;SLC35A1;ARFGAP1;ST6GALNAC4;MOGAT3;BET1L;PGM3;ANKRD28;NUDT14;RAD23B;UGGT1;DYNC1LI2;NAGK;NEU3;LMAN2;NUS1;SYVN1;DYNC1LI1;ST6GALNAC1;GOSR1;MGAT5;COPZ1;ALG13;TRAPPC5;OS9;ST8SIA6;ALG3;ST3GAL3
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.31532857635060696,-1.115563248620397,0.26229508196721313,1.0,1.0,6/25,13.27%,PPP2R5B;FRAT1;FZD2;LRP5;PROC;CSNK1G2
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.2607364219522956,-1.115562512440516,0.24242424242424243,1.0,1.0,28/71,32.20%,ANAPC11;UBB;PSMD3;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;RB1;CDC20;PLK1;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;PSME1;PSMA7;ANAPC10;AURKB;PSMC5;PSMA3
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.26441828868391654,-1.1155402034149522,0.3225806451612903,1.0,1.0,18/46,25.30%,RPS15A;RPS21;SNRPB;RPS23;RPS4X;RPS20;RPS14;RPS3A;GEMIN6;SNRPE;RPS16;RPS6;RPS7;GEMIN4;DDX20;RPS12;GEMIN7;RPS8
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.2575847734434855,1.1154548093070205,0.375,1.0,1.0,12/35,19.03%,TXNL1;KIF14;ARHGAP35;EPSTI1;VANGL1;DLG5;FAM135A;RND1;ARHGAP5;FRS2;WDR6;TMEM59
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.3174819330786615,-1.1153970997864988,0.32786885245901637,1.0,1.0,8/34,11.83%,KLKB1;H2AZ2;H2AZ1;H2BC3;H2AC7;KLK2;H2AC4;H2BC13
prerank,KEGG_2021_Human__RNA polymerase,0.2957514404294886,1.115134347942095,0.29545454545454547,1.0,1.0,5/31,5.88%,POLR2I;POLR2J2;POLR1B;POLR3B;POLR3GL
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.2711152446976161,-1.114476299485254,0.32786885245901637,1.0,1.0,22/46,31.59%,RHOBTB3;COG2;RIC1;VPS51;SCOC;VAMP4;RAB6A;PLIN3;COG6;SYS1;NAPSA;NAA30;VPS54;COG5;GCC2;COG1;RAB9A;COG3;GOLGA4;NAA38;NAA35;STX10
prerank,KEGG_2021_Human__Focal adhesion,-0.23052310400737974,-1.1143371609540562,0.25675675675675674,1.0,1.0,17/154,6.72%,ITGB3;FN1;CAV2;CRKL;MAPK8;LAMC1;PDGFD;PDGFRB;PAK1;PGF;IGF1R;THBS1;AKT1;VEGFA;TLN2;SHC1;PDGFRA
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,-0.30539247038585554,-1.1127358559847538,0.3,1.0,1.0,8/35,18.08%,B4GALT2;FUT8;HEXA;ALG13;ALG3;ST3GAL3;B4GALT3;MGAT2
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.24622815686286914,-1.112618409766719,0.24242424242424243,1.0,1.0,12/71,10.04%,FN1;APOE;KLKB1;LAMC1;QSOX1;MXRA8;LMNB2;HSP90B1;KLK2;PRSS23;PNPLA2;PROC
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.3050063761807823,-1.1122652064398864,0.2698412698412698,1.0,1.0,9/40,11.83%,MTF2;H2AZ2;H2AZ1;H2BC3;H2AC7;RBBP7;EED;H2AC4;H2BC13
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,-0.24277224483334803,-1.1119845387785492,0.3230769230769231,1.0,1.0,14/74,11.91%,CTR9;UBE2Q2;USP9X;RNF20;PEX2;H2BC3;UBB;UBE2G1;UBE2C;PAF1;CDC73;USP5;H2BC13;UBE2L3
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.26630646050141565,-1.1119028354368836,0.27692307692307694,1.0,1.0,23/63,29.39%,SMURF1;HIVEP3;UBB;PSMD3;SKP1;PPARGC1B;PSMA5;CBFB;PSMD6;PSMD12;STAT1;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;FBXW7
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.23721437494050351,-1.111389568878858,0.2702702702702703,1.0,1.0,28/99,21.73%,ECSIT;MAPK8;DUSP6;UBB;NFKB2;MAPK14;IRAK4;SKP1;S100A12;DUSP7;LY96;TLR8;TANK;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;IRF7;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3
prerank,KEGG_2021_Human__Glutathione metabolism,0.23112545927006456,1.111008441606468,0.2857142857142857,1.0,1.0,6/45,7.01%,GSTA4;MGST2;PRDX6;GGT7;OPLAH;G6PD
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,-0.21672232668495015,-1.1096544147313665,0.2328767123287671,1.0,1.0,52/182,24.15%,WAPL;DCTN3;INCENP;KNTC1;PPP2R5B;MZT2A;PLK4;CDK5RAP2;CENPU;CEP192;SKA1;CLASP2;RANGAP1;CENPO;CENPA;NEK2;MAPRE1;DYNC1LI2;HAUS1;CLASP1;CENPS-CORT;HAUS3;RAB33B;AKAP9;TUBA4A;DYNC1LI1;PCM1;CEP57;TUBGCP3;NCAPH;CDC20;NEK9;HAUS7;CEP78;RCC2;PPP2CA;PLK1;NUP37;KNL1;NCAPG;SGO1;ZW10;NUMA1;OFD1;HDAC8;CENPK;PPP1CC;XPO1;PMEPA1;PDS5A;DYNLL2;CENPH
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,-0.2326046271198778,-1.108341320045714,0.3088235294117647,1.0,1.0,32/110,23.54%,GNAI1;DEGS1;NSMAF;MAPK8;PPP2R5B;GNA12;MS4A2;CERS2;PLCB2;AKT1;MAPK14;SPTLC1;S1PR2;NOS3;ACER2;ADORA3;PLD2;RELA;PIK3R1;PIK3R2;AKT2;SGPP2;PPP2CA;CERS5;PIK3CB;RAF1;NFKB1;MAPK3;SGMS1;ABCC1;NRAS;MAPK13
prerank,KEGG_2021_Human__Thyroid hormone synthesis,-0.27494352506221503,-1.1082036930155428,0.3333333333333333,1.0,1.0,20/51,26.06%,CREB3L4;PLCB2;SLC5A5;HSP90B1;DUOX2;IYD;ADCY4;CREB3L2;PRKACA;DUOX1;ATF2;TTF1;ATP1B2;ATF4;ADCY3;ATP1B3;PLCB3;GSR;PAX8;CANX
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.25778254886344193,-1.1079947371391572,0.3333333333333333,1.0,1.0,14/83,8.68%,EXOSC2;EXOSC6;PPP2R5B;SEC31A;ATF3;TATDN2;CREB3L4;EXOSC9;EXTL3;ARFGAP1;SHC1;DCP2;KHSRP;HSP90B1
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,-0.32111244435316116,-1.1073968809837045,0.3333333333333333,1.0,1.0,13/30,27.39%,H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13;H2AC14;MAPK3;DPEP2;UBTF;H4C15;H2BC21;H2AC20
prerank,KEGG_2021_Human__Chronic myeloid leukemia,-0.24040818537442718,-1.1067500041179272,0.273972602739726,1.0,1.0,22/73,21.73%,CRKL;PTPN11;AKT1;SHC1;BAK1;CRK;RB1;GADD45G;RELA;TGFB3;PIK3R1;PIK3R2;AKT2;PIK3CB;E2F2;E2F3;RAF1;NFKB1;CDKN1A;SMAD4;GADD45A;MAPK3
prerank,KEGG_2021_Human__Viral carcinogenesis,0.1928709288991499,1.1057210898612113,0.17391304347826086,1.0,1.0,46/188,19.81%,HDAC3;YWHAB;TBPL2;H2BC7;HDAC11;GTF2H2C_2;H2BC15;H4C12;CASP8;HLA-G;CDC42;DNAJA3;CCND2;CCNA2;CREB1;PXN;H4C11;TBPL1;USP7;PIK3R3;CDKN1B;CASP3;LTBR;CDK1;TBP;CDKN2A;RBL1;SNW1;TRAF3;GTF2B;GTF2E1;HDAC6;CDK6;CHEK1;CDK4;H4C1;EGR2;H4C13;H4C2;TRAF5;DLG1;EIF2AK2;MRPS18B;H2BC4;KRAS;H4C3
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,-0.3123839430098818,-1.105637543911219,0.36619718309859156,1.0,1.0,7/30,12.03%,H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13;POT1
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.17942656074158464,1.1054746110888527,0.19047619047619047,1.0,1.0,40/294,10.26%,MAP3K5;EIF2S1;UQCR10;TUBB3;KLC1;WIPI1;SMCR8;ATG101;NXF1;NDUFB10;NDC1;ATP5PD;ATG13;ANXA7;ACTR10;NDUFS6;POM121C;PFN1;TUBB1;APAF1;COX7B;NUP85;RAB5A;RAB39B;PSMB4;NDUFB7;NUP153;COX8A;HSPA5;VCP;NCBP1;COX4I1;PFN2;ADRM1;ALS2;KIF5A;SDHD;CASP3;DCTN4;NDUFB2
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.34180675095341906,-1.1050438079411433,0.3181818181818182,1.0,1.0,8/20,27.87%,PHKG1;UBB;PHKG2;GYG1;GBE1;GAA;PHKA2;CALM1
prerank,KEGG_2021_Human__Mismatch repair,-0.3224521859787601,-1.1047690505331864,0.31746031746031744,1.0,1.0,8/23,17.82%,LIG1;RFC1;RFC5;RPA3;POLD1;POLD2;MSH6;EXO1
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,-0.25408068544868573,-1.1043929471110747,0.24242424242424243,1.0,1.0,11/76,9.69%,SMURF1;CLTB;FZD2;UBB;PSMD3;PRICKLE1;PSMA5;DAAM1;NCOA3;PSMD6;PSMD12
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.30467676812797917,-1.1036915438867303,0.328125,1.0,1.0,13/25,34.25%,TRAF1;CYLD;TANK;BIRC3;RBCK1;RNF31;IKBKB;TAB3;TRADD;MAP3K7;TAB2;RACK1;XIAP
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,0.30567355167918475,1.103163245795062,0.2564102564102564,1.0,1.0,4/15,13.62%,TNFRSF12A;TNFSF14;LTBR;TRAF3
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,-0.34884169473215576,-1.101003041483076,0.35185185185185186,1.0,1.0,8/21,21.73%,PTPN11;DUSP6;DUSP10;DUSP7;IL6ST;DUSP8;DUSP2;MAPK3
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.21265864349343894,1.1003947322643317,0.2727272727272727,1.0,1.0,27/106,19.03%,RPS24;SRP14;SRPRA;RPL7A;RPS28;SEC61B;SEC61A2;RPL26;DDOST;RPL15;SRPRB;RPL6;RPL36AL;SPCS3;RPL23A;RPSA;SPCS1;RPL18;RPS27;RPL39L;RPL35A;RPL18A;SEC11C;SRP72;RPS27L;RPL3;SEC11A
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,-0.28742746054247287,-1.0998880010039596,0.3050847457627119,1.0,1.0,20/40,36.54%,YKT6;COG2;RIC1;BET1L;RAB33B;GOSR1;VPS45;COG6;RAB36;NAPSA;COG5;COG1;CYTH2;COG3;GOSR2;CYTH3;COG7;MAN2A2;RGPD1;VTI1A
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.32723552804059713,-1.09978058863407,0.39655172413793105,1.0,1.0,8/20,21.57%,CNOT7;PLK2;NPM1;CNOT4;CNOT8;CNOT9;BTG2;CNOT10
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.27728235523980854,-1.0993105792228473,0.3090909090909091,1.0,1.0,9/34,20.13%,PCCA;PCTP;MMUT;HADH;THEM5;MCEE;THEM4;ACOT13;ACBD7
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.20476354467912464,1.0989760536313786,0.30434782608695654,1.0,1.0,28/162,10.75%,PIKFYVE;EZR;ROCK1;ITGB5;ITGA3;DIAPH1;ACTR3;FGD3;ITGAE;ARPC5;ARHGAP35;MYH9;CDC42;PFN1;MRAS;SPATA13;ITGA4;PAK6;PXN;MYL9;ACTR3B;PFN2;ARPC5L;RRAS;PIK3R3;LPAR2;NCKAP1;MYL5
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.3277235605494954,-1.0988220095839925,0.36065573770491804,1.0,1.0,7/22,15.75%,IST1;LEMD2;CHMP4B;TUBA4A;SPAST;TUBB2A;TUBB6
prerank,KEGG_2021_Human__Cardiac muscle contraction,0.2424580228455701,1.0985960175479805,0.20588235294117646,1.0,1.0,8/55,8.64%,UQCR10;FXYD2;ATP2A1;CACNG8;COX7B;CACNA2D2;COX8A;COX4I1
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.34370898245941106,-1.0984265486345421,0.38181818181818183,1.0,1.0,3/18,4.44%,PTPN11;SPRY2;UBB
prerank,KEGG_2021_Human__ABC transporters,-0.2954795232678195,-1.098336757789523,0.3484848484848485,1.0,1.0,14/34,22.93%,ABCB8;ABCB11;ABCC10;ABCC2;ABCB9;ABCB1;ABCD2;ABCA7;ABCA13;ABCC9;ABCB10;ABCB7;ABCC4;ABCC1
prerank,Reactome_2022__Keratinization R-HSA-6805567,-0.29408002344504397,-1.0980401122806287,0.3275862068965517,1.0,1.0,4/30,9.47%,KRT73;KRT8;PKP4;PPL
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.2222645080828216,-1.0979978317392836,0.2571428571428571,1.0,1.0,25/185,10.46%,PHC3;RING1;FOXP3;LMO2;PTPN11;RNF2;H2AZ2;PHC1;H2AZ1;H2BC3;UBB;PCGF5;ARID1B;PSMD3;THBS1;H2AC7;PSMA5;CBFB;ARID1A;CBX4;PHC2;PSMD6;PSMD12;AGO3;H2AC4
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.21419945757285797,-1.097529094437337,0.2857142857142857,1.0,1.0,32/155,16.95%,PHC3;RING1;INCENP;RNF2;NUP210;NR4A2;PHC1;XRCC4;NFKB2;DDX5;RANGAP1;NSMCE2;NR3C2;RARA;IKBKE;NRIP1;PIAS3;NOP58;THRA;CBX4;PHC2;NSMCE1;NUP88;PIAS1;NPM1;RELA;NUP54;POM121;DDX17;RNF168;HDAC4;PML
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.28730403015342476,-1.096998029048375,0.3194444444444444,1.0,1.0,10/39,21.10%,EPHB3;CLTB;CLTCL1;DNM1;MMP9;PSENEN;CLTC;AP2S1;NCSTN;EPHA4
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,-0.2631652180902075,-1.0946717374124482,0.27941176470588236,1.0,1.0,21/55,30.42%,EXOSC2;EXOSC6;CNOT7;EXOSC9;DCP2;LSM1;EIF4A3;EDC3;DCP1B;CNOT4;CNOT8;CNOT9;PARN;CNOT10;PAN3;EXOSC1;EXOSC3;LSM7;EXOSC5;CNOT11;DIS3
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.22331255947781536,1.0941365269318784,0.28,1.0,1.0,19/64,19.71%,ROCK1;VAMP3;DIAPH1;ARHGAP35;ARHGEF17;AKAP13;FMNL3;PKN1;VANGL1;VAV2;ARHGAP1;ARHGAP5;DLC1;ANLN;JUP;ARHGAP26;MACO1;ARHGEF10;ARHGAP21
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.28481126330125517,1.092532247672757,0.3142857142857143,1.0,1.0,11/35,18.58%,PPP2CB;SGK1;CCNA2;PDPK1;RICTOR;USP7;CDK1;CDKN2A;PPP2R1B;PPP2R1A;MDM4
prerank,KEGG_2021_Human__Mineral absorption,-0.29000607900062936,-1.0921275072866934,0.3114754098360656,1.0,1.0,4/36,3.16%,SLC46A1;TRPM7;HMOX2;SLC11A2
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.26780419071045547,-1.0908675168443713,0.2903225806451613,1.0,1.0,18/54,28.17%,SMURF1;FZD2;UBB;PSMD3;PRICKLE1;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,KEGG_2021_Human__Human cytomegalovirus infection,-0.2090313529060254,-1.0905765263867788,0.27692307692307694,1.0,1.0,46/186,21.75%,ITGB3;GNAI1;CRKL;GNAO1;GNA12;TSC2;CREB3L4;PLCB2;IL10RB;AKT1;MAPK14;VEGFA;TBK1;CCL5;GNG3;PDGFRA;BAK1;FAS;GNG5;FASLG;GNB2;CRK;ADCY4;RB1;CREB3L2;RELA;PRKACA;ATF2;PIK3R1;PIK3R2;CALM2;ATF4;TSC1;AKT2;PIK3CB;E2F2;E2F3;CCR5;RAF1;CALM3;NFKB1;CXCR2;CDKN1A;GNG11;MAPK3;PTGS2
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.2940028498278546,1.0901531017673296,0.3170731707317073,1.0,1.0,5/22,9.23%,GNG10;PIK3R5;PDPK1;PIK3CG;GNB5
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.27554836546517103,1.0899914771454589,0.25,1.0,1.0,10/23,25.37%,MAGED1;CASP8;CASP3;APPL1;RIPK1;DAPK3;CFLAR;FASN;NDUFA2;TLR4
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.2502450336377216,-1.0892501748767764,0.30985915492957744,1.0,1.0,10/63,10.39%,ANAPC11;UBB;PSMD3;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26
prerank,KEGG_2021_Human__Salmonella infection,0.19476319130519235,1.0885351728457031,0.28,1.0,1.0,43/226,13.45%,FOS;TUBB3;CXCL8;KLC1;IL6;ACTR3;DYNLT1;CASP8;ARPC5;EXOC5;ACTR10;ARF1;CDC42;PFN1;TUBB1;RAB5A;SNX33;NLRP3;MYL9;RALA;ABI1;ACTR3B;PKN1;PIK3CG;TCF7L1;PFN2;ARPC5L;RRAS;KIF5A;TXN;CD14;CASP3;DCTN4;NCKAP1;MYL5;TCF7L2;MYO6;CYTH1;LEF1;RAB5C;RIPK1;KLC4;TLR6
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.2826426972085908,-1.0884310861975464,0.4166666666666667,1.0,1.0,8/45,10.47%,GALK1;CHIT1;CYB5R1;CYB5R3;NPL;PGM3;NAGK;HEXA
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.31836878955632664,1.0876398943670713,0.34146341463414637,1.0,1.0,5/21,10.07%,FOS;CREB1;AREG;TGFA;CDKN1B
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,0.25959876388247716,1.0872622821149487,0.34285714285714286,1.0,1.0,6/30,10.68%,POLR2I;ELOC;ELL;NELFCD;NELFB;POLR2H
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,-0.25384505986966355,-1.0856888160376696,0.25757575757575757,1.0,1.0,16/61,20.84%,CAPN3;KLKB1;LAMC1;MMP28;DCN;CAPN5;KLK2;BSG;ELANE;MMP9;COL19A1;TPSAB1;BMP1;MMP8;NCSTN;MMP14
prerank,KEGG_2021_Human__Longevity regulating pathway,-0.24703533994850024,-1.0849409604741909,0.27692307692307694,1.0,1.0,29/83,26.19%,ATG5;STK11;TSC2;CREB3L4;IGF1R;AKT1;RPTOR;ADCY4;CREB3L2;RELA;PRKACA;ULK1;ATF2;PIK3R1;HSPA2;PIK3R2;ATF4;TSC1;AKT2;PIK3CB;NFKB1;ADCY3;SESN1;NRAS;SIRT1;PRKAG1;FOXO1;EIF4EBP2;HDAC2
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,-0.3352266460325283,-1.08405200463876,0.3584905660377358,1.0,1.0,10/20,29.57%,HMOX2;ABCC2;CPOX;FLVCR1;FECH;ALAS2;UROD;ABCC1;BLVRA;PPOX
prerank,KEGG_2021_Human__Folate biosynthesis,-0.3352595749370694,-1.082867424865401,0.3548387096774194,1.0,1.0,8/18,33.82%,TPH2;PTS;SPR;FPGS;DHFR;DHFR2;QDPR;PCBD2
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.3371995979536283,-1.082786836895409,0.3888888888888889,1.0,1.0,3/19,4.44%,PTPN11;SPRY2;UBB
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,-0.2859920080673501,-1.081689036589734,0.3448275862068966,1.0,1.0,6/26,13.63%,RNF185;GANAB;UBB;UGGT1;SYVN1;OS9
prerank,Reactome_2022__M Phase R-HSA-68886,-0.19646917100025277,-1.0813099536259265,0.2682926829268293,1.0,1.0,62/360,14.50%,WAPL;DCTN3;INCENP;ANAPC11;KNTC1;PPP2R5B;MZT2A;PLK4;MCPH1;CDK5RAP2;LPIN1;H2AZ2;CENPU;NUP210;CEP192;SKA1;H2AZ1;H2BC3;UBB;PSMD3;CLASP2;RANGAP1;H2AC7;FBXO5;CENPO;CENPA;UBE2C;NEK2;IST1;PSMA5;ANAPC4;MAPRE1;DYNC1LI2;LEMD2;ANAPC5;HAUS1;PSMD6;PSMD12;CHMP4B;CLASP1;CENPS-CORT;HAUS3;CDC26;H2AC4;RAB33B;AKAP9;TUBA4A;DYNC1LI1;PCM1;CEP57;H2BC13;NUP88;EMD;TUBGCP3;RB1;NCAPH;CDC20;RAN;SPAST;NUP54;POM121;TUBB2A
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.2531040124933231,-1.0812317630204231,0.3283582089552239,1.0,1.0,23/65,29.41%,ANAPC11;UBB;PSMD3;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;CDC20;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;PSME1;PSMA7;ANAPC10
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,0.3282521990930448,1.0801666693692815,0.38636363636363635,1.0,1.0,15/15,67.20%,TSPO;FDXR;HSD17B11;FDX2;STARD3NL;TSPOAP1;SRD5A3;SRD5A1;AKR1B15;STARD3;FDX1;AKR1B1;STARD4;POMC;HSD17B12
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,-0.2820415627198208,-1.0785265100426877,0.3333333333333333,1.0,1.0,19/46,29.30%,SMYD3;KMT5B;NFKB2;RBBP7;EED;NSD2;ASH1L;KMT2D;RELA;ASH2L;SETDB2;SETD7;NFKB1;SETDB1;H4C15;EZH2;SETD1A;SUV39H2;AEBP2
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,-0.21663788901781378,-1.077225853286447,0.38461538461538464,1.0,1.0,28/145,18.59%,B4GALT2;DCTN3;YKT6;STX17;SEC31A;FUT8;COG2;B4GALT4;ARFGAP1;MOGAT3;BET1L;ANKRD28;DYNC1LI2;LMAN2;DYNC1LI1;GOSR1;MGAT5;COPZ1;TRAPPC5;ST8SIA6;MANEA;B4GALT3;BET1;COG6;F8;ST6GAL1;TRAPPC4;F5
prerank,KEGG_2021_Human__Long-term depression,-0.2547202582822019,-1.0757814689096394,0.34328358208955223,1.0,1.0,5/44,5.08%,GNAI1;GNAO1;GNA12;IGF1R;PLCB2
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.24052486778665583,-1.0752409416459756,0.27941176470588236,1.0,1.0,35/88,27.39%,H2AZ2;WRAP53;H2AZ1;H2BC3;FEN1;H2AC7;CHTF8;CTC1;ANKRD28;POLR2K;H2AC4;POLR2B;RFC5;SLC19A1;H2BC13;POT1;POLR2D;RPA3;POLD1;CHTF18;POLD2;LRIG1;H2AC14;PIF1;ATRX;POLA2;WRN;POLR2J;CDK2;DKC1;H4C15;H2BC21;POLA1;CCNA1;H2AC20
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,-0.22465651417165383,-1.0752103517269191,0.29577464788732394,1.0,1.0,30/108,22.19%,IL24;PTPN11;PDGFRB;IL3RA;IL10RB;AKT1;STAM;IL12A;PDGFRA;IFNLR1;GFAP;PIAS3;MPL;IL6ST;IL5RA;PIAS1;CSF3R;CISH;PIK3R1;PIK3R2;AKT2;STAT1;IL2RG;PIK3CB;JAK3;RAF1;PIAS2;CDKN1A;PTPN6;OSM
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.24394128300422435,-1.0750852312982337,0.35714285714285715,1.0,1.0,24/70,28.17%,ANAPC11;CDC6;UBB;PSMD3;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;PSMC4;SEM1;PSMD11;PSMD7;CDK2;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;CCNA1;PSME1;PSMA7
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,-0.2684059046602605,-1.0742675415491092,0.4084507042253521,1.0,1.0,18/51,27.39%,H2AZ2;H2AZ1;H2BC3;H2AC7;SYNE1;H2AC4;H2BC13;POT1;HSPA2;H2AC14;SUN1;SYCE2;UBE2I;SYCP1;PMEPA1;H4C15;H2BC21;H2AC20
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.2282821661400979,-1.0736071892210761,0.3108108108108108,1.0,1.0,27/98,21.73%,ECSIT;MAPK8;DUSP6;UBB;NFKB2;MAPK14;IRAK4;SKP1;S100A12;DUSP7;LY96;TANK;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;IRF7;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,-0.2896806433272261,-1.072963684812856,0.3382352941176471,1.0,1.0,8/37,11.49%,OR2B11;OR6C74;OR7C1;OR4F17;OR51M1;OR2A7;OR1A1;OR10H1
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,-0.23466455275903508,-1.07270891614696,0.328125,1.0,1.0,35/86,29.45%,MRPL24;MRPL53;MRPL15;MTFMT;MRPL58;MRPS11;MRPS7;MRPS30;MRPL34;MRPS24;PTCD3;MRPL39;MRPL41;MRPS34;CHCHD1;MRPL4;MRPL1;MRPS18C;MRPS22;MRPS6;MRPL3;MRPL47;MRPS15;AURKAIP1;MRPL37;MTRF1L;MRPS5;MRPS26;MRPL17;MRPL13;MRPS2;MRPS27;MRPL11;MRPS18A;MRPL35
prerank,KEGG_2021_Human__RNA degradation,-0.2497430359627522,-1.0723061954184425,0.2903225806451613,1.0,1.0,21/68,21.63%,EXOSC2;EXOSC6;CNOT7;EXOSC9;DIS3L;DCP2;TOB2;LSM1;EDC3;PABPC1L;DCP1B;CNOT4;CNOT8;LSM8;PNPT1;CNOT9;BTG2;PARN;XRN2;CNOT10;PAN3
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,0.2704916803591565,1.0708337557839545,0.4222222222222222,1.0,1.0,3/33,0.80%,PLCB4;HK1;FXYD2
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.2637860423120653,1.0689531866789739,0.2571428571428571,1.0,1.0,9/37,15.41%,NCOA1;HDAC3;ABCG1;AGO1;ABCA1;GPS2;KDM3A;TNRC6A;SCD
prerank,KEGG_2021_Human__AMPK signaling pathway,-0.2202194205781443,-1.0689094826808345,0.39436619718309857,1.0,1.0,24/102,18.40%,PPP2R5B;SREBF1;CAB39;STK11;TSC2;STRADA;CREB3L4;IGF1R;CPT1A;AKT1;RPTOR;PFKFB3;PFKFB4;ELAVL1;CREB3L2;RAB10;ULK1;PIK3R1;PIK3R2;TSC1;AKT2;RAB14;PPP2CA;PIK3CB
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.30777024575473033,-1.0674436979910165,0.35,1.0,1.0,7/27,12.87%,VPS37A;UBB;VPS37C;VPS37B;CHMP4B;UBAP1;PLIN3
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.2103393261160213,-1.0670706753355654,0.3484848484848485,1.0,1.0,53/169,25.00%,ITGB3;H2AB2;H3C4;MACROH2A2;CLEC7A;H2AZ2;FCGR2A;H3C11;H2AZ1;H2BC3;H2AC7;PLCB2;AKT1;MAPK14;PPIF;H3C10;TLR8;SLC25A5;H2AC4;H2AC12;H2AC17;H2BC13;SELP;ELANE;CLCN5;RELA;SYK;PIK3R1;H4C5;PIK3R2;AKT2;HDAC4;H2AC14;CASP4;AQP9;ITGB2;PIK3CB;RAF1;MACROH2A1;NFKB1;NCF4;FPR1;HDAC8;CR1L;MAPK3;FPR3;H2AC11;MAPK13;H4C8;H3C1;PLCB3;H4C6;H4C15
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.31239933914000845,1.0658005530856391,0.3541666666666667,1.0,1.0,4/18,8.73%,ROCK1;MYH9;MYL9;PKN1
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,-0.2346121551191963,-1.0618258837704067,0.3230769230769231,1.0,1.0,24/84,21.73%,MAPK8;TLR5;AKT1;MAPK14;IRAK4;TBK1;CCL5;IL12A;IKBKE;CXCL10;LY96;TLR8;TIRAP;RELA;TRAF6;PIK3R1;PIK3R2;IRF7;AKT2;STAT1;PIK3CB;NFKB1;MAP2K7;MAPK3
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.22341316174335787,-1.0613999999841173,0.40540540540540543,1.0,1.0,21/104,18.59%,ITGB3;CLEC3B;FN1;TEX264;CYB5R1;QSOX1;THBS1;VEGFA;CD109;ACTN1;RAB27B;TUBA4A;CYRIB;TGFB3;STX4;PPBP;SGPP2;F8;VTI1B;SELENOP;F5
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,-0.29431469008321653,-1.0610582484720246,0.36923076923076925,1.0,1.0,19/33,39.55%,GNAI1;SHC1;GNG3;GNG5;GNB2;ADCY4;GNG11;PRKAR2A;ITGB1;PRKAR1B;GNAZ;GNG7;GNG8;GNG2;PRKAR2B;GNB4;PRKAR1A;GNB1;GNB3
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.23102604230582013,1.0586459214830763,0.3611111111111111,1.0,1.0,14/57,17.99%,NF2;ACTR3;ARPC5;MYH9;CDC42;ABI1;PKN1;NCKAP1;NCK1;VAV2;ABL1;WASF3;ACTR2;MYO10
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.2270064728774928,-1.0581566650996956,0.3611111111111111,1.0,1.0,28/104,21.73%,ECSIT;MAPK8;DUSP6;UBB;NFKB2;MAPK14;IRAK4;SKP1;S100A12;DUSP7;LY96;TANK;TIRAP;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;S100A8;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,-0.20663305743858737,-1.0577268928034507,0.32432432432432434,1.0,1.0,47/219,17.29%,CAV2;GNAI1;APOE;SREBF1;PDK4;H2AZ2;RDH10;H2AZ1;H2BC3;IGF1R;DDX5;H2AC7;CPT1A;AKT1;RDH14;CHD1;SHC1;GNG3;RARA;NRIP1;GTF2F2;DLAT;CBFB;NCOA3;STRN;GNG5;ZDHHC7;POLR2K;GTF2A1;AGO3;GNB2;H2AC4;POLR2B;H2BC13;POLR2D;FOSB;AGO4;MMP9;EEPD1;TFF3;PIK3R1;PIK3R2;RDH11;RARG;AKT2;H2AC14;CDK9
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,-0.2811893443304083,-1.0576112987035595,0.43478260869565216,1.0,1.0,8/39,11.49%,OR2B11;OR6C74;OR7C1;OR4F17;OR51M1;OR2A7;OR1A1;OR10H1
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.24046273300584936,-1.0574479331390192,0.38666666666666666,1.0,1.0,19/74,17.37%,TAF5;ZNF143;INTS12;INTS6;ZC3H8;GTF2F2;ELL2;RPRD1B;PHAX;POLR2K;GTF2A1;POLR2B;POLR2D;ELL3;ICE1;INTS4;CCNK;CDK9;RPAP2
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.35981306149780184,-1.0570136520679667,0.37254901960784315,1.0,1.0,3/15,6.80%,SMURF1;UBB;ARHGEF18
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.27410993443109577,-1.0564529393756554,0.390625,1.0,1.0,21/54,26.67%,FN1;SEC31A;ZC3HC1;SKP1;SHC1;STRN;RNF213;NPM1;MSN;RPS6;PIK3R1;CLTC;RNASEH2A;RBX1;MAPK3;BIRC6;SQSTM1;GCC2;BCL2A1;TPM3;FRS3
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.3072292968529381,1.0557082276468854,0.35714285714285715,1.0,1.0,4/17,9.23%,GNG10;CDC42;PKN1;GNB5
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.2509160680620588,1.0547709950073936,0.4883720930232558,1.0,1.0,11/42,16.27%,NCOA1;DAND5;PMVK;PPARA;ELOVL6;LMBR1;FDFT1;MBD4;ACACB;SCD;HELZ2
prerank,KEGG_2021_Human__Circadian rhythm,0.29354686445366496,1.0545855541841689,0.375,1.0,1.0,4/26,5.93%,BHLHE40;CRY2;CREB1;CUL1
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.20895584698779704,-1.0543685404832555,0.41333333333333333,1.0,1.0,43/175,19.71%,SIKE1;RPS15A;PTPN11;ATG14;TRIM4;NUP210;AKT1;RPS21;SNRPB;TBK1;RPS23;RPS4X;IKBKE;TLR8;RPS20;VPS33B;YWHAQ;NUP88;CNBP;VPS18;G3BP2;RPS14;G3BP1;RPS3A;GEMIN6;NUP54;TRAF6;SNRPE;POM121;RPS16;REXO2;RPS6;RIGI;IRF7;AKT2;VPS45;STAT1;NUP37;NUP58;SEC23A;NUP205;TKFC;RPS7
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,-0.20222811834933727,-1.0528056875072278,0.35064935064935066,1.0,1.0,88/259,30.00%,MCM5;RAD9B;INCENP;ANAPC11;KNTC1;PPP2R5B;RMI2;CENPU;ZNF385A;CDC6;SKA1;H2BC3;UBB;PSMD3;CLASP2;RANGAP1;CENPO;CENPA;UBE2C;PSMA5;ANAPC4;MAPRE1;DYNC1LI2;ANAPC5;PSMD6;NSD2;PSMD12;CLASP1;MCM4;CENPS-CORT;CDC26;YWHAQ;RFC5;DYNC1LI1;H2BC13;RHNO1;MCM7;CDC20;RPA3;REXO2;RNF168;RCC2;PPP2CA;PLK1;EXO1;NUP37;RAD9A;KNL1;MCM10;PSMC4;SGO1;ZW10;CDKN1A;CENPK;CLSPN;SEM1;PPP1CC;XPO1;BARD1;WRN;PSMD11;PSMD7;PIAS4;DYNLL2;CENPH;DBF4;BRIP1;CDK2;PSME2;PSME4;H4C15;PSMB10;UBE2E1;H2BC21;PSMB2;NUP133;CCNA1;PSME1;WEE1;PAFAH1B1;PSMA7;ITGB3BP;CARD16;YWHAH;PKMYT1;ANAPC10;CENPL;AURKB
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.3375767720707076,-1.052131133013664,0.42857142857142855,1.0,1.0,3/19,4.44%,PTPN11;SPRY2;UBB
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.20897979123845575,1.0521205364164208,0.358974358974359,1.0,1.0,7/84,2.77%,B3GLCT;POMGNT1;PGM1;GALNT12;GALT;B4GALT1;POMT2
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.2338653590890491,1.0517278556851577,0.34285714285714286,1.0,1.0,7/45,7.69%,HDAC3;HDAC11;NBEA;MAMLD1;TLE3;CUL1;TLE4
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.2473981106775973,-1.0514688631338869,0.3787878787878788,1.0,1.0,23/66,28.17%,MCM5;CDC6;UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;MCM4;MCM7;PSMC4;RBX1;SEM1;PSMD11;PSMD7;CDK2;PSME2;PSME4;PSMB10;PSMB2;CCNA1;PSME1;PSMA7
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.18335508727339125,-1.051403046971644,0.313953488372093,1.0,1.0,138/500,25.00%,WAPL;MCM5;DCTN3;INCENP;ANAPC11;KNTC1;PPP2R5B;MZT2A;PLK4;MCPH1;CDK5RAP2;LPIN1;H2AZ2;CENPU;NUP210;CEP192;CDC6;SKA1;H2AZ1;H2BC3;UBB;PSMD3;CLASP2;RANGAP1;FEN1;H2AC7;AKT1;FKBPL;FBXO5;CENPO;ESCO2;SKP1;CENPA;UBE2C;NEK2;IST1;PSMA5;CDC25B;ANAPC4;MAPRE1;DYNC1LI2;LEMD2;ANAPC5;HAUS1;PSMD6;PSMD12;CHMP4B;TK1;CLASP1;MCM4;CENPS-CORT;HAUS3;CDC26;H2AC4;RAB33B;AKAP9;RFC5;TUBA4A;DYNC1LI1;PCM1;CEP57;SLC19A1;H2BC13;NUP88;EMD;TUBGCP3;RB1;MCM7;NCAPH;CDC20;RPA3;GINS3;RAN;POLD1;SPAST;NUP54;POM121;TUBB2A;GINS1;POLD2;NEK9;LRIG1;TUBB6;HAUS7;CEP78;AKT2;RCC2;H2AC14;RRM2;PPP2CA;PLK1;ESPL1;NUP37;PPME1;CDK11A;E2F2;E2F3;KNL1;PTK6;NUP58;NCAPG;MCM10;PSMC4;SGO1;NUP205;E2F6;E2F4;ZW10;POLA2;RBX1;CDKN1A;NUMA1;OFD1;HDAC8;LBR;MAPK3;DHFR;CENPK;SEM1;UBE2I;PPP1CC;XPO1;PSMD11;PHLDA1;PMEPA1;PSMD7;TFDP2;PDS5A;DYNLL2;CENPH;DBF4;HSP90AB1;CDK2;CABLES1;PSME2;PSME4;LIN52;H4C15
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.2728154545212832,1.0513708307297784,0.47368421052631576,1.0,1.0,11/31,22.03%,YWHAB;PPP2R5E;PPP2CB;MRAS;MAP3K11;KSR1;PPP2R1B;PPP2R1A;MAP2K1;PPP2R5A;PPP2R5D
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.29836842697637567,-1.0511203414860677,0.42857142857142855,1.0,1.0,9/22,23.70%,CYB5A;UBL4A;EMD;SGTA;PRNP;GET1;CAMLG;GET4;STX1A
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.22296270363019985,1.050890723031379,0.4,1.0,1.0,16/52,19.85%,ITGB5;ATP2A1;ITGA3;CACNG8;ITGA4;CACNA2D2;TCF7L1;TCF7L2;LEF1;JUP;DAG1;SLC8A1;ITGA1;ACTB;SGCA;ITGA6
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,-0.220786115196262,-1.0506372390969485,0.38666666666666666,1.0,1.0,20/100,18.59%,ITGB3;CLEC3B;FN1;TEX264;CYB5R1;QSOX1;THBS1;VEGFA;CD109;ACTN1;RAB27B;TUBA4A;CYRIB;TGFB3;PPBP;SGPP2;F8;VTI1B;SELENOP;F5
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,-0.2363610921962287,-1.0504991632313005,0.3230769230769231,1.0,1.0,16/62,19.87%,FN1;APOE;LAMC1;QSOX1;MXRA8;LMNB2;HSP90B1;PRSS23;PNPLA2;PROC;MELTF;DNAJC3;SGPP2;F5;GAS6;C4A
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,-0.2515832991193167,-1.0503134279858186,0.36666666666666664,1.0,1.0,24/57,33.43%,ERLEC1;UBB;PSMD3;PSMA5;SCUBE2;PSMD6;PSMD12;SYVN1;OS9;PSMC4;SEM1;HHAT;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;ADAM17;PSMC5;PSMA3;PSMC1
prerank,KEGG_2021_Human__Cell adhesion molecules,0.1872713765194362,1.0497589373427283,0.3235294117647059,1.0,1.0,19/109,14.35%,NEGR1;JAM3;HLA-G;CD8A;ITGA4;CLDN7;VSIR;SDC2;NTNG2;CD22;CDH1;CTLA4;NECTIN1;PDCD1LG2;PECAM1;GLG1;MADCAM1;VCAN;HLA-DRB3
prerank,KEGG_2021_Human__Alcoholism,-0.22240796566995832,-1.049679505826354,0.3835616438356164,1.0,1.0,50/140,28.34%,GNAI1;H2AB2;GNAO1;H3C4;MACROH2A2;H2AZ2;H3C11;H2AZ1;H2BC3;CREB3L4;H2AC7;SHC1;GNG3;H3C10;CAMKK1;GNG5;GNB2;H2AC4;H2AC12;H2AC17;H2BC13;FOSB;CREB3L2;PRKACA;ATF2;H4C5;CALM2;ATF4;HDAC4;H2AC14;RAF1;MACROH2A1;CALM3;HDAC8;GNG11;MAPK3;PPP1CC;H2AC11;NRAS;H4C8;H3C1;H4C6;H4C15;HDAC2;H2BC21;ARAF;H2AC20;GNG7;CALM1;GNG8
prerank,KEGG_2021_Human__Melanogenesis,-0.23463630948751324,-1.0493245845951067,0.35384615384615387,1.0,1.0,20/63,24.52%,GNAI1;GNAO1;FZD2;CREB3L4;PLCB2;WNT10A;ADCY4;CREB3L2;WNT10B;PRKACA;CALM2;CAMK2D;RAF1;CALM3;MAPK3;ADCY3;CAMK2G;NRAS;PLCB3;WNT7A
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.22389415631087423,-1.0473575347332191,0.4411764705882353,1.0,1.0,30/109,20.65%,VPS37A;NUP210;H2BC3;H2AC7;CEBPD;RBBP7;EED;VPS37C;DYNC1LI2;VPS37B;CHMP1A;DUT;CHMP4B;H2AC4;H2AC12;DYNC1LI1;H2BC13;UBAP1;NUP88;SNF8;TXN2;NUP54;POM121;PML;H2AC14;NUP37;NUP58;NUP205;NFKB1;CD46
prerank,KEGG_2021_Human__Ras signaling pathway,-0.2178440342992612,-1.0470588964099643,0.40298507462686567,1.0,1.0,31/159,16.00%,BRAP;PTPN11;MAPK8;FGFR1;PDGFD;RASGRP4;PDGFRB;PAK1;PGF;IGF1R;AKT1;RASGRP2;VEGFA;TBK1;SHC1;GNG3;PDGFRA;ABL2;PLA2G2C;GNG5;FASLG;GNB2;FLT3LG;PLD2;RELA;PRKACA;RRAS2;PLA2G6;PIK3R1;PIK3R2;CALM2
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.18670349661875515,1.0466097643003047,0.38235294117647056,1.0,1.0,27/163,12.80%,FOS;TUBB3;CXCL8;EZR;ROCK1;MYO1C;IL6;ACTR3;CASP8;ARPC5;MYH9;ARF1;CDC42;TUBB1;CLDN7;NLRP3;IL1R1;ABI1;ACTR3B;ARPC5L;LPAR2;CASP3;NCKAP1;MYO6;CYTH1;NCK1;RIPK1
prerank,KEGG_2021_Human__RNA transport,-0.20710726157860304,-1.0462706706187563,0.3582089552238806,1.0,1.0,33/164,15.58%,FXR2;EIF2B3;CLNS1A;RPP25;EIF4G2;NUP210;EIF1;RPP40;SNUPN;RANGAP1;SUMO4;SNORD3B-1;MAGOH;PHAX;RAE1;ELAC2;EIF1AY;PYM1;EIF4A3;RPP38;NUP88;THOC2;RAN;PABPC1L;FMR1;UPF1;GEMIN6;POP4;NUP54;POM121;UPF3A;XPO5;GLE1
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,-0.2677898784935534,-1.0454367492662777,0.4393939393939394,1.0,1.0,8/44,14.72%,BEGAIN;FLOT2;NRXN3;NRXN2;LIN7C;DBNL;NLGN3;PPFIBP2
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.2678685165832198,1.0452907687255104,0.34146341463414637,1.0,1.0,10/34,18.48%,PARD6B;CLDN7;CDH13;PATJ;NECTIN1;PRKCI;PARD3;JUP;F11R;AFDN
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.2774195752663058,-1.0443843770835088,0.42857142857142855,1.0,1.0,10/34,14.18%,ACSS1;ACSS2;MDH1;DLAT;FH;GRHPR;LDHA;ADH5;LDHB;ACYP2
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,0.25897545078977435,1.0442396904801436,0.3939393939393939,1.0,1.0,6/35,8.54%,NXF1;NDC1;POM121C;NUP85;NUP153;NCBP1
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.2883649963062109,-1.0437797781280316,0.3968253968253968,1.0,1.0,4/28,6.15%,PTPN11;SPRY2;UBB;SHC1
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.2768848485463471,1.043672432490572,0.28205128205128205,1.0,1.0,3/28,2.51%,HDAC3;HDAC11;MAMLD1
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.24209287823383827,-1.043218592220324,0.3880597014925373,1.0,1.0,32/85,30.00%,ANAPC11;UBB;PSMD3;FBXO5;SKP1;UBE2C;NEK2;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;RB1;CDC20;PLK1;PSMC4;SEM1;PSMD11;PSMD7;CDK2;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;CCNA1;PSME1;PSMA7;ANAPC10;BTRC;AURKB
prerank,KEGG_2021_Human__Cholinergic synapse,-0.23584561540034923,-1.0431937170175898,0.36507936507936506,1.0,1.0,37/77,34.04%,GNAI1;GNAO1;KCNJ2;CREB3L4;PLCB2;AKT1;GNG3;KCNQ1;GNG5;GNB2;ADCY4;CREB3L2;PRKACA;PIK3R1;PIK3R2;ATF4;AKT2;CAMK2D;PIK3CB;GNG11;MAPK3;ADCY3;CAMK2G;NRAS;PLCB3;CACNA1A;GNG7;JAK2;GNG8;MAPK1;FYN;CREB5;CACNA1F;ACHE;CHRNB4;GNG2;CHRNA7
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.20626242718554694,-1.0429252214194724,0.3472222222222222,1.0,1.0,65/197,27.32%,RPS15A;EXOSC2;EXOSC6;NIP7;MRM2;RPP25;RPL37A;NOL6;RPLP0;RPP40;EBNA1BP2;EXOSC9;RPS21;WDR12;UTP6;RPS23;RPS4X;UTP4;RSL24D1;NOP58;ELAC2;SPPL2A;BOP1;RPS20;BYSL;RPP38;NSUN4;UTP18;TRMT112;RPS14;RPL9;RPS3A;PDCD11;UTP14C;RPS16;PNO1;RPS6;RCL1;RPL32;RPL11;PRORP;WDR43;NOL12;RPS7;RPL7;EMG1;XRN2;RPL10A;RPP14;THUMPD1;LTV1;BMS1;RPS12;BUD23;DKC1;NOP56;RPS8;RPL27;EXOSC1;MPHOSPH10;EXOSC3;RPL14;MRPL13;RPL22L1;RPL23
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.22139547486487787,-1.0427709871702826,0.37333333333333335,1.0,1.0,26/97,21.73%,ECSIT;MAPK8;DUSP6;UBB;NFKB2;MAPK14;IRAK4;SKP1;S100A12;DUSP7;LY96;TANK;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,0.2624067860943316,1.0419695865728456,0.375,1.0,1.0,6/34,8.54%,NXF1;NDC1;POM121C;NUP85;NUP153;NCBP1
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,-0.21922490817506324,-1.041639881446869,0.3783783783783784,1.0,1.0,24/116,15.72%,MCM5;ANAPC11;CDC6;UBB;PSMD3;FEN1;SKP1;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;MCM4;CDC26;RFC5;SLC19A1;MCM7;RPA3;GINS3;POLD1;GINS1;POLD2;LRIG1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,-0.20502901974079318,-1.041584565308659,0.3918918918918919,1.0,1.0,32/161,16.95%,PHC3;RING1;INCENP;RNF2;NUP210;NR4A2;PHC1;XRCC4;NFKB2;DDX5;RANGAP1;NSMCE2;NR3C2;RARA;IKBKE;NRIP1;PIAS3;NOP58;THRA;CBX4;PHC2;NSMCE1;NUP88;PIAS1;NPM1;RELA;NUP54;POM121;DDX17;RNF168;HDAC4;PML
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.2250568149049924,-1.0404888184161942,0.391304347826087,1.0,1.0,19/76,17.89%,ERCC5;COPS2;UBB;DDB1;ERCC8;POLR2K;TCEA1;POLR2B;RFC5;SLC19A1;POLR2D;RPA3;POLD1;ERCC1;COPS6;POLD2;LRIG1;ISY1-RAB43;GPS1
prerank,KEGG_2021_Human__Platelet activation,-0.213963841321417,-1.0402716007821242,0.40540540540540543,1.0,1.0,33/105,24.88%,ITGB3;GNAI1;FCGR2A;P2RX1;PLCB2;AKT1;MAPK14;RASGRP2;TLN2;NOS3;TBXA2R;ADCY4;PRKACA;GUCY1B1;P2RY1;SNAP23;SYK;PIK3R1;PIK3R2;MYLK;AKT2;PIK3CB;LCP2;VASP;MAPK3;GP1BB;ADCY3;PPP1CC;MAPK13;VAMP8;PLCB3;ITGB1;ARHGEF1
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,-0.2750252557595624,-1.0399874623678838,0.4,1.0,1.0,18/38,28.26%,IL3RA;CLSTN1;SHC1;INPPL1;IL5RA;SYK;PIK3R1;PIK3R2;STAT1;IL2RG;PIK3CB;JAK3;PTPN6;INPP5D;IL21R;LGALS9;JAK2;IL15RA
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,-0.3552390354505384,-1.039851024453921,0.4166666666666667,1.0,1.0,5/16,18.44%,ITGB3;THBS1;ACTN1;SDC4;TRAPPC4
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.24836711461278574,1.0395588098874924,0.4166666666666667,1.0,1.0,14/47,16.60%,PPP2CB;CCND2;CUL1;E2F5;CDKN1B;CDKN2A;RBL1;CDKN2D;CDKN1C;PPP2R1B;CDK6;ABL1;CDK4;PPP2R1A
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.26659677414939514,-1.03941474721612,0.4126984126984127,1.0,1.0,12/46,13.30%,LPIN1;PLPP1;DGKQ;DGKD;MOGAT3;LPL;PNPLA2;DGKH;GLA;LCLAT1;MBOAT1;MGLL
prerank,Reactome_2022__Autophagy R-HSA-9612973,-0.21456857632033863,-1.0393890793667193,0.38461538461538464,1.0,1.0,25/121,15.23%,ATG5;ATG14;VPS37A;TOMM20;TSC2;RRAGD;UBB;TOMM7;GFAP;SLC38A9;VPS37C;WIPI2;DYNC1LI2;VPS37B;CHMP4B;RPTOR;GABARAPL2;DYNC1LI1;UBAP1;PLIN3;MTERF3;ULK1;ATG10;ATG4A;MLST8
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.31117134827014703,-1.039259284872543,0.4,1.0,1.0,9/18,37.52%,MAPK8;TRAF6;MAP2K7;IRAK2;TAB3;MAP3K7;TAB2;IRAK1;MAPK9
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.2176258718622147,1.039085778921487,0.3611111111111111,1.0,1.0,16/64,16.60%,PDE2A;GNG10;ATP2A1;PPP2R5E;PPP2CB;STIM1;PDE10A;GNB5;KCNMB4;FGR;ORAI2;PECAM1;KCNMB3;PPP2R1B;ATP2B4;PPP2R1A
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.27905377421079325,-1.0383852365925155,0.4264705882352941,1.0,1.0,23/49,29.90%,EXOC7;MYO1E;EXOC3;AKT1;EXOC4;YWHAQ;RAB10;SNAP23;REXO2;AKT2;STX4;RAB14;RALGAPA2;KIF3B;C2CD5;PRKAG1;RAB4A;TBC1D1;EXOC8;CALM1;SLC2A4;YWHAH;LNPEP
prerank,KEGG_2021_Human__Inositol phosphate metabolism,-0.240681798942463,-1.0379478783683858,0.38571428571428573,1.0,1.0,33/66,36.02%,INPP5K;MTMR8;PLCB2;MTMR2;ITPKC;PI4KA;PLCD3;IPMK;INPPL1;MTMR4;SYNJ1;INPP5B;MTM1;PIK3CB;ALDH6A1;PIP4K2C;PLCB3;INPP5D;INPP4B;PIP5K1B;OCRL;PIP5KL1;MIOX;SYNJ2;PI4K2B;PIP5K1A;ISYNA1;PLCD1;PIK3C2B;CDIPT;INPP1;PLCG2;PIK3CD
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,-0.31691343231831,-1.0377241107690156,0.43859649122807015,1.0,1.0,8/20,24.58%,SLC7A8;SLC16A3;BSG;ATP1B2;DEAF1;L1CAM;ATP1B3;ITGB1
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.21295567895255346,-1.0376261629993653,0.4057971014492754,1.0,1.0,17/125,10.22%,SMURF1;GNAO1;CLTB;FZD2;UBB;PSMD3;PRICKLE1;PLCB2;GNG3;PSMA5;DAAM1;NCOA3;GNG5;PSMD6;PSMD12;AGO3;GNB2
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.2891611588449589,-1.0372686102337647,0.3333333333333333,1.0,1.0,7/27,13.65%,MAPK8;DUSP6;MAPK14;DUSP7;RPS6KA2;MEF2C;MAPK7
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.2877243255674039,-1.036690008921223,0.35294117647058826,1.0,1.0,5/29,10.41%,FLOT2;UBB;OGT;FASLG;TANK
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.2441872496002429,1.0355229470992664,0.4117647058823529,1.0,1.0,8/42,11.44%,POLR2I;ELOC;ELL;NCBP1;NELFCD;NELFB;POLR2H;ERCC2
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.3181958086672059,-1.0347282141919247,0.375,1.0,1.0,11/21,28.00%,PLCB2;ITPKC;PLCD3;INPPL1;PLD4;SYNJ1;INPP5B;PLCB3;INPP5D;CALM1;OCRL
prerank,KEGG_2021_Human__Ribosome,-0.21387924755993523,-1.0342932135198784,0.3472222222222222,1.0,1.0,48/133,29.57%,RPS15A;RPL37A;MRPL24;RPLP0;MRPL15;RPS21;MRPS11;RPS23;RPS4X;MRPS7;RSL24D1;MRPL34;RPS26;RPS20;MRPL28;RPS14;RPL9;RPS3A;RPS16;RPS6;RPL32;RPL11;MRPL4;MRPL27;RPS7;RPL7;MRPL1;MRPS18C;RPL10A;MRPS6;MRPL3;RPS12;MRPS15;RPS8;RPL27;MRPS5;RPL14;MRPL17;MRPL13;RPL22L1;RPL23;MRPS2;RPS10;MRPL11;FAU;MRPS18A;MRPL35;RPL37
prerank,KEGG_2021_Human__African trypanosomiasis,-0.3061653518242444,-1.0338177712435828,0.37735849056603776,1.0,1.0,6/26,10.20%,HBA2;HBA1;PLCB2;IL12A;FAS;FASLG
prerank,KEGG_2021_Human__Small cell lung cancer,-0.22212501204067475,-1.0337163433618857,0.42592592592592593,1.0,1.0,25/79,24.58%,FN1;LAMC1;CKS2;AKT1;TRAF1;BAK1;RB1;GADD45G;RELA;TRAF6;BIRC3;PIK3R1;PIK3R2;AKT2;LAMB4;PIK3CB;E2F2;E2F3;NFKB1;CDKN1A;GADD45A;PTGS2;CDK2;FHIT;ITGB1
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,-0.30385094984098937,-1.033501276773924,0.43548387096774194,1.0,1.0,6/31,8.10%,EXOSC2;EXOSC6;ATF3;EXOSC9;DCP2;KHSRP
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.22301010378999112,1.0333165051653137,0.46875,1.0,1.0,13/55,17.99%,ACTR3;ARPC5;MYH9;CDC42;ABI1;FGR;NCKAP1;NCK1;VAV2;ABL1;WASF3;ACTR2;MYO10
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.33231187960489716,-1.0323521987908262,0.3728813559322034,1.0,1.0,4/18,10.22%,GNAI1;GNG3;GNG5;GNB2
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.2198578047132358,-1.0319173189854305,0.4626865671641791,1.0,1.0,28/99,21.73%,MAPK8;DUSP6;UBB;NFKB2;MAPK14;TBK1;SKP1;S100A12;IKBKE;DUSP7;TANK;SARM1;TNIP2;RPS6KA2;MEF2C;RELA;MAPK7;TRAF6;MAPKAPK3;BIRC3;IRF7;NKIRAS2;PPP2CA;N4BP1;NKIRAS1;NFKB1;MAP2K7;MAPK3
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.19573549222374753,-1.0315032280419731,0.39473684210526316,1.0,1.0,44/278,13.30%,HECTD2;UBA7;UFL1;RNF19B;ANAPC11;SMURF1;UBE2Q2;TRIM4;CBLB;UBB;PSMD3;RNF41;UBE2M;FBXO7;SKP1;UBE2G1;RNF130;KLHL25;UBE3D;UBE2C;UBAC1;PSMA5;ANAPC4;ARIH2;FBXW9;ANAPC5;UBA5;FBXO11;PSMD6;RNF213;HACE1;PSMD12;UBE2J1;FBXO27;CDC26;TRIM9;FBXO15;FBXO21;LRRC41;UBE2L3;HECTD1;CDC20;FBXO44;KEAP1
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.2013967116441518,-1.0313989589834756,0.4027777777777778,1.0,1.0,44/174,22.40%,UBA7;PTPN11;EIF4G2;NUP210;TRIM14;TRIM45;OAS3;UBB;PRKCD;NCAM1;TRIM22;GBP1;EIF4A3;NUP88;IFITM1;PTAFR;IRF1;TRIM3;PIAS1;NUP54;PDZD2;POM121;IFIT1;RIGI;IRF7;IFI6;CAMK2D;PML;STAT1;MX2;NUP37;KPNA4;IFIT2;RSAD2;NUP58;TRIM10;NUP205;OAS2;MID1;PTPN6;TRIM68;MAPK3;HERC5;EGR1
prerank,KEGG_2021_Human__Amphetamine addiction,-0.27759945109368156,-1.030768475634604,0.36507936507936506,1.0,1.0,16/38,27.87%,CREB3L4;FOSB;CREB3L2;PRKACA;ATF2;CALM2;ATF4;CAMK2D;CALM3;PPP1CC;CAMK2G;STX1A;SIRT1;PPP3CB;HDAC2;CALM1
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.3177151522285299,-1.0303534306409903,0.41379310344827586,1.0,1.0,14/21,39.55%,GNA15;MAPK14;GNG3;GNG5;GNB2;P2RY1;GNG11;GNG7;GNG8;PLA2G4A;GNG2;GNB4;GNB1;GNB3
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,-0.19209507225647318,-1.0298497392193307,0.43243243243243246,1.0,1.0,66/213,28.41%,ITGB3;FN1;PAQR3;PTPN11;FGFR1;ZDHHC9;PPP2R5B;DUSP6;RASGRP4;PDGFRB;IL3RA;IL17RD;UBB;PSMD3;SHC1;PDGFRA;DUSP10;PSMA5;CNKSR2;NCAM1;DUSP7;PSMD6;PSMD12;FLT3LG;IL6ST;IL5RA;ARHGAP9;PIK3R1;PIK3R2;CAMK2D;IL2RG;PPP2CA;FNTA;PIK3CB;JAK3;IQGAP1;PSMC4;PDE6D;DUSP8;MARK3;RBX1;DUSP2;RGL2;MAPK3;SEM1;PPP1CC;CAMK2G;PSMD11;NRAS;WDR83;PSMD7;PSME2;PSME4;PSMB10;ABHD17C;ARAF;FRS3;EPGN;PSMB2;PSME1;CALM1;FGF13;JAK2;IRS2;PSMA7;RASGEF1A
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.2535335581836536,-1.0297864037700268,0.45614035087719296,1.0,1.0,19/53,28.17%,ERLEC1;UBB;PSMD3;PSMA5;PSMD6;PSMD12;SYVN1;OS9;PSMC4;SEM1;HHAT;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.22515328831901246,1.0297552745572038,0.42424242424242425,1.0,1.0,12/47,17.76%,VAMP3;DIAPH1;VRK2;ARHGAP35;CAPZB;VANGL1;AKAP12;ARHGAP1;CPNE8;ARHGAP5;WHAMM;ARHGAP26
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.18272069691997325,1.0295384510002068,0.4642857142857143,1.0,1.0,19/143,10.15%,CCRL2;GPR132;CXCL8;MC1R;SUCNR1;CXCR1;CXCR3;S1PR1;PTGDR2;RLN2;PLPPR2;AGXT;OXER1;NLRP3;C5;P2RY6;DHX34;HCAR3;LPAR2
prerank,KEGG_2021_Human__Huntington disease,0.17647445091353992,1.028870950179887,0.47619047619047616,1.0,1.0,33/247,10.68%,MAP3K5;PLCB4;POLR2I;UQCR10;TUBB3;KLC1;TBPL2;WIPI1;ATG101;POLR2J2;NDUFB10;ATP5PD;CASP8;ATG13;ACTR10;NDUFS6;TUBB1;APAF1;CREB1;COX7B;PSMB4;NDUFB7;COX8A;COX4I1;TBPL1;IFT57;ADRM1;KIF5A;SDHD;CASP3;DCTN4;NDUFB2;POLR2H
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.26855249065550635,-1.0272527744864728,0.48214285714285715,1.0,1.0,3/34,4.83%,B4GALT2;GALNT3;OGT
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.2428035636331347,-1.0271540630628886,0.4225352112676056,1.0,1.0,19/61,23.53%,CAV2;GNAI1;IGF1R;AKT1;SHC1;GNG3;STRN;GNG5;ZDHHC7;GNB2;MMP9;PIK3R1;PIK3R2;AKT2;SRF;GNG11;MAPK3;XPO1;NRAS
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,-0.2818055615900381,-1.0240099825171933,0.41509433962264153,1.0,1.0,4/33,7.60%,ITGB3;FN1;IL17RD;CNKSR2
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.322460325797815,-1.0232090532420466,0.45,1.0,1.0,3/16,10.87%,STK11;FASLG;BBC3
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.2459227559101629,-1.0222309812240227,0.40350877192982454,1.0,1.0,13/41,24.58%,ITGB3;SMURF1;UBB;UBE2M;LTBP4;MTMR4;TGFB3;ZFYVE9;SMAD4;PPP1CC;XPO1;PMEPA1;ITGB1
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,-0.28962686542078386,-1.0221594468098232,0.42857142857142855,1.0,1.0,6/30,8.33%,PDK4;RDH10;CPT1A;RDH14;RARA;DLAT
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,-0.19145607829152136,-1.0220105234470112,0.4383561643835616,1.0,1.0,75/207,32.20%,ITGB3;FN1;PAQR3;FGFR1;ZDHHC9;PPP2R5B;DUSP6;RASGRP4;PDGFRB;IL3RA;IL17RD;UBB;PSMD3;SHC1;PDGFRA;DUSP10;PSMA5;CNKSR2;NCAM1;DUSP7;PSMD6;PSMD12;FLT3LG;IL5RA;ARHGAP9;PIK3R1;PIK3R2;CAMK2D;IL2RG;PPP2CA;FNTA;PIK3CB;JAK3;IQGAP1;PSMC4;PDE6D;DUSP8;MARK3;RBX1;DUSP2;RGL2;MAPK3;SEM1;PPP1CC;CAMK2G;PSMD11;NRAS;WDR83;PSMD7;PSME2;PSME4;PSMB10;ABHD17C;ARAF;FRS3;EPGN;PSMB2;PSME1;CALM1;FGF13;JAK2;IRS2;PSMA7;RASGEF1A;ERBB3;EREG;ITGA2B;PRKCQ;MAPK1;FYN;VWF;ARRB2;ICMT;PSMC5;PSMA3
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.31314023920819606,1.020570806507105,0.4,1.0,1.0,7/15,22.03%,PPP2R5E;PPP2CB;CSNK1A1;PPP2R1B;PPP2R1A;PPP2R5A;PPP2R5D
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,-0.22348943190427328,-1.020016254660954,0.3939393939393939,1.0,1.0,12/78,11.65%,GNAI1;CACNB3;AKAP5;STK11;SNAP25;PLCB2;GNA15;GNG3;CACNA1E;GNG5;GNB2;ADCY4
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,-0.2319193771768644,-1.0196788222824071,0.3870967741935484,1.0,1.0,19/67,24.40%,TRPV2;MAPK8;PRKCD;PLCB2;MAPK14;ADCY4;PRKACA;PLA2G6;PIK3R1;PIK3R2;CALM2;CAMK2D;PIK3CB;CALM3;ADCY3;PPP1CC;CAMK2G;MAPK13;PLCB3
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,-0.19362984598724317,-1.0187174070006713,0.4305555555555556,1.0,1.0,38/229,15.67%,PHC3;RING1;PTPN11;RNF2;FGFR1;PPP2R5B;PDGFRB;PHC1;TSC2;RRAGD;UBB;PSMD3;AKT1;CLSTN1;IRAK4;RBBP7;PDGFRA;PSMA5;SLC38A9;EED;STRN;CBX4;PHC2;PSMD6;PSMD12;AGO3;RPTOR;FRK;IL1RL1;FLT3LG;ATN1;AGO4;TRAF6;THEM4;MKRN1;MLST8;PIK3R1;PIK3R2
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.2461517312661883,-1.0184994506199747,0.421875,1.0,1.0,25/57,34.42%,UBB;PSMD3;FKBPL;PSMA5;MAPRE1;PSMD6;PSMD12;PLK1;PSMC4;CDKN1A;SEM1;PSMD11;PSMD7;HSP90AB1;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;PSMC1;CCNB2;HSP90AA1
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.32132262670765255,-1.0183996802158393,0.36666666666666664,1.0,1.0,5/20,10.22%,GNA15;GNG3;TBXA2R;GNG5;GNB2
prerank,KEGG_2021_Human__Oocyte meiosis,-0.22213862227356734,-1.0183530599139616,0.47058823529411764,1.0,1.0,40/99,29.80%,ANAPC11;PPP2R5B;SPDYE18;IGF1R;MAPK14;FBXO5;SKP1;ANAPC4;SLK;ANAPC5;CDC26;YWHAQ;ADCY4;RPS6KA2;CDC20;PRKACA;CALM2;CAMK2D;PPP2CA;PLK1;ESPL1;SGO1;CALM3;RBX1;SPDYA;MAPK3;ADCY3;PPP1CC;CAMK2G;MAPK13;CPEB2;CDK2;CPEB4;PPP3CB;SPDYE16;CALM1;YWHAH;PKMYT1;ANAPC10;BTRC
prerank,KEGG_2021_Human__Peroxisome,0.21719378261945466,1.017136629114251,0.4864864864864865,1.0,1.0,18/75,17.55%,ACOT8;PEX5;PMVK;ECH1;ACSL6;MPV17;NUDT12;ACSL1;AGXT;PIPOX;HMGCL;ACSL4;GSTK1;HSD17B4;ACOX1;FAR1;PEX14;PRDX1
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.24300790932092353,-1.0167806604064442,0.4492753623188406,1.0,1.0,17/68,17.11%,H2AZ2;PARP2;H2AZ1;H2BC3;APEX1;FEN1;H2AC7;H2AC4;RFC5;SLC19A1;H2BC13;POT1;RPA3;POLD1;POLD2;LRIG1;H2AC14
prerank,Reactome_2022__TNF Signaling R-HSA-75893,-0.25923613547292007,-1.0159414037966967,0.46153846153846156,1.0,1.0,19/43,34.36%,NSMAF;UBB;TRAF1;CYLD;SPPL2A;TANK;BIRC3;RBCK1;RNF31;IKBKB;TAB3;TRADD;ADAM17;MAP3K7;TAB2;CLIP3;RACK1;XIAP;OTULIN
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,-0.31040889153145856,-1.015227899949013,0.5185185185185185,1.0,1.0,5/17,16.95%,PTPN11;CBFB;AGO3;AGO4;PML
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,-0.3348747031201602,-1.0141497335123535,0.47540983606557374,1.0,1.0,4/15,19.85%,UBB;VLDLR;CLTC;AP2S1
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.26726323515139927,-1.0130367347754687,0.5185185185185185,1.0,1.0,6/31,10.22%,RGS6;GNA15;GNG3;CCT2;GNG5;GNB2
prerank,KEGG_2021_Human__Toxoplasmosis,-0.21747126894480698,-1.0120723484887841,0.47761194029850745,1.0,1.0,21/102,19.96%,GNAI1;MAPK8;GNAO1;LAMC1;IL10RB;AKT1;MAPK14;IRAK4;PPIF;IL12A;LY96;RELA;TRAF6;TGFB3;BIRC3;HSPA2;AKT2;STAT1;LAMB4;CCR5;NFKB1
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.3391204725648195,-1.011225905227399,0.4666666666666667,1.0,1.0,4/17,9.91%,EXOC7;EXOC3;EXOC4;PKD1
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.2803865007833546,-1.0109344276045784,0.45901639344262296,1.0,1.0,11/33,15.72%,FEN1;CHTF8;CTC1;RFC5;SLC19A1;POT1;RPA3;POLD1;CHTF18;POLD2;LRIG1
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.3424714766822121,-1.010566080467516,0.4067796610169492,1.0,1.0,4/15,14.11%,DCP2;LSM1;EDC3;DCP1B
prerank,KEGG_2021_Human__Purine metabolism,0.2040318573109107,1.0102746882766787,0.37142857142857144,1.0,1.0,11/101,6.23%,PDE2A;PGM1;PDE6H;NUDT16;ADSL;ENTPD2;NT5C3B;HDDC3;PDE7A;PDE10A;ADA
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.24099628451868232,-1.0101081912608312,0.4444444444444444,1.0,1.0,12/51,20.58%,ECSIT;TMEM126B;NDUFAF6;NDUFAF1;NDUFV3;NDUFS7;NDUFA6;NDUFB6;NDUFA9;NDUFB5;COA1;NDUFS3
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,-0.28911752705968474,-1.0100998212188113,0.509090909090909,1.0,1.0,5/18,18.64%,SLC30A7;SLC11A2;SLC39A14;SLC30A5;SLC30A6
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,-0.27975846233669255,-1.0098884020880843,0.4393939393939394,1.0,1.0,11/40,17.59%,MCPH1;H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;RAB33B;H2BC13;RB1;H2AC14;PLK1
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,-0.3293088057944731,-1.0095773514936888,0.43333333333333335,1.0,1.0,7/17,22.12%,CRCP;POLR3C;POLR2K;POLR1D;POLR3K;POLR3A;POLR3H
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.2381439097905539,-1.0087746579359802,0.47761194029850745,1.0,1.0,11/46,15.39%,LIG1;ERCC5;DDB1;ERCC8;RAD23B;RFC1;RFC5;RPA3;POLD1;ERCC1;POLD2
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,-0.18221749729867973,-1.0086310620325218,0.38202247191011235,1.0,1.0,69/351,17.55%,RGS19;GNAI1;HRH2;OBSCN;ADM;CCR8;ARHGEF39;RHOB;GNA12;DGKQ;PCDHA4;UTS2R;SCT;RGS6;RGS12;PRKCD;DGKD;PLCB2;GNA15;AKT1;RASGRP2;SHC1;GPR68;CCL5;GNG3;NPFF;CCR7;RAMP1;ARHGEF18;S1PR2;CXCR6;CXCL10;TBXA2R;RGS18;CAMKK1;GNG5;GNB2;TAS2R50;DGKH;LPAR6;TAS2R13;FFAR3;ADCY4;ADORA3;PTAFR;RPS6KA2;MGLL;MAPK7;RHOC;CASR;UTS2B;P2RY1;GPSM1;VIPR1;ARHGEF35;PPAN-P2RY11;GHRL;PIK3R1;UTS2;PIK3R2;GPR183;AKT2;CAMK2D;PDE4C;PPBP;OPN3;PDE1B;PLXNB1;PPP2CA
prerank,KEGG_2021_Human__Fatty acid elongation,-0.2919446415170591,-1.0078126508902225,0.4727272727272727,1.0,1.0,7/25,15.81%,TECR;ELOVL3;ELOVL7;HADH;THEM5;THEM4;HACD2
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.2618337805458778,-1.007021836423944,0.4264705882352941,1.0,1.0,10/45,12.45%,H2AZ2;H2AZ1;H2BC3;H2AC7;POLR2K;H2AC4;POLR2B;H2BC13;POT1;POLR2D
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.2327178695230041,1.0064641067351008,0.4473684210526316,1.0,1.0,5/38,7.22%,PLCB4;CACNA1I;CREB1;NR4A1;SCARB1
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,0.2745358440154353,1.005720148054255,0.4857142857142857,1.0,1.0,4/18,9.44%,ALDH1B1;PANK3;ALDH2;ENPP1
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.19978461301081193,-1.0050863646862713,0.4794520547945205,1.0,1.0,44/177,20.82%,RPS15A;EXOSC2;EXOSC6;NIP7;RPP25;RPL37A;NOL6;RPLP0;RPP40;EBNA1BP2;EXOSC9;RPS21;WDR12;UTP6;RPS23;RPS4X;UTP4;RSL24D1;NOP58;SPPL2A;BOP1;RPS20;BYSL;RPP38;UTP18;RPS14;RPL9;RPS3A;PDCD11;UTP14C;RPS16;PNO1;RPS6;RCL1;RPL32;RPL11;WDR43;NOL12;RPS7;RPL7;EMG1;XRN2;RPL10A;RPP14
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,-0.22169309926623476,-1.0045944249727197,0.4444444444444444,1.0,1.0,31/76,33.43%,RASGRP4;UBB;PSMD3;RASGRP2;SKP1;PSMA5;PSMD6;PSMD12;RELA;TRAF6;PSMC4;NFKB1;SEM1;PSMD11;PSMD7;BCL10;PSME2;PSME4;PSMB10;IKBKB;PSMB2;PSME1;PSMA7;TAB3;BTRC;PRKCQ;MAP3K7;PSMC5;PSMA3;TAB2;PSMC1
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.3172585053377779,-1.004526840632003,0.4918032786885246,1.0,1.0,15/23,39.55%,GNG3;GNG5;GNB2;ADCY4;GNG11;PRKAR2A;PRKAR1B;GNG7;GNG8;GNG2;PRKAR2B;GNB4;PRKAR1A;GNB1;GNB3
prerank,KEGG_2021_Human__Breast cancer,-0.2136146351123156,-1.0041873572289708,0.40540540540540543,1.0,1.0,25/94,21.73%,HEY1;FGFR1;FRAT1;FZD2;NFKB2;IGF1R;LRP5;AKT1;SHC1;BAK1;NCOA3;WNT10A;RB1;GADD45G;WNT10B;PIK3R1;PIK3R2;AKT2;PIK3CB;E2F2;E2F3;RAF1;CDKN1A;GADD45A;MAPK3
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,-0.22786393651204354,-1.0041368508068174,0.45714285714285713,1.0,1.0,23/83,20.65%,VPS37A;NUP210;H2BC3;H2AC7;CEBPD;VPS37C;VPS37B;CHMP1A;CHMP4B;H2AC4;H2AC12;H2BC13;UBAP1;NUP88;SNF8;TXN2;NUP54;POM121;H2AC14;NUP37;NUP58;NUP205;CD46
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.23694356953681736,-1.003782323138781,0.4098360655737705,1.0,1.0,15/53,22.74%,ZDHHC9;GANAB;FUT8;UBB;ST6GALNAC4;ZDHHC20;MGAT5;ST3GAL3;PARP9;ZDHHC5;ST6GAL1;ZDHHC2;PARP16;PARP6;UBE2I
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.2619282602472538,-1.0033477380227083,0.38095238095238093,1.0,1.0,11/36,20.80%,COPS2;PARP2;UBB;DDB1;RAD23B;INO80;COPS6;GPS1;INO80D;INO80E;RBX1
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.28307922139816055,-1.0024668610349268,0.49122807017543857,1.0,1.0,2/29,0.22%,ITGB3;FN1
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,0.24034421684262747,1.0019026795002233,0.48484848484848486,1.0,1.0,6/32,10.68%,POLR2I;ELOC;ELL;NELFCD;NELFB;POLR2H
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,-0.18103685435038847,-1.001783945207897,0.43529411764705883,1.0,1.0,138/381,32.43%,FN1;CRKL;IL24;PTPN11;MAPK8;IL18RAP;DUSP6;RPLP0;IL3RA;PTPN18;SNAP25;UBB;NFKB2;PSMD3;IL10RB;AKT1;CLSTN1;MAPK14;IRAK4;ITGAX;CEBPD;VEGFA;TBK1;SKP1;SHC1;CCL5;S100A12;IL12A;IFNLR1;PSMA5;MAP3K3;HSP90B1;DUSP7;CXCL10;PSMD6;PSMD12;STX3;INPPL1;FASLG;TANK;IL1RL1;CRK;TNIP2;IL6ST;PTAFR;IL5RA;RPS6KA2;MEF2C;CSF3R;CISH;PITPNA;RELA;MAPK7;MMP9;TRAF6;FCER2;MAPKAPK3;SYK;MSN;PIK3R1;PIK3R2;TEC;CRLF1;STX4;STAT1;IL2RG;NKIRAS2;PPP2CA;ITGB2;N4BP1;PIK3CB;ANXA2;JAK3;PSMC4;CCR5;NKIRAS1;NFKB1;FPR1;RNASEH2A;RBX1;CDKN1A;MAP2K7;PTPN6;MAPK3;PTGS2;CA1;SEM1;SQSTM1;PSMD11;STX1A;IL17RA;PSMD7;HNRNPF;ITGB1;PSME2;PSME4;IL4R;SERPINB2;PSMB10;AURKAIP1;FOXO1;INPP5D;CANX;IRAK2;IKBKB;PSMB2;IL21R;PSME1;IL19;LGALS9;HMGB1;FGF13;JAK2;IRS2;PSMA7;IL15RA;ICAM1;TAB3;GSTO1;BTRC;CCM2;GATA3;LONP1;IL18R1;MAP3K7;HNRNPDL;IL7R;IL18BP;MAPK1;FYN;POU2F1;CXCL2;CCL3;PSMC5;MTAP;PSMA3;TAB2;H3C13
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.19741731784708835,1.001727751044601,0.53125,1.0,1.0,14/115,7.41%,ATP6V0B;FXYD2;ATP6V1A;ATP6V0A1;CLCN2;WNK1;ATP2A1;WWP1;SGK1;MCOLN2;ANO9;ATP11B;ATP6V0C;ANO10
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.31310514895310015,-1.0015565872157914,0.4461538461538462,1.0,1.0,12/17,39.55%,PLCB2;GNG3;GNG5;GNB2;GNG11;PLCB3;GNG7;GNG8;GNG2;GNB4;GNB1;GNB3
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.31310514895310015,-1.0015565872157914,0.4461538461538462,1.0,1.0,12/17,39.55%,PLCB2;GNG3;GNG5;GNB2;GNG11;PLCB3;GNG7;GNG8;GNG2;GNB4;GNB1;GNB3
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.23117786099976764,-1.0015262500332978,0.5072463768115942,1.0,1.0,29/78,29.80%,ANAPC11;UBB;PSMD3;FBXO5;SKP1;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;CDC20;PLK1;PSMC4;SEM1;PSMD11;PSMD7;CDK2;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;CCNA1;PSME1;PSMA7;ANAPC10;BTRC
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,-0.23152897460124253,-1.0011818390960978,0.4603174603174603,1.0,1.0,10/69,9.69%,RNF185;ERLEC1;LMBRD1;UBB;PSMD3;ABCB11;PSMA5;ABCC2;PSMD6;PSMD12
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.24445771411410505,1.0010848271561221,0.46153846153846156,1.0,1.0,7/27,17.35%,B2M;AP1G1;LCK;DOCK2;AP1S3;AP1B1;AP1S2
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.268154369770161,1.0009220422250718,0.5121951219512195,1.0,1.0,6/19,16.81%,CDC42;TCF7L1;BNIP2;TCF7L2;ABL1;MAPK11
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,0.2052470816734572,0.9998214350966411,0.5555555555555556,1.0,1.0,7/71,4.03%,CDC25C;YWHAB;H2BC15;POLR1B;RAD50;DNA2;HUS1
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,-0.18524750479175411,-0.9995080448307281,0.4520547945205479,1.0,1.0,46/257,17.55%,PHC3;RING1;PTPN11;RNF2;FGFR1;PPP2R5B;PDGFRB;PHC1;TSC2;RRAGD;UBB;PRKCD;PSMD3;AKT1;CLSTN1;IRAK4;RBBP7;PDGFRA;PSMA5;SLC38A9;EED;STRN;CBX4;CAMKK1;PHC2;PSMD6;PSMD12;AGO3;RPTOR;FRK;IL1RL1;FLT3LG;ADCY4;ATN1;AGO4;TRAF6;THEM4;MKRN1;MLST8;PIK3R1;PIK3R2;AKT2;CAMK2D;PML;PDE1B;PPP2CA
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.26542237320178985,-0.9994301033830022,0.4927536231884058,1.0,1.0,15/43,27.81%,H2AZ2;H2AZ1;H2BC3;H2AC7;RBBP7;H2AC4;H2BC13;TTF1;H2AC14;MTA3;H4C15;HDAC2;H2BC21;H2AC20;GATAD2A
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.19629439511556124,-0.999373213135496,0.4,1.0,1.0,22/153,11.14%,PDP2;ECSIT;TMEM126B;NDUFAF6;PDK4;IDH3G;UQCR11;GSTZ1;SLC16A3;ETFDH;NDUFAF1;NDUFV3;DLAT;IDH3B;SCO2;ATP5ME;NDUFS7;LDHA;NDUFA6;UQCRFS1;BSG;MPC2
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.20870932602887024,-0.9988026506923572,0.45714285714285713,1.0,1.0,49/128,32.40%,MAPK8;SLC7A8;RASGRP4;MS4A2;UBB;PSMD3;RASGRP2;SKP1;SHC1;PSMA5;PSMD6;PSMD12;RELA;TRAF6;SYK;PIK3R1;PIK3R2;TEC;PIK3CB;PSMC4;LCP2;NFKB1;MAP2K7;MAPK3;SEM1;TXK;PSMD11;NRAS;PSMD7;BCL10;PSME2;PSME4;PSMB10;PPP3CB;IKBKB;PSMB2;PSME1;CALM1;PSMA7;AHCYL1;TAB3;BTRC;PRKCQ;MAP3K7;MAPK1;FYN;PSMC5;PSMA3;TAB2
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.27826686962101144,-0.9983598896849717,0.4307692307692308,1.0,1.0,14/27,32.91%,IDH3G;MDH1;DLAT;FH;IDH3B;SUCLG2;CS;DLD;DLST;SUCLA2;PDHB;IDH3A;SDHC;MDH2
prerank,Reactome_2022__Kinesins R-HSA-983189,0.24243125081679717,0.997036999822734,0.5,1.0,1.0,7/35,13.43%,KLC1;KIF11;KIF20A;KIF5A;KIFC2;KLC4;KIF15
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.22713400090863972,0.9969964462454493,0.47368421052631576,1.0,1.0,13/55,16.27%,NCOA1;DAND5;PMVK;PPARA;ELOVL6;LMBR1;INSIG2;FDFT1;MBD4;SCAP;ACACB;SCD;HELZ2
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.2363933534038386,-0.9967922794182811,0.4411764705882353,1.0,1.0,20/47,29.20%,CNOT7;ZNF385A;PLK2;NPM1;REXO2;CNOT4;CNOT8;CNOT9;BTG2;E2F4;CDKN1A;GADD45A;CNOT10;TFDP2;CDK2;CARM1;ARID3A;CCNA1;CNOT11;RGCC
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.18142028588423206,-0.9959963619295777,0.4155844155844156,1.0,1.0,60/298,18.57%,FANCE;UBA7;RAD9B;MAPK8;ERCC5;COPS2;RMI2;H2AZ2;PARP2;TDP1;EYA3;XRCC4;H2AZ1;H2BC3;UBB;APEX1;FEN1;H2AC7;FAAP100;DDB1;ERCC8;RAD23B;PIAS3;INO80;NSD2;POLR2K;TCEA1;CENPS-CORT;H2AC4;POLR2B;SMARCA5;RFC5;SLC19A1;H2BC13;POT1;POLR2D;RHNO1;PIAS1;RPA3;POLD1;USP32;ERCC1;XRCC6;ASCC3;COPS6;XRCC2;POLD2;FTO;MSH6;LRIG1;RAD51AP1;RNF168;UBE2B;H2AC14;ISY1-RAB43;EXO1;GPS1;RAD9A;REV3L;INO80D
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,0.24094049854092964,0.9950431937837302,0.3793103448275862,1.0,1.0,16/29,30.97%,AREG;CNIH3;TGFA;CTSC;FOLR2;COL7A1;CNIH2;LMAN2L;SERPINA1;SEC24D;STX5;CTSZ;SEC24A;TMED2;PREB;CNIH1
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,-0.19898711989906223,-0.995030216075217,0.4473684210526316,1.0,1.0,39/175,20.84%,ITGB3;FN1;CAPN3;KLKB1;LAMC1;MMP28;DCN;P3H2;THBS1;CAPN5;ITGAX;SH3PXD2A;LOXL1;LMNB2;CEACAM8;LTBP4;NCAM1;FBN2;KLK2;ACTN1;COL6A2;BSG;FBLN5;ELANE;MMP9;COL19A1;ITGAD;TGFB3;DST;SDC4;ADAM19;TPSAB1;ITGB2;TRAPPC4;BMP1;PPIB;MMP8;NCSTN;MMP14
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.21213626172393896,-0.9944090631510963,0.4852941176470588,1.0,1.0,22/80,21.57%,ERCC5;COPS2;PARP2;UBB;DDB1;RAD23B;PIAS3;INO80;RFC5;SLC19A1;PIAS1;RPA3;POLD1;ERCC1;COPS6;POLD2;LRIG1;GPS1;INO80D;INO80E;RBX1;ERCC3
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,-0.287922946840131,-0.9943999681435808,0.4696969696969697,1.0,1.0,8/22,21.42%,CD274;SHC1;PIK3R1;PIK3R2;IL2RG;PIK3CB;JAK3;PTPN6
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,-0.20100014990498827,-0.993876917123523,0.47297297297297297,1.0,1.0,37/167,17.88%,CAV2;GNAI1;H2AZ2;H2AZ1;H2BC3;IGF1R;DDX5;H2AC7;AKT1;CHD1;SHC1;GNG3;NRIP1;GTF2F2;CBFB;NCOA3;STRN;GNG5;ZDHHC7;POLR2K;GTF2A1;AGO3;GNB2;H2AC4;POLR2B;H2BC13;POLR2D;FOSB;AGO4;MMP9;TFF3;PIK3R1;PIK3R2;AKT2;H2AC14;CDK9;MYB
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.29427769047994073,-0.9932779054932971,0.45454545454545453,1.0,1.0,18/29,44.06%,SHC1;SYK;TEC;LCP2;TXK;PPP3CB;CALM1;AHCYL1;PLCG2;IGLL5;SOS1;ITPR2;LYN;VAV1;ITK;PLCG1;ITPR3;NFATC2
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.31046697964463327,0.9931123105376215,0.5806451612903226,1.0,1.0,7/17,26.97%,TRIM24;GAB2;FGFR1OP2;LRRFIP1;STAT5A;GRB2;STAT3
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.2914911774786625,0.9929290602705524,0.4634146341463415,1.0,1.0,6/19,15.00%,ROCK1;MYH9;MYL9;ERBB2;RND1;SEMA4D
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,0.2753683890611873,0.9926531356122548,0.4883720930232558,1.0,1.0,4/19,10.79%,ABCG2;GGT7;ABCC5;GSTP1
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,-0.21118498917552792,-0.9918768602155688,0.4393939393939394,1.0,1.0,33/96,29.21%,GNAI1;MAPK8;GNAO1;PLCB2;MAPK14;GNG3;NDUFV3;GNG5;GABRD;GNB2;NDUFS7;NDUFA6;ADCY4;MGLL;PRKACA;NDUFB6;NDUFA9;NDUFB5;NDUFS3;GNG11;MAPK3;PTGS2;ADCY3;MAPK13;PLCB3;CACNA1A;DAGLA;GNG7;NDUFB1;GNG8;GABRP;NDUFS4;NDUFA4
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,-0.23166108871854924,-0.9918572337874517,0.4696969696969697,1.0,1.0,16/59,21.73%,MAPK8;DUSP6;UBB;MAPK14;SKP1;DUSP7;TNIP2;RPS6KA2;MEF2C;MAPK7;TRAF6;MAPKAPK3;PPP2CA;NFKB1;MAP2K7;MAPK3
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,-0.17827129678167578,-0.9896335908211754,0.4090909090909091,1.0,1.0,75/381,17.55%,RGS19;GNAI1;HRH2;OBSCN;ADM;CCR8;ARHGEF39;RHOB;GNA12;DGKQ;PCDHA4;UTS2R;FZD2;SCT;RGS6;ACKR2;RGS12;PRKCD;DGKD;PLCB2;GNA15;AKT1;RASGRP2;SHC1;GPR68;CCL5;GNG3;NPFF;CCR7;RAMP1;ARHGEF18;S1PR2;CXCR6;CXCL10;TBXA2R;RGS18;CAMKK1;GNG5;GNB2;TAS2R50;DGKH;LPAR6;TAS2R13;WNT10A;FFAR3;ADCY4;ADORA3;PTAFR;RPS6KA2;ADGRE3;MGLL;MAPK7;RHOC;CASR;WNT10B;UTS2B;P2RY1;GPSM1;VIPR1;ARHGEF35;PPAN-P2RY11;GHRL;PIK3R1;UTS2;PIK3R2;GPR183;AKT2;CAMK2D;PDE4C;GPR35;PPBP;OPN3;PDE1B;PLXNB1;PPP2CA
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.1968390598850536,-0.9894639885922757,0.4647887323943662,1.0,1.0,61/187,27.32%,RPS15A;EXOSC2;EXOSC6;NIP7;RPP25;RPL37A;NOL6;RPLP0;RPP40;EBNA1BP2;EXOSC9;RPS21;WDR12;UTP6;RPS23;RPS4X;UTP4;RSL24D1;NOP58;SPPL2A;BOP1;RPS20;BYSL;RPP38;UTP18;TRMT112;RPS14;RPL9;RPS3A;PDCD11;UTP14C;RPS16;PNO1;RPS6;RCL1;RPL32;RPL11;WDR43;NOL12;RPS7;RPL7;EMG1;XRN2;RPL10A;RPP14;THUMPD1;LTV1;BMS1;RPS12;BUD23;DKC1;NOP56;RPS8;RPL27;EXOSC1;MPHOSPH10;EXOSC3;RPL14;MRPL13;RPL22L1;RPL23
prerank,KEGG_2021_Human__Gap junction,-0.2280848737004628,-0.9893463641098517,0.5230769230769231,1.0,1.0,12/61,15.75%,GNAI1;PDGFD;PDGFRB;PLCB2;PDGFRA;TUBA4A;ADCY4;MAPK7;PRKACA;GUCY1B1;TUBB2A;TUBB6
prerank,KEGG_2021_Human__Renin secretion,-0.25343455114945007,-0.9892523678048953,0.453125,1.0,1.0,13/40,28.10%,GNAI1;KCNJ2;ACE;PLCB2;PRKACA;GUCY1B1;CALM2;PDE1B;CALM3;PLCB3;PPP3CB;CALM1;PDE3A
prerank,KEGG_2021_Human__Insulin secretion,-0.23822833334765298,-0.9884322360210914,0.515625,1.0,1.0,18/51,24.40%,SNAP25;CREB3L4;PLCB2;KCNMB1;ADCY4;CREB3L2;PRKACA;ATF2;ATP1B2;ATF4;KCNN4;CAMK2D;SLC2A1;ADCY3;ATP1B3;CAMK2G;STX1A;PLCB3
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.21728220725989397,-0.9883316949661136,0.49230769230769234,1.0,1.0,20/85,20.28%,PTPN11;FGFR1;PPP2R5B;PDGFRB;AKT1;CLSTN1;IRAK4;PDGFRA;STRN;IL1RL1;FLT3LG;TRAF6;THEM4;PIK3R1;PIK3R2;AKT2;PPP2CA;PIK3CB;ICOS;PIP4K2C
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.24356553458478725,-0.9878919604273206,0.4576271186440678,1.0,1.0,18/52,28.17%,ERLEC1;UBB;PSMD3;PSMA5;PSMD6;PSMD12;SYVN1;OS9;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,-0.231565096338915,-0.9864890359340471,0.5079365079365079,1.0,1.0,30/75,31.83%,GDE1;SBF2;INPP5K;CLSTN1;MTMR2;PI4KA;INPPL1;TNFAIP8L1;MTMR4;PNPLA7;SYNJ1;PLEKHA1;PIK3R1;PIK3R2;PLEKHA2;RAB14;MTM1;PIK3CB;PIP4K2C;GDPD1;INPP5D;INPP4B;RAB4A;PIP5K1B;OCRL;PIK3R4;SYNJ2;PI4K2B;PLEKHA5;PIP5K1A
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.19280150391320428,0.986053986932634,0.5,1.0,1.0,11/84,8.54%,SAP18;NXF1;PPP2R5E;WDR33;PPP2CB;SSU72;CPSF1;SYMPK;CSTF2T;RNMT;NCBP1
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,-0.2966330021311499,-0.9853178165377183,0.4406779661016949,1.0,1.0,7/21,22.09%,BCKDHA;BCKDK;ACADSB;MCCC1;ALDH6A1;HIBADH;ACAD8
prerank,KEGG_2021_Human__Dopaminergic synapse,-0.22094859326455632,-0.9847500366322022,0.4426229508196721,1.0,1.0,20/92,17.55%,GNAI1;MAPK8;PPP2R5B;GNAO1;CREB3L4;PLCB2;AKT1;MAPK14;GNG3;GNG5;GNB2;CREB3L2;PRKACA;ATF2;CALM2;ATF4;AKT2;CAMK2D;KIF5C;PPP2CA
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,-0.18058534237464025,-0.9840487454981857,0.5,1.0,1.0,75/331,19.85%,SIKE1;RPS15A;PTPN11;ZDHHC9;ZBP1;GANAB;ATG14;TRIM4;NUP210;FUT8;CD79A;UBB;DDX5;AKT1;RPS21;SNRPB;VEGFA;RBBP7;TBK1;ST6GALNAC4;RPS23;RPS4X;IKBKE;TLR8;CHMP4B;RPS20;VPS33B;YWHAQ;NUP88;CNBP;RB1;VPS18;ZDHHC20;MGAT5;G3BP2;KEAP1;RPS14;G3BP1;RPS3A;GEMIN6;NUP54;FXYD7;TRAF6;SNRPE;ST3GAL3;POM121;SAP30;SYK;RPS16;REXO2;RPS6;RIGI;ATP1B2;IRF7;SDC4;AKT2;VPS45;STAT1;PARP9;ZCRB1;NUP37;ZDHHC5;FNTA;ST6GAL1;NRP1;ZDHHC2;NUP58;HAVCR1;JAK3;SEC23A;PARP16;NUP205;TKFC;RPS7;AP2S1
prerank,KEGG_2021_Human__Pancreatic secretion,-0.24502459358234174,-0.9834803250497349,0.543859649122807,1.0,1.0,11/54,12.76%,TPCN2;SCT;PLCB2;PLA2G2C;CTRL;KCNQ1;BST1;AMY2B;RAB27B;ADCY4;TRPC1
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.225108475437693,0.982764839623942,0.5,1.0,1.0,16/51,21.17%,COL13A1;COL28A1;COL6A1;SERPINH1;P4HA2;CD151;CTSS;CTSB;PLOD1;COL7A1;P3H1;COL9A3;PCOLCE;ITGA6;COL6A3;PLOD2
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.21614280240325467,-0.9823767026645503,0.5342465753424658,1.0,1.0,15/85,11.76%,DCTN3;PLK4;CDK5RAP2;CEP192;UBB;SKP1;NEK2;MAPRE1;HAUS1;CLASP1;HAUS3;AKAP9;TUBA4A;PCM1;CEP57
prerank,KEGG_2021_Human__p53 signaling pathway,0.19928414184480836,0.981807057160435,0.40540540540540543,1.0,1.0,17/68,16.62%,ZMAT3;SIAH1;CASP8;CCND2;APAF1;GADD45B;CASP3;PPM1D;CDK1;CDKN2A;SESN2;CDK6;CHEK1;CCNB1;AIFM2;CDK4;CYCS
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,0.21726092043940154,0.9813180806746531,0.36363636363636365,1.0,1.0,8/41,14.56%,IL6;ITGA4;IL10;IL15;LTBR;MADCAM1;HLA-DRB3;TGFB1
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,-0.20864978801589357,-0.9806474577069021,0.5384615384615384,1.0,1.0,21/89,19.88%,CRKL;PLPP1;FCGR2A;PAK1;PRKCD;AKT1;BIN1;ARPC4;LIMK2;INPPL1;CRK;PLD2;SYK;PLA2G6;PIK3R1;PIK3R2;AKT2;PIK3CB;RAF1;WAS;VASP
prerank,KEGG_2021_Human__Malaria,-0.23942983004169724,-0.9804126154064228,0.5079365079365079,1.0,1.0,6/43,6.58%,HBA2;KLRC4-KLRK1;KLRK1;HBA1;THBS1;IL12A
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.2157155653283707,-0.979618209833385,0.4857142857142857,1.0,1.0,18/78,20.28%,PTPN11;FGFR1;PPP2R5B;PDGFRB;AKT1;CLSTN1;IRAK4;PDGFRA;STRN;IL1RL1;FLT3LG;TRAF6;PIK3R1;PIK3R2;PPP2CA;PIK3CB;ICOS;PIP4K2C
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.2808731767166289,-0.9790991889571898,0.46774193548387094,1.0,1.0,8/27,19.59%,DUT;NME3;TXN2;AK1;RRM2;NUDT13;CMPK1;RRM2B
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.28935446893797506,-0.978940351180449,0.5507246376811594,1.0,1.0,8/25,15.39%,CHTF8;CTC1;RFC5;SLC19A1;POT1;POLD1;CHTF18;POLD2
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.23455032007240714,0.9779690152156453,0.43243243243243246,1.0,1.0,8/36,13.51%,EFCAB7;CCND2;CUL1;SPOPL;CSNK1G3;CSNK1G1;DISP1;CSNK1A1
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,-0.29752727116230604,-0.9772672559724191,0.4838709677419355,1.0,1.0,5/20,11.26%,CRCP;POLR3C;POLR2K;POLR1D;POLR3K
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,-0.2441033015091103,-0.9771335838887565,0.5423728813559322,1.0,1.0,24/54,33.43%,PAOX;PSMD3;PSMA5;AGMAT;PSMD6;PSMD12;OAZ3;NPRL2;NQO1;PSMC4;AZIN2;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;SMOX;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,0.27549369461108586,0.9762492990653727,0.4473684210526316,1.0,1.0,5/25,11.55%,LOC112694756;FBP1;PCK2;SLC25A1;ENO1
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.22891134204334274,0.9759132000700287,0.4827586206896552,1.0,1.0,8/44,11.44%,POLR2I;ELOC;ELL;NCBP1;NELFCD;NELFB;POLR2H;ERCC2
prerank,KEGG_2021_Human__Complement and coagulation cascades,-0.22715726201376438,-0.9758269739068315,0.4492753623188406,1.0,1.0,24/56,32.65%,KLKB1;C4BPA;ITGAX;PROC;PROCR;F8;PLAT;ITGB2;F5;C4A;PLAU;CD46;CFHR1;F12;PLAUR;CR1L;SERPINB2;TFPI;C2;C3AR1;CD59;VWF;CFI;C1QA
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,0.17702751982892198,0.9745525985364664,0.5454545454545454,1.0,1.0,45/173,20.21%,CEP76;CEP290;NPHP4;HAUS8;B9D1;CEP152;ODF2;HAUS2;EXOC5;BBS2;ARL13B;NINL;ASAP1;CETN2;CEP164;CCT3;TMEM216;CEP70;CEP72;IFT57;DYNLT2;MARK4;CDK1;NPHP1;CEP63;B9D2;AHI1;IFT88;DYNLT2B;ACTR1A;HDAC6;TCP1;CEP41;RAB8A;BBS7;PPP2R1A;BBS10;IFT43;C2CD3;FBF1;RAB11A;SFI1;HAUS4;TTC21B;RAB11FIP3
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,0.27022806778193814,0.9733505864834007,0.4864864864864865,1.0,1.0,5/18,18.14%,ATP2A1;STIM1;ORAI2;ATP2B4;SLC8A1
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.3008074545334492,-0.9729944449305856,0.5660377358490566,1.0,1.0,10/19,34.99%,IDH3G;IDH3B;SUCLG2;CS;DLST;SUCLA2;IDH3A;MDH2;FAHD1;LDLR
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.22743036948992026,-0.9729630376943283,0.4852941176470588,1.0,1.0,24/71,28.17%,ANAPC11;UBB;PSMD3;UBE2C;NEK2;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;CDC20;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;CCNA1;PSME1;PSMA7
prerank,Reactome_2022__Neddylation R-HSA-8951664,-0.1860127221696885,-0.9727605072700914,0.5641025641025641,1.0,1.0,98/210,39.64%,COPS2;COMMD7;COMMD4;UBB;PSMD3;UBE2M;FBXO7;RBBP7;SKP1;DDB1;KLHL25;PSMA5;PUM2;ERCC8;FBXW9;FBXO11;DCAF4;PSMD6;PSMD12;COMMD6;FBXO27;FBXO15;FBXO21;LRRC41;DCAF10;CISH;FBXO44;KEAP1;COPS6;CCNF;ASB6;CUL9;GPS1;FBXW5;PSMC4;COMMD10;DCUN1D3;FBXO4;RBX1;DCAF6;SEM1;KBTBD8;SQSTM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;COPS5;COMMD8;PSMB2;PSME1;UCHL3;PSMA7;FBXL4;UBE2D3;CARD16;FBXW7;FEM1B;FBXL3;FBXO30;NEDD8;BTRC;KCTD6;ANKRD9;FBXL5;COPS4;FBXL8;CAND1;PSMC5;PSMA3;SOCS6;ASB13;FBXL12;KLHL5;UFD1;PSMC1;KLHL20;FBXW8;EPAS1;SOCS5;DCAF13;RNF7;DCAF16;ASB1;PSMD8;SPSB2;CUL4A;COMMD3;DCUN1D5;SPSB1;RBBP5;FBXO31;DCAF5;PSMB3;DDB2;MUL1;ASB7
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.19461660611961992,-0.9723710888060201,0.5487804878048781,1.0,1.0,29/128,19.15%,MGST1;MAT2B;ABHD10;PAOX;CYP4F2;CYB5R3;GSTZ1;GGT5;ACSS1;CYP27A1;ACSS2;SULT1A1;AKR7A2;GSTM2;MAT2A;AKR7L;ADH5;GSTO2;TRMT112;CYP4B1;NQO2;AOC3;AHCY;SLC26A1;PRNP;CYP46A1;GSTM1;CYP4F3;SULT1A2
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.2463395401755515,-0.9721012998176022,0.4918032786885246,1.0,1.0,22/52,33.43%,UBB;PSMD3;FBXO5;SKP1;PSMA5;PSMD6;PSMD12;CDC20;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;BTRC;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.23897483075126688,-0.9720141399039101,0.49206349206349204,1.0,1.0,22/53,33.43%,UBB;PSMD3;AKT1;SKP1;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSMB10;PSMB2;PSME1;PSMA7;FBXW7;NOTCH4;PSMC5;PSMA3;PSMC1
prerank,KEGG_2021_Human__Influenza A,-0.19784259431225804,-0.9711455803863713,0.6190476190476191,1.0,1.0,33/139,19.96%,KPNA6;OAS3;CALCOCO2;AKT1;IRAK4;TBK1;CCL5;IL12A;BCL2L2-PABPN1;IKBKE;BAK1;FAS;CXCL10;RAE1;SLC25A5;FASLG;RELA;PIK3R1;PIK3R2;IRF7;AKT2;PML;DNAJC3;STAT1;MX2;TPSAB1;PIK3CB;RSAD2;PYCARD;RAF1;OAS2;NFKB1;TNFRSF10B
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,-0.22563111988073847,-0.9706899691215413,0.5507246376811594,1.0,1.0,17/53,26.19%,SREBF1;STK11;AKT1;CCNG2;FASLG;BBC3;YWHAQ;TXN2;REXO2;AKT2;CDKN1A;SMAD4;GADD45A;CITED2;SIRT1;FOXO1;HDAC2
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,-0.20550688175212878,-0.970450381488557,0.5555555555555556,1.0,1.0,24/113,16.75%,PTPN11;PDGFD;PDGFRB;PLPP1;GNA12;DGKQ;TSC2;MS4A2;DGKD;PLCB2;AKT1;SHC1;PDGFRA;DGKH;LPAR6;DNM1;ADCY4;PLD2;SYK;RRAS2;PIK3R1;PIK3R2;TSC1;AKT2
prerank,KEGG_2021_Human__ErbB signaling pathway,-0.21557016936419196,-0.9704462408987922,0.5384615384615384,1.0,1.0,19/73,23.53%,CRKL;MAPK8;PAK1;CBLB;AKT1;SHC1;ABL2;CRK;PIK3R1;PIK3R2;AKT2;CAMK2D;PIK3CB;RAF1;CDKN1A;MAP2K7;MAPK3;CAMK2G;NRAS
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.2786866003032219,-0.9690839598456258,0.5161290322580645,1.0,1.0,10/21,31.15%,PRKCD;MAPK14;PDZD2;S100A8;NCF4;MAPK3;NOXA1;CYBA;PIK3R4;MAPK1
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.22091948218926657,-0.9686197633747902,0.4927536231884058,1.0,1.0,14/65,15.39%,ERCC5;UBB;DDB1;ERCC8;POLR2K;TCEA1;POLR2B;RFC5;SLC19A1;POLR2D;RPA3;POLD1;ERCC1;POLD2
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,0.2679010191125022,0.9686140847829352,0.42424242424242425,1.0,1.0,4/20,6.87%,POLR1B;DNA2;POLD4;PRIM2
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,-0.3208914578298315,-0.9677769765677174,0.55,1.0,1.0,9/16,34.42%,AKT1;PTS;GCHFR;PDSS2;DHFR;COQ2;CALM1;PDSS1;HSP90AA1
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.19881960012283045,-0.9665020111496316,0.5070422535211268,1.0,1.0,34/142,19.58%,TAF5;VPS4B;VPS37A;NUP210;XRCC4;UBB;RANGAP1;FEN1;GTF2F2;VPS37C;VPS37B;POLR2K;GTF2A1;CHMP4B;TCEA1;TAF15;POLR2B;UBAP1;NUP88;POLR2D;RAN;TAF9B;XRCC6;NUP54;POM121;SUPT16H;LRIG1;NELFA;CCNK;CDK9;NUP37;NUP58;CCR5;NUP205
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.21800795470142992,-0.9663509352034573,0.53125,1.0,1.0,15/79,12.42%,DCTN3;MZT2A;PLK4;CDK5RAP2;CEP192;NEK2;MAPRE1;HAUS1;CLASP1;HAUS3;AKAP9;TUBA4A;PCM1;CEP57;TUBGCP3
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,-0.24215346136394172,-0.9653384116408219,0.5166666666666667,1.0,1.0,8/39,13.46%,ANAPC11;UBE2C;ANAPC4;ANAPC5;AGO3;CDC26;AGO4;RELA
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.23439291731055384,0.9651606430410362,0.42857142857142855,1.0,1.0,4/29,5.13%,GSTA4;MGST2;GGT7;OPLAH
prerank,KEGG_2021_Human__Hepatocellular carcinoma,-0.19806464366582627,-0.9649659939827083,0.5138888888888888,1.0,1.0,34/130,21.73%,MGST1;FRAT1;FZD2;ARID1B;IGF1R;LRP5;AKT1;SHC1;BAK1;GSTM2;ARID1A;WNT10A;GSTO2;RB1;KEAP1;GADD45G;WNT10B;TGFB3;PIK3R1;PIK3R2;NQO1;AKT2;GSTM1;PIK3CB;E2F2;E2F3;SMARCD1;RAF1;ARID2;CDKN1A;SMAD4;GADD45A;SMARCB1;MAPK3
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.20096105733541691,0.9648403266514634,0.43333333333333335,1.0,1.0,12/75,10.87%,POLR1B;NDC1;HSPA6;POM121C;SERPINH1;HSPA4L;NUP85;NUP153;HSPA5;ST13;HSBP1;BAG2
prerank,KEGG_2021_Human__Prolactin signaling pathway,-0.23472267285594806,-0.9647297226387073,0.47540983606557374,1.0,1.0,17/54,23.54%,MAPK8;AKT1;MAPK14;SHC1;IRF1;CISH;RELA;PIK3R1;PIK3R2;AKT2;STAT1;PIK3CB;RAF1;NFKB1;MAPK3;NRAS;MAPK13
prerank,KEGG_2021_Human__Glutamatergic synapse,-0.21960917331164623,-0.9647148572760137,0.5303030303030303,1.0,1.0,28/65,35.16%,GNAI1;GNAO1;PLCB2;GNG3;GNG5;GNB2;ADCY4;PLD2;TRPC1;PRKACA;HOMER2;GNG11;MAPK3;ADCY3;PLCB3;CACNA1A;PPP3CB;HOMER1;GNG7;GNG8;GRK3;PLD1;MAPK1;PLA2G4A;GLS2;GNG2;GLUL;GNB4
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,-0.26839853317856727,-0.9645278719128731,0.5147058823529411,1.0,1.0,7/34,12.03%,H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13;POT1
prerank,KEGG_2021_Human__Circadian entrainment,-0.21790311933898787,-0.9640671616364643,0.47058823529411764,1.0,1.0,22/57,28.80%,GNAI1;GNAO1;RYR3;PLCB2;GNG3;GNG5;GNB2;ADCY4;PRKACA;GUCY1B1;CALM2;CAMK2D;CALM3;GNG11;MAPK3;ADCY3;CAMK2G;PLCB3;GNG7;CALM1;GNG8;PER2
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.23331581849292105,-0.9636617177097605,0.5,1.0,1.0,9/41,17.41%,ADAT3;URM1;LCMT2;METTL1;TRMT112;PUS7;PUS3;TP53RK;QTRT1
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,0.300165645584042,0.9615467643747279,0.6,1.0,1.0,4/16,12.70%,CCNA2;E2F5;CDK1;RBL1
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.26937647640481555,0.9611273938188057,0.48936170212765956,1.0,1.0,9/20,25.54%,CTNS;BPNT1;LRRC8E;LRRC8D;NIPA2;ADD2;LRRC8B;SLC66A1;LRRC8C
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,0.21241528956410397,0.9611196467766705,0.5897435897435898,1.0,1.0,9/51,8.71%,NDC1;SNRPD2;GEMIN8;POM121C;NUP85;NUP153;GEMIN2;NCBP1;SNRPF
prerank,KEGG_2021_Human__Chagas disease,-0.21522647990937477,-0.9609552170509427,0.5245901639344263,1.0,1.0,21/91,18.40%,GNAI1;MAPK8;GNAO1;ACE;PLCB2;GNA15;AKT1;MAPK14;IRAK4;CCL5;IL12A;FAS;FASLG;RELA;TRAF6;TGFB3;PIK3R1;PIK3R2;AKT2;PPP2CA;PIK3CB
prerank,KEGG_2021_Human__Coronavirus disease,-0.1863420402905635,-0.9604356388614811,0.5616438356164384,1.0,1.0,43/188,19.97%,RPS15A;MAPK8;RPL37A;RPLP0;FCGR2A;ACE;OAS3;RPS21;MAPK14;IRAK4;TBK1;IL12A;RPS23;RPS4X;IKBKE;RSL24D1;CXCL10;TLR8;RPS26;RPS20;SELP;IL6ST;RPS14;RELA;RPL9;RPS3A;TRAF6;SYK;RPS16;RPS6;PIK3R1;PIK3R2;STAT1;MX2;RPL32;PIK3CB;NRP1;RPL11;OAS2;RPS7;C4A;NFKB1;RPL7
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,-0.28511227312907966,-0.9601633392974785,0.515625,1.0,1.0,3/21,5.12%,PTPN11;PPP2R5B;AKT1
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.1954616322902984,-0.9592008312885515,0.5846153846153846,1.0,1.0,37/103,27.22%,SLC46A1;PCCA;CYB5A;CYB5R3;RFK;LMBRD1;ST20-MTHFS;MMUT;SLC2A3;MCCC1;BST1;PROC;SLC19A2;GSTO2;SLC19A1;PANK1;TPK1;PARP9;PARP16;SLC2A1;PARP6;QPRT;NT5E;FPGS;MTRR;PTGS2;DHFR;ABCC1;PCCB;NAPRT;MTHFD2L;PPCDC;SLC19A3;NAXE;SHMT2;SLC52A1;MMADHC
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.1928188787120183,-0.9587232552972774,0.5180722891566265,1.0,1.0,60/159,32.43%,SOX13;PPP2R5B;BCL9;H2AZ2;FRAT1;CBY1;FZD2;H2AZ1;H2BC3;UBB;PSMD3;LRP5;H2AC7;AKT1;PSMA5;USP8;PSMD6;PSMD12;PROC;H2AC4;CDC73;H2BC13;KMT2D;CSNK1G2;LGR6;ASH2L;AKT2;H2AC14;PPP2CA;CTNNBIP1;PSMC4;SOX6;RBX1;TLE2;SEM1;XPO1;RUNX3;PSMD11;PSMD7;PSME2;PSME4;PYGO2;H4C15;PSMB10;H2BC21;PSMB2;H2AC20;PSME1;PIP5K1B;PSMA7;TCF7;LEO1;BTRC;CCDC88C;CSNK1E;CSNK2A2;TLE1;PSMC5;PSMA3;H3C13
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.18515271706128794,0.9586897517607158,0.5454545454545454,1.0,1.0,9/85,8.22%,CCRL2;CXCL8;MC1R;CXCR1;CXCR3;RLN2;AGXT;NLRP3;C5
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.26747233501318957,-0.9582811887439183,0.5161290322580645,1.0,1.0,12/33,24.45%,MCM5;RAD9B;CDC6;MCM4;RFC5;MCM7;RPA3;RAD9A;MCM10;CLSPN;DBF4;CDK2
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.2529302178004501,-0.9580994291510287,0.4827586206896552,1.0,1.0,16/36,31.98%,ITGB3;FN1;CNKSR2;CAMK2D;IQGAP1;MARK3;MAPK3;CAMK2G;NRAS;ARAF;CALM1;JAK2;ITGA2B;MAPK1;VWF;ARRB2
prerank,KEGG_2021_Human__Alzheimer disease,0.15456806156504704,0.9579729986528974,0.6842105263157895,1.0,1.0,35/292,11.13%,MAP3K5;EIF2S1;PLCB4;UQCR10;CDK5R1;TUBB3;CYBB;IDE;KLC1;WIPI1;ATG101;ATP2A1;NDUFB10;IL6;ATP5PD;CASP8;ATG13;NDUFS6;TUBB1;CSF1;APAF1;COX7B;PSMB4;NDUFB7;COX8A;RTN4;COX4I1;PIK3R3;ADRM1;KIF5A;SDHD;CASP3;NDUFB2;CALML4;RTN3
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,-0.2364454277551693,-0.957109507424532,0.5217391304347826,1.0,1.0,6/43,8.99%,PTPN11;SPRY2;UBB;SHC1;STAM;PAG1
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,0.2869847541702871,0.9564863028605757,0.575,1.0,1.0,2/16,2.53%,REV1;POLR1B
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.2077818818013965,0.9553435668243646,0.5714285714285714,1.0,1.0,16/64,16.60%,TGFBR2;ROCK1;PPP2CB;BAMBI;CUL1;E2F5;ACVR2A;ACVR2B;AMH;TGIF1;RBL1;BMP7;TGFB1;PPP2R1B;RPS6KB1;PPP2R1A
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.22269971429184082,-0.954564361074902,0.6,1.0,1.0,13/68,11.76%,DCTN3;PLK4;CDK5RAP2;CEP192;NEK2;MAPRE1;HAUS1;CLASP1;HAUS3;AKAP9;TUBA4A;PCM1;CEP57
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.2345435385949574,-0.9538156535213272,0.6363636363636364,1.0,1.0,18/57,28.17%,RNF185;ERLEC1;UBB;PSMD3;PSMA5;PSMD6;PSMD12;OS9;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.23967587896333892,0.9532388604932234,0.525,1.0,1.0,10/23,25.75%,SLC43A2;SLC6A6;SLC1A4;SLC38A5;SLC36A1;SLC7A11;SLC38A2;SLC6A12;SLC1A5;SLC38A1
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.2600555520062599,-0.953159601960211,0.5151515151515151,1.0,1.0,8/30,16.89%,UBB;DDB1;RFC5;SLC19A1;RPA3;POLD1;POLD2;UBE2B
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,-0.23796269252918278,-0.9527031246364439,0.6101694915254238,1.0,1.0,5/43,6.86%,APOE;COPS2;UBB;SHC1;GFAP
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.2633243810688491,-0.9525710199613894,0.5223880597014925,1.0,1.0,5/31,10.41%,FLOT2;UBB;OGT;FASLG;TANK
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.2684882571156407,-0.9517827075261222,0.59375,1.0,1.0,8/31,15.39%,UBA7;UBB;RFC5;SLC19A1;RPA3;POLD1;USP32;POLD2
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.30673889695206336,-0.9516878932195322,0.5535714285714286,1.0,1.0,3/16,5.21%,PTPN11;PPP2R5B;MAPK14
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,0.259100124054454,0.9510402963555721,0.5641025641025641,1.0,1.0,5/23,10.68%,POLR2I;NCBP1;NELFCD;NELFB;POLR2H
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.16437708765134068,0.9509496054830744,0.6538461538461539,1.0,1.0,47/219,16.99%,BPGM;CHST13;PGM1;GALT;B4GALT1;NDC1;FUT1;LOC112694756;FUT2;FBP1;CHST7;PPP2CB;POM121C;NUP85;PCK2;NUP153;ABCC5;SLC25A1;SDC2;TALDO1;CHST12;SLC35B3;SORD;TKT;CD44;ENO1;B4GALNT2;CHORDC1;MAN2C1;SLC35D2;B4GALT6;GLYCTK;ST3GAL6;VCAN;XYLT2;PPP2R1B;PGM2L1;RHCE;GLCE;EXT1;PGP;IDUA;MAN2B2;PPP2R1A;NUP214;MAP4K2;ENO2
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,0.21889287143283123,0.9503166317654108,0.5588235294117647,1.0,1.0,14/57,17.53%,ACOT8;IDE;PEX5;ECH1;MPV17;AGXT;PIPOX;HMGCL;GSTK1;HSD17B4;TYSND1;ACOX1;UBE2D2;PEX14
prerank,KEGG_2021_Human__Glucagon signaling pathway,-0.22173995692289356,-0.9500246250551283,0.48484848484848486,1.0,1.0,28/77,27.87%,PHKG1;CREB3L4;CPT1A;PLCB2;AKT1;LDHA;LDHB;CREB3L2;PRKACA;ATF2;CALM2;ATF4;AKT2;CAMK2D;PHKG2;CALM3;SLC2A1;CRTC2;PPP4R3B;PPP4C;CAMK2G;SIRT1;PRKAG1;PLCB3;FOXO1;PPP3CB;PHKA2;CALM1
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,0.2055047829225718,0.948859538899651,0.525,1.0,1.0,10/56,13.41%,EIF2S1;RPS24;RPS28;EIF4A2;EIF4A1;EIF1AX;EIF3G;RPSA;EIF4H;RPS27
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.19560032055813184,0.9487379362026788,0.5172413793103449,1.0,1.0,15/65,17.69%,HDAC3;HDAC11;NBEA;MAMLD1;JAG1;TLE3;CUL1;TLE4;DTX4;SNW1;HDAC6;MIB2;HIF1A;ADAM10;NEURL1
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.19121628574103466,0.9487264427193752,0.5833333333333334,1.0,1.0,14/66,15.78%,POLR2I;ELOC;TAF1;ELL;RNMT;NCBP1;NELFCD;NELFB;POLR2H;ERCC2;TBP;GTF2B;GTF2E1;TAF2
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.22499943856252377,-0.948679251109024,0.5076923076923077,1.0,1.0,25/74,28.17%,ANAPC11;UBB;PSMD3;UBE2C;NEK2;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;CDC20;PLK1;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;CCNA1;PSME1;PSMA7
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,0.23679836489553796,0.9474302293794508,0.627906976744186,1.0,1.0,9/31,17.58%,FCER1G;PIK3R5;CDC42;PDPK1;PIK3CG;PIK3R3;VAV2;LCK;GP6
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,0.27443565010816356,0.947114291507397,0.5952380952380952,1.0,1.0,2/17,2.53%,REV1;POLR1B
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,-0.2116542304362008,-0.9470393736143691,0.5666666666666667,1.0,1.0,31/91,28.17%,RNF185;ERLEC1;UBB;PSMD3;ABCB8;PSMA5;ABCC10;ABCC2;ABCB9;PSMD6;PSMD12;ABCB1;ABCD2;OS9;ABCA7;ABCC9;ABCB10;PSMC4;ABCB7;SEM1;ABCC4;ABCC1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;EIF2S2;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.21382023345010517,-0.9458730052843581,0.5797101449275363,1.0,1.0,29/90,28.17%,LMO2;H2AZ2;H2AZ1;H2BC3;UBB;PSMD3;H2AC7;PSMA5;CBFB;PSMD6;PSMD12;H2AC4;H2BC13;H2AC14;MYB;TAL1;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;H4C15;PSMB10;H2BC21;PSMB2;H2AC20;PSME1;PSMA7
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.23688929602153308,-0.9454801141041091,0.5428571428571428,1.0,1.0,11/50,15.06%,SLC46A1;HMOX2;SLC11A2;UBB;SKP1;STEAP3;GLRX3;FLVCR1;SLC22A17;ATP6V1G1;TFR2
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.20321904410945055,-0.9451993986429578,0.5373134328358209,1.0,1.0,23/103,19.64%,SIKE1;PTPN11;ATG14;TRIM4;NUP210;TBK1;IKBKE;TLR8;NUP88;CNBP;G3BP2;G3BP1;NUP54;TRAF6;POM121;RIGI;IRF7;STAT1;NUP37;NUP58;SEC23A;NUP205;TKFC
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,-0.1656182731397674,-0.9445506553434984,0.6144578313253012,1.0,1.0,115/500,23.27%,SLC22A16;TPCN2;NIPAL2;TRPV2;CLCN6;SLC46A1;SLC30A7;RNF185;SLC9A4;APOE;BEST1;SLC7A8;TRPM7;CYB5R1;HMOX2;HBA1;SCNN1D;MCU;SLC11A2;ERLEC1;ASPH;SLC16A3;SLC25A22;CA4;UBB;PSMD3;SLC28A2;RYR3;SLC35A1;PHB2;SKP1;STEAP3;GNG3;ABCB8;PSMA5;GLRX3;SLC39A14;ABCC10;SLC5A5;SLC44A2;ABCC2;SLC35B4;SLC2A3;ABCB9;AQP6;ATP13A2;NCEH1;GNG5;PSMD6;PSMD12;LPL;SLC7A1;SLC25A5;GNB2;PCSK5;BSG;LSR;ABCB1;ADCY4;ABCD2;SLC6A15;SLC5A2;CLCN5;TRPC1;SLC24A4;TRPC4AP;FLVCR1;MMGT1;OS9;SLC22A17;ATP6V1G1;FXYD7;ABCA7;TFR2;VLDLR;SLC30A5;ATP1B2;SPG7;SLCO4A1;SLC26A1;SLC22A1;CAMK2D;SLC44A4;AQP9;TSC22D3;ABCC9;SLC26A11;ABCB10;SLC30A6;PSMC4;CLTC;BMP1;AP2S1;SLC22A15;SLC29A4;SLC2A1;AKAP1;MCUB;SLC20A1;ATP9A;GNG11;ABCB7;ATP10A;SLC12A4;CA1;SEM1;WNK4;PRKAR2A;SLC4A10;ABCC4;ABCC1;ATP1B3;LRRC8A;CAMK2G;PSMD11
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,0.22817182736110075,0.944513590979854,0.5172413793103449,1.0,1.0,9/46,13.36%,H1-3;ROCK1;CASP8;H1-2;DNM1L;CASP3;SATB1;H1-0;ACIN1
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,-0.2168632827013594,-0.9444007595031495,0.6515151515151515,1.0,1.0,13/71,11.76%,DCTN3;PLK4;CDK5RAP2;CEP192;NEK2;MAPRE1;HAUS1;CLASP1;HAUS3;AKAP9;TUBA4A;PCM1;CEP57
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.24666562942322434,0.9438137044107268,0.55,1.0,1.0,8/30,16.34%,GALNT12;B3GNT9;B3GNT8;B4GALT6;B3GNT5;ST6GALNAC3;GALNT10;GALNT2
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,-0.31317280475384945,-0.9437285769116827,0.5555555555555556,1.0,1.0,3/18,5.90%,PTPN11;PTPN18;TBK1
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,-0.26417635341253903,-0.9428667427347353,0.5909090909090909,1.0,1.0,8/40,11.83%,H2AZ2;H2AZ1;H2BC3;H2AC7;RBBP7;EED;H2AC4;H2BC13
prerank,KEGG_2021_Human__Necroptosis,-0.19668031538710037,-0.9423094454635583,0.5806451612903226,1.0,1.0,19/133,11.66%,MAPK8;VPS4B;H2AB2;ZBP1;TRPM7;MACROH2A2;H2AZ2;H2AZ1;H2AC7;CYLD;SPATA2;FAS;CHMP1A;CHMP4B;SLC25A5;FASLG;H2AC4;H2AC12;H2AC17
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,-0.20747379905432595,-0.9418642446977589,0.589041095890411,1.0,1.0,30/86,27.39%,NUP210;H2BC3;H2AC7;RBBP7;EED;DYNC1LI2;DUT;H2AC4;H2AC12;DYNC1LI1;H2BC13;NUP88;TXN2;NUP54;POM121;PML;H2AC14;NUP37;NUP58;NUP205;NFKB1;CD46;H2AC11;DYNLL2;ITGB1;H4C15;EZH2;H2BC21;NUP133;H2AC20
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.2142863025976164,0.9414578357221187,0.5277777777777778,1.0,1.0,6/48,5.44%,COL13A1;JAM3;ITGB5;ITGA3;ITGAE;ITGA4
prerank,KEGG_2021_Human__Pathways in cancer,-0.1685438530189954,-0.9409458725824207,0.6329113924050633,1.0,1.0,90/391,21.75%,MGST1;FN1;GNAI1;CRKL;HEY1;MAPK8;FGFR1;LAMC1;RASGRP4;PDGFRB;FRAT1;IL3RA;GNA12;CKS2;FZD2;PGF;PIM2;NFKB2;IGF1R;LRP5;PLCB2;AKT1;RASGRP2;VEGFA;SKP1;RUNX1T1;GNG3;TRAF1;IL12A;RARA;PDGFRA;BAK1;FAS;HSP90B1;NCOA3;GSTM2;FH;GNG5;FASLG;GNB2;LPAR6;BBC3;WNT10A;FLT3LG;CRK;GSTO2;ADCY4;IL6ST;PLD2;IL5RA;RB1;CSF3R;KEAP1;GADD45G;RELA;MMP9;WNT10B;PRKACA;TRAF6;TGFB3;DAPK1;BIRC3;PIK3R1;MSH6;PIK3R2;PMAIP1;NQO1;CALM2;AKT2;CAMK2D;PML;STAT1;IL2RG;GSTM1;LAMB4;PIK3CB;E2F2;E2F3;JAK3;RAF1;CALM3;NFKB1;SLC2A1;RBX1;CDKN1A;SMAD4;GADD45A;GNG11;MAPK3;PTGS2
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.20576525822714847,0.9401480537227066,0.4864864864864865,1.0,1.0,10/56,13.41%,EIF2S1;RPS24;RPS28;EIF4A2;EIF4A1;EIF1AX;EIF3G;RPSA;EIF4H;RPS27
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.18340912612468224,-0.9397293676781594,0.625,1.0,1.0,58/181,28.29%,RPS15A;RPL37A;AKAP5;RPLP0;USP33;UBB;PSMD3;CLASP2;RPS21;RPS23;RPS4X;ABL2;PSMA5;MAGOH;RSL24D1;PSMD6;PSMD12;CLASP1;RPS20;EIF4A3;RPS14;RPL9;RPS3A;UPF3A;RPS16;RPS6;NELL2;RPL32;NRP1;RPL11;PSMC4;RPS7;VASP;RPL7;RPL10A;RBX1;SEM1;PRKAR2A;PSMD11;PSMD7;CXCR4;RPS12;PSME2;PSME4;RPS8;PSMB10;PPP3CB;RPL27;PSMB2;RPL14;MRPL13;RPL22L1;RPL23;PSME1;NCK2;PSMA7;RPS10;GSPT1
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.16002330307531032,0.9386126830768586,0.6785714285714286,1.0,1.0,19/165,10.26%,CPT2;PLCB4;UQCR10;TGFBR2;CYBB;PDHA1;ATP2A1;NDUFB10;ATP5PD;NDUFS6;PPARA;COX7B;NDUFB7;COX8A;G6PD;COX4I1;PIK3R3;SDHD;NDUFB2
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.20623676528284648,0.9377146903814984,0.5952380952380952,1.0,1.0,8/44,11.33%,KCND3;GNG10;KCNQ5;KCNK7;KCNG1;GNB5;KCNMB4;KCNC3
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,-0.19798970262821458,-0.9366693004617251,0.5522388059701493,1.0,1.0,29/85,31.23%,PTPN11;CD274;BATF2;AKT1;MAPK14;MAP3K3;TIRAP;RELA;TRAF6;PIK3R1;PIK3R2;AKT2;STAT1;PIK3CB;RAF1;NFKB1;PTPN6;MAPK3;NRAS;MAPK13;CD247;TICAM1;PPP3CB;IKBKB;JAK2;PRKCQ;NFKBIE;MAPK1;CSNK2A2
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,-0.273466379951843,-0.9365765450948984,0.5833333333333334,1.0,1.0,3/23,6.15%,CRKL;CLSTN1;SHC1
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.1581686098727593,0.9363124807381791,0.6,1.0,1.0,41/254,13.41%,CDC25C;CYBB;KLC1;YWHAB;ROCK1;NF2;KIF14;H2BC15;DIAPH1;PPP2R5E;ACTR3;RHPN1;PPP2CB;ARPC5;MYH9;BUB1;CDC42;PFN1;NUP85;BIRC5;PDPK1;PRC1;AREG;MYL9;H2AB1;ABI1;FMNL3;PKN1;PFN2;BUB1B;KIF5A;TAX1BP3;CDKN1B;NCKAP1;BUB3;NCK1;B9D2;H3C7;CENPN;KLC4;RPS27
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.24275123775364055,-0.9359078963685714,0.5909090909090909,1.0,1.0,6/44,6.15%,PPP2R5B;SEC31A;TATDN2;EXTL3;ARFGAP1;SHC1
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.1897358420220034,-0.9351208287418292,0.5714285714285714,1.0,1.0,40/157,22.20%,GFER;PAOX;IDH3G;USP9X;CMC4;TIMM8B;TOMM20;CYB5A;TIMM13;PEX2;UBB;TOMM7;UBL4A;TIMM10B;TIMM8A;ABCD2;EMD;GRPEL2;ATP5MC1;COA6;SGTA;TIMM17A;TIMM9;PRNP;ACOX2;TIMM21;PECR;PEX6;GNPAT;TIMM44;AMACR;GET1;TOMM5;CRAT;CS;CAMLG;PEX12;PAM16;GET4;TOMM22
prerank,KEGG_2021_Human__Thermogenesis,0.16554417722449322,0.935105448876508,0.6206896551724138,1.0,1.0,18/187,6.78%,CPT2;MAP3K5;KDM3B;UQCR10;NDUFB10;ATP5PD;PRDM16;NDUFS6;ACSL6;COX19;CREB1;COX7B;SLC25A20;ATP5MF;COX16;ACSL1;NDUFB7;COX8A
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.2499770693572662,0.9349669397605455,0.575,1.0,1.0,3/24,3.79%,XRCC1;POLR1B;POLD4
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.21583239722466785,-0.9343855913725844,0.5352112676056338,1.0,1.0,20/69,24.48%,TBC1D8B;SNX5;CLTB;AP1G2;AP4B1;BLOC1S3;SNAP23;AP1S1;STX4;YIPF6;CLTC;SORT1;HOMER2;NAPSA;HIP1R;DNASE2;HGS;DNAJC6;VAMP8;SH3D19
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.1906664247711175,0.9338974029580347,0.5263157894736842,1.0,1.0,6/63,7.22%,PDE2A;PLCB4;CACNA1I;CREB1;NR4A1;SCARB1
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,-0.17500637831466329,-0.9335982979674087,0.6338028169014085,1.0,1.0,73/246,28.41%,ITGB3;FN1;PAQR3;PTPN11;FGFR1;ZDHHC9;PPP2R5B;DUSP6;RASGRP4;PDGFRB;IL3RA;IL17RD;UBB;PSMD3;SHC1;PDGFRA;DUSP10;PSMA5;CNKSR2;NCAM1;NCOA3;DUSP7;PSMD6;PSMD12;AGO3;FLT3LG;IL6ST;IL5RA;AGO4;ARHGAP9;PIK3R1;PIK3R2;CAMK2D;IL2RG;PPP2CA;FNTA;PIK3CB;JAK3;IQGAP1;PSMC4;PDE6D;DUSP8;MARK3;RBX1;DUSP2;RGL2;MAPK3;SEM1;PPP1CC;XPO1;CAMK2G;PSMD11;NRAS;WDR83;PSMD7;IGF2BP1;PSME2;PSME4;KALRN;PSMB10;FOXO1;ABHD17C;ARAF;FRS3;EPGN;PSMB2;PSME1;CALM1;FGF13;JAK2;IRS2;PSMA7;RASGEF1A
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,-0.26895205468811784,-0.9335857719877556,0.5892857142857143,1.0,1.0,10/25,32.40%,APOE;COPS2;GFAP;PSENEN;ADAP1;NCSTN;MXD4;EREG;ADAM17;TAB2
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,-0.2537201630487281,-0.9325865640276605,0.5932203389830508,1.0,1.0,6/36,9.03%,NR2C2;NR4A2;NR2F6;NR3C2;RARA;THRA
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.232181275263226,-0.9325637044517981,0.6129032258064516,1.0,1.0,10/56,11.83%,H2AZ2;MYO1E;H2AZ1;H2BC3;H2AC7;POLR2K;H2AC4;SMARCA5;POLR1D;H2BC13
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.19374708492009235,-0.9321401327637293,0.6567164179104478,1.0,1.0,25/106,18.57%,ERCC5;COPS2;PARP2;UBB;DDB1;ERCC8;RAD23B;PIAS3;INO80;POLR2K;TCEA1;POLR2B;RFC5;SLC19A1;POLR2D;PIAS1;RPA3;POLD1;ERCC1;COPS6;POLD2;LRIG1;ISY1-RAB43;GPS1;INO80D
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.1902951157786514,0.9317461306682195,0.5952380952380952,1.0,1.0,7/74,6.50%,NCOA1;MED16;HDAC3;CEBPA;EBF1;PPARA;MED15
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.20192350734433373,0.9316851077994188,0.6578947368421053,1.0,1.0,10/57,13.41%,EIF2S1;RPS24;RPS28;EIF4A2;EIF4A1;EIF1AX;EIF3G;RPSA;EIF4H;RPS27
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,-0.19798116329565196,-0.9307454338534302,0.6025641025641025,1.0,1.0,16/128,9.89%,PLEKHG4;YKT6;FLOT2;OBSCN;RTKN;HMOX2;ARHGDIB;ARHGAP42;ARHGAP23;ARHGEF18;RHPN2;SLK;FAM13A;DAAM1;TEX2;ERBIN
prerank,KEGG_2021_Human__One carbon pool by folate,0.2937127817683883,0.9305366080232836,0.5483870967741935,1.0,1.0,4/17,10.11%,MTHFD1L;MTHFD1;MTHFR;MTHFD2
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.24728063608005327,-0.9305338445881199,0.5645161290322581,1.0,1.0,6/39,8.73%,PAQR3;PPP2R5B;DUSP6;UBB;DUSP10;DUSP7
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.19123323047856453,0.929683540131126,0.5357142857142857,1.0,1.0,7/60,5.88%,ITGB5;ATP2A1;ITGA3;IL6;CACNG8;ITGA4;CACNA2D2
prerank,Reactome_2022__Axon Guidance R-HSA-422475,-0.16788346419931274,-0.9295242695713494,0.6623376623376623,1.0,1.0,121/403,28.29%,ITGB3;EPHB3;RPS15A;PTPN11;MAPK8;FGFR1;PLXNB3;RPL37A;LAMC1;CACNB3;AKAP5;GRB10;RHOB;RPLP0;CLTB;USP33;UBB;PSMD3;CLASP2;RPS21;CLSTN1;MAPK14;CLTCL1;SHC1;RPS23;RPS4X;LIMK2;ABL2;PSMA5;DOK4;FARP2;SEMA6A;MAGOH;NCAM1;RSL24D1;PSMD6;PSMD12;COL6A2;CLASP1;RPS20;CNTN1;DOK2;DNM1;EIF4A3;RDX;RPS6KA2;TRPC1;RPS14;PITPNA;RPL9;MAPK7;RHOC;MMP9;RPS3A;UPF3A;RPS16;MSN;VLDLR;RPS6;PIK3R1;NELL2;PIK3R2;PRNP;PLXNB1;ABLIM2;RPL32;DPYSL4;PIK3CB;NRP1;RPL11;PSENEN;PSMC4;CLTC;SCN1B;RPS7;AP2S1;VASP;DOK1;L1CAM;RPL7;NCSTN;RPL10A;RBX1;EPHA4;SHTN1;MAPK3;RELN;SEM1;ARPC3;PRKAR2A;PSMD11;NRAS;MAPK13;PSMD7;ITGA10;CXCR4;RPS12;HSP90AB1;FES;ITGB1;PSME2;PSME4;KALRN;RPS8;PSMB10;LIMK1;SEMA4A;PPP3CB;RPL27;PSMB2;RPL14;MRPL13;RPL22L1;RPL23;PSME1;ARHGEF12;NCK2;IRS2;PSMA7;RPS10;GSPT1
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.18457776953894908,0.9295178492952623,0.5666666666666667,1.0,1.0,22/94,18.32%,KLC1;KIF11;KIF20A;ACTR10;CTSE;CAPZB;IFI30;KIF5A;DCTN4;AP1G1;CTSS;CTSC;KLC4;KIF15;HLA-DRB3;CTSB;CAPZA1;ACTR1A;AP1S3;AP1B1;AP1S2;LAG3
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,-0.18772485879803313,-0.9295031396016572,0.5921052631578947,1.0,1.0,22/136,14.42%,RNF185;NUP210;SLC11A2;ERLEC1;LMBRD1;UBB;PSMD3;SLC35A1;MAP4K5;ABCB11;PSMA5;SLC5A5;ABCC2;PSMD6;PSMD12;BSG;NUP88;SLC5A2;SLC24A4;OS9;NUP54;POM121
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,-0.21454336155599346,-0.9290777225602517,0.6333333333333333,1.0,1.0,15/80,12.42%,DCTN3;MZT2A;PLK4;CDK5RAP2;CEP192;NEK2;MAPRE1;HAUS1;CLASP1;HAUS3;AKAP9;TUBA4A;PCM1;CEP57;TUBGCP3
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.18015828459872818,0.929016011970043,0.5625,1.0,1.0,14/90,11.31%,POLR1B;NDC1;HSPA6;POM121C;SERPINH1;HSPA4L;NUP85;NUP153;HSPA5;VCP;ST13;HSBP1;BAG2;EEF1A1
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.2780299709687909,-0.92841162451973,0.5263157894736842,1.0,1.0,16/27,39.55%,GNA12;GNA15;GNG3;GNG5;GNB2;GNG11;MAPK3;GNG7;GNG8;MAPK1;ARRB2;GNG2;GNA13;GNB4;GNB1;GNB3
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.16624735574014948,-0.9280870980421312,0.6790123456790124,1.0,1.0,75/386,19.23%,ITGB3;CRKL;PTPN11;FGFR1;APOE;CD274;GALNT3;DUSP6;LAMC1;PDGFD;COPS2;PDGFRB;HNRNPA1;GRB10;SPINT1;PTPN18;SPRY2;PGF;UBB;PRKCD;RNF41;IGF1R;THBS1;AKT1;MAPK14;VEGFA;SHC1;LMNB2;FER;STAM;PDGFRA;GFAP;ID3;GTF2F2;DUSP7;PAG1;USP8;POLR2K;COL6A2;ERBIN;PCSK5;POLR2B;FLT3LG;CRK;DNM1;POLR2D;FOSB;RPS6KA2;MEF2C;MAPK7;MMP9;ATP6V1G1;RANBP10;THEM4;MAPKAPK3;ID1;MLST8;MEF2D;GGA3;PIK3R1;PIK3R2;LRIG1;TEC;AKT2;STAT1;PLAT;IL2RG;PPP2CA;PIK3CB;NRP1;PTK6;PSENEN;SRF;JAK3;CLTC
prerank,KEGG_2021_Human__Arachidonic acid metabolism,-0.2586222331517958,-0.9257669624006618,0.5737704918032787,1.0,1.0,5/38,8.29%,CYP4F2;LTA4H;GGT5;PLA2G2C;PLB1
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.22439839356271085,-0.9244859964568777,0.5833333333333334,1.0,1.0,26/64,33.43%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;RELA;PSMC4;NFKB1;SEM1;PSMD11;PSMD7;BCL10;PSME2;PSME4;PSMB10;IKBKB;PSMB2;PSME1;PSMA7;BTRC;MAP3K7;NFKBIE;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.2718445447183353,0.924419644835692,0.6585365853658537,1.0,1.0,2/18,2.54%,ATP2A1;B4GALT1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.21660792279589045,-0.922780357339458,0.6119402985074627,1.0,1.0,11/73,10.39%,ANAPC11;UBB;PSMD3;UBE2C;NEK2;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,-0.17722987100073576,-0.9226382160573168,0.6097560975609756,1.0,1.0,40/200,17.13%,HRH2;ADM;CCR8;PCDHA4;UTS2R;FZD2;SCT;ACKR2;GPR68;CCL5;GNG3;NPFF;CCR7;RAMP1;S1PR2;CXCR6;CXCL10;TBXA2R;GNG5;GNB2;TAS2R50;LPAR6;TAS2R13;WNT10A;FFAR3;ADORA3;PTAFR;ADGRE3;CASR;WNT10B;UTS2B;P2RY1;VIPR1;PPAN-P2RY11;GHRL;UTS2;GPR183;GPR35;PPBP;OPN3
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.1791588325018537,0.9225687871981486,0.6341463414634146,1.0,1.0,21/82,18.74%,CDK5R1;TAF1;POLR1B;RAD50;DNA2;HUS1;CCNA2;TP53INP1;HIPK2;RBBP8;HIPK1;TBP;RFC4;TOP3A;PRKAB1;CHEK1;TAF2;MAPK11;DYRK2;MDM4;TAF12
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.20792936805202977,-0.9223394413203565,0.5833333333333334,1.0,1.0,36/95,32.40%,CLEC7A;UBB;PRKCD;NFKB2;PSMD3;UBE2M;SKP1;PSMA5;PSMD6;PSMD12;RELA;TRAF6;SYK;PYCARD;PSMC4;NFKB1;SEM1;PSMD11;PSMD7;BCL10;PSME2;PSME4;PSMB10;PPP3CB;IKBKB;PSMB2;PSME1;CALM1;PSMA7;AHCYL1;TAB3;BTRC;MAP3K7;PSMC5;PSMA3;TAB2
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.21964719885684303,0.9217082169581128,0.625,1.0,1.0,5/34,7.72%,NDC1;POM121C;NUP85;NUP153;GNL3
prerank,KEGG_2021_Human__Amoebiasis,-0.19390956191146022,-0.9216071080441502,0.5737704918032787,1.0,1.0,16/73,18.40%,FN1;LAMC1;CD1C;PLCB2;GNA15;SERPINB9;IL12A;ACTN1;RELA;PRKACA;TGFB3;PIK3R1;PIK3R2;LAMB4;ITGB2;PIK3CB
prerank,KEGG_2021_Human__Chemokine signaling pathway,-0.1859952728420903,-0.9213792606411678,0.6376811594202898,1.0,1.0,34/153,20.11%,GNAI1;CRKL;CCR8;PAK1;PRKCD;PLCB2;AKT1;RASGRP2;CCR4;SHC1;CCL5;GNG3;CCR7;CCR10;CXCR6;CXCL10;GNG5;GNB2;CRK;ADCY4;RELA;PRKACA;PIK3R1;PIK3R2;AKT2;PPBP;STAT1;PIK3CB;JAK3;CCR5;RAF1;WAS;NFKB1;CXCR2
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.213991421838308,-0.9209885048518411,0.5915492957746479,1.0,1.0,19/73,19.58%,H2AZ2;NUP210;IPO8;H2AZ1;H2BC3;H2AC7;POLR2K;H2AC4;POLR2B;H2BC13;NUP88;POLR2D;RAN;NUP54;POM121;H2AC14;NUP37;NUP58;NUP205
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,-0.2356913866885313,-0.9201570089151363,0.5675675675675675,1.0,1.0,13/40,31.52%,CYP4F2;LTA4H;GGT5;FAAH2;CYP4B1;CYP4F3;PTGS2;DPEP2;ABCC1;PTGDS;PTGES3;ALOX5AP;PLA2G4A
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.16892923147942757,0.9193482004496212,0.7307692307692307,1.0,1.0,19/159,9.60%,MAP3K5;EIF2S1;UBXN6;NGLY1;EDEM2;UBXN2A;HSPA6;SEC61B;PDIA3;SEC61A2;DDOST;HSPA4L;CUL1;HSPA5;VCP;HSPBP1;FBXO2;SEC63;PPP1R15A
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.17399145632178553,0.9182580379733614,0.6216216216216216,1.0,1.0,10/103,5.88%,KCNE1;PLCB4;FXYD2;ATP2A1;PIK3R5;PPP2R5E;PPP2CB;CACNG8;CREB1;CACNA2D2
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,-0.21722764468411487,-0.9177310860766899,0.6,1.0,1.0,16/62,21.73%,MAPK8;DUSP6;UBB;MAPK14;SKP1;DUSP7;TNIP2;RPS6KA2;MEF2C;MAPK7;TRAF6;MAPKAPK3;PPP2CA;NFKB1;MAP2K7;MAPK3
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.1970042075460735,-0.9174544896928353,0.5882352941176471,1.0,1.0,37/95,33.43%,UBB;PRKCD;PSMD3;AKT1;SKP1;PSMA5;UBL4A;SRXN1;PSMD6;PSMD12;KEAP1;NQO1;ATF4;AKT2;PSMC4;RBX1;SEM1;SQSTM1;PSMD11;SESN1;PSMD7;BRIP1;GSR;PSME2;PSME4;PSMB10;PSMB2;PSME1;TRIM21;PSMA7;PHGDH;BTRC;CSNK2A2;PSMC5;PSMA3;UFD1;PSMC1
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.21134183529482925,-0.917117881622898,0.6363636363636364,1.0,1.0,18/77,17.68%,TAF5;CTR9;GTF2F2;IWS1;POLR2K;GTF2A1;PAF1;TCEA1;TAF15;POLR2B;CDC73;POLR2D;TAF9B;SUPT16H;NELFA;CCNK;CDK9;DMAP1
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,-0.3058627936892588,-0.9153903838231766,0.6379310344827587,1.0,1.0,6/15,17.82%,RPA3;POLD1;POLD2;MSH6;LRIG1;EXO1
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,-0.20866836669482453,-0.915213515776116,0.6060606060606061,1.0,1.0,37/91,32.20%,FOXK1;UBB;PSMD3;OGT;H2AC7;MBD6;PSMA5;INO80;PSMD6;PSMD12;H2AC4;H2AC12;UCHL1;H2AC14;INO80D;PSMC4;INO80E;SEM1;BARD1;H2AC11;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;H2AC20;PSME1;UCHL3;PSMA7;MBD5;UCHL5;NEDD8;ACTR5;MCRS1;PSMC5;PSMA3
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.24166205414284295,-0.9151487533986877,0.6323529411764706,1.0,1.0,13/38,26.14%,ANAPC11;UBE2C;ANAPC4;ANAPC5;CDC26;RB1;E2F2;E2F3;ATRX;CDKN1A;TFDP2;CDK2;UBE2E1
prerank,KEGG_2021_Human__Cell cycle,0.1729571875170871,0.9150031297440734,0.7692307692307693,1.0,1.0,26/120,16.40%,CDC25C;YWHAB;MCM2;ORC3;BUB1;CCND2;CCNA2;ZBTB17;GADD45B;CUL1;E2F5;BUB1B;CDKN1B;BUB3;CDK1;CDKN2A;RBL1;CDKN2D;CDKN1C;ANAPC2;TGFB1;CDK6;ABL1;CHEK1;CCNB1;CDK4
prerank,Reactome_2022__G1/S Transition R-HSA-69206,-0.19078140119885295,-0.9145031656364563,0.625,1.0,1.0,42/128,28.17%,MCM5;CDC6;UBB;PSMD3;AKT1;FBXO5;SKP1;PSMA5;PSMD6;PSMD12;TK1;MCM4;RB1;MCM7;RPA3;AKT2;RRM2;PPP2CA;PTK6;MCM10;PSMC4;E2F6;E2F4;POLA2;CDKN1A;DHFR;SEM1;PSMD11;PSMD7;TFDP2;DBF4;CDK2;CABLES1;PSME2;LIN52;PSMB10;POLA1;PSMB2;CCNA1;PSME1;WEE1;PSMA7
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.23777749561534314,-0.9141995916655864,0.6206896551724138,1.0,1.0,20/49,33.43%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;BTRC;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,-0.17433529872858775,-0.9137551336799805,0.6410256410256411,1.0,1.0,70/194,32.30%,FLOT2;MAPK8;DFFB;UBB;PRKCD;PSMD3;OGT;AKT1;H1-4;PSMA5;BAK1;LY96;PSMD6;PSMD12;CHMP4B;PROC;UACA;AVEN;FASLG;TANK;HMGB2;BBC3;TP53BP2;YWHAQ;DBNL;IRF1;ELANE;MAPT;DFFA;DAPK1;REXO2;BIRC3;PMAIP1;AKT2;CASP4;PPP1R13B;FNTA;ARHGAP10;PSMC4;TNFRSF10B;MAPK3;CLSPN;SEM1;PSMD11;PSMD7;TFDP2;DYNLL2;STK24;PSME2;PSME4;PSMB10;TICAM1;PSMB2;CASP5;PSME1;GZMB;HMGB1;PSMA7;YWHAH;CASP6;CASP7;TRADD;PRKCQ;MAPK1;BID;RIPK3;PSMC5;MLKL;PSMA3;OMA1
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,-0.1993027203707193,-0.9136325377575899,0.6129032258064516,1.0,1.0,15/79,18.11%,B4GALT2;B4GALT4;DCN;HS2ST1;DSE;HEXA;ST3GAL3;ARSB;B4GALT3;CHPF;SDC4;SLC26A1;CHST11;SGSH;CSGALNACT1
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.28159314759537774,-0.9123496932196111,0.5686274509803921,1.0,1.0,3/17,10.60%,APOE;LPL;PCSK5
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,0.21781040820915493,0.9119823243876896,0.6060606060606061,1.0,1.0,2/29,2.19%,NCOA1;ARNT2
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,-0.267552518037679,-0.9111986998014409,0.5873015873015873,1.0,1.0,12/29,29.97%,CDC6;FBXO5;TK1;RRM2;E2F6;E2F4;DHFR;TFDP2;LIN52;POLA1;CCNA1;LIN54
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,-0.18701266851240833,-0.9110909714020969,0.6349206349206349,1.0,1.0,21/108,16.29%,ATG5;ATG14;TOMM20;TSC2;RRAGD;UBB;TOMM7;SLC38A9;WIPI2;DYNC1LI2;CHMP4B;RPTOR;GABARAPL2;DYNC1LI1;PLIN3;MTERF3;ULK1;ATG10;ATG4A;MLST8;TSC1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.2283518519151465,0.9104487221940383,0.6842105263157895,1.0,1.0,14/32,26.28%,RAD50;DNA2;EME1;RBBP8;PALB2;TOP3A;BRCA1;MUS81;RAD51C;RAD51;RMI1;SPIDR;SLX1A;SLX4
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,0.27777771236540877,0.9102487985181413,0.631578947368421,1.0,1.0,2/17,2.53%,REV1;POLR1B
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.27697916410124396,-0.9098391341855223,0.6290322580645161,1.0,1.0,10/24,23.77%,POLR2K;AGO3;POLR2B;POLR2D;AGO4;RAN;XPO5;DGCR8;DROSHA;POLR2J
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,-0.26699859743504384,-0.909677076537443,0.7,1.0,1.0,8/24,21.63%,CNOT7;EIF4A3;CNOT4;CNOT8;CNOT9;PARN;CNOT10;PAN3
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.22123669881664385,-0.9084466646785245,0.5932203389830508,1.0,1.0,15/57,23.97%,PTPN11;OAS3;IFITM1;IRF1;IFIT1;IRF7;IFI6;STAT1;MX2;IFIT2;RSAD2;OAS2;PTPN6;EGR1;IFIT3
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,-0.19186803918961468,-0.9078956309295844,0.5833333333333334,1.0,1.0,43/108,33.43%,SMURF1;ERLEC1;UBB;PSMD3;SKP1;PSMA5;IFT122;SCUBE2;PSMD6;PSMD12;CDC73;SYVN1;ADCY4;WDR19;IFT140;OS9;PSMC4;RBX1;OFD1;SEM1;HHAT;PRKAR2A;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PRKAR1B;IFT52;PSMB2;PSME1;PSMA7;SPOP;SMOX;BTRC;ADAM17;IFT172;ARRB2;PSMC5;PSMA3;MKS1;PTCH1;PSMC1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.27953524337493996,-0.9071092779285294,0.6111111111111112,1.0,1.0,6/27,11.26%,ZNF143;CRCP;POLR3C;POLR2K;POLR1D;POLR3K
prerank,Reactome_2022__Hemostasis R-HSA-109582,-0.16585536793028158,-0.9067962396660316,0.7625,1.0,1.0,123/459,25.13%,ITGB3;CLEC3B;FN1;GNAI1;TEX264;PTPN11;PPP2R5B;KLKB1;SLC7A8;CYB5R1;RHOB;GNA12;DGKQ;DOCK9;SLC16A3;P2RX1;PRKCD;QSOX1;THBS1;CD99L2;DGKD;GNA15;AKT1;MAPK14;ITGAX;RASGRP2;KIF1C;VEGFA;SHC1;GNG3;CEACAM8;VPREB3;KCNMB1;CD109;KIF21A;DOCK4;TBXA2R;ACTN1;EHD3;GNG5;CLEC1B;PROC;GNB2;DGKH;KIF6;RAB27B;BSG;CRK;DOK2;TUBA4A;MPL;HBD;IRF1;CYRIB;LRP8;MGLL;PRCP;GUCY1B1;AKAP10;P2RY1;TGFB3;SYK;S100A10;PROCR;PIK3R1;PIK3R2;ATP1B2;KIF19;SDC4;EHD1;VPS45;STX4;KIF5C;PPBP;PDE1B;SGPP2;F8;PLAT;PPP2CA;VTI1B;MYB;ITGB2;SELENOP;PIK3CB;ANXA2;F5;SELL;LCP2;GRB14;GAS6;DEAF1;L1CAM;TNFRSF10B;KIF16B;PLAU;KIF3B;AKAP1;F12;PLAUR;PTPN6;GNG11;CD177;MAPK3;RBSN;PRKAR2A;ABCC4;KIF21B;ATP1B3;CD2;IRAG1;PICK1;NRAS;SRI;CD58;ITGA10;KIF22;CEACAM1;CDK2;CABLES1;ITGB1;AK3;MFN1;SERPINB2
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.21297924860701167,-0.9062612478909201,0.6567164179104478,1.0,1.0,23/70,28.17%,ANAPC11;UBB;PSMD3;UBE2C;PSMA5;ANAPC4;ANAPC5;PSMD6;PSMD12;CDC26;CDC20;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;UBE2E1;PSMB2;CCNA1;PSME1;PSMA7
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,-0.21275217598561874,-0.9046416765085754,0.6617647058823529,1.0,1.0,15/63,19.15%,MGST1;MAT2B;ABHD10;GSTZ1;GGT5;SULT1A1;GSTM2;MAT2A;GSTO2;TRMT112;AHCY;SLC26A1;PRNP;GSTM1;SULT1A2
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.17175146560605525,0.9044645537574248,0.6521739130434783,1.0,1.0,9/94,6.45%,CYBB;ITGB5;VAMP3;SEC61B;PDIA3;HLA-G;SEC61A2;B2M;PSMB4
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.21969896951185652,-0.9043548769194187,0.6451612903225806,1.0,1.0,17/54,28.17%,SMURF1;UBB;PSMD3;PSMA5;CBFB;PSMD6;PSMD12;PSMC4;SEM1;RUNX3;PSMD11;PSMD7;PSME2;PSMB10;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,-0.24693233492080138,-0.9037790500152254,0.5535714285714286,1.0,1.0,10/37,19.39%,KLRK1;SHC1;SIGLEC14;CLEC5A;SYK;CD300LB;PIK3R1;PIK3R2;PIK3CB;LCP2
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,-0.22472165370111105,-0.9036395973127381,0.6290322580645161,1.0,1.0,20/49,27.04%,WRAP53;FEN1;CHTF8;CTC1;ANKRD28;RFC5;SLC19A1;POT1;RPA3;POLD1;CHTF18;POLD2;LRIG1;PIF1;POLA2;WRN;CDK2;DKC1;POLA1;CCNA1
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.27962387992146603,-0.9030270294599644,0.6181818181818182,1.0,1.0,8/20,32.28%,PEX2;ABCD2;PEX12;GDAP1;ATAD1;ABCD1;PXMP2;PEX3
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,-0.16244585977489326,-0.9026221728162518,0.7402597402597403,1.0,1.0,124/420,28.29%,ITGB3;EPHB3;RPS15A;PTPN11;MAPK8;FGFR1;PLXNB3;RPL37A;LAMC1;CACNB3;AKAP5;GRB10;RHOB;RPLP0;CLTB;USP33;UBB;PSMD3;CLASP2;RPS21;CLSTN1;MAPK14;CLTCL1;SHC1;RPS23;RPS4X;LIMK2;ABL2;PSMA5;DOK4;FARP2;SEMA6A;MAGOH;NCAM1;RSL24D1;PSMD6;PSMD12;COL6A2;CLASP1;RPS20;CNTN1;DOK2;DNM1;EIF4A3;RDX;RPS6KA2;TRPC1;RPS14;PITPNA;RPL9;MAPK7;RHOC;MMP9;RPS3A;UPF3A;RPS16;MSN;VLDLR;RPS6;PIK3R1;NELL2;PIK3R2;PRNP;PLXNB1;ABLIM2;RPL32;DPYSL4;PIK3CB;NRP1;RPL11;PSENEN;PSMC4;CLTC;SCN1B;RPS7;AP2S1;VASP;DOK1;L1CAM;RPL7;NCSTN;RPL10A;RBX1;EPHA4;SHTN1;MAPK3;RELN;SEM1;ARPC3;SCD5;PRKAR2A;PSMD11;NRAS;MAPK13;PSMD7;ITGA10;CXCR4;RPS12;HSP90AB1;FES;ITGB1;PSME2;PSME4;KALRN;RPS8;PSMB10;LIMK1;SEMA4A;PPP3CB;RPL27;HDAC2;NAB2;PSMB2;RPL14;MRPL13;RPL22L1;RPL23;PSME1;ARHGEF12;NCK2;IRS2;PSMA7;RPS10;GSPT1
prerank,KEGG_2021_Human__Pancreatic cancer,-0.20003050216551596,-0.90242546774967,0.6274509803921569,1.0,1.0,22/74,21.73%,MAPK8;AKT1;VEGFA;BAK1;PLD2;RB1;GADD45G;RELA;TGFB3;PIK3R1;PIK3R2;AKT2;STAT1;PIK3CB;E2F2;E2F3;RAF1;NFKB1;CDKN1A;SMAD4;GADD45A;MAPK3
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.17216658651023686,-0.9018684372429798,0.6666666666666666,1.0,1.0,45/167,25.36%,DCTN3;YKT6;RHOBTB3;COG2;RIC1;KIF1C;ARFGAP1;RAB18;BET1L;VPS51;KIF21A;SCOC;DYNC1LI2;NBAS;RAB33B;KIF6;DYNC1LI1;STX18;VAMP4;GOSR1;RAB6A;PLIN3;COPZ1;PLA2G6;KIF19;VPS45;COG6;KIF5C;SYS1;KIF16B;RAB36;ZW10;SEC22B;KIF3B;NAPSA;NAA30;COPE;KIF21B;RINT1;VPS54;KIF22;DYNLL2;COG5;COPB2;GCC2
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.21605038826034026,-0.9016984363451912,0.6071428571428571,1.0,1.0,23/52,35.37%,NFKB2;MAPK14;CYLD;TXN2;RELA;TRAF6;BIRC3;CASP4;CASP2;PYCARD;NFKB1;MAPK13;HSP90AB1;IRAK2;IKBKB;MEFV;TAB3;MAP3K7;SUGT1;TAB2;P2RX7;IRAK1;TXNIP
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,-0.17277459164999384,-0.9009785870369704,0.65625,1.0,1.0,64/244,24.58%,ITGB3;FN1;FGFR1;PPP2R5B;LAMC1;PDGFD;PDGFRB;IL3RA;STK11;TSC2;PGF;CREB3L4;IGF1R;THBS1;AKT1;VEGFA;GNG3;PDGFRA;NOS3;HSP90B1;GNG5;COL6A2;RPTOR;FASLG;GNB2;LPAR6;YWHAQ;FLT3LG;CSF3R;CREB3L2;RELA;THEM4;SYK;MLST8;ATF2;RPS6;PIK3R1;PIK3R2;ATF4;TSC1;AKT2;IL2RG;PPP2CA;MYB;LAMB4;PIK3CB;PKN3;DDIT4;JAK3;RAF1;NFKB1;CRTC2;CDKN1A;GNG11;MAPK3;RELN;OSM;LPAR5;HGF;NRAS;ITGA10;HSP90AB1;CDK2;ITGB1
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,-0.2166258988560792,-0.9009059232968065,0.6,1.0,1.0,16/58,21.73%,FGFR1;PDGFRB;SLC16A3;AKT1;PDGFRA;SCO2;LDHA;LDHB;PIK3R1;PIK3R2;AKT2;PDK1;PIK3CB;RAF1;SLC2A1;MAPK3
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.2637104867343171,-0.9004376341958843,0.5873015873015873,1.0,1.0,9/24,20.50%,OSBPL3;ABCB11;CYP27A1;AKR1C1;OSBPL1A;ACOX2;CYP46A1;AMACR;NCOA2
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.22547864715664406,-0.9001875329214223,0.6779661016949152,1.0,1.0,23/57,33.43%,UBB;NFKB2;PSMD3;UBE2M;SKP1;PSMA5;PSMD6;PSMD12;RELA;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;BTRC;PSMC5;PSMA3;PSMC1
prerank,KEGG_2021_Human__Tryptophan metabolism,0.2238821844205605,0.8993020298506366,0.65625,1.0,1.0,5/31,7.64%,ACAT1;KYAT3;INMT;ALDH1B1;ALDH2
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,0.19911961198834024,0.8989047703740005,0.6666666666666666,1.0,1.0,17/58,19.71%,ROCK1;VAMP3;DIAPH1;ARHGAP35;ARHGEF17;AKAP13;PKN1;VANGL1;VAV2;ARHGAP1;ARHGAP5;DLC1;ANLN;JUP;ARHGAP26;ARHGEF10;ARHGAP21
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,-0.2568042401014847,-0.8983358958464654,0.6271186440677966,1.0,1.0,4/22,11.33%,CRKL;LAMC1;LMNB2;CRK
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.20012356569688286,-0.8977883117762242,0.5873015873015873,1.0,1.0,32/84,32.20%,UBB;PSMD3;AKT1;SKP1;PSMA5;CDC25B;PSMD6;PSMD12;RB1;AKT2;PTK6;PSMC4;E2F4;CDKN1A;SEM1;PSMD11;PSMD7;TFDP2;CDK2;CABLES1;PSME2;LIN52;PSMB10;PSMB2;CCNA1;PSME1;WEE1;PSMA7;LIN54;CKS1B;PSMC5;PSMA3
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.22481722797696096,0.8976454128491317,0.6666666666666666,1.0,1.0,2/25,1.46%,RPS6KA4;EZR
prerank,KEGG_2021_Human__Other glycan degradation,0.27695531065226303,0.8970552797705276,0.6190476190476191,1.0,1.0,4/15,16.44%,AGA;MAN2C1;FUCA2;MAN2B2
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.20669360070385168,-0.8967100151425343,0.6764705882352942,1.0,1.0,15/78,13.65%,ANAPC11;H2AZ2;H2AZ1;H2BC3;UBB;H2AC7;UBE2C;ANAPC4;ANAPC5;CDC26;H2AC4;H2BC13;RPS6KA2;RELA;MAPK7
prerank,KEGG_2021_Human__MicroRNAs in cancer,-0.18095634833883495,-0.8966978269468081,0.6428571428571429,1.0,1.0,41/142,26.19%,ITGB3;CRKL;PDGFRB;SPRY2;THBS1;VEGFA;SHC1;PDGFRA;CDC25B;BAK1;RPTOR;SLC7A1;RECK;CRK;ABCB1;HMGA2;RDX;MAPK7;MMP9;PIK3R1;PIK3R2;HDAC4;PIK3CB;E2F2;E2F3;DDIT4;RAF1;NFKB1;PLAU;CDKN1A;MAPK3;PTGS2;UBE2I;ABCC1;NRAS;SIRT1;IGF2BP1;BMPR2;PIM1;EZH2;HDAC2
prerank,KEGG_2021_Human__Pertussis,-0.20675538328371482,-0.8961461322738452,0.6440677966101694,1.0,1.0,17/68,19.96%,GNAI1;MAPK8;C4BPA;MAPK14;IRAK4;IL12A;LY96;TIRAP;IRF1;RELA;TRAF6;CALM2;ITGB2;PYCARD;CALM3;C4A;NFKB1
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.215387128210945,-0.8957531063907789,0.6229508196721312,1.0,1.0,3/55,0.62%,ITGB3;FN1;CLCN6
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.2676791969502067,0.8956411309343246,0.5116279069767442,1.0,1.0,8/17,22.03%,PPP2R5E;PPP2CB;CSNK1A1;PPP2R1B;FRAT2;PPP2R1A;PPP2R5A;PPP2R5D
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,0.23948008773088547,0.8948967053607517,0.5909090909090909,1.0,1.0,2/26,2.45%,ACOT8;ACOXL
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,-0.2816781357961888,-0.8943895986466012,0.6071428571428571,1.0,1.0,5/16,24.96%,MCU;PHB2;SPG7;MCUB;MICU2
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,-0.19459170593481917,-0.8940147254526565,0.6338028169014085,1.0,1.0,38/85,37.11%,UBB;PSMD3;SKP1;PSMA5;IFT122;PSMD6;PSMD12;ADCY4;WDR19;IFT140;PSMC4;RBX1;OFD1;SEM1;PRKAR2A;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PRKAR1B;IFT52;PSMB2;PSME1;PSMA7;SMOX;BTRC;IFT172;PSMC5;PSMA3;MKS1;PTCH1;PSMC1;WDR35;PRKAR2B;DYNC2H1;PSMD8;PRKAR1A
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.1719779863387725,0.8938837735125701,0.5862068965517241,1.0,1.0,17/106,13.41%,EIF2S1;RPS24;RPL7A;RPS28;EIF4A2;RPL26;RPL15;RPL6;RPL36AL;EIF4A1;EIF1AX;RPL23A;EIF3G;RPSA;RPL18;EIF4H;RPS27
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,-0.27994052189483787,-0.892639924784417,0.5517241379310345,1.0,1.0,10/20,32.17%,TXN2;AHCY;SQOR;ETHE1;ADO;MTRR;ENOPH1;VSIG2;MPST;MTAP
prerank,KEGG_2021_Human__Renal cell carcinoma,-0.210939158260155,-0.8923434799291965,0.6557377049180327,1.0,1.0,19/64,23.53%,CRKL;PTPN11;PAK1;AKT1;VEGFA;FH;CRK;TGFB3;PIK3R1;PIK3R2;AKT2;PIK3CB;RAF1;SLC2A1;RBX1;CDKN1A;MAPK3;HGF;NRAS
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,-0.22739217810653245,-0.892148583427864,0.5833333333333334,1.0,1.0,9/53,12.45%,PTPN11;HNRNPA1;SPRY2;UBB;SHC1;GTF2F2;POLR2K;POLR2B;POLR2D
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.17535618153142768,0.8910838151345031,0.7222222222222222,1.0,1.0,6/101,2.13%,NCOA1;PLCB4;MED16;FXYD2;HDAC3;ATP2A1
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,-0.17981908328671384,-0.8904811388288624,0.75,1.0,1.0,48/136,32.40%,PTPN11;MAPK8;IL18RAP;PTPN18;UBB;NFKB2;PSMD3;IRAK4;TBK1;SKP1;S100A12;PSMA5;MAP3K3;PSMD6;PSMD12;TANK;IL1RL1;TNIP2;RELA;TRAF6;NKIRAS2;N4BP1;PSMC4;NKIRAS1;NFKB1;RBX1;PTPN6;SEM1;SQSTM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;IRAK2;IKBKB;PSMB2;PSME1;HMGB1;PSMA7;TAB3;BTRC;IL18R1;MAP3K7;IL18BP;PSMC5;PSMA3;TAB2
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.20748150809079835,-0.8903141592116183,0.7142857142857143,1.0,1.0,9/52,15.67%,PTPN11;FGFR1;PDGFRB;CLSTN1;PDGFRA;STRN;FLT3LG;PIK3R1;PIK3R2
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.16138503121396616,0.8901125310999034,0.8571428571428571,1.0,1.0,24/164,12.45%,IL9R;TGFBR2;CXCL8;IL13RA1;CXCR1;CXCR3;IL6;TNFRSF12A;TNFRSF10D;CSF1;IL20RB;TNFSF14;IL1R1;IL2RB;ACVR2A;ACVR2B;PRLR;IL10;IL15;AMH;TNFSF4;LTBR;CLCF1;IL23R
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.23572070868100517,0.8898716275515305,0.7209302325581395,1.0,1.0,6/26,14.56%,TGFBR2;BAMBI;SRFBP1;PPP1R15A;NEDD4L;TGFB1
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.2347280525351692,-0.8892725860726575,0.6176470588235294,1.0,1.0,7/36,15.92%,TRIM4;ZRANB1;UBB;PROC;TNIP2;TRAF6;RIGI
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.2154643804991702,-0.8891380479531574,0.6774193548387096,1.0,1.0,7/44,10.41%,EXOC7;BBIP1;EXOC3;CCT2;EXOC4;PKD1;UNC119B
prerank,KEGG_2021_Human__Measles,-0.18297362430135178,-0.88897220674264,0.71875,1.0,1.0,29/117,20.65%,MAPK8;OAS3;CBLB;AKT1;IRAK4;TBK1;IL12A;IKBKE;BAK1;FAS;FASLG;BBC3;RELA;TRAF6;MSN;PIK3R1;HSPA2;PIK3R2;CLEC4M;IRF7;AKT2;STAT1;IL2RG;MX2;PIK3CB;JAK3;OAS2;NFKB1;CD46
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,0.16880236096184903,0.8883526158451233,0.625,1.0,1.0,18/114,13.41%,EIF2S1;RPS24;RPL7A;EIF2B4;RPS28;EIF4A2;RPL26;RPL15;RPL6;RPL36AL;EIF4A1;EIF1AX;RPL23A;EIF3G;RPSA;RPL18;EIF4H;RPS27
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.225493441930775,-0.8880140080711406,0.6376811594202898,1.0,1.0,6/46,6.15%,PPP2R5B;SEC31A;TATDN2;EXTL3;ARFGAP1;SHC1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.2701830930286968,-0.8861165235088134,0.6333333333333333,1.0,1.0,6/26,11.26%,CRCP;POLR3C;GTF3C2;POLR2K;POLR1D;POLR3K
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.23269626839193097,-0.8856188384561149,0.5882352941176471,1.0,1.0,7/35,13.63%,RNF185;GANAB;UBB;RAD23B;UGGT1;SYVN1;OS9
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.1877327397051705,0.8851384614929184,0.7241379310344828,1.0,1.0,8/68,7.98%,CDC25C;CDK5R1;H2BC15;DNMT3B;CASP8;PRIM2;GOLGA2;H2AB1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.17636304406145928,-0.8843050990695647,0.726027397260274,1.0,1.0,48/150,28.84%,RPS15A;RPL37A;RPLP0;USP33;UBB;PSMD3;RPS21;RPS23;RPS4X;PSMA5;MAGOH;RSL24D1;PSMD6;PSMD12;RPS20;EIF4A3;RPS14;RPL9;RPS3A;UPF3A;RPS16;RPS6;RPL32;RPL11;PSMC4;RPS7;RPL7;RPL10A;RBX1;SEM1;PSMD11;PSMD7;RPS12;PSME2;PSME4;RPS8;PSMB10;RPL27;PSMB2;RPL14;MRPL13;RPL22L1;RPL23;PSME1;PSMA7;RPS10;GSPT1;FAU
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.22697206499882736,-0.8842243730339253,0.6451612903225806,1.0,1.0,5/35,11.55%,DCTN3;DNAJA1;NR3C2;DYNC1LI2;DYNC1LI1
prerank,KEGG_2021_Human__TNF signaling pathway,-0.19034610372102997,-0.8840546687636772,0.6301369863013698,1.0,1.0,42/100,32.40%,MAPK8;JUNB;CREB3L4;AKT1;MAPK14;CCL5;TRAF1;FAS;CXCL10;IRF1;CREB3L2;RELA;MMP9;BIRC3;ATF2;PIK3R1;PIK3R2;ATF4;AKT2;PIK3CB;NFKB1;MMP14;MAP2K7;MAPK3;PTGS2;MAPK13;LTA;IKBKB;ICAM1;TAB3;CASP7;TRADD;IL18R1;MAP3K7;MAPK1;CEBPB;CREB5;RIPK3;CXCL2;CASP10;MLKL;TAB2
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.24079423841998646,-0.8831554694484091,0.6376811594202898,1.0,1.0,12/35,27.63%,H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13;H2AC14;SIRT1;H4C15;H2BC21;H2AC20;TAF1D
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,-0.17203980683314984,-0.8831298491330556,0.7,1.0,1.0,40/166,21.75%,MAPK8;ATG14;CCR8;UBB;AKT1;MAPK14;CCR4;VEGFA;TBK1;GNG3;IKBKE;BAK1;FAS;GNG5;GNB2;GABARAPL2;IL6ST;RB1;RELA;SYK;PIK3R1;PIK3R2;CALM2;IRF7;AKT2;MICB;STAT1;PIK3CB;E2F2;E2F3;CLEC2B;CCR5;RAF1;CALM3;NFKB1;CDKN1A;MAP2K7;GNG11;MAPK3;PTGS2
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.21885878414200316,-0.8829979811827251,0.6666666666666666,1.0,1.0,13/52,21.57%,COPS2;UBB;DDB1;ERCC8;POLR2K;TCEA1;POLR2B;POLR2D;COPS6;ISY1-RAB43;GPS1;RBX1;ERCC3
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.22017955282557167,-0.882955416847717,0.65625,1.0,1.0,20/50,33.43%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;ARHGAP10;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;OMA1;PSMC1
prerank,KEGG_2021_Human__Serotonergic synapse,-0.1889415772977496,-0.882252924962138,0.7166666666666667,1.0,1.0,19/64,28.34%,GNAI1;GNAO1;PLCB2;GNG3;TPH2;GNG5;GNB2;TRPC1;PRKACA;RAF1;GNG11;MAPK3;PTGS2;NRAS;PLCB3;CACNA1A;ARAF;GNG7;GNG8
prerank,Reactome_2022__RAS Processing R-HSA-9648002,-0.2576795716838249,-0.8821244153073581,0.5932203389830508,1.0,1.0,8/17,32.02%,ZDHHC9;FNTA;PDE6D;NRAS;ABHD17C;CALM1;PRKCQ;ICMT
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.19371618906003624,-0.8813668081376203,0.7142857142857143,1.0,1.0,16/95,15.07%,GNAI1;HRH2;ADM;FCGR2A;SCT;PLK2;GGT5;MAPK14;GNG3;RAMP1;GNG5;GNB2;ADCY4;VIPR1;SYK;PPAN-P2RY11
prerank,KEGG_2021_Human__Cholesterol metabolism,-0.2384032572854709,-0.8813108525405629,0.65,1.0,1.0,5/33,9.71%,APOE;ABCB11;CYP27A1;NCEH1;LPL
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,0.23406397064462103,0.8810202026510164,0.6857142857142857,1.0,1.0,2/28,0.44%,NCOA1;ACOT8
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,-0.2807014669086908,-0.8805447529312003,0.6666666666666666,1.0,1.0,2/16,5.13%,ANG;CDH18
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,-0.23352292765045046,-0.8804876662143737,0.6551724137931034,1.0,1.0,11/38,24.56%,PTPN11;GRB10;FER;MMP9;PIK3R1;PIK3R2;TEC;STAT1;PTPN6;NRAS;FES
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,-0.22316007380424924,-0.8799333316225754,0.576271186440678,1.0,1.0,15/47,26.06%,GANAB;UBB;DDX5;ST6GALNAC4;CHMP4B;RB1;ST3GAL3;PARP9;ZCRB1;ST6GAL1;PARP16;PARP6;UBE2I;PALS1;CANX
prerank,Reactome_2022__Translation R-HSA-72766,0.14531195434992833,0.8796969847500254,0.9,1.0,1.0,36/276,11.68%,EIF2S1;RPS24;SRP14;MTIF2;SRPRA;RPL7A;EIF2B4;MRPL55;MRPS25;RPS28;EIF4A2;SEC61B;SEC61A2;NARS1;RPL26;DDOST;RPL15;MRPS16;MRPL23;SRPRB;PPA1;RPL6;RPL36AL;EIF4A1;EIF1AX;MRPL54;EEF2;SPCS3;RPL23A;MTIF3;MRPL52;EIF3G;RPSA;SPCS1;EEF1A1;MRPL21
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,-0.24296406984482605,-0.879564586747158,0.5714285714285714,1.0,1.0,7/30,19.85%,APOE;UBB;NCEH1;LSR;VLDLR;CLTC;AP2S1
prerank,KEGG_2021_Human__Apelin signaling pathway,-0.17940262859327347,-0.8789638512312746,0.6842105263157895,1.0,1.0,31/106,24.40%,GNAI1;RYR3;PLCB2;AKT1;GNG3;NOS3;GNG5;GNB2;GABARAPL2;ADCY4;MEF2C;PRKACA;RRAS2;MEF2D;RPS6;CALM2;MYLK;AKT2;HDAC4;PLAT;RAF1;CALM3;SMAD4;GNG11;MAPK3;EGR1;ADCY3;NRAS;BORCS8-MEF2B;PRKAG1;PLCB3
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.22597229971665034,-0.8789163203874982,0.5932203389830508,1.0,1.0,6/37,13.73%,FANCE;UBB;FAAP100;CENPS-CORT;RPA3;ERCC1
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.2580721744868325,-0.8786158438713174,0.631578947368421,1.0,1.0,6/22,16.75%,AKT1;THEM4;MLST8;PIK3R1;PIK3R2;AKT2
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,0.26434769131072633,0.8785014010139998,0.6764705882352942,1.0,1.0,1/16,0.19%,CDC25C
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.17089825794753788,0.8781225452240686,0.6451612903225806,1.0,1.0,17/107,13.41%,EIF2S1;RPS24;RPL7A;RPS28;EIF4A2;RPL26;RPL15;RPL6;RPL36AL;EIF4A1;EIF1AX;RPL23A;EIF3G;RPSA;RPL18;EIF4H;RPS27
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.2490651913414541,-0.877396613318813,0.6142857142857143,1.0,1.0,4/27,8.68%,APOE;HBA1;MARCO;HSP90B1
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.18710222535878102,-0.8768456798496782,0.7096774193548387,1.0,1.0,25/110,20.74%,RPS15A;RPL37A;SMG5;RPLP0;RPS21;RPS23;RPS4X;MAGOH;RSL24D1;SMG9;RPS20;EIF4A3;RPS14;RPL9;RPS3A;UPF1;UPF3A;RPS16;RPS6;PPP2CA;RPL32;RPL11;RPS7;RPL7;RPL10A
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.18893922791455292,-0.8766848074828066,0.6666666666666666,1.0,1.0,16/112,11.83%,UHRF1;MTF2;H2AZ2;MYO1E;H2AZ1;H2BC3;H2AC7;RBBP7;EED;POLR2K;SAP30BP;TET1;H2AC4;SMARCA5;POLR1D;H2BC13
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,-0.1981249533199503,-0.8765498242648594,0.6805555555555556,1.0,1.0,24/76,28.09%,H2AZ2;H2AZ1;H2BC3;H2AC7;RBBP7;POLR2K;H2AC4;POLR1D;RRN3;H2BC13;TTF1;H2AC14;ERCC3;MTA3;MAPK3;DPEP2;UBTF;H4C15;HDAC2;H2BC21;H2AC20;TAF1D;GATAD2A;POLR1G
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.1981249533199503,-0.8765498242648594,0.6805555555555556,1.0,1.0,24/76,28.09%,H2AZ2;H2AZ1;H2BC3;H2AC7;RBBP7;POLR2K;H2AC4;POLR1D;RRN3;H2BC13;TTF1;H2AC14;ERCC3;MTA3;MAPK3;DPEP2;UBTF;H4C15;HDAC2;H2BC21;H2AC20;TAF1D;GATAD2A;POLR1G
prerank,KEGG_2021_Human__Human papillomavirus infection,0.14434228427604717,0.8761047972826863,0.8333333333333334,1.0,1.0,39/253,13.97%,PARD6B;ATP6V0B;ATP6V1A;TBPL2;ATP6V0A1;ITGB5;ITGA3;PPP2R5E;CASP8;PPP2CB;HLA-G;JAG1;COL6A1;CDC42;CCND2;HES2;CCNA2;CREB1;ITGA4;DLG2;PXN;ATP6V0C;PATJ;TBPL1;TCF7L1;PIK3R3;CDKN1B;HES4;CASP3;TUBG2;LAMC3;TCF7L2;THBS3;TBP;RBL1;PRKCI;CSNK1A1;TRAF3;PARD3
prerank,KEGG_2021_Human__Base excision repair,-0.23707108277136432,-0.8746400488921086,0.59375,1.0,1.0,4/33,4.96%,LIG1;PARP2;APEX1;FEN1
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.23524463856830724,-0.8746037742437576,0.6428571428571429,1.0,1.0,7/39,12.03%,H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13;POT1
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.17485311415885277,-0.8745542403936359,0.6578947368421053,1.0,1.0,37/139,25.00%,RAD9B;MAPK8;RMI2;PARP2;TDP1;EYA3;XRCC4;H2BC3;UBB;FEN1;NSD2;SMARCA5;RFC5;SLC19A1;H2BC13;RHNO1;RPA3;POLD1;ERCC1;XRCC6;XRCC2;POLD2;RAD51AP1;RNF168;EXO1;RAD9A;PAXIP1;PPP4C;CLSPN;SEM1;UBE2I;BARD1;WRN;PIAS4;BRIP1;CDK2;H4C15
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.24389968500226228,0.8741454181656503,0.5909090909090909,1.0,1.0,6/25,13.08%,CREB1;PDPK1;NR4A1;RICTOR;CDKN1B;FOXO4
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,-0.20830075283518165,-0.8736972780912772,0.6206896551724138,1.0,1.0,25/56,37.52%,PTPN11;MAPK8;STK11;CPT1A;AKT1;RELA;AKT2;NFKB1;SLC2A1;PRKAG1;IKBKB;LEPR;JAK2;IRS2;SLC2A4;TRADD;PRKCQ;NFKBIE;ACSBG1;CPT1B;PRKAG2;PRKAB2;MTOR;POMC;MAPK9
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.18991924055198178,0.8729537135116416,0.7222222222222222,1.0,1.0,16/54,21.45%,PARD6B;CLDN7;CDH13;PATJ;RSU1;CD151;NECTIN1;PRKCI;PARD3;JUP;F11R;ILK;AFDN;ITGA6;LIMS1;CDH8
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.14069476188969204,0.8728088600190324,0.9444444444444444,1.0,1.0,40/364,10.26%,MAP3K5;EIF2S1;PLCB4;UQCR10;CDK5R1;TUBB3;CYBB;KLC1;WIPI1;SMCR8;ATG101;ATP2A1;NDUFB10;IL6;ATP5PD;CASP8;ATG13;ACTR10;NDUFS6;HTRA2;TUBB1;CSF1;APAF1;COX7B;RAB5A;RAB39B;PSMB4;NDUFB7;COX8A;HSPA5;VCP;COX4I1;IFT57;ADRM1;ALS2;KIF5A;SDHD;CASP3;DCTN4;NDUFB2
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.23065175157676243,-0.8722059154327647,0.7096774193548387,1.0,1.0,9/37,15.72%,PARP2;APEX1;FEN1;RFC5;SLC19A1;RPA3;POLD1;POLD2;LRIG1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.1913202956340659,-0.8708272004936203,0.7076923076923077,1.0,1.0,24/85,24.58%,ITGB3;SMURF1;USP9X;UBB;UBE2M;ARHGEF18;LTBP4;CDK8;TGIF2;MTMR4;TGFB3;CCNK;STAT1;CDK9;E2F4;ZFYVE9;RNASEH2A;SMAD4;MAPK3;PPP1CC;XPO1;PMEPA1;TFDP2;ITGB1
prerank,KEGG_2021_Human__ECM-receptor interaction,-0.20080923459011363,-0.8707617113737567,0.6842105263157895,1.0,1.0,4/55,4.80%,ITGB3;FN1;LAMC1;THBS1
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,-0.21057530988782153,-0.8700714986815109,0.7121212121212122,1.0,1.0,11/55,17.13%,FLOT2;UBB;OGT;BAK1;CHMP4B;FASLG;TANK;IRF1;ELANE;BIRC3;CASP4
prerank,KEGG_2021_Human__Butanoate metabolism,-0.2832067351767095,-0.8693859313949707,0.64,1.0,1.0,4/19,13.67%,OXCT1;HADH;BDH2;ABAT
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,-0.17461117689269326,-0.8693566327932476,0.6527777777777778,1.0,1.0,28/145,17.99%,TAF5;RAD9B;JMY;TTC5;RMI2;STK11;ZNF385A;UBB;AKT1;MAPK14;RBBP7;PPP1R13L;TAF15;TP53BP2;RFC5;RHNO1;RPA3;TAF9B;PDZD2;MLST8;SUPT16H;TP53RK;AKT2;PML;PPP2CA;PPP1R13B;EXO1;RAD9A
prerank,KEGG_2021_Human__Bile secretion,-0.2160558840817915,-0.8692355713241112,0.6875,1.0,1.0,15/43,24.21%,SCT;ABCB11;ABCC2;NCEH1;ABCB1;ADCY4;PRKACA;ATP1B2;SLC22A1;AQP9;SLC2A1;ADCY3;ABCC4;ATP1B3;SLC51A
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.20681736532493128,0.8690099685881592,0.6363636363636364,1.0,1.0,5/34,7.72%,NDC1;POM121C;NUP85;NUP153;GNL3
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,-0.21396934774601523,-0.8683305920979393,0.7164179104477612,1.0,1.0,11/47,18.52%,UBA7;UBB;DDB1;RFC5;SLC19A1;RPA3;POLD1;USP32;POLD2;UBE2B;REV3L
prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.16348412235178947,0.8673970702533779,0.8275862068965517,1.0,1.0,21/177,10.84%,MAP3K5;EIF2S1;PLCB4;FOS;CXCL8;CYBB;RAP1A;IL6;HSPA6;CASP8;CDC42;APAF1;ABCG1;PDPK1;HSPA5;NLRP3;ABCA1;PIK3R3;CD14;CASP3;CALML4
prerank,KEGG_2021_Human__Type II diabetes mellitus,-0.24167326068140257,-0.8673108417649398,0.6545454545454545,1.0,1.0,17/34,39.43%,MAPK8;PRKCD;CACNA1E;PIK3R1;PIK3R2;PIK3CB;MAPK3;CACNA1A;IKBKB;IRS2;SLC2A4;MAPK1;HKDC1;PIK3CD;MTOR;MAPK9;INSR
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,-0.27966695682654286,-0.8669216151007673,0.6724137931034483,1.0,1.0,5/15,23.82%,PGA4;TTF1;ZDHHC2;NAPSA;CKAP4
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,-0.21238220970274774,-0.8664810203060279,0.7017543859649122,1.0,1.0,16/40,31.52%,GNAI1;PRKCD;PLCB2;GNA15;CAMKK1;ADCY4;CAMK2D;PDE1B;PRKAR2A;CAMK2G;PLCB3;PRKAR1B;CALM1;AHCYL1;MAPK1;PLA2G4A
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,-0.20186822012682681,-0.8664223888790316,0.7183098591549296,1.0,1.0,9/57,11.83%,H2AZ2;H2AZ1;H2BC3;H2AC7;POLR2K;H2AC4;POLR1D;RRN3;H2BC13
prerank,KEGG_2021_Human__Spliceosome,-0.18033576668605875,-0.8663586394994534,0.7,1.0,1.0,34/139,22.80%,PQBP1;HNRNPA1;PLRG1;TXNL4A;DDX5;SNRPB;DHX15;SRSF5;U2SURP;MAGOH;CCDC12;CRNKL1;EIF4A3;THOC2;SNRPE;CHERP;HNRNPA3;HSPA2;SF3B5;RP9;SRSF7;ISY1-RAB43;PPIL1;LSM8;CWC15;SRSF4;TCERG1;DHX38;SF3B6;SRSF3;SNRPD1;SNRPC;PPIH;CTNNBL1
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,0.19009375168786183,0.8628527818415902,0.6923076923076923,1.0,1.0,7/59,8.24%,NCOA1;FMO4;MTARC2;ARNT2;ALDH1B1;ALDH2;CMBL
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.19189281176930528,-0.8628400356877289,0.6515151515151515,1.0,1.0,31/82,32.20%,UBB;PSMD3;AKT1;SKP1;PSMA5;PSMD6;PSMD12;RB1;AKT2;PTK6;PSMC4;E2F4;CDKN1A;SEM1;PSMD11;PSMD7;TFDP2;CDK2;CABLES1;PSME2;LIN52;PSMB10;PSMB2;CCNA1;PSME1;WEE1;PSMA7;LIN54;CKS1B;PSMC5;PSMA3
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.2036193448169364,-0.862056412353234,0.7611940298507462,1.0,1.0,11/71,11.83%,H2AZ2;MYO1E;H2AZ1;H2BC3;H2AC7;RBBP7;POLR2K;H2AC4;SMARCA5;POLR1D;H2BC13
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.2018029220053913,0.8614897874545103,0.6388888888888888,1.0,1.0,5/35,7.72%,NDC1;POM121C;NUP85;NUP153;GNL3
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,-0.28815486414233515,-0.8612169417407739,0.625,1.0,1.0,1/16,0.32%,EPHB3
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.1963324696305619,0.8610746854373613,0.5666666666666667,1.0,1.0,6/46,7.72%,POLR2I;NDC1;POM121C;NUP85;NUP153;GNL3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.23144496937815712,-0.8610390325451945,0.6615384615384615,1.0,1.0,12/36,26.14%,ANAPC11;UBE2C;ANAPC4;ANAPC5;CDC26;RB1;E2F2;E2F3;CDKN1A;TFDP2;CDK2;UBE2E1
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.20286578194512145,0.860347693294922,0.7608695652173914,1.0,1.0,7/49,9.71%,NEGR1;PIGT;PGAP1;NRN1L;PIGF;NTNG2;DPM1
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.21815608421317648,-0.8602794728138824,0.71875,1.0,1.0,17/40,32.91%,MAT2B;MDH1;MAT2A;LDHA;LDHB;GOT1;AHCY;KYAT1;ENOPH1;PHGDH;AHCYL1;SRM;BCAT2;GSS;MPST;MTAP;MDH2
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.17418767770076635,-0.8598940544477927,0.7397260273972602,1.0,1.0,49/153,27.32%,RPS15A;RPL37A;RPLP0;NUP210;RPS21;RPS23;IPO5;RPS4X;GTF2F2;RSL24D1;POLR2K;POLR2B;RPS20;NUP88;POLR2D;RAN;RPS14;RPL9;RPS3A;NUP54;POM121;RPS16;RPS6;DNAJC3;RPL32;NUP37;KPNA4;RPL11;NUP58;CLTC;GRSF1;NUP205;RPS7;RPL7;RPL10A;XPO1;POLR2J;RPS12;RPS8;KPNA3;CANX;RPL27;KPNA5;XK;RPL14;NUP133;MRPL13;RPL22L1;RPL23
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.20097465009623322,-0.859604414128094,0.6666666666666666,1.0,1.0,9/68,8.75%,IL24;IL18RAP;CCR8;IL10RB;CCR4;CCL5;CCR7;CCR10;CXCL10
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.18840802610810087,0.8595534069468062,0.6896551724137931,1.0,1.0,5/50,7.27%,ATP6V0B;ATP6V1A;ATP6V0A1;RAB3A;ATP6V0C
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,-0.19645668442016864,-0.859471881809388,0.6612903225806451,1.0,1.0,26/69,31.98%,ITGB3;FN1;CLCN6;DUSP6;DUSP10;CNKSR2;DUSP7;AKAP9;ZC3HAV1;CAMK2D;IQGAP1;DUSP8;MARK3;MAPK3;PPP1CC;CAMK2G;NRAS;ARAF;CALM1;JAK2;AGGF1;AGK;ITGA2B;MAPK1;VWF;ARRB2
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.19592736483167347,-0.8591277143759243,0.631578947368421,1.0,1.0,24/77,25.11%,RPP25;NOL6;RPP40;UTP6;SNORD3B-1;REXO5;UTP4;NOP58;RPP38;UTP18;RAN;POP4;UTP14C;REXO2;EFL1;RCL1;WDR43;EMG1;XRN2;XPO1;DROSHA;BMS1;DKC1;NOP56
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.2174538493230802,-0.8588182314101247,0.7049180327868853,1.0,1.0,17/51,28.17%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.23243840899349463,0.8582054859751326,0.6216216216216216,1.0,1.0,4/27,7.09%,PDIA3;HLA-G;B2M;HSPA5
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.1612676111231286,-0.8580499427227228,0.85,1.0,1.0,58/341,16.89%,HECTD2;UBA7;UFL1;RNF19B;ANAPC11;SMURF1;UBE2Q2;SEC31A;ATG14;TRIM4;CBLB;UBB;PSMD3;RNF41;UBE2M;FBXO7;SKP1;UBE2G1;RNF130;KLHL25;UBE3D;UBE2C;UBAC1;PSMA5;ANAPC4;ARIH2;FBXW9;ANAPC5;LY96;UBA5;FBXO11;PSMD6;RNF213;HACE1;PSMD12;UBE2J1;FBXO27;CDC26;TRIM9;TIRAP;FBXO15;FBXO21;LRRC41;UBE2L3;HECTD1;CDC20;FBXO44;KEAP1;RNF182;SNAP23;MKRN1;DET1;S100A8;CCNF;ASB6;PJA2;STX4;UBE2B
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,0.218631681415107,0.8573449842324892,0.6486486486486487,1.0,1.0,6/33,11.44%,POLR2I;NCBP1;NELFCD;NELFB;POLR2H;ERCC2
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.2878121293902866,-0.8572949494603297,0.625,1.0,1.0,12/18,39.55%,GNA15;GNG3;GNG5;GNB2;GNG11;GNG7;GNG8;GNG2;GNB4;POMC;GNB1;GNB3
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",-0.22607469687230852,-0.8568007572876967,0.6811594202898551,1.0,1.0,7/41,12.03%,H2AZ2;H2AZ1;H2BC3;H2AC7;H2AC4;H2BC13;POT1
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.24659146215353756,0.8566153721791402,0.6976744186046512,1.0,1.0,3/17,7.39%,CREB1;PDPK1;RASGRF2
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.1897281016243067,-0.855918639665352,0.7384615384615385,1.0,1.0,17/112,12.43%,H2AB2;H3C4;MACROH2A2;H2AZ2;FCGR2A;H3C11;H2AZ1;H2BC3;H2AC7;SNRPB;H3C10;ACTN1;H2AC4;H2AC12;H2AC17;H2BC13;ELANE
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.2087084313022663,0.8558448176796821,0.7,1.0,1.0,4/36,5.36%,PLCB4;NBEA;PRKX;CREB1
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,0.27398639867882074,0.8558158222383935,0.7352941176470589,1.0,1.0,11/15,42.85%,HLA-DRB3;ZAP70;LCK;CD3D;HLA-DPA1;CD4;HLA-DRB4;HLA-DRB1;TARP;HLA-DQA1;HLA-DRA
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.2576964666829809,-0.8557823157622098,0.7,1.0,1.0,6/27,11.26%,CRCP;POLR3C;GTF3C2;POLR2K;POLR1D;POLR3K
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,-0.25485174377091757,-0.8551787251785989,0.6981132075471698,1.0,1.0,7/35,11.26%,ZNF143;CRCP;POLR3C;GTF3C2;POLR2K;POLR1D;POLR3K
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,-0.1918946061596309,-0.8550522413402544,0.7910447761194029,1.0,1.0,21/83,20.28%,DGKQ;MTMR8;DGKD;PLCB2;MTMR2;ITPKC;PI4KA;PLCD3;IPMK;INPPL1;DGKH;MTMR4;SYNJ1;PIK3R1;PIK3R2;CALM2;INPP5B;MTM1;PIK3CB;CALM3;PIP4K2C
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.20744287971726547,-0.8547727364041501,0.78125,1.0,1.0,26/57,33.45%,CTR9;GTF2F2;IWS1;POLR2K;PAF1;TCEA1;POLR2B;CDC73;POLR2D;SUPT16H;NELFA;CCNK;CDK9;DMAP1;ERCC3;ELOA;POLR2J;LEO1;GTF2H5;EAF1;MLLT3;SSRP1;GTF2F1;SKIC8;NCBP2;SUPT6H
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,-0.25281669111573846,-0.8546562227987504,0.6511627906976745,1.0,1.0,11/27,28.55%,ENTPD7;DPYD;SCO2;GDA;ENTPD5;UPB1;ENTPD1;NT5E;NUDT9;NT5C;NUDT18
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,-0.24754502744851953,-0.8543367297326732,0.6818181818181818,1.0,1.0,10/23,30.43%,MMP28;ELANE;MMP9;COL19A1;MMP8;MMP14;MMP11;PHYKPL;ADAM9;ADAM17
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.25136407593668075,-0.8539093804697819,0.6415094339622641,1.0,1.0,11/21,36.84%,MAML2;AKT1;MAML3;AKT2;RBPJ;FOXO1;MAML1;GATD3;KAT2B;IAPP;NOTCH1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,0.22024925010639052,0.8537995173194541,0.6666666666666666,1.0,1.0,2/23,1.53%,TXNL1;ROCK1
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.21613122215797398,0.8537066721547438,0.7222222222222222,1.0,1.0,14/33,26.28%,RAD50;DNA2;EME1;RBBP8;PALB2;TOP3A;BRCA1;MUS81;RAD51C;RAD51;RMI1;SPIDR;SLX1A;SLX4
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.1951382915856687,-0.8531799873268556,0.75,1.0,1.0,28/77,32.20%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;RELA;PSMC4;NFKB1;SEM1;PSMD11;NRAS;PSMD7;BCL10;PSME2;PSME4;PSMB10;PPP3CB;IKBKB;PSMB2;PSME1;CALM1;PSMA7;BTRC;MAP3K7;NFKBIE;PSMC5;PSMA3
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,-0.19777288123267678,-0.8526644623055664,0.6716417910447762,1.0,1.0,9/67,10.22%,OBSCN;ARHGEF39;RHOB;GNA12;GNG3;ARHGEF18;TBXA2R;GNG5;GNB2
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.24937550368433703,-0.8525860462939022,0.640625,1.0,1.0,5/23,12.45%,HNRNPA1;GTF2F2;POLR2K;POLR2B;POLR2D
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,-0.20640313579965794,-0.852464443297628,0.7258064516129032,1.0,1.0,14/59,18.60%,KLKB1;H2AZ2;RHOB;H2AZ1;H2BC3;H2AC7;KLK2;H2AC4;YWHAQ;H2BC13;RHOC;REXO2;H2AC14;PKN3
prerank,KEGG_2021_Human__IL-17 signaling pathway,-0.20250372407738504,-0.8515947584729064,0.6949152542372882,1.0,1.0,29/69,32.40%,MAPK8;MAPK14;TBK1;IKBKE;HSP90B1;CXCL10;ANAPC5;FOSB;ELAVL1;RELA;MAPK7;MMP9;TRAF6;S100A8;NFKB1;MAPK3;PTGS2;MAPK13;IL17RA;HSP90AB1;IKBKB;FOSL1;TAB3;TRADD;MAP3K7;MAPK1;CEBPB;CXCL2;TAB2
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.16183441604404536,-0.8515899043493139,0.7948717948717948,1.0,1.0,57/220,24.69%,TAF5;VPS4B;VPS37A;NUP210;XRCC4;UBB;PSMD3;RANGAP1;FEN1;SKP1;PSMA5;GTF2F2;VPS37C;VPS37B;PSMD6;PSMD12;POLR2K;GTF2A1;CHMP4B;SLC25A5;TCEA1;TAF15;POLR2B;UBAP1;NUP88;POLR2D;NPM1;RAN;TAF9B;XRCC6;NUP54;POM121;SUPT16H;LRIG1;AP1S1;NELFA;CCNK;CDK9;NUP37;NUP58;PSMC4;CCR5;NUP205;AP2S1;RBX1;ERCC3;TAF4;SEM1;XPO1;PSMD11;ELOA;POLR2J;PSMD7;CXCR4;PSME2;PSME4;CD247
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.16278481146236928,-0.85095080825377,0.7948717948717948,1.0,1.0,50/238,19.58%,HNRNPA0;RNPC3;METTL14;PQBP1;HNRNPA1;NUP210;PLRG1;TXNL4A;CHTOP;DDX5;DHX9;SNRPB;DHX15;POLDIP3;SRSF5;GTF2F2;U2SURP;MAGOH;CRNKL1;DNAJC8;POLR2K;PAPOLA;POLR2B;EIF4A3;NUP88;POLR2D;THOC2;ELAVL1;NUP54;SNRPE;POM121;CHERP;HNRNPA3;RBM42;GLE1;SF1;SF3B5;SRSF7;ISY1-RAB43;PPIL1;TFIP11;LSM8;ZCRB1;NUP37;CWC15;SRSF4;NUP58;DHX38;SF3B6;NUP205
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.19570975937549537,0.850922642935167,0.7021276595744681,1.0,1.0,16/37,26.97%,HDAC3;KIFC3;AP3M1;CCT3;CCT6B;TCP1;KIF13A;DCAF7;FBXW4;FBXW10;LONP2;CCNE1;CCNE2;TP53;SPHK1;STAT3
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.17896197794480095,-0.8493428907365788,0.7746478873239436,1.0,1.0,27/129,17.90%,TAF5;VPS4B;VPS37A;NUP210;UBB;RANGAP1;GTF2F2;VPS37C;VPS37B;POLR2K;GTF2A1;CHMP4B;TCEA1;TAF15;POLR2B;UBAP1;NUP88;POLR2D;RAN;TAF9B;NUP54;POM121;SUPT16H;NELFA;CCNK;CDK9;NUP37
prerank,Reactome_2022__Apoptosis R-HSA-109581,-0.1665669639930546,-0.8490100868444267,0.8133333333333334,1.0,1.0,60/166,32.30%,MAPK8;DFFB;UBB;PRKCD;PSMD3;AKT1;H1-4;PSMA5;BAK1;LY96;PSMD6;PSMD12;PROC;UACA;AVEN;FASLG;TANK;HMGB2;BBC3;TP53BP2;YWHAQ;DBNL;MAPT;DFFA;DAPK1;REXO2;PMAIP1;AKT2;PPP1R13B;FNTA;ARHGAP10;PSMC4;TNFRSF10B;MAPK3;CLSPN;SEM1;PSMD11;PSMD7;TFDP2;DYNLL2;STK24;PSME2;PSME4;PSMB10;TICAM1;PSMB2;PSME1;GZMB;HMGB1;PSMA7;YWHAH;CASP6;CASP7;TRADD;PRKCQ;MAPK1;BID;PSMC5;PSMA3;OMA1
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.2147377708658782,-0.8486065746040552,0.7288135593220338,1.0,1.0,8/56,9.69%,UBB;NFKB2;PSMD3;UBE2M;SKP1;PSMA5;PSMD6;PSMD12
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,0.23087053808651295,0.8485806076292929,0.6341463414634146,1.0,1.0,6/17,24.22%,PANK3;ENPP1;COASY;VNN2;FASN;SLC25A16
prerank,KEGG_2021_Human__Colorectal cancer,0.17405935824562702,0.8484164220850638,0.775,1.0,1.0,16/82,15.24%,TGFBR2;FOS;GADD45B;BIRC5;AREG;RALA;TCF7L1;PIK3R3;TGFA;CASP3;APPL1;TCF7L2;LEF1;TGFB1;MLH1;RPS6KB1
prerank,KEGG_2021_Human__Ferroptosis,0.19841552357579806,0.8484126454787202,0.6857142857142857,1.0,1.0,16/39,27.47%,CYBB;ACSL6;SLC39A8;ACSL1;PCBP2;ACSL4;SLC7A11;MAP1LC3B;FTL;GCLC;GPX4;LPCAT3;TP53;SLC40A1;GCLM;ALOX15
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.22580884996744022,-0.8480148467812161,0.6666666666666666,1.0,1.0,6/32,15.02%,DCTN3;RAB18;DYNC1LI2;DYNC1LI1;RAB6A;PLA2G6
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.1833117205407085,0.8478769415458581,0.78125,1.0,1.0,12/55,13.90%,RUVBL1;H2BC15;TLE3;TLE4;H2AB1;BCL9L;TCF7L1;TRRAP;TCF7L2;LEF1;H3C7;SMARCA4
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.19539178266063884,-0.8477772459978439,0.7142857142857143,1.0,1.0,31/78,33.62%,HEY1;MAML2;UBB;PSMD3;AKT1;SKP1;PSMA5;PSMD6;PSMD12;MAML3;PSENEN;PSMC4;NCSTN;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSMB10;RBPJ;PSMB2;PSME1;PSMA7;FBXW7;NOTCH4;PSMC5;PSMA3;MAML1;GATD3;PSMC1;KAT2B
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.21653147338792667,-0.8476749641614247,0.7571428571428571,1.0,1.0,12/56,12.61%,H2AZ2;H2AZ1;H2BC3;H2AC7;H1-4;EP400;H2AC4;HIRA;H2BC13;HMGA2;POT1;RB1
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.2700089151117816,-0.8466956422417665,0.6721311475409836,1.0,1.0,5/20,14.60%,SCT;GNG3;GNG5;GNB2;VIPR1
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,-0.2001294702263668,-0.8466915853341568,0.7536231884057971,1.0,1.0,12/54,17.78%,MAPK8;AKT1;BAK1;UACA;AVEN;BBC3;TP53BP2;YWHAQ;REXO2;PMAIP1;AKT2;PPP1R13B
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.17771357418498596,-0.8465516875279588,0.7794117647058824,1.0,1.0,14/98,12.87%,GNAI1;CHRFAM7A;KCNJ15;KCNJ2;AKAP5;PLCB2;GNG3;LIN7C;CAMKK1;GNG5;GNB2;ADCY4;RPS6KA2;MAPT
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,-0.2123785207605819,-0.8454011432220494,0.6212121212121212,1.0,1.0,8/44,13.36%,TAF5;GTF2F2;POLR2K;GTF2A1;TAF15;POLR2B;POLR2D;TAF9B
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.21272959294746,-0.844850327731121,0.7301587301587301,1.0,1.0,20/51,33.43%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSMB10;PSMB2;PSME1;PSMA7;BTRC;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.18609464191514444,-0.8446060735238927,0.7205882352941176,1.0,1.0,30/87,29.57%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;RSL24D1;RPS20;TRMT112;RPS14;RPL9;RPS3A;RPS16;RPS6;RPL32;RPL11;RPS7;RPL7;RPL10A;RPS12;RPS8;RPL27;RPL14;MRPL13;RPL22L1;RPL23;RPS10;GSPT1;FAU;RPL37
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.2400088318620594,0.8445347822720591,0.7428571428571429,1.0,1.0,9/25,22.14%,KDM3B;ARID5B;KDM5A;H3C7;KDM3A;KDM1A;KDM6A;KDM1B;KDM6B
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,-0.2717280302653308,-0.8444240567492317,0.6935483870967742,1.0,1.0,3/15,11.29%,UBB;ABL2;FLT3LG
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,0.21380622172195235,0.8441670685963069,0.696969696969697,1.0,1.0,7/44,8.17%,TOP1;NDC1;POM121C;NUP85;BIRC5;NUP153;TOP2B
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.2049969658038147,-0.8437188370972455,0.711864406779661,1.0,1.0,9/42,19.96%,BNIP3L;STEAP3;RABGGTB;BBC3;TP53BP2;PMAIP1;PPP1R13B;CASP2;TNFRSF10B
prerank,KEGG_2021_Human__Olfactory transduction,-0.2007819446889173,-0.8435090435254886,0.7808219178082192,1.0,1.0,15/60,19.81%,OR2B11;OR6C74;OR7C1;OR4F17;OR51M1;OR2A7;OR1A1;OR10H1;SLC24A4;PRKACA;CALM2;CAMK2D;PDE1B;OR2M3;CALM3
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.27108246232538047,-0.8432181067195473,0.6842105263157895,1.0,1.0,2/18,2.52%,HEY1;MAML2
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.19964033151600527,0.8428651114105223,0.7272727272727273,1.0,1.0,4/44,3.56%,ALPK1;TIFA;USP18;CASP8
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.2067602426192505,-0.8427856184511157,0.703125,1.0,1.0,18/49,28.96%,RPS15A;RPS21;RPS23;RPS4X;EIF3K;RPS20;RPS14;RPS3A;RPS16;RPS6;RPS7;EIF3C;RPS12;RPS8;EIF2S2;RPS10;FAU;EIF3J
prerank,KEGG_2021_Human__Proteasome,-0.21404847864903823,-0.8427763911687539,0.6865671641791045,1.0,1.0,18/44,33.43%,PSMD1;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,-0.16602627523116958,-0.8427267893230309,0.8513513513513513,1.0,1.0,32/175,17.55%,RGS19;GNAI1;CCR8;PCDHA4;RGS6;RGS12;PRKCD;PLCB2;GNA15;CCL5;GNG3;CCR7;S1PR2;CXCR6;CXCL10;RGS18;CAMKK1;GNG5;GNB2;TAS2R50;TAS2R13;ADCY4;ADORA3;CASR;GPSM1;GPR183;CAMK2D;PDE4C;PPBP;OPN3;PDE1B;PPP2CA
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.16800744707453308,-0.8418154972692884,0.8333333333333334,1.0,1.0,59/151,34.51%,TRPV2;MAPK8;ATG5;TRPM7;MCU;OAS3;PRKCD;PLCB2;MAPK14;IRAK4;TBK1;CCL5;IFI16;IKBKE;ANTXR2;ERBIN;TANK;GABARAPL2;GBP1;TXN2;RELA;CASR;TRAF6;BIRC3;IRF7;CASP4;STAT1;PYCARD;OAS2;NFKB1;MAPK3;RBCK1;MAPK13;DEFA1B;PLCB3;HSP90AB1;MFN1;RNF31;TICAM1;IKBKB;CASP5;MEFV;CYBA;TAB3;CARD16;DEFA1;MAP3K7;NLRP6;MAPK1;RIPK3;CXCL2;SUGT1;TAB2;P2RX7;IRF3;CAMP;XIAP;HSP90AA1;TRPM2
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.1936956144341022,-0.8418136990850673,0.7611940298507462,1.0,1.0,18/71,20.08%,NUP210;CHTOP;POLDIP3;SRSF5;MAGOH;EIF4A3;NUP88;THOC2;NUP54;POM121;GLE1;SRSF7;NUP37;SRSF4;NUP58;DHX38;NUP205;SRSF3
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.1937104833647817,-0.8413866165924404,0.7575757575757576,1.0,1.0,21/81,21.88%,UBA7;EIF4G2;NUP210;OAS3;UBB;EIF4A3;NUP88;NUP54;PDZD2;POM121;IFIT1;RIGI;STAT1;MX2;NUP37;KPNA4;NUP58;NUP205;OAS2;MAPK3;HERC5
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.21839180509567552,-0.8412496770246968,0.7464788732394366,1.0,1.0,10/36,19.58%,NUP210;RANGAP1;NUP88;NPM1;RAN;NUP54;POM121;NUP37;NUP58;NUP205
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.2412513974869674,-0.8402319977238146,0.7090909090909091,1.0,1.0,7/38,11.26%,ZNF143;CRCP;POLR3C;GTF3C2;POLR2K;POLR1D;POLR3K
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.24276903418962403,0.8398086864731075,0.7209302325581395,1.0,1.0,2/18,4.44%,NCOA1;PPARA
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,-0.18574346456007146,-0.8392748879762992,0.7377049180327869,1.0,1.0,25/82,25.66%,FN1;MAPK8;PRKCD;PLCB2;AKT1;MAPK14;VEGFA;NOS3;PLCD3;RELA;TGFB3;PIK3R1;PIK3R2;AKT2;STAT1;PIK3CB;NFKB1;SMAD4;MAPK3;EGR1;NRAS;MAPK13;PLCB3;PIM1;FOXO1
prerank,KEGG_2021_Human__cAMP signaling pathway,0.15812934756555322,0.8392593292853933,0.7857142857142857,1.0,1.0,15/125,10.84%,FOS;FXYD2;RAP1A;SUCNR1;ROCK1;ATP2A1;PPARA;CREB1;PDE10A;MYL9;RRAS;PIK3R3;HCAR3;AMH;CALML4
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.18445658762261058,-0.8366936948474082,0.782608695652174,1.0,1.0,28/91,28.17%,TNFRSF9;UBB;NFKB2;PSMD3;UBE2M;SKP1;PSMA5;PSMD6;PSMD12;FASLG;TANK;EDA;BIRC3;TNFSF13;PSMC4;SEM1;CD27;PSMD11;PSMD7;PSME2;PSME4;TNFRSF17;CD40;PSMB10;LTA;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.17179388774398752,-0.8366708250454078,0.8026315789473685,1.0,1.0,32/134,20.74%,RPS15A;RPL37A;RPLP0;NUP210;RPS21;RPS23;IPO5;RPS4X;GTF2F2;RSL24D1;POLR2K;POLR2B;RPS20;NUP88;POLR2D;RPS14;RPL9;RPS3A;NUP54;POM121;RPS16;RPS6;DNAJC3;RPL32;NUP37;RPL11;NUP58;GRSF1;NUP205;RPS7;RPL7;RPL10A
prerank,KEGG_2021_Human__Basal transcription factors,0.200091305730697,0.8357611540730714,0.7142857142857143,1.0,1.0,9/41,15.78%,TBPL2;GTF2H2C_2;TAF1;TBPL1;ERCC2;TBP;GTF2B;GTF2E1;TAF2
prerank,KEGG_2021_Human__Starch and sucrose metabolism,0.23415599294744577,0.8356550054407027,0.7567567567567568,1.0,1.0,2/24,1.80%,HK1;PGM1
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.206873936300327,0.8350882222293738,0.6666666666666666,1.0,1.0,9/37,15.31%,VAMP3;DIAPH1;CAPZB;VANGL1;BAIAP2L2;AKAP12;ARHGAP1;RHOF;ARHGAP5
prerank,KEGG_2021_Human__Wnt signaling pathway,0.15623918618877056,0.8349220494822125,0.7777777777777778,1.0,1.0,17/106,13.51%,PLCB4;SIAH1;RUVBL1;BAMBI;TLE3;LGR4;CCND2;CUL1;PRICKLE2;TLE4;SENP2;TCF7L1;VANGL1;TCF7L2;LEF1;LRP6;CSNK1A1
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,-0.19915921590138538,-0.8336211315321334,0.7619047619047619,1.0,1.0,22/52,35.16%,GNAO1;FZD2;PLCB2;GNG3;GNG5;AGO3;GNB2;AGO4;GNG11;NRAS;PLCB3;PPP3CB;GNG7;CALM1;GNG8;TCF7;MAP3K7;PDE6G;GNG2;AGO2;PDE6A;GNB4
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.19421915027948208,-0.8336014467074281,0.7121212121212122,1.0,1.0,11/63,15.07%,GNAI1;HRH2;ADM;SCT;GNG3;RAMP1;GNG5;GNB2;ADCY4;VIPR1;PPAN-P2RY11
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.2814397809136201,-0.8332043179384137,0.7586206896551724,1.0,1.0,1/15,0.03%,GALK1
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,-0.14762830492669127,-0.8327633440613641,0.8928571428571429,1.0,1.0,40/386,9.11%,PLEKHG4;FAM169A;YKT6;FLOT2;OBSCN;RTKN;COPS2;ARHGEF39;HMOX2;USP9X;RHOB;RNF20;ARHGDIB;ARHGAP42;SH3BP1;DOCK9;UBXN11;CDC42BPB;SH3PXD2A;KCTD3;DNMBP;STEAP3;ARHGAP23;STAM;CCT2;ARHGEF18;ABL2;FARP2;PKP4;DOCK4;RHPN2;TNFAIP1;SLK;FAM13A;DAAM1;NCOA3;ARHGAP17;TEX2;ACTN1;FMNL1
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",0.19446145637202245,0.8312749786188849,0.6388888888888888,1.0,1.0,8/31,17.71%,SLC33A1;ARL2BP;NLRP3;SLC35B3;SLC35D2;ARL2;SLC27A1;SLC35B2
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,-0.22793823759566412,-0.8310245827726502,0.746268656716418,1.0,1.0,10/31,26.45%,MCM5;CDC6;MCM4;MCM7;RPA3;MCM10;POLA2;DBF4;CDK2;POLA1
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,-0.27147213615952637,-0.8306895152835106,0.6851851851851852,1.0,1.0,5/16,23.54%,MAPK14;SHC1;MAPKAPK3;NRAS;MAPK13
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.18484903004427758,-0.8304746030541743,0.6984126984126984,1.0,1.0,27/96,25.49%,HEY1;SMURF1;HIVEP3;UBB;PSMD3;AKT1;SKP1;PPARGC1B;PSMA5;CBFB;PSMD6;PSMD12;RB1;AKT2;HDAC4;STAT1;PSMC4;RBX1;CDKN1A;SMAD4;MAPK3;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,-0.16498878001994666,-0.8295305689017272,0.8333333333333334,1.0,1.0,30/159,17.33%,LMO2;H3C4;DUSP6;BMP2K;FUT8;SPINT1;H3C11;TCF3;PBX3;IGF1R;DDX5;RUNX1T1;TRAF1;RARA;BAK1;H3C10;MEIS1;NSD2;TAF15;HMGA2;ELANE;MEF2C;GADD45G;RELA;MMP9;ATF1;BIRC3;PML;CDK9;PLAT
prerank,KEGG_2021_Human__Shigellosis,-0.155839871804683,-0.8293601563885796,0.90625,1.0,1.0,25/224,9.85%,CRKL;MAPK8;ATG5;H3C4;SEPTIN6;ATG14;H3C11;RRAGD;UBB;PRKCD;TLR5;CALCOCO2;PLCB2;AKT1;MAPK14;ARPC4;TBK1;TLN2;SKP1;CCL5;WIPI2;H3C10;ACTN1;PLCD3;RPTOR
prerank,KEGG_2021_Human__Arginine biosynthesis,-0.272083766655525,-0.8290447916837154,0.660377358490566,1.0,1.0,4/15,15.77%,GPT2;NOS3;NAGS;GOT1
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.20708590191750623,-0.8286661289109627,0.746031746031746,1.0,1.0,19/49,33.43%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;CARD16;PSMC5;PSMA3;PSMC1
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,-0.21680048174907207,-0.8284654162019539,0.746031746031746,1.0,1.0,11/38,24.40%,CLTB;PLCB2;CLTCL1;KLK2;DNM1;PRKACA;ATP1B2;CLTC;AP2S1;ATP1B3;PLCB3
prerank,KEGG_2021_Human__Yersinia infection,0.15333553196526883,0.8284579063742901,0.8780487804878049,1.0,1.0,16/128,9.93%,FOS;CXCL8;ROCK1;IL6;ACTR3;ARPC5;CD8A;CDC42;ITGA4;PXN;NLRP3;ACTR3B;PKN1;ARPC5L;PIK3R3;IL10
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.2592282342738066,-0.8280524297966839,0.7142857142857143,1.0,1.0,12/21,36.84%,HEY1;MAML2;MAML3;STAT1;RBPJ;DLGAP5;PBX1;MAML1;GATD3;KAT2B;WWC1;NOTCH1
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,-0.18435823712923236,-0.8278397646343292,0.8082191780821918,1.0,1.0,34/90,33.43%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;RELA;TRAF6;PIK3R1;PIK3R2;PIK3CB;PSMC4;NFKB1;SEM1;PSMD11;PSMD7;BCL10;PSME2;PSME4;CD247;PSMB10;INPP5D;IKBKB;PSMB2;PSME1;PSMA7;BTRC;PRKCQ;MAP3K7;PSMC5;PSMA3;TAB2;CD3E;PSMC1
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.1992848045718404,-0.827436824842001,0.7083333333333334,1.0,1.0,17/54,28.46%,TBC1D8B;SNX5;AP4B1;BLOC1S3;AP1S1;YIPF6;CLTC;SORT1;HOMER2;NAPSA;HIP1R;DNAJC6;VAMP8;SH3D19;BLOC1S1;OCRL;CLINT1
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.21843361529718558,0.8273135468131242,0.8,1.0,1.0,4/20,14.93%,TUBB3;CCT3;CCT6B;TCP1
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.2426474557204033,0.8254212303670801,0.7045454545454546,1.0,1.0,3/22,5.29%,RUVBL1;TERF1;CCNA2
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.1865529406839026,-0.825417032902174,0.7636363636363637,1.0,1.0,15/56,24.97%,ATG5;TOMM20;UBB;TOMM7;DYNC1LI2;DYNC1LI1;PLIN3;MTERF3;ULK1;TOMM5;TOMM22;SQSTM1;DYNLL2;PRKAG1;MFN1
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,-0.1833850679115152,-0.8239644848304444,0.7419354838709677,1.0,1.0,16/71,21.73%,ITGB3;FGFR1;LAMC1;NCAM1;CNTN1;DNM1;RDX;RPS6KA2;MSN;NRP1;CLTC;SCN1B;AP2S1;L1CAM;SHTN1;MAPK3
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.20223377661154524,-0.8224324455566514,0.7076923076923077,1.0,1.0,20/57,27.39%,H2AZ2;H2AZ1;H2BC3;H2AC7;RARA;CBFB;H2AC4;H2BC13;CSF3R;PML;H2AC14;MYB;TAL1;GFI1;CDKN1A;TFDP2;CDK2;H4C15;H2BC21;H2AC20
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.1964789365468017,-0.8222296767604835,0.7457627118644068,1.0,1.0,24/64,34.25%,UBB;PSMD3;AKT1;PSMA5;PSMD6;PSMD12;FRK;MKRN1;AKT2;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;CSNK2A2;PSMC5;PSMA3;PSMC1;XIAP
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.1835223675017022,-0.8207520459179388,0.7575757575757576,1.0,1.0,31/88,29.57%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;RSL24D1;RPS20;RPS14;RPL9;RPS3A;RPS16;RPS6;DNAJC3;RPL32;RPL11;GRSF1;RPS7;RPL7;RPL10A;RPS12;RPS8;RPL27;XK;RPL14;MRPL13;RPL22L1;RPL23;RPS10;FAU;RPL37
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.17303550664413966,-0.8204994313210733,0.8309859154929577,1.0,1.0,45/139,29.16%,MCM5;RAD9B;RMI2;CDC6;H2BC3;UBB;PSMD3;PSMA5;PSMD6;NSD2;PSMD12;MCM4;YWHAQ;RFC5;H2BC13;RHNO1;MCM7;RPA3;REXO2;RNF168;EXO1;RAD9A;MCM10;PSMC4;CLSPN;SEM1;BARD1;WRN;PSMD11;PSMD7;PIAS4;DBF4;BRIP1;CDK2;PSME2;PSME4;H4C15;PSMB10;H2BC21;PSMB2;PSME1;WEE1;PSMA7;YWHAH;PKMYT1
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.237557074692501,-0.8200040460897116,0.5964912280701754,1.0,1.0,7/24,20.01%,MARS1;GARS1;AIMP2;SARS1;KARS1;AARS1;TARS1
prerank,KEGG_2021_Human__Morphine addiction,0.18915477607430975,0.8194678202242711,0.868421052631579,1.0,1.0,7/51,9.23%,PDE2A;GNG10;GABRR2;PDE7A;PDE10A;GRK6;GNB5
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.1423715501267186,0.8191918573957443,0.9117647058823529,1.0,1.0,14/110,10.26%,UQCR10;NDUFB10;ATP5PD;NDUFS6;COX19;COX7B;ATP5MF;COX16;NDUFB7;COX8A;NUBPL;COX4I1;SDHD;NDUFB2
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.2290634658666979,0.8190265395704356,0.6388888888888888,1.0,1.0,4/18,15.63%,CDC25C;CDK1;RBL1;CCNB1
prerank,KEGG_2021_Human__Hepatitis B,-0.16821141553968083,-0.8187778255158038,0.8688524590163934,1.0,1.0,44/140,27.31%,MAPK8;CREB3L4;AKT1;MAPK14;IRAK4;TBK1;DDB1;IKBKE;FAS;FASLG;TIRAP;YWHAQ;RB1;CREB3L2;RELA;MMP9;TRAF6;TGFB3;ATF2;PIK3R1;PIK3R2;IRF7;ATF4;AKT2;STAT1;PIK3CB;E2F2;E2F3;JAK3;RAF1;NFKB1;CDKN1A;SMAD4;MAP2K7;MAPK3;NRAS;MAPK13;CDK2;TICAM1;ARAF;EGR3;IKBKB;CCNA1;TLR3
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.26304538885744766,-0.8184271386376868,0.746268656716418,1.0,1.0,3/16,11.78%,UBB;SKP1;TNIP2
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.1955327663893307,-0.8183840191574524,0.7678571428571429,1.0,1.0,21/60,25.11%,NOL6;UTP6;UTP4;NOP58;SPPL2A;UTP18;TRMT112;RPS14;PDCD11;UTP14C;PNO1;RPS6;RCL1;WDR43;RPS7;EMG1;THUMPD1;BMS1;BUD23;DKC1;NOP56
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,-0.16381775316002373,-0.8183116280954748,0.8636363636363636,1.0,1.0,19/140,13.67%,GNAI1;CHRFAM7A;KCNJ15;KCNJ2;SYN3;CACNB3;AKAP5;SNAP25;PLCB2;GNG3;CACNA1E;LIN7C;CAMKK1;GNG5;GNB2;ADCY4;RPS6KA2;MAPT;ABAT
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.22697112998357818,0.8182356995122537,0.7906976744186046,1.0,1.0,7/20,23.09%,CARD8;APAF1;CASP3;CDKN2A;CYCS;BAX;C1QBP
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.14622603386381286,-0.817291651536114,0.9404761904761905,1.0,1.0,106/437,24.41%,MGST1;DEGS1;APRT;CHIT1;RAB31;HMOX2;CAB39;FCGR2A;CYB5R3;SNAP25;LTA4H;P2RX1;GLIPR1;MMP28;PRKCD;PSMD3;QSOX1;MAPK14;ITGAX;CREG1;PLEKHO2;GRN;RAB18;S100A12;CCT2;CEACAM8;IST1;TBC1D10C;PSMA5;DPP7;DERA;SLC44A2;SLC2A3;BST1;ALDH3B1;PSMD6;PSMD12;SIGLEC14;VPS35L;FRK;UNC13D;DBNL;DYNC1LI1;STK11IP;PTAFR;ELANE;TOM1;RAB6A;ADGRE3;MS4A3;RAB10;CLEC5A;MMP9;XRCC6;PRCP;IRAG2;ILF2;ARSB;SCAMP1;ARHGAP9;SNAP23;RAP2B;YPEL5;PRDX5;S100A8;PPBP;DNAJC3;ARMC8;RAB14;ABCA13;CPNE3;CRISPLD2;NBEAL2;MGAM;RAB44;ITGB2;ANXA2;MNDA;IQGAP1;PYCARD;SELL;OLFM4;GYG1;NFKB1;CXCR2;PLAU;MMP8;FPR1;NCSTN;PLAUR;PTPN6;CD177;GM2A;CDK13;TMC6;GMFG;ADGRG3;PSMD11;NRAS;LRG1;CKAP4;PSMD7;CD58;CEACAM1;VAMP8;HSP90AB1
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.22226302719783098,0.8167237940034291,0.6764705882352942,1.0,1.0,5/19,16.60%,VRK2;SIRT2;CDK1;CCNB1;PPP2R1A
prerank,Reactome_2022__Inflammasomes R-HSA-622312,-0.23555388218971263,-0.8166228209535475,0.7407407407407407,1.0,1.0,10/21,35.37%,NFKB2;TXN2;RELA;PYCARD;NFKB1;HSP90AB1;MEFV;SUGT1;P2RX7;TXNIP
prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.17270956944470334,0.8149411217073064,0.8421052631578947,1.0,1.0,6/90,2.63%,ELOC;HK1;CYBB;PDHA1;ANGPT1;IL6
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.15454576112670698,0.8144564410949904,0.78125,1.0,1.0,22/108,19.39%,LAIR2;HLA-G;KLRC1;CD8A;B2M;JAML;ITGA4;CD300E;SLAMF6;CLEC2D;CD22;SIGLEC9;KLRD1;SLAMF7;MADCAM1;CD300LG;PILRA;ULBP3;CD3D;KLRG1;SH2D1B;SIGLEC7
prerank,KEGG_2021_Human__Osteoclast differentiation,-0.17106714127575323,-0.8142851188453165,0.8309859154929577,1.0,1.0,25/117,23.54%,ITGB3;MAPK8;FCGR2A;JUNB;NFKB2;AKT1;MAPK14;CYLD;FOSB;RELA;TRAF6;SYK;PIK3R1;PIK3R2;TEC;AKT2;STAT1;PIK3CB;LCP2;NFKB1;NCF4;MAP2K7;MAPK3;SQSTM1;MAPK13
prerank,Reactome_2022__mRNA Capping R-HSA-72086,0.2198790953198905,0.8142066140515926,0.7714285714285715,1.0,1.0,5/29,11.44%,POLR2I;RNMT;NCBP1;POLR2H;ERCC2
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.14900918570641186,0.8135468264978091,0.8157894736842105,1.0,1.0,26/110,20.98%,KLC1;GATA1;KIF11;KIF20A;CDC42;RAB5A;CAPZB;KIF5A;ITPK1;KIFC2;IRF2;H3C7;KLC4;KIF15;CAPZA1;PHF21A;ABL1;ZFPM1;DOCK2;SIN3A;H3-3B;KIFC1;KDM1A;DOCK7;KIF13B;MAFK
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.17348070011981853,-0.813335330837368,0.7727272727272727,1.0,1.0,37/107,32.20%,CD79A;UBB;PSMD3;CLSTN1;SKP1;PSMA5;PSMD6;PSMD12;TRPC1;RELA;SYK;PIK3R1;PSMC4;NFKB1;PTPN6;SEM1;PSMD11;NRAS;PSMD7;BCL10;PSME2;PSME4;PSMB10;PPP3CB;CD79B;IKBKB;PSMB2;PSME1;CALM1;PSMA7;AHCYL1;BTRC;MAP3K7;NFKBIE;FYN;PSMC5;PSMA3
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.20690867641300031,-0.8128788894813269,0.7777777777777778,1.0,1.0,18/47,33.43%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.20085280469024996,-0.8127743374135277,0.7931034482758621,1.0,1.0,9/54,11.91%,CTR9;RNF20;PEX2;H2BC3;UBB;PAF1;CDC73;H2BC13;UBE2L3
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.20404252373247206,0.8126798635333852,0.6842105263157895,1.0,1.0,7/33,15.57%,CHST13;CHST7;SDC2;CHST12;VCAN;XYLT2;IDUA
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.1869547913230523,0.8114836576264182,0.8181818181818182,1.0,1.0,8/59,11.44%,POLR2I;ELOC;FOS;ELL;NELFCD;NELFB;POLR2H;ERCC2
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.19955967359786544,-0.8110306319423295,0.7536231884057971,1.0,1.0,7/53,11.83%,MAPK8;EYA3;H2BC3;UBB;NSD2;SMARCA5;H2BC13
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.20084098092550054,0.8105114197203063,0.7777777777777778,1.0,1.0,11/34,21.99%,CDC42;TALDO1;RALA;PDCD4;IL10;CNN2;CAPZA1;TCP1;S100A9;HSPA9;SNRPA1
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,-0.28162003445018957,-0.8102377426713951,0.7777777777777778,1.0,1.0,9/15,41.63%,PROC;PROCR;F8;F5;CD177;PF4V1;PF4;THBD;PROS1
prerank,Reactome_2022__Neuronal System R-HSA-112316,-0.15602881599607635,-0.8100005437522646,0.8028169014084507,1.0,1.0,35/203,18.17%,GNAI1;BEGAIN;CHRFAM7A;FLOT2;KCNJ15;KCNJ2;SYN3;CACNB3;AKAP5;NRXN3;SNAP25;PLCB2;NRXN2;GNG3;CACNA1E;KCNMB1;KCNQ1;LIN7C;CAMKK1;GNG5;GNB2;DBNL;ADCY4;RPS6KA2;MAPT;NLGN3;ABAT;PPFIBP2;KCNN4;SLC22A1;CAMK2D;SH2D3C;KCNH2;KCNA7;ABCC9
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.2562311595265476,0.8096912320597683,0.6756756756756757,1.0,1.0,8/17,25.11%,CCND2;CDKN1B;CDKN1C;CDK6;CDK4;CCNE1;CCNE2;E2F1
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.16582424252245637,0.8095256773416237,0.8181818181818182,1.0,1.0,16/83,15.96%,CYBB;VAMP3;VRK2;ARHGAP35;JAG1;CDC42;LAMTOR1;ABI1;PKN1;VANGL1;NCKAP1;VAV2;ARHGAP1;ARAP3;ARHGAP5;SWAP70
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.19657411922772022,-0.8094199071571607,0.75,1.0,1.0,21/56,33.43%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;BTRC;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.19845107957968833,-0.809230313681994,0.7903225806451613,1.0,1.0,21/55,33.43%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;BTRC;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.19845107957968833,-0.809230313681994,0.7903225806451613,1.0,1.0,21/55,33.43%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;BTRC;PSMC5;PSMA3;PSMC1
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.2296559915091631,0.8089844087766896,0.6888888888888889,1.0,1.0,4/26,9.49%,FXYD2;SGK1;PDPK1;PIK3R3
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,-0.15688018608345247,-0.8083962852282802,0.7894736842105263,1.0,1.0,30/156,20.42%,SLC22A16;SLC30A7;SLC9A4;SLC7A8;SLC11A2;SLC16A3;SLC25A22;SLC28A2;SLC35A1;SLC39A14;SLC5A5;SLC44A2;SLC35B4;SLC2A3;SLC7A1;SLC25A5;BSG;SLC6A15;SLC5A2;SLC24A4;SLC30A5;SLCO4A1;SLC26A1;SLC22A1;SLC44A4;SLC26A11;SLC30A6;SLC22A15;SLC29A4;SLC2A1
prerank,KEGG_2021_Human__Homologous recombination,0.19018025811063372,0.8082574085608022,0.717948717948718,1.0,1.0,7/41,13.95%,RAD50;RPA2;POLD4;EME1;RBBP8;PALB2;TOP3A
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.19931979452868454,0.8076727209888538,0.8285714285714286,1.0,1.0,6/30,12.61%,SIAH1;EZR;CDC42;PKN1;AGAP2;NCK1
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.24183310860006288,-0.8074804697115122,0.8166666666666667,1.0,1.0,10/20,39.55%,PLCB2;TAS2R50;TAS2R13;SCN1B;TAS2R20;TAS2R14;TAS2R4;GNB1;TRPM4;GNB3
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.21304651603976296,0.8067219174583277,0.7111111111111111,1.0,1.0,4/27,7.47%,UVRAG;CHMP6;SDC2;VCP
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,-0.19431026954009842,-0.8061044440353641,0.7833333333333333,1.0,1.0,11/50,16.20%,RRAGD;SH3BP4;SLC38A9;KPTN;RPTOR;NPRL2;ATP6V1G1;CASTOR1;NPRL3;MLST8;MIOS
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.24157970366474926,0.8060313303694595,0.66,1.0,1.0,6/17,19.85%,ITGA3;LAMC3;NID1;LAMA5;ITGA1;ITGA6
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.2515178188757286,-0.8052831236849537,0.65,1.0,1.0,5/21,12.97%,PIWIL2;POLR2K;POLR2B;POLR2D;TDRKH
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,-0.24487463393393755,-0.8052041758891394,0.8333333333333334,1.0,1.0,7/20,22.75%,LPIN1;MOGAT3;PLIN3;MGLL;GPAT2;GPD2;PPP1CC
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,-0.17034123896598025,-0.8050062288809059,0.8493150684931506,1.0,1.0,32/113,24.40%,GNAI1;GNA12;CREB3L4;PLCB2;AKT1;PPIF;NOS3;KCNMB1;SLC25A5;ADCY4;ADORA3;MEF2C;CREB3L2;GUCY1B1;MEF2D;ATF2;ATP1B2;CALM2;MYLK;ATF4;AKT2;SRF;RAF1;CALM3;VASP;MAPK3;ADCY3;PPP1CC;ATP1B3;IRAG1;BORCS8-MEF2B;PLCB3
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,0.17981768002016135,0.8043092417452007,0.8095238095238095,1.0,1.0,5/41,11.78%,FXYD2;ATP2A1;ATP11B;ATP11A;ATP10D
prerank,KEGG_2021_Human__Epstein-Barr virus infection,-0.1584066954662686,-0.804150542312342,0.8805970149253731,1.0,1.0,47/181,24.76%,MAPK8;PSMD1;OAS3;NFKB2;PSMD3;AKT1;MAPK14;IRAK4;TBK1;IKBKE;BAK1;FAS;CXCL10;PSMD6;PSMD12;RB1;GADD45G;RELA;TRAF6;SAP30;FCER2;SYK;PIK3R1;PIK3R2;IRF7;AKT2;STAT1;PIK3CB;E2F2;E2F3;JAK3;ENTPD1;PSMC4;OAS2;NFKB1;CDKN1A;MAP2K7;GADD45A;SEM1;RUNX3;PSMD11;MAPK13;PSMD7;CD58;CDK2;CD247;CD40
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.24095294826494196,-0.803523400421535,0.6842105263157895,1.0,1.0,8/19,35.29%,MAPK14;TRAF6;MAPKAPK3;IRAK2;TAB3;MAP3K7;TAB2;IRAK1
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.18927407204730037,-0.8031323766356815,0.803030303030303,1.0,1.0,19/73,21.88%,UBA7;EIF4G2;NUP210;UBB;EIF4A3;NUP88;NUP54;PDZD2;POM121;IFIT1;RIGI;STAT1;MX2;NUP37;KPNA4;NUP58;NUP205;MAPK3;HERC5
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,0.16553874123521567,0.8022470281539346,0.9285714285714286,1.0,1.0,23/80,23.39%,NXF1;NDC1;WDR33;POM121C;CPSF1;SYMPK;NUP85;NUP153;FYTTD1;NCBP1;THOC7;UPF3B;SARNP;CPSF3;NUP214;SRSF9;NUP155;THOC3;FIP1L1;CDC40;NUP98;SRSF6;U2AF1
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,-0.1822924455929006,-0.8018517852878803,0.7936507936507936,1.0,1.0,27/95,23.54%,CRKL;DUSP6;MAPK14;SHC1;ID3;DUSP7;CRK;DNM1;FOSB;RPS6KA2;MEF2C;MAPK7;MAPKAPK3;ID1;MEF2D;PIK3R1;PIK3R2;PPP2CA;PIK3CB;SRF;CLTC;AP2S1;RNASEH2A;MAPK3;EGR1;NRAS;MAPK13
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,-0.24347588199866815,-0.8018380307220108,0.6792452830188679,1.0,1.0,3/21,9.76%,CACNB3;NCAM1;COL6A2
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,-0.18190283611639363,-0.8014117598974659,0.819672131147541,1.0,1.0,29/107,23.54%,CRKL;PTPN11;DUSP6;MAPK14;SHC1;ID3;DUSP7;PCSK5;CRK;DNM1;FOSB;RPS6KA2;MEF2C;MAPK7;MAPKAPK3;ID1;MEF2D;PIK3R1;PIK3R2;PPP2CA;PIK3CB;SRF;CLTC;AP2S1;RNASEH2A;MAPK3;EGR1;NRAS;MAPK13
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.16436184504956328,0.8000905998562587,0.8285714285714286,1.0,1.0,17/81,18.02%,NF2;ACTR3;ARPC5;MYH9;CDC42;PLPP5;ABI1;PKN1;FGR;NCKAP1;NCK1;VAV2;ABL1;WASF3;ACTR2;MYO10;PRKCSH
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,0.1846621256641093,0.8000092361109833,0.8620689655172413,1.0,1.0,14/58,19.67%,HDAC3;SAP18;H2BC15;ARID4A;H2AC21;GPS2;H3C7;MTA2;PHF21A;SUDS3;H2AC19;ARID4B;H2BC4;KDM1A
prerank,KEGG_2021_Human__Gastric cancer,-0.16997539955360347,-0.7999604868184659,0.819672131147541,1.0,1.0,27/96,24.52%,FRAT1;FZD2;LRP5;AKT1;SHC1;BAK1;WNT10A;ABCB1;RB1;GADD45G;WNT10B;TGFB3;PIK3R1;PIK3R2;AKT2;PIK3CB;E2F2;E2F3;RAF1;CDKN1A;SMAD4;GADD45A;MAPK3;HGF;NRAS;CDK2;WNT7A
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.2502782274558729,-0.7992264463300592,0.7619047619047619,1.0,1.0,5/23,15.41%,UBB;LY96;SARM1;TRAF6;BIRC3
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.2220172151046213,0.7991240484936765,0.8125,1.0,1.0,5/20,17.69%,JAG1;YBX1;MIB2;ADAM10;NEURL1
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,-0.21061123993995895,-0.7985824716285093,0.7638888888888888,1.0,1.0,14/40,25.50%,SLC46A1;HBA1;NRIP1;LY96;CLEC1B;MEF2C;MEF2D;NCOA6;NCOA2;CRTC2;XPO1;SIRT1;BRIP1;CARM1
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.14612962516580175,-0.7982517611656386,0.961038961038961,1.0,1.0,88/336,25.50%,BNIP3L;TAF5;RAD9B;JMY;TTC5;RMI2;CNOT7;STK11;ZNF385A;TSC2;RRAGD;UBB;PLK2;AKT1;MAPK14;RBBP7;STEAP3;GTF2F2;SLC38A9;RABGGTB;UBL4A;PPP1R13L;POLR2K;SCO2;AGO3;RPTOR;TCEA1;TAF15;POLR2B;BBC3;TP53BP2;YWHAQ;RFC5;POLR2D;RHNO1;RPA3;NPM1;TXN2;AGO4;TAF9B;PDZD2;REXO2;MLST8;SUPT16H;PRDX5;PMAIP1;CNOT4;TSC1;TP53RK;CNOT8;AKT2;NELFA;CCNK;PML;CDK9;PPP2CA;PPP1R13B;EXO1;RAD9A;CNOT9;COX6A1;CASP2;DDIT4;BTG2;RRM2B;TNFRSF10B;E2F4;PIP4K2C;CDKN1A;GADD45A;ERCC3;CNOT10;CDK13;TAF4;BARD1;WRN;SESN1;ELOA;POLR2J;TFDP2;PRKAG1;BRIP1;CDK2;GSR;RABGGTA;FANCI;COX20;CARM1
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.18594281048458577,-0.7978504473173774,0.8153846153846154,1.0,1.0,19/78,19.59%,TSC2;RRAGD;AKT1;SLC38A9;UBL4A;SCO2;AGO3;RPTOR;YWHAQ;TXN2;AGO4;REXO2;MLST8;PRDX5;TSC1;AKT2;COX6A1;DDIT4;RRM2B
prerank,KEGG_2021_Human__Autoimmune thyroid disease,0.19221018123421782,0.7977679297286632,0.8181818181818182,1.0,1.0,5/33,14.35%,HLA-G;PRF1;IL10;CTLA4;HLA-DRB3
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.2128011238884166,-0.7977561649586605,0.8,1.0,1.0,8/38,15.39%,UBA7;UBB;RFC5;SLC19A1;RPA3;POLD1;USP32;POLD2
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,-0.15634395639874632,-0.7977519911350172,0.8701298701298701,1.0,1.0,38/188,19.27%,HNRNPA0;RNPC3;PQBP1;HNRNPA1;PLRG1;TXNL4A;DDX5;DHX9;SNRPB;DHX15;SRSF5;GTF2F2;U2SURP;MAGOH;CRNKL1;DNAJC8;POLR2K;PAPOLA;POLR2B;EIF4A3;POLR2D;ELAVL1;SNRPE;CHERP;HNRNPA3;RBM42;SF1;SF3B5;SRSF7;ISY1-RAB43;PPIL1;TFIP11;LSM8;ZCRB1;CWC15;SRSF4;DHX38;SF3B6
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.22640923613415498,-0.7976271934055943,0.8688524590163934,1.0,1.0,6/29,17.26%,PTPN11;UBB;SHC1;CSF3R;SYK;STAT1
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,0.21446823832649956,0.7968751701944897,0.7,1.0,1.0,3/25,7.28%,PIGT;PGAP1;PIGF
prerank,KEGG_2021_Human__Spinocerebellar ataxia,-0.16275325567325663,-0.796167283080272,0.8823529411764706,1.0,1.0,34/118,25.49%,MAPK8;ATG14;PSMD1;MCU;ULK2;PSMD3;PLCB2;AKT1;PPIF;PSMA5;PUM2;WIPI2;PSMD6;PSMD12;SLC25A5;ULK1;VLDLR;PIK3R1;PIK3R2;AKT2;ERN1;PIK3CB;ATXN2;PSMC4;RELN;XBP1;ATXN10;SEM1;PSMD11;PSMD7;PLCB3;NOP56;CACNA1A;RBPJ
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.23899708447836893,-0.79608161281509,0.746031746031746,1.0,1.0,8/20,31.15%,CISH;STAT1;PTPN6;MAPK3;JAK2;IRS2;ADAM17;MAPK1
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.14834440268208018,0.7960022697312862,0.8,1.0,1.0,19/92,19.67%,FXYD2;SAP18;ROCK1;S1PR1;ARID4A;ITGA4;IL1R1;COMT;NCK1;RIPK1;MTA2;PHF21A;CRBN;SUDS3;CYSLTR1;TLR9;IFNAR1;ARID4B;KDM1A
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,0.18642592236953126,0.7957613259326456,0.8157894736842105,1.0,1.0,5/37,9.93%,CXCL8;IL6;CSF1;IL1R1;IL10
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.2440483123073126,-0.7950040766943003,0.765625,1.0,1.0,8/19,31.73%,UBB;TRAF6;BIRC3;TICAM1;IKBKB;TLR3;UBE2D3;RIPK3
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,-0.15544440093225192,-0.7942467239723453,0.9104477611940298,1.0,1.0,38/183,21.73%,GNAI1;CRKL;MAPK8;GNAO1;PAK1;AP1G2;ATR;AKT1;MAPK14;IRAK4;TBK1;SKP1;DDB1;GNG3;LIMK2;BAK1;FAS;GNG5;FASLG;GNB2;CRK;RELA;APOBEC3F;TRAF6;PIK3R1;PIK3R2;CALM2;AP1S1;AKT2;PIK3CB;CCR5;RAF1;CALM3;NFKB1;RBX1;MAP2K7;GNG11;MAPK3
prerank,KEGG_2021_Human__Viral myocarditis,0.17856336670338607,0.793981213654739,0.8285714285714286,1.0,1.0,18/52,29.14%,CASP8;HLA-G;PRF1;CASP3;EIF4G3;HLA-DRB3;ABL1;CYCS;DAG1;ACTB;SGCA;RAC2;EIF4G1;HLA-DPA1;CD80;DMD;RAC3;CAV1
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.1949597144717467,-0.7932623120232096,0.8333333333333334,1.0,1.0,7/54,11.83%,MAPK8;EYA3;H2BC3;UBB;NSD2;SMARCA5;H2BC13
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,-0.21630966698767906,-0.7931093278763299,0.7910447761194029,1.0,1.0,14/34,34.36%,UBB;TRAF1;CYLD;SPPL2A;TANK;BIRC3;RBCK1;RNF31;IKBKB;TRADD;CLIP3;RACK1;XIAP;OTULIN
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,-0.18063360457232258,-0.7928248461126144,0.8412698412698413,1.0,1.0,22/67,28.87%,UBB;PSMD3;VEGFA;PSMA5;PSMD6;PSMD12;WTIP;PSMC4;RBX1;CITED2;SEM1;PSMD11;PSMD7;HIF1AN;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;MIA3;UBE2D3
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.15862846965900057,-0.7925046525780935,0.875,1.0,1.0,45/146,28.17%,MCM5;CDC6;UBB;PSMD3;AKT1;FBXO5;SKP1;PSMA5;PSMD6;PSMD12;TK1;MCM4;RB1;MCM7;RPA3;AKT2;RRM2;PPP2CA;E2F2;E2F3;PTK6;MCM10;PSMC4;E2F6;E2F4;POLA2;CDKN1A;DHFR;SEM1;PSMD11;PSMD7;TFDP2;DBF4;CDK2;CABLES1;PSME2;LIN52;PSMB10;POLA1;PSMB2;CCNA1;PSME1;WEE1;JAK2;PSMA7
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.16370700228061896,0.7917301810298226,0.8387096774193549,1.0,1.0,6/59,5.88%,ITGB5;ATP2A1;ITGA3;CACNG8;ITGA4;CACNA2D2
prerank,KEGG_2021_Human__Salivary secretion,0.17363585314039687,0.7917246294902366,0.7575757575757576,1.0,1.0,4/53,4.84%,PLCB4;FXYD2;CST3;LYZ
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.25468322667144927,-0.7914343544048795,0.6964285714285714,1.0,1.0,2/16,6.15%,PRKCD;SHC1
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.21217657024346506,-0.790402346827756,0.84375,1.0,1.0,7/34,16.82%,ARHGDIB;CREB3L4;DYNC1LI2;DYNC1LI1;CREB3L2;PRKACA;STX4
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.17144294610912608,-0.7898386202663129,0.8484848484848485,1.0,1.0,19/110,13.21%,H2AZ2;H2AZ1;H2BC3;DDX5;H2AC7;CHD1;NRIP1;GTF2F2;CBFB;NCOA3;POLR2K;GTF2A1;AGO3;H2AC4;POLR2B;H2BC13;POLR2D;FOSB;AGO4
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,-0.2454043091121204,-0.7895143038236209,0.6923076923076923,1.0,1.0,5/17,19.00%,ACTN1;PIK3R1;PIK3R2;PIK3CB;IQGAP1
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.1755591632895051,-0.7891190600520568,0.8260869565217391,1.0,1.0,33/95,29.57%,RPS15A;RPL37A;RPLP0;ATF3;RPS21;RPS23;RPS4X;RSL24D1;RPS20;RPS14;RPL9;RPS3A;RPS16;RPS6;ATF4;RPL32;RPL11;IMPACT;RPS7;RPL7;RPL10A;RPS12;ASNS;RPS8;RPL27;EIF2S2;RPL14;MRPL13;RPL22L1;RPL23;RPS10;FAU;RPL37
prerank,Reactome_2022__Protein Folding R-HSA-391251,-0.16635832540733583,-0.7887044007567848,0.828125,1.0,1.0,11/82,11.52%,ARFGEF2;TBCA;WRAP53;RGS6;GNA15;GNG3;CCT2;FBXW9;GNG5;GNB2;TUBA4A
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.14220631013871796,-0.787818868109458,0.9024390243902439,1.0,1.0,120/365,31.49%,ITGB3;FN1;HEY1;CLCN6;PTPN11;FGFR1;PPP2R5B;SEC31A;ZC3HC1;DUSP6;PDGFRB;MAML2;ERLEC1;TSC2;UBB;PSMD3;LRP5;AKT1;CLSTN1;SKP1;SHC1;PDGFRA;DUSP10;PSMA5;GTF2F2;CDK8;CNKSR2;DUSP7;STRN;PSMD6;RNF213;PSMD12;POLR2K;ERBIN;PROC;POLR2B;AKAP9;FLT3LG;SYVN1;PORCN;POLR2D;NPM1;OS9;ZC3HAV1;MSN;MLST8;RPS6;PIK3R1;PIK3R2;MAML3;AKT2;CAMK2D;HDAC4;STAT1;PPP2CA;PIK3CB;PSENEN;IQGAP1;PSMC4;CLTC;DUSP8;MARK3;ICOS;ZFYVE9;NCSTN;RNASEH2A;RBX1;CDKN1A;SMAD4;HDAC8;MAPK3;BIRC6;SEM1;HHAT;PPP1CC;SQSTM1;CAMK2G;PSMD11;NRAS;POLR2J;PSMD7;PSME2;PSME4;GCC2;PSMB10;RBPJ;FOXO1;BCL2A1;ZMYM2;HDAC2;TPM3;ARAF;FRS3;ETV6;EPGN;PSMB2;CPSF6;PSME1;CALM1;FGF13;JAK2;IRS2;PSMA7;AGGF1;AGK;ERBB3;FBXW7;EREG;GOLGA4;SMAD2;LONP1;ADAM17;ITGA2B;CCNC;GTF2F1;MAPK1;FYN;VWF;TBL1X;CEBPB
prerank,KEGG_2021_Human__Bladder cancer,-0.20147679010349423,-0.7874370884545273,0.7321428571428571,1.0,1.0,12/37,23.53%,THBS1;VEGFA;RB1;MMP9;DAPK1;E2F2;E2F3;RAF1;CDKN1A;UPK3A;MAPK3;NRAS
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.15146692662486133,-0.7864799085427108,0.9230769230769231,1.0,1.0,36/248,14.52%,MAT2B;USP9X;TRIM4;TOMM20;FOXK1;USP33;ZRANB1;H2BC3;UBB;PSMD3;OGT;H2AC7;MBD6;STAM;CYLD;PSMA5;RAD23B;INO80;MYSM1;USP8;STAMBP;PSMD6;PSMD12;PROC;TANK;H2AC4;USP5;H2AC12;TNIP2;H2BC13;CDC20;KEAP1;TAF9B;USP32;TRAF6;UCHL1
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.26312797604620697,-0.7854891836167016,0.782608695652174,1.0,1.0,5/17,20.43%,PIGQ;PIGM;PIGW;PIGP;PIGO
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.20105301986878432,-0.7854191609217043,0.7763157894736842,1.0,1.0,9/34,19.58%,NUP210;RANGAP1;NUP88;RAN;NUP54;POM121;NUP37;NUP58;NUP205
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.19639362526204088,0.7853953908240987,0.7931034482758621,1.0,1.0,9/35,18.24%,NDC1;POM121C;NUP85;NUP153;CDK1;CCNB1;NEK6;NUP214;NUP155
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.18242269506226944,-0.7848991187561154,0.8507462686567164,1.0,1.0,24/75,28.52%,UBB;PSMD3;SKP1;PSMA5;UBL4A;SRXN1;PSMD6;PSMD12;NQO1;ATF4;PSMC4;RBX1;SEM1;SQSTM1;PSMD11;PSMD7;BRIP1;GSR;PSME2;PSMB10;PSMB2;PSME1;PSMA7;PHGDH
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,-0.16655828599857891,-0.7846348533435316,0.8857142857142857,1.0,1.0,18/104,15.62%,HRH2;ADM;UTS2R;SCT;P2RX1;NPFF;S1PR2;TBXA2R;THRA;GABRD;LPAR6;ADORA3;PTAFR;UTS2B;P2RY1;VIPR1;GHRL;UTS2
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.19483661207910702,0.7846116171542475,0.8292682926829268,1.0,1.0,5/33,9.49%,CDC42;PDPK1;RICTOR;PKN1;PIK3R3
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.1824517091898512,-0.7843278554240092,0.835820895522388,1.0,1.0,24/74,27.59%,RAD9B;RMI2;H2BC3;UBB;NSD2;RFC5;H2BC13;RHNO1;RPA3;RNF168;EXO1;RAD9A;PPP4C;CLSPN;UBE2I;BARD1;WRN;PIAS4;BRIP1;CDK2;H4C15;H2BC21;CCNA1;TIMELESS
prerank,KEGG_2021_Human__Hepatitis C,-0.16202980209987816,-0.7840389350377153,0.9523809523809523,1.0,1.0,34/124,23.53%,OAS3;AKT1;TBK1;IKBKE;BAK1;FAS;CXCL10;FASLG;YWHAQ;RB1;PIAS1;RELA;TRAF6;IFIT1;PIK3R1;PIK3R2;IRF7;AKT2;STAT1;MX2;PPP2CA;PIK3CB;E2F2;E2F3;RSAD2;RAF1;OAS2;NFKB1;CD81;CDKN1A;MAPK3;CLDN4;EIF2AK1;NRAS
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.16076598141677367,-0.7834694177632585,0.8235294117647058,1.0,1.0,44/145,27.32%,RPS15A;RPL37A;RPLP0;ATF3;RRAGD;SH3BP4;RPS21;RPS23;RPS4X;SLC38A9;KPTN;RSL24D1;RPTOR;RPS20;NPRL2;RPS14;RPL9;ATP6V1G1;RPS3A;CASTOR1;NPRL3;RPS16;MLST8;RPS6;ATF4;MIOS;RPL32;RPL11;IMPACT;RPS7;RPL7;RPL10A;SESN1;WDR59;RPS12;ASNS;RPS8;RPL27;TCIRG1;EIF2S2;RPL14;MRPL13;RPL22L1;RPL23
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,-0.21915570325015668,-0.7831404471811828,0.7457627118644068,1.0,1.0,6/32,17.49%,SYN3;SNAP25;LIN7C;ABAT;SLC22A1;SH2D3C
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.25595657696893037,-0.7825962967135093,0.7272727272727273,1.0,1.0,4/15,16.75%,AKT1;YWHAQ;REXO2;AKT2
prerank,KEGG_2021_Human__Thyroid cancer,0.18476150812452416,0.7820622055695033,0.8421052631578947,1.0,1.0,16/35,29.88%,GADD45B;CDH1;TCF7L1;TCF7L2;LEF1;KRAS;MAP2K1;BAX;MYC;TP53;CCDC6;TPR;PPARG;MAP2K2;NTRK1;BRAF
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.1896245337476986,-0.7818717622557556,0.7878787878787878,1.0,1.0,11/63,13.21%,H2AZ2;H2AZ1;H2BC3;THBS1;H2AC7;CBFB;AGO3;H2AC4;H2BC13;KMT2D;AGO4
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,-0.23771854443608492,-0.7795692446246484,0.746268656716418,1.0,1.0,12/20,44.90%,SHC1;ERBIN;PIK3R1;NRAS;ERBB3;EREG;HSP90AA1;PIGU;PTPN12;SOS1;PLCG1;EGF
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,0.19410574662365362,0.7788386158959338,0.7777777777777778,1.0,1.0,29/29,80.62%,PKN1;NCK1;HLA-DRB3;ZAP70;LCK;CD3D;HLA-DPA1;CD4;SPNS1;HLA-DRB4;GRAP2;HLA-DRB1;ARHGEF7;TARP;HLA-DQA1;HLA-DRA;EVL;PKN2;PLCG1;ITK;HLA-DRB5;FYB1;PLCG2;CD101;CD3E;CD247;VASP;WAS;LCP2
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.21535559965758075,0.7784792507364034,0.7333333333333333,1.0,1.0,9/23,24.27%,RAD50;DNA2;RBBP8;PALB2;TOP3A;BRCA1;RAD51C;RAD51;RMI1
prerank,KEGG_2021_Human__Parkinson disease,-0.14963728732120865,-0.7767137705713147,0.9466666666666667,1.0,1.0,36/208,16.93%,UBA7;GNAI1;MAPK8;UQCR11;PSMD1;MCU;UBB;PSMD3;RYR3;UBE2G1;PPIF;PSMA5;NDUFV3;PSMD6;PSMD12;UBE2J1;SLC25A5;NDUFS7;NDUFA6;UQCRFS1;TUBA4A;UBE2L3;MAPT;TXN2;ATP5F1E;PRKACA;NDUFB6;TUBB2A;UCHL1;ATP5MC1;TUBB6;CALM2;ATF4;CAMK2D;ERN1;KIF5C
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.15120328332052024,0.7762830742387046,0.8518518518518519,1.0,1.0,11/85,10.60%,H2BC15;POLR1B;B4GALT1;RAD50;TERF1;CATSPER2;CATSPER1;CD9;H2AB1;CATSPERB;RBBP8
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.2252077304549755,-0.7762376667205031,0.7377049180327869,1.0,1.0,8/27,21.45%,KLKB1;PROC;PRCP;PROCR;F8;F5;F12;CD177
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,0.22084708896196248,0.7759115095285419,0.7857142857142857,1.0,1.0,5/21,14.85%,ARL13B;VCP;UBE2N;IFT88;HDAC6
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,-0.160895592920084,-0.7757092116825539,0.875,1.0,1.0,13/129,9.11%,PLEKHG4;YKT6;ARHGDIB;ARHGAP42;DOCK9;CDC42BPB;SH3PXD2A;KCTD3;DNMBP;STEAP3;DAAM1;ARHGAP17;FMNL1
prerank,KEGG_2021_Human__Apoptosis,-0.16289148808002502,-0.7752779300749082,0.9154929577464789,1.0,1.0,31/129,22.02%,MAPK8;IL3RA;DFFB;PARP2;CTSF;AKT1;LMNB2;TRAF1;BAK1;FAS;FASLG;BBC3;TUBA4A;GADD45G;RELA;DFFA;BIRC3;PIK3R1;PIK3R2;PMAIP1;ATF4;AKT2;ERN1;PIK3CB;CASP2;RAF1;NFKB1;TNFRSF10B;GADD45A;MAPK3;BIRC6
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",0.18118441813045172,0.774442032836407,0.7209302325581395,1.0,1.0,6/34,12.97%,BPGM;SRR;AGXT;PIPOX;GAMT;GLYCTK
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.2667380166703207,-0.7738392284371023,0.7368421052631579,1.0,1.0,10/15,39.55%,GNG3;GNG5;GNB2;GNG11;GNG7;GNG8;GNG2;GNB4;GNB1;GNB3
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.21643137081724734,-0.7737654022647092,0.7833333333333333,1.0,1.0,14/25,37.11%,PRKCD;CAMKK1;ADCY4;CAMK2D;PDE1B;PRKAR2A;CAMK2G;PRKAR1B;CALM1;MAPK1;PLA2G4A;KPNA2;PRKAR2B;PRKAR1A
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.13209232574226124,0.7721722878063164,0.96,1.0,1.0,18/190,7.98%,ACTA2;HDAC3;HDAC11;ATP2A1;H2BC15;NBEA;MAMLD1;B4GALT1;JAG1;PLXND1;TLE3;CREB1;CUL1;AGO1;PSMB4;YBX1;TLE4;H2AB1
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.25538567210416596,-0.7718939308731511,0.7272727272727273,1.0,1.0,2/15,4.74%,LMBRD1;MMUT
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.15115880039805799,-0.7711138702257679,0.9178082191780822,1.0,1.0,54/179,28.17%,DCTN3;MZT2A;PLK4;CDK5RAP2;CEP192;UBB;PSMD3;FKBPL;SKP1;NEK2;PSMA5;CDC25B;MAPRE1;HAUS1;PSMD6;PSMD12;CLASP1;HAUS3;AKAP9;TUBA4A;PCM1;CEP57;TUBGCP3;HAUS7;CEP78;PPP2CA;PLK1;PPME1;CDK11A;E2F3;PSMC4;RBX1;CDKN1A;OFD1;SEM1;XPO1;PSMD11;PHLDA1;PSMD7;HSP90AB1;CDK2;PSME2;PSME4;LIN52;HAUS5;PSMB10;SDCCAG8;PSMB2;CCNA1;CDK11B;PSME1;WEE1;PAFAH1B1;PSMA7
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,-0.25493328192492226,-0.7707989657664014,0.7142857142857143,1.0,1.0,5/15,24.06%,PIAS3;PIAS1;PIAS2;UBE2I;PIAS4
prerank,KEGG_2021_Human__Cushing syndrome,-0.15929094601000715,-0.7704582026344381,0.8591549295774648,1.0,1.0,27/102,24.52%,GNAI1;FZD2;CREB3L4;PLCB2;FH;NCEH1;USP8;WNT10A;ADCY4;RB1;KMT2D;CREB3L2;WNT10B;PRKACA;ATF2;ATF4;ASH2L;CAMK2D;E2F2;E2F3;CDKN1A;MAPK3;ADCY3;CAMK2G;PLCB3;CDK2;WNT7A
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.16921586879140388,-0.7700782097063221,0.9253731343283582,1.0,1.0,30/90,29.57%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;RSL24D1;RPS20;RPS14;RPL9;RPS3A;UPF1;RPS16;RPS6;RPL32;RPL11;RPS7;RPL7;RPL10A;RPS12;RPS8;RPL27;RPL14;MRPL13;RPL22L1;RPL23;RPS10;GSPT1;FAU;RPL37
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,-0.2441425064343986,-0.769938171272288,0.7636363636363637,1.0,1.0,4/16,17.14%,HEXA;HYAL1;ARSB;SGSH
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,-0.15519472825119143,-0.7697318888619135,0.9342105263157895,1.0,1.0,24/159,15.67%,PLEKHG4;YKT6;ARHGEF39;ARHGDIB;ARHGAP42;SH3BP1;DOCK9;ARHGAP23;ARHGEF18;ABL2;FARP2;DOCK4;FAM13A;ARHGAP17;FMNL1;ERBIN;MPP7;PLD2;EMD;DEF6;ARHGAP9;SNAP23;PIK3R1;PIK3R2
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.1681865924242811,0.7693171513864555,0.813953488372093,1.0,1.0,7/51,9.90%,AMN;LMF2;ABCG1;LDLRAP1;SCARB1;ABCA1;LMF1
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.17299225172719027,0.7683743421406901,0.8974358974358975,1.0,1.0,6/47,9.89%,NBEA;PRKX;CREB1;PDPK1;RASGRF2;PPM1F
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,-0.18154693488620016,-0.7681278078767741,0.855072463768116,1.0,1.0,13/63,20.82%,YKT6;STX17;SEC31A;ANKRD28;LMAN2;TRAPPC5;BET1;F8;TRAPPC4;F5;SEC23A;SEC22B;NAPSA
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.24647551873274606,-0.7667731625934605,0.8275862068965517,1.0,1.0,13/21,39.55%,PLCB2;GNG3;GNG5;GNB2;GNG11;PLCB3;GNG7;CALM1;GNG8;GNG2;GNB4;GNB1;GNB3
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,-0.18041827714180328,-0.7661854043049242,0.9285714285714286,1.0,1.0,15/67,20.42%,NUP210;SLC11A2;SLC35A1;MAP4K5;SLC5A5;BSG;NUP88;SLC5A2;SLC24A4;NUP54;POM121;NUP37;NUP58;NUP205;SLC2A1
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.15457426224968207,0.7654194440153629,0.7857142857142857,1.0,1.0,12/75,14.29%,ROCK1;ACTR3;ARPC5;MYH9;CDC42;SDC2;MYL9;PKN1;EPHA1;VAV2;SDCBP;EPHB1
prerank,KEGG_2021_Human__beta-Alanine metabolism,-0.21815529093909689,-0.7650369295959679,0.7894736842105263,1.0,1.0,10/24,29.65%,DPYD;ALDH3B1;UPB1;ABAT;AOC3;ALDH6A1;EHHADH;ALDH9A1;AOC2;SMOX
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.1828103304821192,-0.7649354555986436,0.8448275862068966,1.0,1.0,12/49,19.27%,RNPC3;TXNL4A;SNRPB;GTF2F2;POLR2K;POLR2B;POLR2D;SNRPE;SF3B5;SRSF7;ZCRB1;SF3B6
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,0.18218856076940354,0.7646811328626087,0.8611111111111112,1.0,1.0,5/40,7.72%,NDC1;POM121C;NUP85;NUP153;GNL3
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.21535434592771394,0.7628260676214584,0.8205128205128205,1.0,1.0,3/23,5.36%,NBEA;PRKX;CREB1
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.1693722585582998,-0.7626832572676505,0.9411764705882353,1.0,1.0,16/78,20.83%,PTPN11;FGFR1;PDGFRB;TSC2;AKT1;CLSTN1;PDGFRA;STRN;FLT3LG;MLST8;PIK3R1;PIK3R2;AKT2;PIK3CB;ICOS;CDKN1A
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.16951156287168423,-0.7622509757721284,0.9090909090909091,1.0,1.0,29/88,29.57%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;RSL24D1;RPS20;RPS14;RPL9;RPS3A;RPS16;RPS6;SARS1;RPL32;RPL11;RPS7;RPL7;RPL10A;RPS12;RPS8;RPL27;RPL14;MRPL13;RPL22L1;RPL23;RPS10;FAU;RPL37
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.1628514241151049,-0.761760154323198,0.8939393939393939,1.0,1.0,11/90,11.05%,ECSIT;TMEM126B;NDUFAF6;UQCR11;ETFDH;NDUFAF1;NDUFV3;SCO2;NDUFS7;NDUFA6;UQCRFS1
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,-0.19115485735969462,-0.7610221807156737,0.782608695652174,1.0,1.0,25/39,43.60%,PLCB2;ITPKC;PLCD3;IPMK;INPPL1;PLD4;SYNJ1;INPP5B;PLCB3;INPP5D;INPP4B;CALM1;OCRL;MIOX;ISYNA1;PLCD1;INPP1;PLCG2;MTMR9;IPPK;NUDT3;INPP5A;PLCG1;PLCB1;IP6K2
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.14951255606404895,0.7607951446755642,0.9333333333333333,1.0,1.0,12/65,16.31%,VAMP3;VRK2;ARHGAP35;CDC42;LAMTOR1;MAP3K11;VANGL1;VAV2;ARHGAP1;NDUFA5;ARHGAP5;DOCK2
prerank,KEGG_2021_Human__Taste transduction,0.1819560844321754,0.7606269744154511,0.8043478260869565,1.0,1.0,4/33,8.88%,PLCB4;ENTPD2;TAS2R60;TAS2R30
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.1490774626860149,-0.759979663080572,0.9333333333333333,1.0,1.0,53/177,28.17%,DCTN3;MZT2A;PLK4;CDK5RAP2;CEP192;UBB;PSMD3;FKBPL;SKP1;NEK2;PSMA5;CDC25B;MAPRE1;HAUS1;PSMD6;PSMD12;CLASP1;HAUS3;AKAP9;TUBA4A;PCM1;CEP57;TUBGCP3;HAUS7;CEP78;PPP2CA;PLK1;PPME1;CDK11A;PSMC4;RBX1;CDKN1A;OFD1;SEM1;XPO1;PSMD11;PHLDA1;PSMD7;HSP90AB1;CDK2;PSME2;PSME4;LIN52;HAUS5;PSMB10;SDCCAG8;PSMB2;CCNA1;CDK11B;PSME1;WEE1;PAFAH1B1;PSMA7
prerank,KEGG_2021_Human__VEGF signaling pathway,-0.17523081406856925,-0.7599699230611394,0.8095238095238095,1.0,1.0,14/52,23.54%,AKT1;MAPK14;VEGFA;NOS3;MAPKAPK3;PIK3R1;PIK3R2;AKT2;PIK3CB;RAF1;MAPK3;PTGS2;NRAS;MAPK13
prerank,KEGG_2021_Human__Lysine degradation,-0.18733774179205553,-0.7598441266076749,0.8142857142857143,1.0,1.0,21/58,29.21%,SMYD3;KMT5B;HADH;NSD2;ASH1L;KMT2D;PRDM7;SETDB2;SETD7;HYKK;SETDB1;EZH1;PRDM2;EHHADH;EZH2;SETD1A;PHYKPL;DLD;ALDH9A1;SUV39H2;DLST
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.19698842075826006,-0.7596078385560854,0.8095238095238095,1.0,1.0,12/38,24.06%,NUP210;NUP88;PIAS1;NUP54;POM121;PML;NUP37;NUP58;NUP205;PIAS2;UBE2I;PIAS4
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,-0.15046907477254587,-0.7594318171472165,0.9113924050632911,1.0,1.0,36/180,19.27%,HNRNPA0;PQBP1;HNRNPA1;PLRG1;TXNL4A;DDX5;DHX9;SNRPB;DHX15;SRSF5;GTF2F2;U2SURP;MAGOH;CRNKL1;DNAJC8;POLR2K;PAPOLA;POLR2B;EIF4A3;POLR2D;ELAVL1;SNRPE;CHERP;HNRNPA3;RBM42;SF1;SF3B5;SRSF7;ISY1-RAB43;PPIL1;TFIP11;LSM8;CWC15;SRSF4;DHX38;SF3B6
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.17556554880841765,-0.7594041850164033,0.8333333333333334,1.0,1.0,14/63,17.58%,UBB;DDB1;ERCC8;POLR2K;TCEA1;POLR2B;RFC5;SLC19A1;POLR2D;RPA3;POLD1;POLD2;LRIG1;ISY1-RAB43
prerank,KEGG_2021_Human__Long-term potentiation,-0.18135347249721523,-0.7591975379282713,0.8888888888888888,1.0,1.0,16/46,27.87%,PLCB2;RPS6KA2;PRKACA;CALM2;ATF4;CAMK2D;RAF1;CALM3;MAPK3;PPP1CC;CAMK2G;NRAS;PLCB3;PPP3CB;ARAF;CALM1
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,-0.1622176350624117,-0.7586242908341583,0.9436619718309859,1.0,1.0,39/110,32.40%,UBB;NFKB2;PSMD3;IRAK4;SKP1;S100A12;PSMA5;MAP3K3;PSMD6;PSMD12;TANK;TNIP2;RELA;TRAF6;NKIRAS2;N4BP1;PSMC4;NKIRAS1;NFKB1;RBX1;SEM1;SQSTM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;IRAK2;IKBKB;PSMB2;PSME1;HMGB1;PSMA7;TAB3;BTRC;MAP3K7;PSMC5;PSMA3;TAB2
prerank,KEGG_2021_Human__Prion disease,-0.14447613987280075,-0.75799069180434,0.9333333333333333,1.0,1.0,42/221,19.13%,CAV2;MAPK8;LAMC1;UQCR11;PSMD1;MCU;PRKCD;PSMD3;CREB3L4;RYR3;MAPK14;CCL5;PPIF;PSMA5;NDUFV3;NCAM1;PSMD6;PSMD12;SLC25A5;NDUFS7;NDUFA6;UQCRFS1;TUBA4A;CREB3L2;ATP5F1E;PRKACA;NDUFB6;TUBB2A;ATF2;PIK3R1;HSPA2;PIK3R2;ATP5MC1;TUBB6;ATF4;PRNP;KIF5C;NDUFA9;PIK3CB;COX6A1;NDUFB5;PSMC4
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.2436684665328576,-0.7567811817676029,0.7846153846153846,1.0,1.0,4/17,15.75%,TBCA;TUBA4A;TUBB2A;TUBB6
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,0.19970866928705638,0.7567033144781427,0.8333333333333334,1.0,1.0,8/27,22.43%,GPAT3;MIGA1;AGPAT5;PLA2G4B;PRKCSH;DDHD1;PLD6;AGPAT2
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,-0.1721420513956205,-0.7556944214265792,0.8787878787878788,1.0,1.0,15/60,23.54%,MAPK8;MS4A2;AKT1;MAPK14;SYK;PIK3R1;PIK3R2;AKT2;PIK3CB;LCP2;RAF1;MAP2K7;MAPK3;NRAS;MAPK13
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.1908738385653184,-0.7553279904101592,0.8709677419354839,1.0,1.0,19/49,34.62%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;PSMC1;CCND1
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,-0.1600706833726803,-0.7552020802895156,0.8875,1.0,1.0,23/107,19.58%,MCPH1;LPIN1;H2AZ2;NUP210;H2AZ1;H2BC3;H2AC7;LEMD2;H2AC4;RAB33B;H2BC13;NUP88;EMD;RB1;NUP54;POM121;NEK9;H2AC14;PPP2CA;PLK1;NUP37;NUP58;NUP205
prerank,KEGG_2021_Human__Acute myeloid leukemia,-0.168301649926364,-0.755098545881127,0.8666666666666667,1.0,1.0,22/65,28.80%,DUSP6;PIM2;AKT1;RUNX1T1;RARA;RELA;PIK3R1;PIK3R2;AKT2;PML;PIK3CB;RAF1;NFKB1;MAPK3;NRAS;PIM1;BCL2A1;ARAF;IKBKB;CCNA1;TCF7;PER2
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,-0.18408261336061826,-0.7550543638527704,0.8787878787878788,1.0,1.0,6/63,5.02%,APOE;USP9X;H2AZ1;H2BC3;UBB;H2AC7
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,-0.18878866359522806,-0.7543590489644865,0.85,1.0,1.0,11/52,18.40%,PTPN11;FGFR1;GRB10;SHC1;FLT3LG;ATP6V1G1;THEM4;PIK3R1;PIK3R2;AKT2;PIK3CB
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,0.18296893976974932,0.7532086026196283,0.8,1.0,1.0,4/34,6.51%,NDC1;POM121C;NUP85;NUP153
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.21128749182130493,-0.7519861347598432,0.8392857142857143,1.0,1.0,13/38,24.39%,RAD9B;RMI2;RFC5;RHNO1;RPA3;XRCC2;RAD51AP1;EXO1;RAD9A;SEM1;BARD1;WRN;BRIP1
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.1838087603773948,0.7514636676874199,0.8275862068965517,1.0,1.0,4/34,6.51%,NDC1;POM121C;NUP85;NUP153
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.20970983490848777,-0.7512874476883068,0.7936507936507936,1.0,1.0,17/30,40.56%,AKAP5;GNG3;GNG5;GNB2;IQGAP1;GNG11;PRKAR2A;PRKAR1B;GNG7;GNG8;GNG2;PRKAR2B;GNB4;PRKAR1A;GNB1;GNB3;ITPR2
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,-0.23291448272281634,-0.75037337838262,0.7241379310344828,1.0,1.0,2/18,6.77%,SMURF1;NOG
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,-0.14656577991623643,-0.7494334231179796,0.9722222222222222,1.0,1.0,24/157,17.14%,GALK1;APRT;GALNT3;PCCA;ADAMTS6;LMBRD1;UBB;DCN;MMUT;THBS1;CYP27A1;MCCC1;PROC;HEXA;NUS1;ALG13;ALG3;ST3GAL3;ARSB;GFPT1;SDC4;AHCY;PRNP;SGSH
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.16988052217281402,-0.7487195176960523,0.8552631578947368,1.0,1.0,22/74,27.39%,H2AZ2;H2AZ1;H2BC3;H2AC7;SYNE1;MSH5;H2AC4;H2BC13;POT1;RPA3;HSPA2;H2AC14;SUN1;SYCE2;UBE2I;MLH3;SYCP1;PMEPA1;CDK2;H4C15;H2BC21;H2AC20
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,-0.22557177497795336,-0.7486207953728462,0.8727272727272727,1.0,1.0,7/27,19.39%,KLRK1;SHC1;SYK;PIK3R1;PIK3R2;PIK3CB;LCP2
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.16177933989495363,0.7471052042175113,0.8529411764705882,1.0,1.0,15/43,26.97%,KHDRBS2;ARHGAP35;ERBB2;CBL;CDKN1B;LRRK2;HIF1A;CDK4;GPNMB;KHDRBS1;CCNE1;HBEGF;SYNGAP1;NRG4;STAT3
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,-0.16091831096587209,-0.7466948292405791,0.9090909090909091,1.0,1.0,26/99,25.10%,ITGB3;SMURF1;USP9X;UBB;UBE2M;NOG;ARHGEF18;LTBP4;CDK8;TGIF2;MTMR4;TGFB3;CCNK;STAT1;CDK9;E2F4;ZFYVE9;RNASEH2A;SMAD4;MAPK3;PPP1CC;XPO1;PMEPA1;TFDP2;ITGB1;BMPR2
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,0.18050315958047436,0.7461175491340619,0.7872340425531915,1.0,1.0,4/24,14.93%,TUBB3;CCT3;CCT6B;TCP1
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.16130760878240166,-0.7456476555342685,0.9014084507042254,1.0,1.0,31/96,29.57%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;EIF3K;RSL24D1;RPS20;RPS14;RPL9;RPS3A;RPS16;RPS6;RPL32;RPL11;RPS7;RPL7;EIF3C;RPL10A;RPS12;RPS8;RPL27;RPL14;MRPL13;RPL22L1;RPL23;RPS10;FAU;EIF3J;RPL37
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.25059102929877897,-0.7448736545823093,0.74,1.0,1.0,2/17,5.76%,PRKCD;VEGFA
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.18410395520354664,-0.7448319131874087,0.8870967741935484,1.0,1.0,3/49,2.18%,OBSCN;MAPK8;ARHGEF39
prerank,KEGG_2021_Human__GnRH secretion,0.1700603109387671,0.7446559713234648,0.8421052631578947,1.0,1.0,2/44,0.43%,PLCB4;CACNA1I
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.24425223008910477,-0.7439703531586952,0.8153846153846154,1.0,1.0,3/17,15.51%,UBB;SHC1;PIK3R1
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.20642618264703622,0.7424781710835003,0.8,1.0,1.0,4/24,11.55%,CTSG;B2M;RAB5A;ENO1
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.19807132313305686,-0.7423903202480867,0.8636363636363636,1.0,1.0,9/33,19.58%,NUP210;NUP88;NPM1;RAN;NUP54;POM121;NUP37;NUP58;NUP205
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,-0.16689247638282773,-0.7410206439869124,0.8709677419354839,1.0,1.0,30/70,35.16%,GNAI1;PRKCD;PLCB2;GNA15;GNG3;CAMKK1;GNG5;GNB2;ADCY4;CAMK2D;PDE4C;PDE1B;PPP2CA;GNG11;PRKAR2A;CAMK2G;PLCB3;PPP3CB;PRKAR1B;GNG7;CALM1;GNG8;AHCYL1;MAPK1;PLA2G4A;GNG2;KPNA2;PRKAR2B;CDK5;GNB4
prerank,KEGG_2021_Human__Inflammatory bowel disease,-0.1749208247740145,-0.7400848276343399,0.8507462686567164,1.0,1.0,8/54,17.43%,FOXP3;IL18RAP;TLR5;IL12A;RELA;TGFB3;STAT1;IL2RG
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,0.14231341122394683,0.7400228543636568,0.9722222222222222,1.0,1.0,19/110,16.50%,NCOA1;ACOT8;DAND5;PMVK;PPARA;ELOVL6;LMBR1;INSIG2;LDLRAP1;FDFT1;MBD4;SCAP;ACACB;TSPO;HSD17B4;FDXR;SCD;HELZ2;HSD17B11
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.15555928783637357,-0.7397965639317454,0.8591549295774648,1.0,1.0,36/110,30.47%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;MARS1;RSL24D1;RPS20;RPS14;RPL9;RPS3A;RPS16;RPS6;AIMP2;AHCY;SARS1;KARS1;RPL32;RPL11;RPS7;RPL7;RPL10A;RPS12;GSR;RPS8;RPL27;RPL14;MRPL13;RPL22L1;RPL23;RPS10;FAU;RPL37;QARS1;VSIG2
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,0.13965828575234412,0.7386765541521075,0.967741935483871,1.0,1.0,24/141,16.35%,CPT2;ACOT8;HTD2;ACOXL;ACSL6;PRXL2B;ELOVL6;ACADL;SLC25A20;ACSL1;SLC25A1;ELOVL1;ACSF2;ELOVL5;PPT1;HACD4;ACSL4;ACAA2;ACAD10;HSD17B4;SCD;HSD17B8;MORC2;ACOX1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,-0.20530244323475522,-0.7385239972732481,0.8548387096774194,1.0,1.0,8/34,15.67%,FLOT2;UBXN11;PKP4;TNFAIP1;ANKRD26;PIK3R1;DST;PIK3R2
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.18614570558668753,0.7380950916313572,0.8108108108108109,1.0,1.0,7/28,18.88%,GNG10;NLRP3;RAB11FIP2;GNB5;ADCY7;AQP3;RAB11A
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,-0.1858941510351883,-0.7366005428235991,0.8714285714285714,1.0,1.0,8/48,13.09%,H2AZ2;H2AZ1;H2BC3;H2AC7;MSH5;H2AC4;H2BC13;RPA3
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.19844756510712297,-0.7362274631112217,0.8363636363636363,1.0,1.0,8/34,19.72%,STS;FN3KRP;FN3K;PROC;EIF5A2;ARSB;F8;GAS6
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.18274437061687354,-0.7362050696014601,0.90625,1.0,1.0,27/60,37.88%,H2AZ2;MAML2;H2AZ1;H2BC3;H2AC7;AGO3;H2AC4;H2BC13;AGO4;MAML3;H2AC14;E2F3;TFDP2;H4C15;RBPJ;H2BC21;H2AC20;NOTCH4;MAML1;H3C13;KAT2B;AGO2;CCND1;H2AC6;NOTCH1;ELF3;H2BC11
prerank,KEGG_2021_Human__Cellular senescence,-0.14537722667370645,-0.734016754340898,0.9620253164556962,1.0,1.0,40/143,25.83%,RAD9B;TRPM7;RAD1;MCU;TSC2;ATR;AKT1;MAPK14;SLC25A5;RB1;GADD45G;RELA;NBN;TGFB3;RRAS2;PIK3R1;PIK3R2;CALM2;TSC1;AKT2;RAD9A;PIK3CB;E2F2;E2F3;RAF1;CALM3;NFKB1;E2F4;CDKN1A;GADD45A;MAPK3;PPP1CC;SQSTM1;NRAS;MAPK13;SIRT1;CDK2;LIN52;FOXO1;PPP3CB
prerank,KEGG_2021_Human__Adherens junction,-0.1647076764564291,-0.7335068564820381,0.8484848484848485,1.0,1.0,7/61,9.08%,FGFR1;CTNND1;IGF1R;FER;SSX2IP;FARP2;ACTN1
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,-0.15264902834028532,-0.731672397134074,0.9305555555555556,1.0,1.0,30/112,25.00%,RAD9B;RMI2;PARP2;H2BC3;UBB;FEN1;NSD2;RFC5;SLC19A1;H2BC13;RHNO1;RPA3;POLD1;ERCC1;XRCC2;POLD2;RAD51AP1;RNF168;EXO1;RAD9A;PPP4C;CLSPN;SEM1;UBE2I;BARD1;WRN;PIAS4;BRIP1;CDK2;H4C15
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.24632266634512312,-0.7304654384135989,0.8103448275862069,1.0,1.0,10/16,39.55%,GNG3;GNG5;GNB2;GNG11;GNG7;GNG8;GNG2;GNB4;GNB1;GNB3
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.21203486059498847,0.7303283691746163,0.7567567567567568,1.0,1.0,2/17,6.29%,SPTBN1;GAB2
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,-0.20720886543139888,-0.7300028888835739,0.7666666666666667,1.0,1.0,3/22,11.73%,GALNT3;ST6GALNAC4;ST6GALNAC1
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.21743865840552845,0.7286603375590958,0.8181818181818182,1.0,1.0,1/16,0.95%,PIKFYVE
prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.15278394264986978,0.7286582304343713,0.9487179487179487,1.0,1.0,9/57,14.60%,C1S;DEFA3;C5;CFD;FCGR3B;IL10;KRT10;HLA-DRB3;FCGR3A
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.2136226308489782,-0.7283940803329861,0.8103448275862069,1.0,1.0,11/32,24.39%,RAD9B;RMI2;RFC5;RHNO1;RPA3;EXO1;RAD9A;SEM1;BARD1;WRN;BRIP1
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.18389068038965345,-0.7281777437217596,0.8709677419354839,1.0,1.0,15/50,22.40%,DUSP6;MAPK14;ID3;DUSP7;FOSB;RPS6KA2;MEF2C;MAPK7;ID1;MEF2D;PPP2CA;SRF;RNASEH2A;MAPK3;EGR1
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.20227902375203755,-0.7281350665773625,0.8,1.0,1.0,11/34,24.39%,RAD9B;RMI2;RFC5;RHNO1;RPA3;ERCC1;EXO1;RAD9A;BARD1;WRN;BRIP1
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,-0.19827330991301892,-0.7279617056388701,0.8125,1.0,1.0,4/25,10.42%,TECR;ELOVL3;ELOVL7;FADS1
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.22580116977942744,-0.727535069083002,0.855072463768116,1.0,1.0,11/19,44.90%,SHC1;ERBIN;PIK3R1;NRAS;ERBB3;EREG;HSP90AA1;PIGU;SOS1;PLCG1;EGF
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,-0.17795321506342082,-0.7273164552212507,0.8194444444444444,1.0,1.0,12/51,19.58%,LPIN1;NUP210;LEMD2;NUP88;EMD;NUP54;POM121;NEK9;PLK1;NUP37;NUP58;NUP205
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.18551617895757092,-0.7271153767688513,0.875,1.0,1.0,18/49,33.43%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,-0.14580051380993247,-0.7266456121172303,0.9863013698630136,1.0,1.0,36/168,22.68%,GNAI1;HRH2;MAPK8;ADM;FCGR2A;SCT;MYO1E;NFKB2;PLK2;GGT5;MAPK14;GNG3;RAMP1;GNG5;GNB2;CRK;ADCY4;ENTPD5;TXN2;RELA;VIPR1;SYK;PPAN-P2RY11;PYCARD;ENTPD1;WAS;GPBAR1;NFKB1;NT5E;GNG11;BRK1;CD163;MAPK3;DPEP2;ARPC3;PRKAR2A
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.14575805771799036,-0.7266195538376109,0.96,1.0,1.0,47/174,27.42%,MAT2B;USP9X;TOMM20;USP33;H2BC3;UBB;PSMD3;H2AC7;CYLD;PSMA5;USP8;PSMD6;PSMD12;TANK;H2AC4;USP5;H2AC12;H2BC13;CDC20;KEAP1;TAF9B;USP32;TRAF6;BIRC3;RIGI;H2AC14;PSMC4;SMAD4;SNX3;CLSPN;SEM1;H2AC11;PSMD11;HGS;USP20;PSMD7;USP11;PSME2;PSME4;PSMB10;USP12;USP28;H2BC21;PSMB2;CCNA1;H2AC20;PSME1
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,-0.17969657801722722,-0.7260713553995239,0.8955223880597015,1.0,1.0,5/47,7.02%,SLC30A7;EXOC7;ACE;EXOC3;EXOC4
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,-0.21410971104088822,-0.7255718398307038,0.7884615384615384,1.0,1.0,5/24,15.44%,RRAGD;SLC38A9;RPTOR;MLST8;RPS6
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,0.22917596221774622,0.724796254839747,0.8378378378378378,1.0,1.0,2/18,3.56%,USP18;CASP8
prerank,KEGG_2021_Human__Leishmaniasis,0.15164164335204183,0.7232481134983909,0.9705882352941176,1.0,1.0,11/71,14.60%,FOS;CYBB;MARCKSL1;ITGA4;FCGR3B;IL10;EEF1A1;CR1;HLA-DRB3;TGFB1;FCGR3A
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.19730749779274248,0.7225817861929293,0.8571428571428571,1.0,1.0,9/24,24.27%,RAD50;DNA2;RBBP8;PALB2;TOP3A;BRCA1;RAD51C;RAD51;RMI1
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.15244211508291264,0.7179135983681413,0.90625,1.0,1.0,17/57,23.39%,WDR33;CPSF1;SYMPK;CSTF2T;FYTTD1;NCBP1;THOC7;UPF3B;SARNP;CPSF3;SRSF9;THOC3;NUDT21;FIP1L1;CDC40;SRSF6;U2AF1
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,-0.1830762927381856,-0.717651035271923,0.875,1.0,1.0,11/36,23.90%,ASPH;RYR3;TRPC1;FXYD7;ATP1B2;CAMK2D;ABCC9;DMPK;ATP1B3;CAMK2G;SRI
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.1632695293811263,-0.7163480443331139,0.90625,1.0,1.0,28/84,29.57%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;RSL24D1;RPS20;RPS14;RPL9;RPS3A;RPS16;RPS6;RPL32;RPL11;RPS7;RPL7;RPL10A;RPS12;RPS8;RPL27;RPL14;MRPL13;RPL22L1;RPL23;RPS10;FAU;RPL37
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.1511762978101177,-0.7159104281595933,0.9545454545454546,1.0,1.0,26/102,24.83%,DCTN3;KIF1C;ARFGAP1;RAB18;KIF21A;DYNC1LI2;NBAS;KIF6;DYNC1LI1;STX18;RAB6A;COPZ1;PLA2G6;KIF19;KIF5C;KIF16B;ZW10;SEC22B;KIF3B;NAPSA;COPE;KIF21B;RINT1;KIF22;DYNLL2;COPB2
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.19062467735596414,-0.71562847329051,0.9152542372881356,1.0,1.0,12/32,32.40%,MAPK14;CYLD;TRAF6;BIRC3;CASP4;CASP2;MAPK13;IRAK2;IKBKB;TAB3;MAP3K7;TAB2
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.2365033334190732,-0.7151323415094676,0.8245614035087719,1.0,1.0,4/19,13.09%,UBB;RFC5;SLC19A1;RPA3
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.17753127939346247,-0.7147091535972679,0.8507462686567164,1.0,1.0,17/44,33.43%,PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;PSMC1
prerank,KEGG_2021_Human__Axon guidance,0.13871975551104485,0.7137920384257362,0.9655172413793104,1.0,1.0,23/126,15.90%,PARD6B;ROCK1;SEMA4B;PLXNC1;PLXNA3;CDC42;PAK6;PDPK1;RASA1;NTNG2;MYL9;RRAS;PIK3R3;MYL5;EPHA1;NCK1;BMP7;PARD3;EPHB1;RND1;SEMA4D;ABL1;SEMA3C
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.18448276275931297,0.7136874682107045,0.9459459459459459,1.0,1.0,3/29,5.36%,NBEA;PRKX;CREB1
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.17651745725510062,-0.713663879818179,0.8852459016393442,1.0,1.0,24/59,34.62%,UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PTK6;PSMC4;CDKN1A;SEM1;PSMD11;PSMD7;CDK2;PSME2;PSMB10;PSMB2;CCNA1;PSME1;PSMA7;CKS1B;PSMC5;PSMA3;PSMC1;CCND1
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,-0.2014883732922198,-0.713335748373051,0.8947368421052632,1.0,1.0,8/26,26.78%,PTPN11;UBB;FLT3LG;PIK3R1;CDKN1A;NRAS;ZMYM2;ETV6
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,-0.16080829953717146,-0.7126743853179596,0.835820895522388,1.0,1.0,14/81,17.18%,GNAI1;HRH2;ADM;SCT;SHC1;GNG3;RAMP1;GNG5;GNB2;ADCY4;VIPR1;PPAN-P2RY11;PDE4C;PDE1B
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.14617594492279412,0.712561461514795,0.9583333333333334,1.0,1.0,11/83,11.39%,FCHO2;VAMP3;TOR1B;LDLRAP1;AREG;NLRP3;KIAA0319;TGFA;CBL;SH3GL1;REPS1
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.16822298353137718,-0.7122119872801219,0.859375,1.0,1.0,20/63,28.91%,ZNF385A;UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;CDKN1A;SEM1;PSMD11;PSMD7;CDK2;PSME2;PSME4;PSMB10;PSMB2;CCNA1;PSME1;PSMA7;CARD16
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.1697514811798917,-0.712148005845847,0.8939393939393939,1.0,1.0,16/66,19.58%,RANGAP1;IST1;LEMD2;CHMP4B;TUBA4A;EMD;RAN;SPAST;NUP54;POM121;TUBB2A;TUBB6;PPP2CA;NUP37;NUP58;NUP205
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.1587121310417126,-0.711806380715163,0.9491525423728814,1.0,1.0,33/90,32.40%,NFKB2;IRAK4;TRAF1;CYLD;LY96;TIRAP;EDA;GADD45G;RELA;TRAF6;SYK;BIRC3;NFKB1;PLAU;GADD45A;PTGS2;UBE2I;PIAS4;BCL10;CD40;TICAM1;LTA;BCL2A1;IKBKB;ICAM1;TAB3;PIDD1;TRADD;PRKCQ;MAP3K7;CSNK2A2;CXCL2;TAB2
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.18319769721579743,-0.7114355333173534,0.864406779661017,1.0,1.0,15/48,24.39%,RAD9B;RMI2;RFC5;RHNO1;RPA3;XRCC2;MSH6;RAD51AP1;EXO1;RAD9A;SEM1;BARD1;WRN;NTHL1;BRIP1
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,-0.21026118465695334,-0.7113189799370949,0.8333333333333334,1.0,1.0,7/23,25.64%,TNFRSF9;FASLG;EDA;TNFSF13;CD27;TNFRSF17;LTA
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,0.20405797995280844,0.7112377545606579,0.8918918918918919,1.0,1.0,2/21,6.29%,TRIM24;GAB2
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.1742065108108514,-0.7109333706728027,0.875,1.0,1.0,23/52,40.16%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;PSMC5;PSMA3;PSMC1;PSMD8;HSPA1A;PSMB3;PABPC1;PSMB5
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.17826315767075213,-0.7107641467418988,0.9032258064516129,1.0,1.0,16/52,28.17%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,KEGG_2021_Human__FoxO signaling pathway,-0.15328013563728837,-0.7101396869175273,0.9577464788732394,1.0,1.0,40/112,31.63%,MAPK8;PLK4;STK11;IGF1R;PLK2;AKT1;MAPK14;CCNG2;FASLG;GABARAPL2;GADD45G;TGFB3;PIK3R1;PIK3R2;AKT2;PLK1;PIK3CB;SETD7;RAF1;HOMER2;CDKN1A;SMAD4;GADD45A;MAPK3;NRAS;MAPK13;SIRT1;PRKAG1;CDK2;FOXO1;ARAF;IKBKB;HOMER1;IRS2;SLC2A4;CAT;CSNK1E;IL7R;MAPK1;STK4
prerank,KEGG_2021_Human__Oxytocin signaling pathway,-0.14756915007088306,-0.7101160016538347,0.96,1.0,1.0,27/110,24.40%,GNAI1;GNAO1;KCNJ2;CACNB3;RYR3;PLCB2;NOS3;ADCY4;MEF2C;MAPK7;PRKACA;GUCY1B1;CALM2;MYLK;CAMK2D;CACNG6;RAF1;CALM3;CDKN1A;MAPK3;PTGS2;ADCY3;PPP1CC;CAMK2G;NRAS;PRKAG1;PLCB3
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.21429822665922893,0.7094043149055516,0.8181818181818182,1.0,1.0,14/15,68.79%,CBL;KIT;LCK;GRB2;SRC;YES1;SH2B2;SOCS1;PRKCA;LYN;SOS1;SH2B3;SOCS6;FYN
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,-0.16187803816674695,-0.7088433402197075,0.9264705882352942,1.0,1.0,14/66,20.08%,CHTOP;LSM10;SNRPB;POLDIP3;SRSF5;MAGOH;PAPOLA;EIF4A3;THOC2;SNRPE;SRSF7;SRSF4;DHX38;SRSF3
prerank,KEGG_2021_Human__Fanconi anemia pathway,-0.1725252343237934,-0.7074881830044256,0.8275862068965517,1.0,1.0,8/54,13.73%,FANCE;RMI2;ATR;FAAP100;CENPS-CORT;RPA3;TELO2;ERCC1
prerank,KEGG_2021_Human__Protein digestion and absorption,-0.1724542705048822,-0.7072643959208018,0.9104477611940298,1.0,1.0,9/49,16.68%,PGA4;SLC7A8;CTRL;KCNQ1;COL6A2;COL19A1;PRCP;ATP1B2;KCNN4
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.13660704963492676,0.7068313231523932,0.9642857142857143,1.0,1.0,7/82,6.45%,VAMP3;SEC61B;PDIA3;HLA-G;SEC61A2;B2M;PSMB4
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.19095547178686667,-0.7067416626447747,0.8208955223880597,1.0,1.0,8/31,19.58%,NUP210;MAP4K5;NUP88;NUP54;POM121;NUP37;NUP58;NUP205
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.19622724654388232,-0.7064858774999775,0.8771929824561403,1.0,1.0,13/40,24.39%,RAD9B;RMI2;RFC5;RHNO1;RPA3;XRCC2;RAD51AP1;EXO1;RAD9A;SEM1;BARD1;WRN;BRIP1
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.1971360369841422,-0.7054528796132841,0.8309859154929577,1.0,1.0,8/27,22.74%,RANGAP1;RAN;NUP54;POM121;NUP37;NUP58;NUP205;UBE2I
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,0.21169674089024323,0.7053047528229289,0.875,1.0,1.0,3/18,10.68%,POLR2I;NCBP1;POLR2H
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,0.21169674089024323,0.7053047528229289,0.875,1.0,1.0,3/18,10.68%,POLR2I;NCBP1;POLR2H
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.19578784236608576,0.7051248724798519,0.9142857142857143,1.0,1.0,6/23,21.14%,HSPA6;SERPINH1;HSBP1;RLN1;HSPA1L;DNAJB6
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.162529082988602,-0.7049978412604918,0.90625,1.0,1.0,10/82,10.04%,PPP2R5B;FRAT1;ZRANB1;UBB;PSMD3;SKP1;PSMA5;PSMD6;PSMD12;PROC
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.23259363889635815,0.7048504472569971,0.9090909090909091,1.0,1.0,4/15,19.56%,RAB3A;PPFIA4;SLC1A2;SLC38A2
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.22562994589774188,-0.7045210686929622,0.8297872340425532,1.0,1.0,3/15,13.83%,TBK1;IFI16;XRCC6
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,-0.1565899496529448,-0.7042794243930042,0.9454545454545454,1.0,1.0,10/76,11.52%,ARFGEF2;WRAP53;RGS6;GNA15;GNG3;CCT2;FBXW9;GNG5;GNB2;TUBA4A
prerank,KEGG_2021_Human__Non-small cell lung cancer,-0.1542146637770769,-0.7038773100752641,0.9322033898305084,1.0,1.0,19/66,24.58%,AKT1;BAK1;RB1;GADD45G;PIK3R1;PIK3R2;AKT2;KIF5C;PIK3CB;E2F2;E2F3;JAK3;RAF1;CDKN1A;GADD45A;MAPK3;HGF;NRAS;FHIT
prerank,KEGG_2021_Human__Asthma,0.2055680738715377,0.7029830984803173,0.9117647058823529,1.0,1.0,3/22,14.35%,FCER1G;IL10;HLA-DRB3
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.2071159401767522,-0.7024357292789768,0.8412698412698413,1.0,1.0,8/27,22.74%,APOE;VEGFA;TFAP2E;NPM1;KCTD15;CDKN1A;CITED2;UBE2I
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.21056655844799854,-0.7022520679084214,0.8,1.0,1.0,2/17,6.53%,UBB;STAM
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.18798968562050208,-0.701524611460863,0.859375,1.0,1.0,17/29,46.64%,AKT1;RBBP7;PDZD2;AKT2;PML;PIP4K2C;HDAC2;GATAD2A;BRPF3;CHD3;RBBP4;EP300;PIP4K2B;AKT3;BRD1;GATAD2B;ING5
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.1896309504947747,0.7012245030725427,0.868421052631579,1.0,1.0,4/27,11.44%,POLR2I;RNMT;POLR2H;ERCC2
prerank,KEGG_2021_Human__Tuberculosis,0.12994073971853867,0.7007254180309979,1.0,1.0,1.0,23/148,14.60%,ATP6V0B;FCER1G;ATP6V0A1;IL6;CASP8;APAF1;CREB1;RAB5A;ATP6V0C;FCGR3B;IL10;CD14;MRC2;CASP3;CALML4;CR1;RAB5C;CTSS;TLR6;KSR1;HLA-DRB3;TGFB1;FCGR3A
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,-0.2142346176747716,-0.7005790748010048,0.8620689655172413,1.0,1.0,4/19,15.72%,UBB;STAM;USP8;LRIG1
prerank,KEGG_2021_Human__B cell receptor signaling pathway,-0.15703016388345742,-0.7001941774026488,1.0,1.0,1.0,21/79,26.85%,CD79A;AKT1;INPPL1;IFITM1;RELA;SYK;PIK3R1;PIK3R2;AKT2;PIK3CB;RAF1;NFKB1;CD81;PTPN6;MAPK3;NRAS;BCL10;PPP3CB;INPP5D;CD79B;IKBKB
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.20551098018423203,-0.6994375830328456,0.8666666666666667,0.9996315384217613,1.0,6/21,24.96%,MCU;PHB2;SPG7;AKAP1;MCUB;MICU2
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,0.2036090448453214,0.6989477422241042,0.8333333333333334,1.0,1.0,2/16,6.15%,ATP5PD;ATP5MF
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.17383750551013646,-0.6983885952069255,0.9180327868852459,0.9994550041772438,1.0,16/48,28.17%,PSMD3;PSMA5;PSMD6;PSMD12;OAZ3;NQO1;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.14120256518275215,-0.6980302079251969,0.922077922077922,0.9986857625091353,1.0,45/127,34.56%,OBSCN;NSMAF;MAPK8;ARHGEF39;UBB;TRAF1;ARHGEF18;CYLD;SPPL2A;FASLG;TANK;RELA;TRAF6;ARHGEF35;BIRC3;CASP2;PSENEN;NFKB1;TNFRSF10B;NCSTN;RBCK1;SQSTM1;ARHGEF1;RNF31;KALRN;HDAC2;IKBKB;ARHGEF12;ITGB3BP;TAB3;TRADD;ADAM17;MAP3K7;ARHGEF5;CASP10;ARHGEF3;MCF2L;TAB2;ARHGDIA;CLIP3;RACK1;GNA13;XIAP;OTULIN;PREX1
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,-0.19170044812310139,-0.69783153234923,0.8620689655172413,0.9976993775473262,1.0,10/32,26.17%,CLTB;AP1G2;AP4B1;AP1S1;CLTC;DNASE2;HGS;DNAJC6;VAMP8;BLOC1S1
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,-0.23221575646363224,-0.6977886230866328,0.864406779661017,0.9965609285712251,1.0,4/17,17.26%,PTPN11;IL6ST;CRLF1;STAT1
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",0.18756697373014636,0.6957364056444598,0.8478260869565217,1.0,1.0,3/25,7.02%,ADSL;GLUD1;AGXT
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.16279700962054344,0.6949100875837743,0.7777777777777778,1.0,1.0,4/37,6.51%,NDC1;POM121C;NUP85;NUP153
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.1720649121052902,-0.6926989694867814,0.8983050847457628,1.0,1.0,4/38,9.76%,FGFR1;CACNB3;NCAM1;COL6A2
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,-0.19233812036502895,-0.692078708038986,0.9137931034482759,1.0,1.0,3/27,6.53%,SPRY2;UBB;STAM
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.1372122660039565,-0.6918389763914793,0.9117647058823529,0.9990453679705881,1.0,60/166,32.20%,HMOX2;HBA1;STAP2;UBB;PRKCD;PSMD3;AKT1;SKP1;PSMA5;UBL4A;SRXN1;PSMD6;PSMD12;SCO2;TXN2;KEAP1;NCOA6;PRDX5;PRDX3;NQO1;ATF4;AKT2;COX6A1;PTK6;PSMC4;NUDT2;NCF4;NCOA2;RBX1;SEM1;SQSTM1;ABCC1;PSMD11;SESN1;PSMD7;BRIP1;ERO1A;GSR;PSME2;PSME4;COX20;PSMB10;CARM1;PSMB2;PSME1;TRIM21;CYBA;BLVRA;PSMA7;PHGDH;SURF1;BTRC;CSNK2A2;PRDX2;TBL1X;COX7A2L;COX5A;GPX3;PSMC5;PSMA3
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,-0.18974878475831614,-0.6913503635155586,0.8833333333333333,0.9982179422997428,1.0,12/35,27.51%,COPS2;RNF20;CCT2;ACTN1;STK38;MSI2;GPS1;RHOBTB1;HSP90AB1;SRRM1;PHIP;PDE5A
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,0.16418082740333415,0.6907181644605613,0.8260869565217391,1.0,1.0,4/26,14.93%,TUBB3;CCT3;CCT6B;TCP1
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,-0.15919296238971273,-0.6901428257597022,0.9264705882352942,0.998070264754885,1.0,11/65,17.55%,PTPN11;PPP2R5B;CD274;AKT1;BTLA;THEM4;MLST8;PIK3R1;PIK3R2;AKT2;PPP2CA
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,0.19373825031445388,0.688110264330681,0.7878787878787878,1.0,1.0,13/27,31.39%,CCNA2;E2F5;CDK1;RBL1;DYRK1A;MYC;CCNE1;CCNE2;E2F1;CDC25A;PCNA;TOP2A;LIN9
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.21678468655627808,-0.6829918408547104,0.9047619047619048,1.0,1.0,2/18,6.15%,PTPN11;SHC1
prerank,KEGG_2021_Human__Retinol metabolism,0.19746951110364555,0.6809596763968092,0.88,1.0,1.0,5/19,17.18%,ALDH1A2;DHRS9;DHRS4L2;RDH5;PNPLA4
prerank,KEGG_2021_Human__Notch signaling pathway,0.14856594529480527,0.6804143578125145,0.8484848484848485,1.0,1.0,5/48,9.64%,DTX3L;JAG1;TLE3;TLE4;DTX4
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,-0.1416189381340387,-0.6801284944299238,0.9736842105263158,1.0,1.0,22/122,20.82%,DCTN3;YKT6;STX17;SEC31A;COG2;ARFGAP1;BET1L;ANKRD28;DYNC1LI2;LMAN2;DYNC1LI1;GOSR1;COPZ1;TRAPPC5;BET1;COG6;F8;TRAPPC4;F5;SEC23A;SEC22B;NAPSA
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,-0.2255154571960957,-0.6775277757065906,0.8909090909090909,1.0,1.0,5/16,21.36%,KLKB1;PROC;PRCP;F8;F12
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.14011788537092928,-0.6767370404303179,0.974025974025974,1.0,1.0,43/127,32.20%,NUP210;UBB;PSMD3;RANGAP1;SKP1;PSMA5;PSMD6;PSMD12;SLC25A5;NUP88;NPM1;RAN;NUP54;POM121;AP1S1;CDK9;NUP37;NUP58;PSMC4;NUP205;AP2S1;RBX1;SEM1;XPO1;PSMD11;PSMD7;PSME2;PSME4;CD247;PSMB10;PSMB2;NUP133;PSME1;HMGA1;PSMA7;SGIP1;SLC25A6;BTRC;FYN;NUP107;PSMC5;BANF1;PSMA3
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.19677060950917097,-0.6764114678162712,0.9038461538461539,1.0,1.0,12/37,24.39%,RAD9B;RMI2;RFC5;RHNO1;RPA3;XRCC2;EXO1;RAD9A;SEM1;BARD1;WRN;BRIP1
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,-0.164245602335661,-0.6735838035217123,0.9090909090909091,1.0,1.0,25/67,33.43%,SMURF1;UBB;PSMD3;PSMA5;PSMD6;PSMD12;CDC73;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;SPOP;SMOX;ARRB2;PSMC5;PSMA3;PTCH1;PSMC1
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.15911175854882992,-0.6730705220678828,0.9032258064516129,1.0,1.0,13/64,17.99%,RAD9B;RMI2;UBB;RFC5;SLC19A1;RHNO1;RPA3;POLD1;XRCC2;POLD2;RAD51AP1;EXO1;RAD9A
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.20056695519681458,-0.6730278688139957,0.9090909090909091,1.0,1.0,17/31,41.54%,CD79A;CLSTN1;TRPC1;SYK;PIK3R1;PTPN6;CD79B;CALM1;AHCYL1;FYN;PIK3AP1;PLCG2;IGLL5;SOS1;ITPR2;LYN;VAV1
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.17797812374983663,-0.6701770679468299,0.9508196721311475,1.0,1.0,15/35,34.85%,UBB;CDK8;TGIF2;CCNK;CDK9;E2F4;RNASEH2A;SMAD4;MAPK3;TFDP2;SMAD2;CCNC;MAPK1;MEN1;CCNT2
prerank,KEGG_2021_Human__Basal cell carcinoma,-0.16893293347511162,-0.6699085038656006,0.9016393442622951,1.0,1.0,11/34,29.44%,FZD2;BAK1;WNT10A;GADD45G;WNT10B;CDKN1A;GADD45A;WNT7A;WNT7B;TCF7;POLK
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,-0.19777371980945663,-0.6697376403762663,0.8805970149253731,1.0,1.0,12/27,33.32%,MAML2;UBB;CNTN1;FCER2;MAML3;PSENEN;NCSTN;RBPJ;GZMB;MAML1;MIB1;GATD3
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.16165230179086248,0.6689020601539508,0.9722222222222222,1.0,1.0,5/45,10.68%,TRIM24;POLR2I;GAB2;NCBP1;POLR2H
prerank,Reactome_2022__TCR Signaling R-HSA-202403,-0.14664239846333607,-0.6677846696518362,0.971830985915493,1.0,1.0,43/111,36.34%,UBB;PSMD3;SKP1;PSMA5;PAG1;PSMD6;PSMD12;RELA;TRAF6;PIK3R1;PIK3R2;PIK3CB;PSMC4;LCP2;WAS;VASP;NFKB1;SEM1;PSMD11;PSMD7;BCL10;PSME2;PSME4;CD247;PSMB10;INPP5D;IKBKB;PSMB2;PSME1;PSMA7;BTRC;PRKCQ;MAP3K7;PSMC5;PSMA3;TAB2;CD3E;PTPN22;PSMC1;CD101;PTPRC;PLCG2;PSMD8
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,-0.12849712640385832,-0.6673952838013106,0.9873417721518988,1.0,1.0,45/200,22.99%,ANAPC11;MAPK8;TCF3;ATR;NFKB2;CREB3L4;AKT1;TLN2;MAP3K3;ANAPC4;ANAPC5;SLC25A5;CDC26;ADCY4;RB1;CDC20;RAN;CREB3L2;RELA;PRKACA;RANBP3;TGFB3;ATF2;PIK3R1;PIK3R2;ATF4;AKT2;IL2RG;ESPL1;ITGB2;PIK3CB;NRP1;E2F2;E2F3;SRF;JAK3;NFKB1;SLC2A1;CRTC2;CDKN1A;SMAD4;MAPK3;EGR1;ADCY3;XPO1
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.21464867489849904,0.6668500203378583,0.8918918918918919,1.0,1.0,2/15,4.59%,PLXNC1;PLXND1
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.15866571061485146,-0.6661861621588239,0.953125,1.0,1.0,5/66,6.80%,OBSCN;MAPK8;ARHGEF39;UBB;ARHGEF18
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.16126366089665242,0.6661145298226823,0.926829268292683,1.0,1.0,10/41,21.41%,PIKFYVE;C1S;C5;CR2;CR1;C8G;CPNE2;TTF2;C5AR1;MASP2
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.15468195816648875,-0.6654589294980925,0.927536231884058,1.0,1.0,23/75,28.09%,H2AZ2;H2AZ1;H2BC3;H2AC7;POLR2K;SAP30BP;H2AC4;SMARCA5;POLR1D;H2BC13;SAP30;TTF1;H2AC14;ERCC3;DPEP2;UBTF;SIRT1;H4C15;HDAC2;H2BC21;H2AC20;TAF1D;POLR1G
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,-0.15495404780455224,-0.6646543046339991,0.890625,1.0,1.0,20/65,28.91%,ZNF385A;UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;CDKN1A;SEM1;PSMD11;PSMD7;CDK2;PSME2;PSME4;PSMB10;PSMB2;CCNA1;PSME1;PSMA7;CARD16
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,0.13051149201368795,0.6640395497590019,1.0,1.0,1.0,16/119,12.59%,FCHO2;VAMP3;ACTR3;ARPC5;TOR1B;RAB5A;LDLRAP1;AREG;NLRP3;KIAA0319;TGFA;CBL;SH3GL1;REPS1;HIP1;RAB5C
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.21660750012285332,-0.6636498124297757,0.8360655737704918,1.0,1.0,3/16,10.41%,LY96;FASLG;TANK
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.15846627847363198,0.662184428064559,0.96,1.0,1.0,6/38,11.85%,ALDH1B1;ALDH2;CARNS1;ARG1;P4HA2;GAMT
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,-0.14469908892650438,-0.6616873808976751,0.9571428571428572,1.0,1.0,33/86,34.55%,ADM;GNA12;PRKCD;PLCB2;RAMP1;PLA2G2C;KCNMB1;ADCY4;PRKACA;GUCY1B1;PLA2G6;CALM2;MYLK;RAF1;CALM3;MAPK3;ADCY3;PPP1CC;IRAG1;PLCB3;ARHGEF1;ARAF;CALM1;ARHGEF12;MYH10;PRKCQ;NPR2;MAPK1;PLA2G4A;CACNA1F;MYH11;GNA13;PRKCH
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.21233624390557548,0.6613649903596229,0.9090909090909091,1.0,1.0,4/15,15.39%,SDC2;SLC35D2;GLCE;EXT1
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.1409403839699011,-0.6594732356794145,0.9594594594594594,1.0,1.0,31/89,33.62%,SMURF1;MAML2;UBB;PSMD3;PSMA5;CBFB;PSMD6;PSMD12;MAML3;HDAC4;PSMC4;CDKN1A;SMAD4;SEM1;RUNX3;PSMD11;NRAS;PSMD7;PSME2;PSMB10;RBPJ;PSMB2;PSME1;PSMA7;TCF7;PSMC5;PSMA3;MAML1;GATD3;PSMC1;KAT2B
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.12585278733059352,-0.6588041188246058,1.0,0.9998867391573134,1.0,46/227,21.67%,SMYD3;UTY;KMT5B;H2AZ2;H2AZ1;H2BC3;NFKB2;ARID1B;OGT;H2AC7;RBBP7;KDM2B;KAT8;EED;EP400;ELP3;ARID1A;ZZZ3;NSD2;H2AC4;PRMT3;H2AC12;ASH1L;H2BC13;KMT2D;RELA;SUPT20H;KDM5D;SAP30;MORF4L1;ASH2L;H2AC14;DMAP1;SETDB2;SMARCD1;PRMT7;SETD7;PRMT6;ARID2;NFKB1;TAF5L;NCOA2;SETDB1;HDAC8;MTA3;SMARCB1
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,-0.14648085314019632,-0.6585723768826023,0.9558823529411765,0.9988542450247623,1.0,15/89,18.42%,ITGB3;PGF;PRKCD;AKT1;MAPK14;VEGFA;CRK;THEM4;MAPKAPK3;MLST8;PIK3R1;PIK3R2;AKT2;PIK3CB;NRP1
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.14852306921257885,-0.6568469572582795,0.9411764705882353,0.9988841159397039,1.0,19/70,24.83%,KIF1C;ARFGAP1;KIF21A;NBAS;KIF6;STX18;COPZ1;KIF19;KIF5C;KIF16B;ZW10;SEC22B;KIF3B;NAPSA;COPE;KIF21B;RINT1;KIF22;COPB2
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,-0.1852703522270841,-0.6564661847134933,0.9705882352941176,0.9980170269418072,1.0,18/29,45.54%,MAPK8;SHC1;SYK;LCP2;MAP2K7;MAPK3;NRAS;MAPK1;PLCG2;IGLL5;MAPK9;SOS1;RNASE1;LYN;VAV1;PLCG1;MAP3K1;PKN2
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.14051430160940695,-0.656147135330788,0.9859154929577465,0.9971518952554179,1.0,28/108,25.00%,RAD9B;RMI2;H2BC3;UBB;NSD2;RFC5;SLC19A1;H2BC13;RHNO1;RPA3;POLD1;ERCC1;XRCC2;POLD2;RAD51AP1;RNF168;EXO1;RAD9A;PPP4C;CLSPN;SEM1;UBE2I;BARD1;WRN;PIAS4;BRIP1;CDK2;H4C15
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.1482448671546751,-0.6539615151965393,0.9848484848484849,0.9975813044087849,1.0,28/88,29.57%,RPS15A;RPL37A;RPLP0;RPS21;RPS23;RPS4X;RSL24D1;RPS20;RPS14;RPL9;RPS3A;RPS16;RPS6;RPL32;RPL11;RPS7;RPL7;RPL10A;RPS12;RPS8;RPL27;RPL14;MRPL13;RPL22L1;RPL23;RPS10;FAU;RPL37
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,-0.15606814650649448,-0.6522006516816442,0.9166666666666666,0.9977738660778285,1.0,17/60,28.17%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;NRAS;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.1679114998799106,-0.6519435603467163,0.9420289855072463,0.9968499234165816,1.0,21/51,33.62%,HEY1;MAML2;UBB;SKP1;CDK8;MAML3;HDAC4;PSENEN;NCSTN;RBX1;HDAC8;RBPJ;HDAC2;FBXW7;ADAM17;CCNC;TBL1X;MAML1;MIB1;GATD3;KAT2B
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,-0.18925231825308797,-0.6517835958519119,0.9152542372881356,0.9958289621769166,1.0,17/31,39.55%,GNG3;AQP6;GNG5;GNB2;ADCY4;AQP9;GNG11;PRKAR2A;PRKAR1B;GNG7;GNG8;GNG2;PRKAR2B;GNB4;PRKAR1A;GNB1;GNB3
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.17626274800096625,0.6515123097875188,0.9,1.0,1.0,9/26,24.27%,RAD50;DNA2;RBBP8;PALB2;TOP3A;BRCA1;RAD51C;RAD51;RMI1
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.21018412282139537,0.6491817717169989,0.9777777777777777,1.0,1.0,15/15,79.00%,EPHA1;NANOG;NR6A1;KLF4;STAT3;TSC22D1;FOXP1;DPPA4;HHEX;EPAS1;PBX1;SMAD2;FGF13;EOMES;SMAD4
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.15268113632082905,-0.6488104056982548,0.9701492537313433,0.9965796251595066,1.0,22/72,28.09%,H2AZ2;H2AZ1;H2BC3;H2AC7;POLR2K;SAP30BP;H2AC4;SMARCA5;POLR1D;H2BC13;SAP30;TTF1;H2AC14;ERCC3;DPEP2;UBTF;H4C15;HDAC2;H2BC21;H2AC20;TAF1D;POLR1G
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.18961240536349633,-0.6485066823717796,0.9038461538461539,0.9956230515132362,1.0,9/26,29.02%,UBB;ARSB;SGSH;GYG1;GBE1;KHK;GAA;NAGLU;SLC37A4
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.1618258285081565,-0.6480183714628955,0.9322033898305084,0.9947920726849232,1.0,16/51,28.17%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,-0.1510007608051654,-0.6477252204843706,1.0,0.9937903127855318,1.0,11/73,16.81%,DCTN3;YKT6;COG2;ARFGAP1;BET1L;DYNC1LI2;DYNC1LI1;GOSR1;COPZ1;BET1;COG6
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.13999084957021182,-0.6435390206711802,0.9714285714285714,0.9950941932101398,1.0,27/87,30.06%,FN1;AKT1;ITGAX;CEBPD;VEGFA;IL12A;HSP90B1;FASLG;MMP9;FCER2;PIK3R1;STAT1;IL2RG;ITGB2;JAK3;RNASEH2A;CDKN1A;PTGS2;ITGB1;IL4R;FOXO1;FGF13;JAK2;ICAM1;CCM2;GATA3;LONP1
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,-0.16283668470021637,-0.6434529222804339,0.9491525423728814,0.9940082048304729,1.0,19/54,33.43%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;CARD16;PSMC5;PSMA3;PSMC1
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.17345768917278442,-0.6421624859847187,0.9545454545454546,0.9936128885997049,1.0,3/40,4.44%,HEY1;MAML2;UBB
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.2015339291294027,-0.6417552962947692,0.8095238095238095,0.9927396690664896,1.0,3/17,13.05%,METTL21A;PRMT3;METTL22
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.17430070137066095,0.6385532464220371,0.8378378378378378,1.0,1.0,10/20,31.98%,OPLAH;FDXR;GCLC;TBXAS1;FDX2;GGT1;MAOA;GCLM;CYP2R1;CYP1B1
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.19239561122969423,-0.6372206813558441,0.9272727272727272,0.9940879681029751,1.0,8/29,23.54%,CRKL;MAPK14;SHC1;CRK;MAPKAPK3;MAPK3;NRAS;MAPK13
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.14863982560836647,-0.6370184044200813,0.953125,0.9931671642914329,1.0,24/60,36.34%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;WTIP;PSMC4;RBX1;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7;UBE2D3;PSMC5;PSMA3;PSMC1;EPAS1;LIMD1;PSMD8
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,0.1872785528402389,0.6362542081584053,0.9117647058823529,1.0,1.0,9/18,35.21%,PTPRJ;HLA-DRB3;LCK;CD3D;HLA-DPA1;CSK;CD4;HLA-DRB4;HLA-DRB1
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,-0.1970840348625057,-0.632370548627478,0.9285714285714286,0.9945731741151258,1.0,3/18,12.87%,UBB;GFAP;PLIN3
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.12047762129092564,0.6319071701139323,0.9696969696969697,1.0,1.0,12/84,14.45%,HDAC3;MAGED1;ARHGEF17;AKAP13;RASGRF2;RTN4;CASP3;ARHGEF15;PRKCI;VAV2;ARHGEF19;PLEKHG2
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.162957819650622,0.6304720025522199,0.8717948717948718,1.0,1.0,9/27,26.97%,TRIM24;GAB2;FRS2;FGFR1OP2;LRRFIP1;STAT5A;BAG4;GRB2;STAT3
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.1703335971322159,-0.6293404718090106,0.9682539682539683,0.995230520443229,1.0,6/30,16.79%,UBB;RPTOR;MLST8;HSPA2;DEDD2;CAMK2D
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,-0.1472405962751512,-0.6281467739916547,0.9508196721311475,0.994677766393065,1.0,34/76,37.88%,H2AZ2;MAML2;H2AZ1;H2BC3;H2AC7;AGO3;H2AC4;H2BC13;RAB6A;AGO4;ST3GAL3;MAML3;H2AC14;E2F3;RFNG;TFDP2;H4C15;RBPJ;H2BC21;H2AC20;NOTCH4;POGLUT1;MAML1;H3C13;MFNG;KAT2B;AGO2;CCND1;H2AC6;ST3GAL4;LFNG;NOTCH1;ELF3;H2BC11
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.14816987740575358,0.6259733400961525,0.9705882352941176,1.0,1.0,8/42,14.93%,CDC42;TALDO1;RALA;PDCD4;IL10;CNN2;CAPZA1;TCP1
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.1248397940486853,0.6225995723376265,1.0,1.0,1.0,15/67,20.09%,CTNS;SLC8B1;SLC43A2;SLC6A6;SLC4A5;SLC1A4;SLC38A5;SLC36A1;SLC1A2;SLC7A11;AHCYL2;SLC12A7;SLC8A1;SLC38A2;SLC9A9
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.15603056505080803,0.6221824250028996,0.9210526315789473,1.0,1.0,5/33,13.36%,ROCK1;CASP8;CASP3;SATB1;ACIN1
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.16863849591978813,-0.6190371576276716,0.9516129032258065,0.9986871745646505,1.0,6/30,21.73%,USP9X;UBB;TGIF2;STAT1;SMAD4;MAPK3
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,-0.2099568461921898,-0.6179382065096288,0.8333333333333334,0.9982049118615195,1.0,2/15,12.05%,STS;AKR1C1
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.1686087011471694,0.6174556354142027,0.925,1.0,1.0,5/22,17.07%,BBS2;CCT3;TCP1;BBS7;BBS10
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,-0.18489558152314534,-0.6172266916560177,0.8620689655172413,0.9974681835652376,1.0,4/21,16.23%,DCN;HEXA;ST3GAL3;SDC4
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.15132940049023827,0.6154320770184962,1.0,1.0,1.0,4/31,10.03%,PRKX;CREB1;IL10;FGR
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.1697903595983116,0.6123938408263279,0.9767441860465116,1.0,1.0,1/23,0.23%,TXNL1
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.15475248710392928,-0.6097790064557301,0.9836065573770492,1.0,1.0,15/52,28.17%,UBB;PSMD3;PSMA5;PSMD6;PSMD12;PSMC4;SEM1;PSMD11;PSMD7;PSME2;PSME4;PSMB10;PSMB2;PSME1;PSMA7
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.1684796509810878,-0.6078680176361659,0.96875,0.999763398943182,1.0,4/35,11.21%,IL12A;FAS;FASLG;ICA1
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.16939427986937974,0.607295787816136,0.868421052631579,1.0,1.0,5/24,15.91%,PDPK1;RICTOR;PKN1;VAV2;JUP
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,0.17000986332176077,0.6066829910896794,0.9487179487179487,1.0,1.0,5/25,17.55%,CYBB;TXNRD2;GSTP1;CYCS;PRDX1
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.17567510905493566,-0.6042122788244153,0.9454545454545454,1.0,1.0,8/24,27.93%,BAK1;CHMP4B;IRF1;ELANE;CASP4;CASP5;GZMB;HMGB1
prerank,KEGG_2021_Human__Endometrial cancer,0.14130735058216,0.6037384604567821,0.972972972972973,1.0,1.0,18/54,26.30%,GADD45B;PDPK1;ERBB2;CDH1;TCF7L1;PIK3R3;TCF7L2;LEF1;MLH1;ILK;KRAS;MAP2K1;BAX;MYC;APC;TP53;GRB2;BAD
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.18225162422256827,-0.6027129368110932,0.90625,0.9995650287420599,1.0,7/22,27.87%,SNAP25;ANTXR2;SV2A;MAP2K7;STX1A;HSP90AB1;CALM1
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.1960318569115375,0.6023466581428671,0.9705882352941176,1.0,1.0,2/15,8.73%,PLXNA3;PKN1
prerank,Reactome_2022__Drug ADME R-HSA-9748784,-0.1495953252225219,-0.6010843930245262,0.9726027397260274,0.9990728773666204,1.0,6/44,11.48%,SLC28A2;GGT5;ABCC2;SULT1A1;BSG;ABCB1
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,-0.18247387839314197,-0.5992407071036739,0.9523809523809523,0.9989081826475823,1.0,6/20,24.63%,MVD;NUS1;FNTA;PDSS2;ZMPSTE24;DHDDS
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.15015613872672826,-0.5985014113435684,0.9682539682539683,0.9981038837184436,1.0,12/47,26.29%,TDP1;XRCC4;H2BC3;NSD2;H2BC13;XRCC6;RNF168;PAXIP1;BARD1;PIAS4;H4C15;H2BC21
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.17635525413836925,-0.5979952484121962,0.9552238805970149,0.9972169135423226,1.0,5/20,23.39%,AKAP5;CAMK2D;AP2S1;CAMK2G;PICK1
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,0.16839746392654126,0.5954795051975885,0.975609756097561,1.0,1.0,22/22,83.18%,PPP2CB;PPP2R1B;PPP2R1A;PDE4D;PPP2R5D;PPP3R1;PPP1CA;PPP3CA;PRKACB;PRKCA;PPP3CC;PDE4B;PDE4A;PRKAR1A;CDK5;PRKAR2B;CALM1;PRKAR1B;PPP3CB;PRKAR2A;PPP2CA;PDE4C
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.1966857248345263,-0.5951835076246302,0.9166666666666666,0.9974162397231875,1.0,9/16,44.90%,SHC1;ERBIN;NRAS;ERBB3;EREG;HSP90AA1;SOS1;PLCG1;EGF
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,-0.15704623678955892,-0.5913518593979926,1.0,0.9977475186063408,1.0,9/33,24.07%,UBB;AGO3;RB1;AGO4;ID1;E2F2;E2F3;MAPK3;TFDP2
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,-0.20711900430049657,-0.5909397968175988,0.9818181818181818,0.9968638388071449,1.0,3/15,13.89%,TAS2R50;TAS2R13;CASR
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.17635674469843193,-0.5907984227089003,0.9696969696969697,0.9958860118832037,1.0,3/21,10.90%,UBB;RNF213;VPS33B
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.1403576288016566,0.5891579547621578,0.9772727272727273,1.0,1.0,4/41,7.39%,PRKX;CREB1;PDPK1;RASGRF2
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,0.11418874691274938,0.5880485769042252,1.0,1.0,1.0,19/101,19.41%,NCOA1;RUVBL1;ENY2;H2BC15;ELP2;H2AC21;SGF29;TRRAP;BRD8;H3C7;JADE3;ING3;KAT6A;USP22;ACTL6A;TAF12;H2AC19;ING4;H2BC4
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,-0.16051443917592295,-0.5878736996367776,0.9508196721311475,0.9959299709957872,1.0,5/32,14.61%,STS;GLTP;NEU3;HEXA;ARSB
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.15359516152259894,0.58721603476296,0.9782608695652174,1.0,1.0,8/31,18.42%,SDC2;SLC35D2;VCAN;XYLT2;GLCE;EXT1;IDUA;IDS
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.12196090163627737,-0.5808066256716303,1.0,0.9974357529219835,1.0,38/119,32.40%,CLEC7A;UBB;PRKCD;NFKB2;PSMD3;UBE2M;SKP1;PSMA5;PSMD6;PSMD12;RELA;TRAF6;SYK;PYCARD;PSMC4;NFKB1;SEM1;PSMD11;NRAS;PSMD7;BCL10;PSME2;PSME4;PSMB10;PPP3CB;IKBKB;PSMB2;PSME1;CALM1;PSMA7;AHCYL1;TAB3;BTRC;MAP3K7;FYN;PSMC5;PSMA3;TAB2
prerank,KEGG_2021_Human__T cell receptor signaling pathway,-0.12539520037474344,-0.5804342839866731,0.9848484848484849,0.9965203397648484,1.0,30/96,31.22%,MAPK8;PAK1;CBLB;AKT1;MAPK14;RELA;PIK3R1;PIK3R2;TEC;AKT2;PIK3CB;LCP2;RAF1;NFKB1;ICOS;MAP2K7;PTPN6;MAPK3;NRAS;MAPK13;BCL10;CD247;PPP3CB;IKBKB;NCK2;PRKCQ;MAP3K7;NFKBIE;MAPK1;FYN
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.13153318766731167,-0.5787276273927545,0.9850746268656716,0.9959177928676779,1.0,12/82,16.75%,ITGB3;PRKCD;AKT1;MAPK14;VEGFA;CRK;THEM4;MAPKAPK3;MLST8;PIK3R1;PIK3R2;AKT2
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,-0.1308297953549253,-0.5763387042002835,0.9672131147540983,0.9956629272995535,1.0,22/80,28.17%,UBB;PSMD3;PSMA5;NCOA3;PSMD6;PSMD12;AGO3;AGO4;PSMC4;SEM1;XPO1;PSMD11;PSMD7;IGF2BP1;PSME2;PSME4;KALRN;PSMB10;FOXO1;PSMB2;PSME1;PSMA7
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.14312758833695688,-0.5751880017925882,0.9846153846153847,0.9949075087287609,1.0,11/49,21.73%,USP9X;UBB;CDK8;TGIF2;CCNK;STAT1;CDK9;E2F4;RNASEH2A;SMAD4;MAPK3
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.14784857294941647,-0.5678961704270883,0.9824561403508771,0.9963347476685248,1.0,16/35,41.76%,DYNC2I1;IFT122;WDR19;IFT140;KIF3B;DYNLL2;IFT52;DYNLT5;IFT172;WDR35;TNPO1;DYNC2H1;KIFAP3;KIF3C;IFT46;IFT22
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.17511934096348086,-0.5621722930311465,0.9473684210526315,0.9971993551870647,1.0,1/19,1.91%,LAMC1
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.15612763422886053,0.5617047495224726,0.9722222222222222,1.0,1.0,1/24,0.65%,ELOC
prerank,KEGG_2021_Human__Primary immunodeficiency,0.1398102875076034,0.5562809945145096,1.0,1.0,1.0,9/32,23.20%,CD8A;ADA;DCLRE1C;ZAP70;LCK;CD3D;TNFRSF13C;RFX5;TAP1
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.1875230443267773,-0.5561590209675717,0.9852941176470589,0.997764786030421,1.0,4/17,20.67%,UBB;CNTN1;PSENEN;NCSTN
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.1802240306580804,-0.5555290201035863,0.9230769230769231,0.996867803004219,1.0,6/15,29.95%,CCNG2;CDKN1A;SMAD4;GADD45A;FOXO1;SMAD2
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,0.14163782078229778,0.5522615326486913,0.9722222222222222,1.0,1.0,3/35,5.75%,CTSG;LYZ;PGLYRP1
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.16033185326716803,-0.5509528235970064,0.9692307692307692,0.9968627647085097,1.0,6/31,19.33%,MMP28;LOXL1;COL6A2;MMP9;DST;BMP1
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,-0.12437872550454007,-0.5475052874375903,1.0,0.9967984668042192,1.0,37/81,42.83%,MAPK8;MAML2;MAPK14;IL12A;RELA;MAML3;STAT1;IL2RG;JAK3;NFKB1;MAPK3;RUNX3;MAPK13;CD247;IL4R;RBPJ;PPP3CB;IKBKB;JAK2;GATA3;PRKCQ;NFKBIE;MAPK1;MAML1;CD3E;HLA-DOA;NOTCH1;MAPK9;IL12RB1;HLA-DRB5;JAK1;STAT6;STAT4;IFNGR1;IL4;NOTCH3;PLCG1
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.16261837472812718,-0.5469884579395606,0.9436619718309859,0.9957869985397376,1.0,9/21,37.90%,PPEF1;FNTA;CALM1;PRKCQ;PDE6G;SLC24A1;PDE6A;RNF7;GNB1
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.15875876433907515,0.543687497111673,0.9777777777777777,1.0,1.0,1/19,2.54%,B4GALT1
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,0.13509276358825104,0.5431270389851917,0.9473684210526315,1.0,1.0,4/29,12.62%,POLR1B;POLR2H;ERCC2;TBP
prerank,KEGG_2021_Human__Allograft rejection,0.1321291899667777,0.5417041647154948,1.0,1.0,1.0,4/33,14.35%,HLA-G;PRF1;IL10;HLA-DRB3
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,-0.12250726015972763,-0.541298875750334,1.0,0.9958659366785259,1.0,5/83,5.63%,PTPN11;ANG;FBLIM1;CDH18;SKAP2
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,-0.15949550239938792,-0.5398993299416663,0.9846153846153847,0.9952239312699916,1.0,2/22,6.15%,UBB;SHC1
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,-0.15996228354767972,-0.5388677726864091,0.9272727272727272,0.994370840813876,1.0,2/19,9.47%,PKP4;PPL
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.13183649798859035,-0.5376506582991247,0.9552238805970149,0.9934488309629222,1.0,17/46,35.82%,RBBP7;POLR2K;POLR1D;RRN3;TTF1;ERCC3;MTA3;UBTF;HDAC2;TAF1D;GATAD2A;POLR1G;GTF2H5;MTA1;KAT2B;CHD3;TAF1A
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.13190318975149076,0.5376031594114975,0.9767441860465116,0.9986409999998896,1.0,7/37,17.41%,C1S;C5;CR2;CR1;C8G;CPNE2;TTF2
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.16216534640560698,-0.5365300850345189,0.9821428571428571,0.992564125521418,1.0,1/19,1.57%,SREBF1
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.15519973769058412,0.536257274260256,1.0,0.9962464372229344,1.0,19/19,84.50%,PIK3R3;KIT;LCK;STAT5A;GRB2;SRC;STAT3;YES1;PIK3CA;HRAS;STAT5B;LYN;SOS1;FYN;JAK2;NRAS;STAT1;PIK3R2;PIK3R1
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,-0.1334706547092616,-0.5360601090633744,0.96875,0.9915518876180412,1.0,19/52,33.49%,RPLP0;IL12A;IL6ST;PITPNA;MSN;CRLF1;STAT1;ANXA2;CA1;HNRNPF;PSME2;SERPINB2;AURKAIP1;CANX;JAK2;GSTO1;HNRNPDL;MTAP;IL23A
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,-0.11600325780905078,-0.531022754175617,1.0,0.991599576902401,1.0,35/94,36.22%,PTPN11;KLRC4-KLRK1;PAK1;KLRK1;SHC1;FAS;FASLG;SYK;PIK3R1;PIK3R2;MICB;ITGB2;PIK3CB;LCP2;RAF1;TNFRSF10B;PTPN6;MAPK3;NRAS;CD247;PPP3CB;ARAF;GZMB;ICAM1;SH3BP2;MAPK1;FYN;BID;RAC1;PTK2B;SHC4;SH2D1A;PLCG2;PIK3CD;CD244
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,-0.16331499285672402,-0.5281015148676662,0.9696969696969697,0.9911305838766442,1.0,5/21,18.99%,CISH;PIK3R1;PIK3R2;IL2RG;JAK3
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,-0.14698137597548938,-0.5000860073646003,0.984375,0.9952013175095036,1.0,5/27,15.51%,GTF2F2;POLR2K;POLR2B;POLR2D;PIK3R1
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.1446572788045849,-0.487573239533851,0.9571428571428572,0.9957838903410631,1.0,15/20,56.77%,PPEF1;FNTA;CALM1;PRKCQ;PDE6G;PDE6A;RNF7;GNB1;RCVRN;CHURC1-FNTB;PDE6B;GUCA1B;PRKCA;METAP2;NMT1
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.1228587157795267,0.46615157842571425,1.0,1.0,1.0,5/25,17.69%,JAG1;DTX4;MIB2;ADAM10;NEURL1
prerank,KEGG_2021_Human__Ovarian steroidogenesis,-0.12732251753828316,-0.46326955212894644,1.0,0.9973950974354656,1.0,5/25,22.57%,IGF1R;ADCY4;PRKACA;PTGS2;ADCY3
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.1345901639344262,0.4624983252088425,0.9782608695652174,1.0,1.0,18/18,86.55%,PKN1;RELB;ICAM2;CREBBP;RPS6KA5;ARHGEF7;HRAS;PRKACB;ICAM3;PRKCA;PKN2;RNASE3;EP300;LYN;FYN;NRAS;NFKB1;RELA
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,-0.14626405114615787,-0.4484322558429135,1.0,0.9974947908092554,1.0,10/17,46.59%,SLC28A2;GSTM1;ABCC4;HPRT1;IMPDH2;GMPS;RNASE1;VAV1;NME2;TPMT
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,0.13184351437001424,0.4448550508629912,1.0,0.9993593034110926,1.0,16/16,86.83%,PLA2G4B;PLBD1;LPCAT3;PNPLA8;PLAAT2;ABHD4;PLAAT4;LPCAT4;PLA2G12A;PLA2G4C;PLAAT3;PLAAT1;PLA2G4A;MBOAT2;PLA2G6;MBOAT1
prerank,KEGG_2021_Human__Th17 cell differentiation,0.08776207813142421,0.4358975775273356,1.0,0.9974932063786311,1.0,13/98,16.81%,TGFBR2;FOS;IL6;IL1R1;IL2RB;CD3G;IL23R;HLA-DRB3;TGFB1;ZAP70;LCK;HIF1A;MAPK11
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.12012095918901498,-0.3634537906864511,0.9836065573770492,0.9996146165434607,1.0,1/19,3.81%,CDC6
